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Assessing Maternal Morbidity in India, Pakistan, Kenya and Malawi 
 
Background  
For every woman who dies during pregnancy and childbirth, many more suffer ill-
health, the burden of which is highest in low- and middle-income countries. The PhD 
study sought to assess the extent and type of maternal morbidity in these settings. 
 
Methods  
A descriptive observational cross-sectional study was conducted to assess physical 
(infectious and medical/obstetric), psychological and social morbidity. Socio-
demographic factors, education, socioeconomic status, reported symptoms, clinical 
examination and laboratory investigations, quality of life, and satisfaction with health 
were assessed. Relationships between morbidity and maternal characteristics were 
investigated using logistic regression analysis. 
 
Findings  
11454 women were assessed in India (2099), Malawi (2923), Kenya (3145), and 
Pakistan (3287). Almost 3 out of 4 women had ≥1 symptom (73.5%), abnormalities 
on clinical examination (71.3%) or laboratory investigation (73.5%). In total, 9.0% of 
women had an identified infectious disease (HIV, malaria, syphilis or chest infection) 
and 23.1% had signs of early sepsis with an identifiable source of infection in 43%. 
HIV positive status was highest in Malawi (14.5%) as was malaria (10.4%). Overall, 
47.9% of women were anaemic, 11.5% had other medical or obstetric conditions, 
25.1% psychological and 36.6% social morbidity. Infectious morbidity was highest in 
Malawi (40.5%) and Kenya (38.5%), psychological and social morbidity was highest in 
Pakistan (47.3%, 60.2%). Morbidity was not limited to a core at risk group; only 1.2% 
had a combination of all four morbidities.  
 




Age, socioeconomic status, educational, previous pregnancies, and adverse maternal 
or neonatal outcomes were associated with different types of morbidity per country, 
but there was no consistent direction of strength of association. For each country, 
women with medical/obstetric morbidity was more likely to report psychological and 
infectious morbidity, apart from Malawi. Women with an infectious morbidity were 
more likely to report medical/obstetric, psychological and social morbidity in Pakistan 
and Malawi. Women with psychological morbidity were more likely to report social 
morbidity in Pakistan and Kenya. 
 
Conclusion  
Despite women reporting that they have a good quality of life and are satisfied with 
their health, there is evidence of a significant burden of infectious, medical/obstetric, 
psychological, and social morbidity in women during and after pregnancy. At present 
available antenatal and postnatal care packages do not include comprehensive 
screening for all forms of ill-health.  
 
This study demonstrates that women have health needs, beyond simply the physical 
aspects of health and includes psychological and social well-being. To ensure all 
women have the right to the highest attainable standard of health and well-being, 
current antenatal and postnatal care packages need to be adapted and improved to 
provide comprehensive, holistic care in a way that meets a woman’s health needs. 
 
 






CHAPTER 1: INTRODUCTION 
1.1 Introduction  
This chapter introduces concepts necessary to understand the background to this 
research project. This chapter gives an overview of the current priorities in global 
maternal health. The history of the international maternal health agenda from the 
year 2000, and the Millennium Development Goals (MDGs) are presented. Progress 
of interventions to address the MDG 5a are described and the Sustainable 
Development Goal (SDG) 3 is considered. The change in international priorities from 
woman “surviving to thriving” pregnancy is highlighted. The internationally agreed 
definitions and criteria for measurement of maternal death and Severe Acute 
Maternal Morbidity (SAMM) are reviewed. The continuum of maternal health, the 
concept of maternal morbidity, previous descriptions of maternal morbidity and the 
need for a standardised methodology and identification criteria to measure maternal 
morbidity in a comprehensive approach is considered. The overall aim, objectives and 
key research questions are summarised at the end of this chapter. The chapter ends 
with a summary. 
 
1.2 Background  
Worldwide, it was estimated that 303,000 women died due to pregnancy-related 
complications in 2015, equating to an estimated 830 women dying every day (WHO 
2015b). An estimated 99% of these deaths occur in low- and middle-income countries 
(LMIC) (WHO 2015b). In addition, almost 2.6 million stillbirths and an estimated 2.7 
million neonatal deaths occurred annually in 2015 (WHO 2015ba). Many of these 
maternal and perinatal deaths can be prevented or avoided through actions that are 
proven to be effective and affordable (WHO 2015b).  
 
Over the past decade, the international community have been working to support 
evidence-based strategies to prevent maternal and newborn mortality, especially in 
LMIC where the burden is highest (WHO 2015b). In addition to preventing mortality, 




there is a current renewed focus on improving quality of care and decreasing the 
numbers of women who suffer ill-health (maternal morbidity), and experience short- 
or long-term disabilities and complications that have a negative impact on the 
woman, related to their pregnancy (Zafar 2015, Chou 2016). 
 
Millennium Development Goals  
In 2000, world leaders at the United Nations (UN) constructed eight development goals 
and targets in critical areas of health and socioeconomic development to improve the 
lives of women, men and children to be attained by 2015, the MDG (UN 2000). 
Reducing pregnancy related mortality was MDG 5a, adopted by the international 
community (UN 2000). Under MDG 5a, countries committed to reducing maternal 
mortality by 75% between 1990 and 2015 (UN 2000).  
 
Maternal death and maternal mortality rates  
The WHO application of International Classification of Disease version 10 (ICD-10) to 
deaths during pregnancy, childbirth and the puerperium, defines maternal death as 
the “death of a woman while pregnant or within 42 days of the end of pregnancy, 
irrespective of the duration and site of the pregnancy, from any cause related to or 
aggravated by the pregnancy or its management, but not from accidental or 
incidental causes” (WHO 2012a). The Maternal Mortality Ratio (MMR) (per 100,000 
live births) represents the risk associated with each pregnancy, or “the obstetric risk” 
(WHO 2017b). Worldwide, maternal deaths have commonly been considered 
indicators of maternal health. Specifically, MMR has been the main maternal health 
indicator to monitor progression of the MDG 5a (UN 2000).  
 
MDG 5a was an important catalyst for the reductions in MMR that have been 
achieved in many settings (WHO 2015a). Over the past decade, much progress has 
been recorded, with a significant reduction (43%) in the estimated number of 
maternal deaths worldwide since 1990 (WHO 2015a). In some countries, annual 
declines in maternal mortality between 2000 and 2010 were above 5.5%, the rate 
needed to achieve MDG 5A (WHO 2015a). Globally, the total number of maternal 






deaths decreased from an estimated 523,000 in 1990 to 289,000 in 2015 (WHO 
2015a). The estimated global MMR declined from 400 to 216 deaths per 100,000 live 
births in 1990 and 2015 respectively, representing an average annual decline of 2.3% 
(WHO 2015a). However, despite good progress is some settings, many low-income 
countries (LICs), particularly in Sub-Saharan Africa and post conflict settings, did not 
make sufficient progress to meet MDG 5a (WHO 2015a). Currently the MMR are 
highest in sub-Saharan African countries such as Sierra Leone, Chad, Central African 
Republic, Sudan, Democratic Republic of the Congo and Nigeria. The current global 
MMR is approximately 216 maternal deaths per 100,000 live births, and this 
estimated MMR has declined by an average of 3.0% per year between 2000 and 2015, 
more than doubling the estimated average annual decline of 1.2% between 1990 and 
2000 (WHO 2015a, WHO 2017c).  Furthermore, the estimated MMR in LMIC is 239 
per 100 000 live births which is an estimated 20 times higher than that of the MMR 
in high income countries (WHO 2015a). The difference between MMR can reflect 
inequality in the access to and quality of emergency and routine care for women 
during and after pregnancy between different countries. Table 1.1 displays examples 
of MMR for different regions and countries that are included in this research project.  
 
Table 1.1: Maternal mortality ratios for different regions and countries (WHO 
2015a) 
Type of income country (World Bank 2017) MMR per 100,000 live births 
Global 216 
High income countries combined 12 
Low- and middle-income countries combined 239 
Study countries 
included in research 
project 
Type of country MMR per 100,000 live births 
India Lower middle income 174 
Pakistan Lower middle income 178 
Kenya Low income 510 
Malawi Low income 634 
 




Key global interventions to decrease maternal and 
neonatal mortality  
The proportion of births attended by skilled healthcare provider is a useful healthcare 
indicator and is a measure of the ability of health system to provide adequate care 
during birth (WHO 2016c). Globally, coverage of skilled birth attendance (SBA) has 
increased from 61% in 2000 to 78% in 2016 (WHO 2017d). However, despite steady 
improvement, both globally and across various countries, millions of births are not 
assisted by a skilled birth attendant. In Sub-Saharan Africa, approximately only half 
of all live births were delivered with the assistance of a skilled birth attendant in 2016 
(WHO 2017d).  
 
Efforts to reduce adverse outcomes for pregnant women and newborn babies have 
largely been directed at interventions that need to be in place around the time of 
birth, including the availability of emergency care. These interventions have been 
highlighted in two international documents published by the WHO: Strategies 
Toward Ending Preventable Maternal Mortality (EPMM) (WHO 2015b) and the Every 
Newborn Action Plan (ENAP) (WHO 2015c). These strategic documents aim to 
catalyse global action to eliminate the wide disparities in the risk of death and end 
preventable maternal and newborn mortality and stillbirths within a generation 
(WHO 2015b, WHO 2015c).  
 
The effective implementation of evidence-based interventions during the time of 
childbirth and immediately after birth are particularly critical to continue to reduce 
maternal deaths, stillbirths and early neonatal deaths - the “triple return” (WHO 
2015a). A total of 50 essential interventions for reproductive, maternal, newborn and 
child health, for which there is evidence of effectiveness, have been described and 
are being further evaluated in different settings in LMIC, with the aim to demonstrate 
significant and sustainable impacts on maternal, newborn and child survival (WHO 
2015a, Lassi 2015).  
 






Although the focus on the time around birth is crucial to save lives, until recently, less 
emphasis has been placed on ensuring availability and quality of other aspects of the 
“continuum of care” including measures to ensure well-being and to improve routine 
and general health for women during and after pregnancy (UN 2015b). This 
imbalance has been highlighted in the latest global initiatives, in which the scope of 
global maternal health goals has been expanded moving from a focus on preventing 
death to formulating targets and emphasizing the importance of health and well-
being (UN 2015b).  
 
Sustainable Development Goals 
Although MDG 5a was not universally achieved by 2015, the new Sustainable 
Development Goals (SDG) have been agreed internationally with new global 
strategies and accompanying targets (UN 2015b). The post-2015 agenda of the SDG 
is broader than the previous MDG agenda, with a greater number of non-health goals 
and a strong focus on inequity reduction (UN 2015b).  
 
The SDGs consist of 17 goals aimed to stimulate action in areas of critical importance 
for humanity and the planet from 2015-2030 (UN 2015b). The goals are categorized 
into five areas (5 P’s): people, planet, prosperity, peace and partnership (UN 2015b). 
Of the 17 SDGs, eight goals are indirectly related to maternal and newborn health, 
while one goal (SDG 3) explicitly deals with health (UN 2015b) (Table 1.2). 
  




Table 1.2: Sustainable Development Goals related to health 
Sustainable Development Goals Related to 
health 
1.  End poverty in all its forms everywhere Yes - 
indirectly  
2.  End hunger, achieve food security and improved nutrition 
and promote sustainable agriculture 
Yes - 
indirectly 




4.  Ensure inclusive and equitable quality education and 
promote lifelong learning opportunities for all 
Yes - 
indirectly 
5.  Achieve gender equality and empower all women and girls Yes - 
indirectly 
6.  Ensure availability and sustainable management of water 
and sanitation for all 
Yes - 
indirectly 
7.  Ensure access to affordable, reliable, sustainable and 
modern energy for all 
No 
8.  Promote sustained, inclusive and sustainable economic 




9.  Build resilient infrastructure, promote inclusive and 
sustainable industrialization and foster innovation 
No 
10.  Reduce inequality within and among countries Yes - 
indirectly 




12.  Ensure sustainable consumption and production patterns No 




14.  Conserve and sustainably use the oceans, seas and marine 
resources for sustainable development 
No 
15.  Protect, restore and promote sustainable use of terrestrial 
ecosystems, sustainably manage forests, combat 
desertification, and halt and reverse land degradation and 
halt biodiversity loss 
No 
16.  Promote peaceful and inclusive societies for sustainable 
development, provide access to justice for all and build 
effective, accountable and inclusive institutions at all levels 
Yes, 
indirectly 
17.  Strengthen the means of implementation and revitalize the 
global partnership for sustainable development 
No 
 






SGD 3 is to ensure healthy lives and promote well-being for all at all ages (UN 2015b). 
A sub-target of SDG 3 concerning health care for women, is SDG 3.1, a reduction in 
the global MMR to less than 70 per 100,000 live births by 2030 (UN 2015b). Many 
countries have united behind the new SDG 3.1 target but continued and sustained 
global efforts to develop innovative strategies to achieve this ambitious target are 
required (WHO 2015a).  
 
The Global Strategy for Women’s, Children’s and Adolescents Health complements 
the SDG 3 to ensure healthy lives and promote well-being (UN 2015a). This strategy 
emphasises that all women have the right to the highest attainable standard of health 
and well-being including physical, mental and social aspects (UN 2015b). The current 
international aim is to ensure that every woman in every setting has an equal chance 
to “survive and thrive” during and after pregnancy (UN 2015a). The updated global 
strategy strives for a world in which every mother can enjoy a wanted and healthy 
pregnancy and childbirth and realise their full potential, resulting in enormous social, 
demographic and economic benefits (UN 2015a). Moving from the MDGs to the 
SDGs, the scope of global maternal health targets have been expanded from a focus 
on preventing death to an emphasis on the importance of health and well-being (UN 
2015b).  
Maternal mortality accounts for a small fraction of the overall burden of poor 
maternal health (Chou 2016). By concentrating only on why women are dying, many 
LMIC, may overlook other major complications and conditions that women suffer 
during and after pregnancy (Chou 2016). 
Historically, maternal mortality and morbidity have been studied in isolation from 
one another (Geller 2006). However, to achieve further global reductions in MMR 
and to improve maternal health, there is a need to broaden focus to the entire 
spectrum of maternal morbidity, beyond maternal mortality (Vandenkruik 2013). 
Extending the attention of research and preventative efforts to include maternal 
morbidity, will strengthen the global understanding of the continuum of maternal 
health and ill-health (Vandenkruik 2013). 




1.3 Expanding understanding of maternal health  
In the following sections of this chapter, the definitions of maternal death and severe 
acute maternal morbidity, and the criteria used to measure these outcomes are 
described. The continuum of maternal health is explained and the concept of 
maternal morbidity is introduced, along with a current definition. Previous 
descriptions of maternal morbidity are discussed, and the need for a standardised 
methodology and data collection tool to measure maternal morbidity is highlighted. 
 
Maternal health indicators and definitions 
To monitor global progress in reducing maternal mortality and improving maternal 
health, several definitions and identification criteria have been developed. 
Maternal death 
Maternal death is defined as “the death of a woman while pregnant or within 42 
days of termination of pregnancy, irrespective of the duration and site of the 
pregnancy, from any cause related to or aggravated by the pregnancy or its 
management but not from accidental or incidental causes” (WHO 2012a). 
Complications during pregnancy and childbirth are a leading cause of death among 
women of reproductive age (WHO 2015b). The major complications that directly 
account for nearly 75% of all worldwide maternal deaths are: 
• Haemorrhage  
• Hypertensive disorders of pregnancy  
• Infection 
• Obstructed labour 
• Complications of early pregnancy (WHO 2015b) 
The remainder, known as indirect deaths, are associated with pre-existing medical 
disorders such as heart disease, diabetes; or are associated with infections such as 
HIV, tuberculosis or malaria during pregnancy (WHO 2012a). The WHO has published 
criteria, detailing how to categorise maternal deaths (direct or indirect) and these 
criteria has been used internationally, in maternal death surveillance and in-depth 
reviews (WHO 2012a) (Table 1.3).  






Table 1.3. Groups of underlying causes of death during pregnancy, childbirth and 
the puerperium in mutually exclusive, totally inclusive groups (WHO 2012a). 
Type of 
maternal death  








Abortion, miscarriage, ectopic pregnancy 
and other conditions leading to maternal 
death and a pregnancy with abortive 
outcome. 
Maternal 





Hypertensive disorders in pregnancy, 
childbirth, and the puerperium. Oedema, 
proteinuria and hypertensive disorders in 
pregnancy, childbirth and the puerperium. 
Maternal 
death: direct  
3. Obstetric 
haemorrhage 
Obstetric diseases or conditions directly 
associated with haemorrhage. 
Maternal 




diseases or conditions. 
Maternal 
death: direct  
5. Other obstetric 
complications 
All other direct obstetric conditions not 
included in groups to 1–4. 
Maternal 




Unanticipated complications of 
management.  
Severe adverse effects and other 
unanticipated complications of medical 
and surgical care during pregnancy, 






Cardiac disease (including pre-existing 
hypertension) 
Endocrine conditions.  
Gastrointestinal tract conditions  
Central nervous system conditions  
Respiratory conditions  
Genitourinary conditions  
Autoimmune disorders  
Skeletal diseases  
Psychiatric disorders  
Neoplasms 






Maternal death during pregnancy, 
childbirth and the puerperium where the 









Death during pregnancy, childbirth and 
the puerperium due to external causes. 




Severe acute maternal morbidity  
The WHO has defined SAMM as “a woman who nearly died but survived a 
complication that occurred during pregnancy, childbirth or within 42 days of 
termination of pregnancy” (Say 2009). This concept is also known as "maternal near 
miss" (MNM) and refers to a life-threatening disorder that can result in a near miss 
with or without enduring morbidity or mortality (Say 2009). Furthermore, the WHO 
has defined potentially life-threatening condition or morbidity as a “clinical 
conditions or diseases that can threaten a woman’s life during pregnancy and labour 
and after termination of pregnancy” (WHO 2011a). This is also known as “severe 
maternal complications” (WHO 2011a). 
 
Different methods and identified criteria have been developed to identify SAMM 
cases. These approaches include disease specific, interventions, organ dysfunction 
and the WHO criteria, each with its own advantages and disadvantages (Mantel 1998, 
Waterstone 2001, Say 2009). As an example, Table 1.4 displays the WHO criteria to 
measure SAMM (WHO 2011a).  
  






Table 1.4: The WHO SAMM criteria (WHO 2011a) 
Organ system 
dysfunction 










(absence of pulse/ 




















rate>40 or <6 bpm 
Severe hypoxemia  
Oxygen saturation 












fluids or diuretics 
Severe acute 
azotemia Creatinine 
≥300 µmol/l or 3.5 
mg/dl 













of blood or red 






































The SAMM concept can be used as a tool to measure and monitor the quality of 
maternity care and the WHO currently recommends the use of MNM indicators to 
assess the quality of maternity care (WHO 2011a). Characterising SAMM is valuable 
for monitoring the quality of health facility care and for assessing the incidence of 
potentially life-threatening complications (Tunçalp 2012). In addition, cases of SAMM 
are an appropriate comparison group for maternal deaths and can be used to identify 
quality of care issues related to preventability (Adler 2012, Filippi 2009). The different 
forms of criterion available allows for routine measurement and monitoring of SAMM 
across different settings in many LMIC (Tunçalp 2012, van den Akker 2013). It has 
been suggested that SAMM can be used as a better healthcare indicator than 
maternal mortality alone for monitoring and evaluating maternal health programs in 
many LMIC (Say 2004, Kaye 2011, Tunçalp 2012). 
 
Much of the recent research on maternal morbidity has focused mainly on SAMM, 
which is generally assessed at secondary or tertiary healthcare levels using 
internationally accepted criteria to investigate deficiencies in maternal care as a 
complementary measure into the investigations of the causes of maternal deaths and 
to assess the quality of care given (Tunçalp 2013, van den Akker 2011). There is, 
however a gap in current knowledge regarding how non-severe or non-acute 
maternal morbidity is understood and assessed in a standardised and comparable 
way across LMIC.  
 
Continuum of maternal health  
Maternal mortality has been described as the “the tip of the iceberg” with a burden 
of poorly documented and misunderstood maternal ill-health or morbidity as the 
“base of the iceberg” (Liskin 1992, Fortney 1997). 
 






Figure 1.1: Hypothetical “iceberg” demonstrating continuum from maternal 
health to maternal death (adapted by the lead researcher from Liskin 1992). 
 
 
Maternal morbidity can represent a critical stage in the connection between a 
healthy maternal population and maternal death (Figure 1.1 and Figure 1.2). While 
some women with ill-health or morbidity will recover with or without treatment, 
others will not (Chou 2016). Understanding the scope of maternal morbidity coupled 
with early recognition and appropriate management is an important step in 
improving maternal health and potentially averting preventable maternal deaths 
(Tunçalp 2013). This approach to maternal health recognises that death is the last 
stop on a continuum of adverse pregnancy events, if maternal morbidity is not 
recognised, detected and managed appropriately. It is thought that efforts to prevent 
the progression of the severity of morbid conditions will prevent more severe 
complications and maternal death (Geller 2002). The continuum of maternal health 
can be sub-divided into clinical and epidemiologic ranges that permit an analysis of 
factors, including preventability factors that may differentiate deaths, severe acute, 
potentially life threatening and non-severe morbidities (Geller 2004). However, 
determining clear thresholds for a normal pregnancy and locating intermediate 
points between severe, potentially life threatening and non-severe morbidity is 
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Figure 1.2: Continuum of spectrum of maternal health, morbidity and death 
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Whilst the causes of maternal mortality and morbidity may not be simply connected, 
it is recognised that many women suffer both short- and long-term consequences of 
pregnancy and childbirth; the major burden of which is highest in women living in 
LMIC (Zafar 2015). It is well recognised that behind every maternal death, there are 
potential preventable preceding events which may have contributed (Tunçalp 2013). 
It is thought that recognising and addressing maternal morbidities before they 
become severe and potentially life-threatening, will improve the survival of mothers 
and their babies and will improve their overall health and well-being during and after 
pregnancy (Zafar 2015, Say 2016). To date, recent research on factors contributing to 
maternal morbidity have focused mainly on the severe acute type of maternal 
morbidity (Say 2009, Ferdous 2012, van den Akker 2013).  
1.4 Maternal morbidity  
There is a current gap in the knowledge of the understanding, extent and 
measurement of non-severe maternal morbidity as a component of the continuum 
of maternal health. Maternal morbidity has been described as a broad and complex 
concept that affects women, their children, families, communities and societies 
(Filippi 2016). The following sections describe current definitions of health, ill-health 
and maternal morbidity. 
 
All pregnancies 











Definitions of health and ill-health  
The WHO definition of health is “a state of complete physical, mental and social well-
being and not merely the absence of disease or infirmity” (WHO 1948). Within this 
framework, reproductive health addresses the reproductive processes, functions and 
system at all stages of life (WHO 2016b). The WHO definition of reproductive health 
emphasises that people “can have a responsible, satisfying and safe sex life and that 
they have the capability to reproduce and the freedom to decide if, when and how 
often to do so” (WHO 2016b). Alternatively, reproductive morbidity has previously 
been defined as “any morbidity or dysfunction of the reproductive tract, or any 
morbidity which is a consequence of reproductive behaviour including pregnancy, 
abortion, childbirth, or sexual behaviour and may include those of a psychological 
nature” (WHO 2005a). 
 
Definition of maternal morbidity  
There have been several descriptions and definitions of non-severe and non-acute 
maternal morbidity. For example, Bacak et al defined maternal morbidity as “a group 
of physical or physiologic conditions, resulting from or aggravated by pregnancy that 
adversely affects a woman’s health” (Bacak 2005). On the other hand, Danel et al 
referred to maternal morbidity as “a condition that adversely affects a woman’s 
physical health during childbirth beyond what would be expected in normal delivery” 
(Danel 2003). Maternal or obstetric morbidity has also previously been defined as 
“morbidity in a woman who has been pregnant (regardless of the site or duration of 
the pregnancy) from any cause related to or aggravated by the pregnancy or its 
management, but not from accidental or incidental causes”, and is a subset of 
reproductive morbidity (National Research Council 2000). Researchers have 
previously emphasised that maternal morbidity can be physical or psychological and 
can result from direct or indirect causes (Hardee 2011). The WHO have recently 
defined maternal morbidity as “any health condition that is attributed to or 
aggravated by pregnancy and childbirth which has a negative impact on the woman’s 
wellbeing” (Firoz 2013). This definition is imprecise at present, without a time limit, 




does not clarify between different types of morbidity and does not lend itself to 
objective operational study without clearer refinement.  
 
Components of maternal morbidity 
With the proposed WHO definition of maternal morbidity, different types of 
conditions (including physical, psychological, and social) can potentially have a 
negative impact on a woman’s wellbeing during and after pregnancy, and the specific 
extent and burden of which may vary from woman to woman (Zafar 2015). Each type 
of morbidity could have an impact on a woman of varying severity.  
 
For example, the current definition of maternal morbidity can include conditions 
referred to as “common discomforts of pregnancy”, symptoms that are often 
associated with the “normal” physiological changes in the maternal condition by 
being pregnancy (for example, nausea and vomiting, heartburn, constipation, breast 
tenderness, backache). These “normal” physiological changes due to pregnancy may 
have a negative effect on the women’s well-being and functioning and can, therefore, 
represent maternal morbidity. Other components of health included in the definition 
of maternal morbidity may be of various severity and could include conditions similar 
to the causes of SAMM and/or maternal mortality listed previously in Table 1.3 and 
Table 1.4.  
 
A WHO maternal morbidity working group have explored and summarised what 
conditions may contribute to maternal morbidity, and have proposed identification 
criteria to measure this (Say 2016, Chou 2016). The summary of possible conditions 
emphasises the wide range of indirect conditions of morbidity that women may 
experience during and after pregnancy and childbirth, listing more than 180 
diagnoses and dividing them into 14 organ dysfunction categories, ranging from 
obstetric to cardiorespiratory and rheumatology conditions (Chou 2016). To date, no 
study has used this data collection tool to measure maternal morbidity in LMIC and 
therefore the true extent of maternal morbidity is not known. 
 






It has been estimated that for every woman who dies related to pregnancy, 20 or 30 
more suffer maternal morbidity (Dakka 1980, Ashford 2002). Based on the 
mathematical modelling of available data, estimates suggest that of the 136 million 
women who give birth each year, an estimated 1.4 million women experience SAMM, 
9.5 million experience other types of complications and 20 million suffer from long-
term disabilities (WHO 2015c). Other research based upon primary data suggests that 
the magnitude of maternal morbidity could be much larger (Zafar 2015).  
 
Community-based studies conducted in various countries report that women suffer 
significant morbidity both during and after pregnancy with up to 41% of women 
experiencing some form of morbidity, many of which were preventable (Bhatia 
1996). There has been much research and systematic reviews focussed on the 
prevalence and impact of individual diseases, highlighting that women are suffering 
many treatable complications during and after pregnancy in LMIC e.g. sepsis, 
anaemia, hypertension, diabetes, haemorrhage (van den Broek 2003, Calvert 2012, 
Calvert 2013). Furthermore, it is well recognised that maternal health is linked to 
newborn babies’ health and maternal morbidity can be associated with poor fetal 
and newborn health outcomes (Garcia-Moreno 2005, Satyanarayana 2011). 
However, to date, no study has measured the prevalence of maternal morbidity as a 
comprehensive and holistic measurement in different LMIC.  
 
Rationale for this study  
As part of the need to develop innovative strategies, as well as effective, evidence-
based and low-cost methods to improve and monitor maternal health, there is now 
a focus on maternal morbidity in terms of definition, measurement, and 
interventions (Zafar 2015, Say 2016, Chou 2016). There are internationally accepted 
definitions and identification criteria in place for SAMM and maternal death (WHO 
2009, 2012a). In contrast, criteria to identify non-severe maternal morbidity has not 
been internationally agreed and the true extent of maternal morbidity is currently 
largely unknown (Chou 2016). Furthermore, the influence of various aspects of health 




(physical, psychological and social) and their impact on women and/or health 
outcomes are currently not well documented (Zafar 2015). Currently, when 
considering the current definition of maternal morbidity, there is a lack of 
understanding regarding what women themselves consider ill-health and their 
experiences (subjective measures) compared to the clinical findings (objective 
measures) assessed, documented and defined as morbidity by a healthcare provider 
(Zafar 2015).  
 
Maternal morbidity is a complex and broad concept and its presentation and severity 
are suspected to be along a spectrum or continuum linked to potentially life-
threatening conditions, SAMM and/or maternal death (Geller 2006). For a more 
accurate estimation of the global burden of maternal morbidity, clarity is needed on 
a measurement tool, assessments need to be conducted at the population level and 
self-reported morbidity may need to be “validated” (Zafar 2015). Agreed 
international identification criteria for maternal morbidity during and after 
pregnancy is crucial to provide accurate prevalence of the burden of maternal 
morbidity across settings where the need is greatest.  
 
  







The aim of the research project is to assess maternal morbidity using a new 
assessment tool to obtain estimates of maternal morbidity during and after 
pregnancy in India, Pakistan, Kenya and Malawi. 
 
Objectives 
1. To field test a new data collection tool to comprehensively measure maternal 
morbidity. 
2. To apply this new data collection tool to women during and after pregnancy 
in healthcare facilities, in different settings in four LMIC.  
3. To determine the prevalence and types of maternal morbidity in each setting. 
4. To determine the prevalence of maternal morbidity at five assessment stages 
during and after pregnancy. 
5. To assess what factors are associated with maternal morbidity in women 
during and after pregnancy. 
6. To assess whether there is an association between the different types of 
morbidity. 
  




Research questions  
In this research study, there are four research questions.  
Table 1.5: Research questions for the study  
Number  Research question 
1. What is the prevalence of maternal morbidity and what types of ill-
health (symptoms, signs and investigations) contribute to maternal 
morbidity? 
2. What is the prevalence of maternal morbidity at different stages of 
pregnancy? 
3. Is there an association between the different types of maternal 
morbidity and age, socioeconomic status, educational level, number of 
previous pregnancies, and/or adverse maternal or neonatal outcomes 
in the most recent pregnancy? 
4. Is there an association between the different types of morbidity, 










1.6 Chapter summary  
This chapter has set the scene for the proposed research project and has given an 
overview of the current priorities in global maternal health. Progress of interventions 
to address the MDG 5a have been described and the SDG 3 has been considered. The 
definitions and criteria for measurement of maternal death and SAMM have been 
highlighted. The continuum of maternal health, the concept of maternal morbidity, 
previous descriptions of maternal morbidity and the need for a standardised 
methodology to measure maternal morbidity has been described. The overall aim, 
objectives and key research questions have been summarised. 
 
Summary box 
• Maternal morbidity is a broad concept that encompasses a comprehensive 
approach to maternal health and can include physical, psychological and 
social aspects. 
• Currently, there are no national figures for the number of women who 
report different types of ill-health due to pregnancy across different 
countries and settings.  
• A challenge in the understanding of maternal morbidity has been the lack 
of clear, consistent and transparent methodology. 
• The measurement of maternal morbidity has the potential to be an 
important indicator of women’s health and could help inform policy and 
program decisions and resource allocations to improve maternal health. 
• Better information on women’s well-being and morbidity during and after 
pregnancy will help plan targeted, effective antenatal and postnatal care 
and education, ensuring that all women not only survive, but also thrive 








1.7 Overview of thesis  
This thesis is structured by chapters as follows: 
 
Chapter 1: Introduction  
This chapter has just been described in detail and has introduced the concept of 
maternal morbidity and has described the overall aim, objectives and key research 
questions of this research project.  
 
Chapter 2: Literature review  
The following chapter describes studies that have assessed maternal morbidity 
previously, and presents a systematic review of studies that have measured the 
prevalence of and/or associations between two of more different types of maternal 
morbidity in LMIC.  
 
Chapter 3: Methodology  
This chapter describes the positionality of the research project, lead researcher 
contribution, study design, study settings, study population and sampling. How the 
sample size is determined and the data collection tool and the process of piloting is 
described. This chapter describes the process of data collection, processing, cleaning, 
coding and analysis. This chapter concludes with how the quality of the data was 
assured and ethical considerations are described and addressed. 
 
Chapter 4, 5, 6 and 7: Results  
These chapters present the main results of the research study, structured in 
sequence to address each key research question. For the purposes of this thesis, 
results for the study settings are presented per country in the following sequence: 
India, Pakistan, Kenya and Malawi. Where appropriate, results are presented as a 
combined study population.  
 






• Chapter 4, the first results chapter, presents the burden of maternal morbidity 
per country and as a combined study population. 
• Chapter 5, the second results chapter, presents the prevalence of maternal 
morbidity per assessment stage of pregnancy per country and as a combined 
study population.  
• Chapter 6, the third results chapter, presents the factors associated with 
maternal morbidity per country. 
• Chapter 7, the fourth results chapter, presents the associations between 
different types of maternal morbidity per country.  
 
Results are presented in a narrative text accompanied by tables and figures. Where 
supplementary information is necessary, this is presented in the appendices. At the 
end of each results chapter, the main findings are summarised and compared to 
published literature. Further positioning of the findings from all the results chapters 
are further compared to available literature in the main discussion chapter of this 
thesis in more detail.  
 
Chapter 8: Discussion and recommendations 
In this chapter, the results of the study are discussed. This chapter begins with an 
overview of the principal findings and each key objective and accompanying research 
question is considered and interpreted. This chapters considers the strengths and 
weaknesses of the study, generalisability of the results and relation of the results to 
other studies. This chapter also discusses the meaning of the study, implications for 
clinical practice and implications for research. Recommendations are given and key 
future research priorities are suggested.  
 
Chapter 9: Conclusion  
In this chapter, a clear and concise conclusion to the research study is given.  




CHAPTER 2 LITERATURE REVIEW  
2.1 Introduction  
The systematic review in this chapter was conducted to explore available evidence 
on the prevalence of maternal morbidity and/or associations between different types 
of maternal morbidity in low- and middle-income countries. In addition, approaches 
to the measurement of maternal morbidity used in LMIC were reviewed. This chapter 
gives a background to the conceptualisation of ill-health and maternal morbidity and 
how it is described for the purposes of this systematic review. The methods section 
of this chapter describes how the systematic review was conducted. A description of 
included studies with related quality assessment is then presented. In the results 
section, the main findings from the included studies are presented using a narrative 
synthesis, alongside diagrams and summary tables. The discussion explains what the 
results mean; major findings are highlighted; strengths and limitations of the review 
are discussed; and explanation is provided on key similarities and differences with 
other studies before conclusions are drawn. The chapter ends with a summary.  
2.2 Background 
In the introduction chapter, it was highlighted that one of the key goals of the global 
strategic plan is to ensure all women have the highest attainable standard of health 
and well-being (UN 2015a). WHO has defined health as “a state of complete (physical, 
mental and social) well-being and not merely the absence of disease or infirmity” 
(WHO 1948). There is a current debate that this definition is out-dated and needs to 
be re-formulated to consider health in a context of functionality, capacity, 
adaptability and the ability to perform activities of daily living despite having a 
disease or disability (Huber 2011). However, to date there is no alternative 
internationally recognised and agreed definition of health. There have been various 
proposals to develop the definition of health using the concept of “health, as the 
ability to adapt and to self-manage” with a continued emphasis on the importance of 
the three domains of health: physical, mental, and social (Huber 2011). 
 






Regarding maternal morbidity, in 2013, the WHO defined maternal morbidity as: 
“Any health condition attributed to and/or aggravated by pregnancy and childbirth 
that has a negative impact on the woman’s wellbeing” (Firoz 2013). This definition 
can therefore in principle, include physical, mental (or psychological) and/or social 
conditions that are attributed to and/or aggravated by pregnancy.  
 
Definitions 
Maternal morbidity: “Any health condition attributed to and/or aggravated by 
pregnancy and childbirth that has a negative impact on the woman’s wellbeing” 
(Firoz 2013). 
Health: “complete physical, mental and social wellbeing and not merely the 
absence of disease or infirmity” (WHO 1948).  
 
There have been many systematic reviews to assess the prevalence of single physical, 
or mental (psychological), or social diseases or conditions that negatively impact a 
women’s health and wellbeing during and after pregnancy. To date, to the best of the 
lead researcher’s knowledge, no systematic review has described the prevalence of, 
and/or associations between two or more different types of maternal morbidity that 
have a negative impact on women during and/or after pregnancy.  
 
Therefore, for the purposes of this systematic review, the concept of maternal 
morbidity is classified as two of more of the following components or categories of 
health:  
 
1. Physical  
2. Mental (or psychological)  
3. Social  
 
 





For the purposes of this systematic review of literature, for example, the different 
types or categories of maternal morbidity could include the following diseases or 
conditions (although these are not definitive).  
1. Physical morbidity: (a) infectious or (b) medical/obstetric.  
a) Infectious morbidity: HIV, malaria, syphilis, sepsis and other general infections. 
b) Medical/obstetric morbidity: anaemia, hypertensive disorders of pregnancy, 
haemorrhage and other common medical or obstetric conditions.  
2. Psychological morbidity: common mental disorders: depression, puerperal 
psychosis, anxiety, stress and/or thoughts of self-harm. 
3. Social morbidity: domestic violence, substance use and lack of social support.  
 
Objective  
The objective is to systematically review the literature to assess studies that have 
measured the prevalence of and/or associations between at least two types of 
maternal morbidity, in women in LMIC, and to review the types of data collection 
tools that were used. 
 
Research questions 
The main research questions for this systematic review are: 
1. What studies have been conducted in LMIC that have measured two or more 
components of ill-health (maternal morbidity) in women during and/or after 
pregnancy? 
2. What data collection tools have been used to assess different types of 
maternal morbidities (physical, psychological, social) described in these 
studies? 
3. What is the prevalence of the different types of maternal morbidities 
(physical, psychological, social) described in these studies? 
4. Are there associations between the different types of maternal morbidities 
(physical, psychological, social) described in these studies, and if so what are 
the reported associations? 






2.3 Methodology  
Databases used  
Four electronic databases were searched using the same search terms. The databases 
were selected based on their relevance to the topic and the wide geographic reach. 
1. Medline  
2. CINAHL plus 
3. Global Health  
4. Web of Science  
Search strategy 
A search strategy was designed to include terms and key words relevant to the review 
objectives. The term “maternal morbidity” and associated keywords, were used as 
main search terms (Table 2.1). For each aspect of maternal morbidity (“physical”, 
“psychological”, and “social”) search terms and related keywords were selected 
based on the corresponding common causes of maternal mortality that could in 
principle be detected during routine maternity care during and/or after pregnancy. 
For example, common causes of physical maternal mortality would include 
“haemorrhage”, “hypertensive disorders of pregnancy”, and “sepsis”. Search terms 
and keywords for psychological morbidity included “common mental health 
disorders”. An example of maternal mortality due to psychological ill-health is suicide 
and therefore “suicidal ideation” and “thoughts of self-harm” were included as 
keywords. Examples of maternal mortality due to social circumstances includes 
“domestic violence”, and “overdose of substance use” (for example “illicit drugs”). 
Search terms and keywords for social morbidity therefore included “domestic 
violence”, “substance use” and other common social determinants of health. In 
addition to the common causes of types of maternal mortality that could in principle 
be detected during routine maternity care, well recognised indirect causes of 
maternal ill-health across LMIC were also included, such as “HIV”, “tuberculosis”, 
“malaria”, “syphilis” and “anaemia”.  
 




An initial exploratory limited search using Web of Science was conducted using 
Booleans "AND/OR" to combine keywords and phrases related to this review. This 
preliminary search helped to identify relevant keywords contained in the title, 
abstract and subject descriptors of papers (Table 2.1). Terms identified in the first 
stage and the synonyms used in the respective databases were used in a further 











Table 2.1: MeSH terms and keywords used  
Topic  MeSH terms  Keywords  
Maternal Parturition OR 
Pregnanc* OR 
Prenatal care OR 
Postnatal care OR 
Obstetric labor complication* 
Labor OR Obstetric 
OR Puerperal OR 
Maternal OR Delivery 
OR Intrapartum OR 
Antenatal 
Morbidity  Morbid* OR  
Pregnancy complications  
Unwell OR Ill* OR 
Disorder* 
Disease* 
Physical  Infection* OR 
Puerperal infection* OR 
Sepsis OR Systematic inflammatory 
response syndrome* OR HIV* OR  
Malaria OR tuberculosis OR syphilis OR 
Haemorrhage OR haemorrhage OR 
Postpartum haemorrhage OR urinary 
incontinence OR 
Anemia or anaemia OR 
Pre-eclampsia OR 
Hypertension OR 
Pregnancy induced hypertension  
Medical OR 
Obstetric 
Psychological  Mental health OR Depression OR 
Postpartum depression OR 
Self-mutilation OR 
Suicide OR Anxiety OR Psycho* OR 
Neurosis OR Mental disorder* OR  
Stress disorder*  
Suicidal ideation OR 
Self-harm 
Social  Domestic violence OR 
Intimate partner violence OR 
Substance related disorders OR 
Alcohol* OR Tobacco use OR 
Smoking OR Street drugs OR 
Inhalant abuse OR 
Hypnotics and sedatives OR 
Gender based 
violence OR 




Developing countr* OR 
Low income countr* OR 
Middle income countr* OR 
Low resource setting* OR 
Global south  
 









Reference lists and bibliographies of key topic articles were also searched and any 
additional papers necessary were obtained. A record of researched databases was 
performed using tracking sheets. The four databases were searched for all published 
studies, available in English, between 2007-2017, limited to human and female 
populations.  
 
Inclusion and exclusion criteria  
The inclusion criteria used in this systematic review are set out in Table 2.2 and the 
exclusion criteria are set out in Table 2.3. The aim was to assess maternal morbidity, 
and therefore, the study population was limited to women during and after 
pregnancy. When deciding on the inclusion criteria for the timeframe over which to 
assess women, the definitions for maternal mortality and SAMM were reviewed. 
Each of these internationally recognised definitions (described in the introduction 
chapter) have a clear timeframe, that is “while pregnant or within 42 days of 
termination of pregnancy” (WHO 2009, WHO 2012). The current maternal morbidity 
definition is “open”, and therefore could in principle include diseases or conditions 
that affect women beyond the standard definition the postnatal stage. For the 
purposes of this systematic review, studies were included if they assessed women 
during pregnancy, childbirth or up to twelve weeks postnatal. The rationale for the 
twelve-week postnatal time-frame, as opposed to the standard six-week postnatal 
cut off time frame, was to capture maternal morbidities that may first develop or 
manifest beyond the first six weeks after childbirth, but that may still be due to the 
pregnancy and/or childbirth. The methodology was limited to cross-sectional 
surveys; cohort studies; observational, prospective studies; secondary data analysis; 
retrospective analysis, and case note reviews to enable the reporting of prevalence 
of and/or associations between maternal morbidities measured in these types of 
studies.  
 
The sample size was limited to studies that assessed 500 or more women. This 
rationale was partly arbitrarily and to enable more accurate comparisons between 
any prevalence reported in the included studies and the findings of this proposed 






study at each assessment stage. The sample size calculation for this study was a 
minimum of 576 women at each of the five assessment stages of pregnancy, with an 
overall total of 2880.  
 
The outcome was limited to quantitative data on maternal morbidity of two of more 
types of physical, psychological and/or social morbidities, in keeping with the 
concepts of the WHO current definitions of health and maternal morbidity. Any study 
reporting on one type of maternal morbidity only and any study that examined trend, 
risk factors or associations only, were excluded.  
 
In keeping with the continuum of maternal health described in the introduction 
chapter and Figure 1.2, any study that reported severe or potentially life-threatening 
complications of pregnancy, that would require emergency obstetric care, were 
excluded. For example, studies reporting on severe acute maternal morbidity or 
maternal near miss were excluded.  
 
The review is limited to studies from LMIC as this is the primary interest of the lead 
researcher; the burden of maternal morbidity is expected to be highest in women 
living in LMIC or resource poor settings; and the burden and epidemiology of disease 
is likely to be different in LMIC compared to high-income countries or settings, 
especially regarding infectious disease, including HIV, tuberculosis and malaria.  
 
Dates were limited for the past ten years (2007-2017), based on the concept of 
reviewing recent data. Due to lack of translation support and for convenience, the 
language was limited to English.  
  




Table 2.2: Inclusion criteria for the systematic review 
Methodology  Cross-sectional survey; cohort study; observational, 
prospective, retrospective analysis, secondary data analysis; 
case note review. 
Study 
population  
Women during pregnancy, childbirth or up to twelve weeks 
after the end of the pregnancy. 
Sample size  ≥500 women. 
Outcome  Quantitative data on the prevalence of and/or associations 
between, maternal morbidity including two of more of the 
following morbidities:  
1. Physical  
2. Psychological  
3. Social  




Table 2.3: Exclusion criteria for the systematic review  
Methodology  Qualitative research, commentary or communication articles, 
systematic or narrative reviews, case series, case control studies. 
Study 
population  
Non-pregnant women or postpartum women more than twelve 
weeks after delivery of baby. 
Sample size  Less than 500. 
Outcome  Severe acute maternal morbidity or maternal near miss. 
Reported outcomes on one type of morbidity only. 
Reported maternal morbidity outcomes without providing 
primary data. 
Settings High income countries. 
Dates Before 2007. 
Language Non-English. 
 






Hits from the database search 
Table 2.4 displays the “hits” obtained from the four databases using the search terms 
and keywords, categorised into different possible combinations of types of maternal 
morbidity (“physical”, “psychological”, “social”), linked to the overall search resulting 
from the use of the term “maternal morbidity” and associated keywords. For the 
purposes of this review, physical maternal morbidity was initially separated into 
infectious and non-infectious search categories but then combined when linked using 
“AND/OR” to other types of possible morbidities. Across the four databases, when 
the overall search for “maternal morbidity” was linked using “AND/OR” to two or 
more types of morbidities, there were more hits in the following categories: physical 
and social (1325; 46.7% of total), physical and psychological (754; 26.5%) compared 
to psychological and social (494; 17.4%). When “maternal morbidity” search was 
linked to three types of morbidity (“physical”, “psychological”, “social”), there were 
267 (9.4%) “hits” (Table 2.4). 




Table 2.4: Database hits for search terms and keywords used in the systematic review  






















AND Psychological    All 363  391 754 
Maternal 
morbidity  




   AND Social  All 994  331 1325 
Maternal 
morbidity  
AND     AND Psychological  AND Social  All 280  214 494 
Maternal 
morbidity  




AND  Psychological  AND Social  All  157  110 267 
Limits Female, English language, 2007-2017 





The search from four databases yielded 2840 potentially relevant publications (Table 
2.4). Using the inclusion and exclusion criteria, the lead researcher screened all titles 
and abstracts. After screening titles and abstracts for relevance, 49 papers were 
retrieved for full text review (Figure 2.1). All included studies were summarised and 
outcomes of interest were extracted and used to populate pre-designed summary 
tables (Summary Table 1 and 2) (Appendix 1 and 2). For eight papers, a second 
opinion was obtained from the primary supervisor regarding whether to include or 
exclude the publications. Upon applying the inclusion criteria, the search was further 
narrowed to 26 studies that are reviewed in detail in this chapter. Other studies were 































Twenty-three studies were excluded at full text stage. Most of these studies were 
excluded because they were conducted in a general female, non-pregnant population 
and assessed gynaecological outcomes only (n=12); the outcome was a single 
morbidity only (n=6); the outcome was neonatal morbidity only (n=2); the outcome 
was severe acute maternal morbidity (n=2); or the outcome was the effect on the 
health system only (n=1) (Appendix 3).  
 
Included studies 
By combining the search terms, 2840 studies were identified from the four databases 
and after screening for relevance, 49 were retrieved for full text review (Figure 3). 
Upon applying the eligibility criteria, the search was narrowed down to 26 studies 
which were included in the review.  
 
Quality assessment 
The quality of evidence for each study was assessed using the Grading of 
Recommendations, Assessment Development and Evaluation (GRADE) tool adapted 
from the Critical Analysis Skills Programme (CASP) tool (Grade Working Group 2004, 
Atkins 2004). This tool was used because of its objective approach to grade the 
quality of studies. Individual studies were assessed against a set of criteria and given 
a score. For the purposes of this review, there were eleven variables and the scoring 
system for each variable was: no=0; yes, to an extent=1; yes, fully= 2. This scoring 
system gave a maximum score of 22. If a study scored less than 10, it was considered 
low quality. If a study scored 10-17, it was considered medium quality. If a study 
scored 18-22, it was considered high quality. Identified bias throughout the studies 
was reviewed. The details of the scoring of the quality of each study are displayed in 










Each study was reviewed to ensure ethical approval had been granted by a research 
ethics committee and that this was documented in each paper. Ethical issues 
regarding risks (for example informed consent, confidentiality and safety of the 
women involved in the studies) were considered.  
 
Data synthesis 
A narrative synthesis approach was used to describe outcomes investigated in this 
review. The main outcomes extracted and summarised for this review include: the 
different types of maternal morbidity measured (physical, psychological, and/or 
social); the data collection tools used to measure maternal morbidity; the prevalence 
of the described maternal morbidities; and the reported associations (if any) between 
the types of maternal morbidity. Where a standardised data collection tool was used, 
this was described. The methodology and results of studies belonging to the same 
outcome category were compared for similarities and differences 
 
2.4 Results  
In this section of the chapter, the characteristics and outcomes for the included 
studies are described, accompanied by diagrams and summary tables. Initially, the 
data extracted from each study was in one large summary table. For ease of 
readability, the lead researcher has split the larger main summary table into two 
summary tables. Summary Table 1 (Appendix 1) provides a summary of included 
studies, study design, country, setting, study participants, objective, main conclusion 
of the study and the quality score of the study. Summary Table 2 (Appendix 2) 
provides a summary of the main findings from the included studies, specifically what 
types of morbidity were measured, how the data was collected, prevalence of 
morbidities described where provided and, reported associations between the types 





A total of 26 publications were included in the review. Two of the included studies 
were conducted by the same authors group (Faisal-Cury 2009, Faisal-Cury 2010; and 
Shamu 2014, Shamu 2016). In these publications, the same methodology was 
reported in two papers, but there was a different emphasis on the results and 
outcomes reported per publication. For the purposes of this review, the first 
publication is referenced in the methodology section. Both publications were 
included in the summary tables and the prevalence and/or associations for each 
publication are described in the results section. However, to avoid duplication, the 
total number of studies described in the methodology section was 24.  
 
In the following results section, when relating the findings to any of the included 
studies, for ease of readability, categories with ten or less studies are referenced and 
alphabetical ordering is used.  
 
Characteristics of studies included  
Geographical spread  
The 24 studies were from a total of 15 different countries, across five continents. 
Seven studies were conducted in low-income countries and eight studies were 
conducted in middle-income countries (five lower-middle and three upper-middle 
income countries). Of the included studies, one study was conducted in two 
countries: Malawi and Pakistan (Zafar 2015). Three studies were carried out in South 
Africa (Brittain 2017, Tsai 2016, Wong 2017); three in Bangladesh (Nasreen 2011, 
Natasha 2015, Surkan 2017); two in Ethiopia (Hanlon 2009, Wado 2014); Kenya 
(Chersich 2009, Ukachukwu 2009); Pakistan (Karmaliani 2009, Waqas 2015), and 
Tanzania (Isaksen 2015, Stöckl 2010). One study was conducted in each of the 
following countries: Brazil (Faisal-Cury 2009); Iran (Hassan 2014); India (Prost 2012); 
Malawi (Stewart 2014); Rwanda (Ntaganira 2008); Mexico (Romero-Gutiérrez 2011); 
Morocco (Assarag 2013), Timor-Leste (Rees 2016); and Zimbabwe (Shamu 2014). The 
geographical distribution of country in which the study was conducted is given in 
Figure 2.2. The number in the circles represents the number of studies in that 
country. 




Figure 2.2: Geographical distribution of studies included in the systematic review 
 
Study design 
Sixteen studies used a cross sectional survey study design. Four studies were 
observation prospective cohort studies (Faisal-Cury 2009, Karmaliani 2009, Patra 
2008, Wado 2014). Three studies were secondary data analysis of large population 
databases (Isaksen 2015, Surkan 2017, Tsai 2016). One study was a survey that 
extracted data from medical case notes retrospectively (Ukachukwu 2009).  
 
Sample size  
Nine studies had a sample size of 500-749 women, four studies had a sample size of 
≥2500 women (Isaksen 2015, Prost 2008, Surkan 2017, Zafar 2015), six studies had a 
sample size of 1000-1499 women (Assarag 2013, Karmaliani 2009, Hassan 2014, 
Hanlon 2009, Stöckl 2010, Tsai 2016), three studies had a sample size of 1500-1999 
(Romero-Gutiérrez 2011, Rees 2016, Ukachukwu 2009) and two studies had a sample 





Table 2.5: Number of studies in each category of sample size  







Total number 24 
 
Source of data and data collection method 
A review of the included studies showed that most (20) studies used face-to-face 
interviews to collect primary data from women using questionnaires. One study 
extracted data from medical cases notes (Ukachukwu 2009) and three studies 
conducted secondary analysis on existing published databases and registers (Isaksen 
2015, Surkan 2017, Tsai 2016). There was no mention of primary electronic data 
collection in any study. 
 
Included studies that used secondary data analysis  
In three studies, the data used to estimate levels and types of maternal morbidity 
were from databases of hospital admissions, discharges and birth registers (Isaken 
2015, Surkan 2017, Tsai 2016). Isaksen et al 2015 conducted secondary data analysis 
on data related to 34,090 births between 2000 and 2010, obtained from the medical 
birth registry at Kilimanjaro Christian Medical Centre in Moshi, Tanzania, to assess 
alcohol use in pregnant women and to describe associations between alcohol 
consumption and health-related maternal and fetal outcomes (Isaksen 2015). Surkan 
et al conducted secondary data analysis using population-based data from a 
community trial among 39,000 married women living in a rural area after childbirth, 
to assess the relation between women's reported morbidity symptoms from 
childbirth to three months postpartum, and subsequent depression symptoms 
assessed at six months postpartum (Surkan 2017). Tsai et al conducted secondary 




data analysis of population based data collected as part of a longitudinal study during 
home visits of 1328 pregnant women in South Africa, to estimate the association 
between intimate domestic violence and depression in pregnant women (Tsai 2016). 
In all the cases of secondary data analysis, data was directly extracted and analysed 
from these databases using the authors own data collection tool, with little or no 
detail of the exact variables collected described, in the paper. 
 
In one study, Ukachukwu et al collected data on sociodemographic, recorded 
antenatal care activities and maternal morbidities from case notes of all pregnancies 
and births over a two-year period in Kikuyu Hospital, Kenya. Data was directly 
extracted from the medical case notes of study participants with no mention nor 
description of any tool or form specifically designed for data extraction regarding 
maternal morbidities (Ukachukwu 2009). 
 
Included studies that used primary data collection  
Stages of pregnancy assessed 
A total of 20 studies used a cross sectional study design to collect data from women 
during and/or after pregnancy. In 14 studies, data was collected using surveys from 
women during pregnancy. In 10 of these 14 studies, the gestation or time of 
pregnancy was not given by weeks or trimester. In two studies, women were assessed 
in the second trimester (Karmaliani 2009, Rees 2016) and in one study women were 
assessed in the third trimester (Nasreen 2011). In one study, women were either 
assessed in the second or third trimester (Faisal-Cury 2009). In six studies, data was 
collected using a cross sectional survey from women postnatally, after childbirth. Two 
studies assessed women within 12 weeks of childbirth (Assarag 2013, Prost 2012). In 
two studies, data collection was carried out at more than one assessment stage of 
pregnancy (Chersich 2009, Zafar 2015). 2 weeks), middle (12-24 weeks) and late (24-
26 weeks) after childbirth (Chersich 2009). Zafar et al used a cross sectional survey to 
assess different women at three different assessment stages, both during (early and 




postnatally and asked women to recall complications experienced during pregnancy 
and at the time of childbirth (Prost 2012).  
 
Site of data collection  
In most studies (10), data collection took place during a visit to the outpatient clinic 
of a healthcare facility. In five studies, these healthcare facilities were 
tertiary/provincial hospitals (Chersich 2009, Hassan 2014, Natasha 2015, Romero-
Gutiérrez 2011, Waqas 2015); in one this was a secondary level or district hospital 
(Stewart 2014) and in four studies, these were at primary healthcare facility level 
(Brittain 2017, Faisal-Cury 2009, Ntaganira 2008, Rees 2016, Shamu 2014). In nine 
studies, data collection took place in the community or home of women (Assarag 
2013, Hanlon 2009, Karmaliani 2009, Tsai 2016, Stöckl 2010, Nasreen 2011, Prost 
2012; Wado 2014, Zafar 2015). In two studies, data was collected at both the health 
facility and at the home of women.  
 
Data collection  
Most of the studies that collected primary data relied solely on women’s self-
reported symptoms. In four studies, clinical examination and/or laboratory tests 
were also carried out at the same time of face-to-face interview (Assarag 2013, 
Chersich 2009, Wado 2014, Zafar 2015).  
 
Number of types of morbidity assessed  
Ten studies assessed psychological and social ill-health (Faisal-Cury 2009, Faisal-Cury 
2010, Karmaliani 2009, Nasreen 2011, Rees 2016, Shamu 2014, Shamu 2016, Stöckl 
2010, Tsai 2016, Wong 2017). Five studies assessed physical and psychological ill-
health (Assarag 2013, Natasha 2015, Surkan 2017, Ukachukwu 2009, Zafar 2015). One 
study assessed physical and social ill-health (Isaksen 2015). Seven studies assessed 
aspects of physical, psychological and social ill-health (Brittian 2017, Chersich 2009, 
Hanlon 2009, Prost 2012, Stewart 2014, Wado 2014, Waqas 2015). 
 




Descriptions of maternal morbidity   
In the following part of the results section of this chapter, the different types of data 
collection tools, measurements, prevalence of and associations between maternal 
morbidities reported in the included studies, are described.  
 
For the purposes of the review, maternal morbidity included physical, psychological 
and social aspects of ill-health. In this results section, each type of maternal 
morbidity, the data collection tool used, and prevalence’s reported in the included 
studies are described using narrative synthesis with accompanying summary tables. 
The associations between the different types of maternal morbidity are described 
separately at the end of the results section of this chapter.  
 
Physical morbidity 
Data collection tools  
A total of 17 included studies described a form of physical morbidity. Different types 
of data collection tools were used, were not well reported and were mostly described 
as simply “questionnaires”. Some questionnaires were described as semi-structured 
and other included open-ended questions. There was no single standardised 
validated questionnaire to measure physical morbidity across the different studies. A 
large variety of data items were collected across the included studies, including 
symptoms, clinical signs elicited during examination, results of investigations, and 
clinical diagnoses. Different studies reported different types of physical morbidity. In 
most studies, co-morbidities were listed with no reference to any classification 
system. It was not possible to present a summary table of data collection tools, as no 
study used a validated international classification or tool to assess physical morbidity.  
 
Types and prevalence of physical morbidity reported  
Of the 17 studies that reported physical morbidity, HIV status was considered the 
primary measure of physical morbidity in four of these studies (Ntaganir 2008, Shamu 





Assarag defined physical morbidity in 1523 women using self-reported symptoms and 
then aggregated the symptoms together into one category; and reported overall 
prevalence of physical morbidity as 44% of women with at least one self-reported 
physical complaint. In this study, 60% of women had a medical condition diagnosed 
by a healthcare provider (Assarag 2013). During a postpartum consultation, 8% of 
women self-reported complaints considered due to genital infections (mainly vaginal 
discharge) and 5% of women reported breast problems (Assarag 2013). Other 
gynaecological and obstetric problems (sexual problems, uterine prolapse, and 
infected episiotomy) were self-reported by 10% of women (Assarag 2013). Burning 
during urination and urinary leakage were self-reported in 2% and 1% of women 
respectively (Assarag 2013). When assessed objectively by a healthcare provider, 60% 
of women received a diagnosis of a complication, and of these women, 9% received 
more than one diagnosis (Assarag 2013). The most common medical diagnosis made 
by a healthcare provider was related to gynaecological problems (22%) (genital 
infection, uterine prolapse, cystocele, bad repair of an episiotomy), followed by 
laboratory-confirmed anaemia (19%) (Assarag 2013).  
 
Chersich et al used their own structured questionnaire as a data collection tool for 
self-reported symptoms; conducted clinical examinations; collected blood, cervical 
swabs for laboratory investigations and offered the Papanicolaou (PAP) smear 
(Chersich 2009). Chersich et al reported physical morbidity and the prevalence as: 
52% of women had anaemia; 31% had bacterial vaginosis; 25% had abnormal vaginal 
discharge; 17% had abdominal pain; 10% had dysuria; 7% had candida; 7% had 
trichomonas vaginalis; 6% had febrile symptoms; 5% had severe anaemia; 4% had 
nitrites in their urine; and 1% had incontinence (Chersich 2009). 
 
Faisal-Cury et al used the term “obstetric complications” to describe physical 
morbidity and, in addition to face-to-face questionnaires with 831 women, collected 
information on the weight and gestational age at birth of the newborn baby from the 
hospital records of the newborn baby. Overall, 7.0% of women interviewed had a 
baby with low birth weight and 6.9% had a preterm birth (Faisal-Cury 2010).  





Hassan et al used a variety of measures to assess physical morbidity in 1300 women, 
including adverse maternal outcomes such as: antenatal hospitalization (55.4%), 
vaginal bleeding during pregnancy (31.0%), preterm labour (30.3%); Caesarean 
section (24.4%), abortion (1.5%) and premature rupture of the membranes (0.1%) 
(Hassan 2014).  
 
Hanlon et al also used a variety of measures to assess physical morbidity in 1065 
pregnant women, and reported women with a past neonatal death (25.0%); ≥1 
episode of fever in pregnancy (13.1%); ≥1 episode of malaria (15.9%); low birth 
weight (7.1%); past stillbirth (4.3%); and “poor/bad global health” (3.8%) (Hanlon 
2009).  
 
Natasha et al assessed physical morbidity in 748 women as gestational diabetes 
(51%), hypertension (13%); and a history of neonatal death (3.7%) (Natasha 2015). 
The prevalence of gestational diabetes in this study was very high as the main 
objectives of this survey was to compare the prevalence of depression during 
pregnancy in a pre-selected population, with or without gestational diabetes 
(Natasha 2015). This is a bias sample and not a true representative of gestational 
diabetes in a pregnant population in Bangladesh. 
 
Prost et al reported that 46.3% of women recalled “problems” in the antepartum 
stage; at delivery (35.1%); in the postpartum stage (30.5%); and 1.7% of women 
delivered by Caesarean section (Prost 2012). “Problems” included any one of the 
following: “severe stomach pain; excessive vomiting; fever for more than 24 hours; 
excessive vaginal bleeding; jaundice; reduced/no fetal movement; self-reported 
symptoms of malaria; high fever in the three days before labour, foul smelling vaginal 
discharge; prolonged labour; fits or convulsions; retained placenta; tear around birth 
passage; umbilical cord around infant's neck; foul smelling discharge; leaking from 
vagina”. The possibility of list of “problems” were adapted slightly depending on the 




(for example, no questions antenatal haemorrhage in the postnatal stage) (Prost 
2012).  
 
Romero-Gutiérrez et al reported “maternal and neonatal complications” as measures 
of physical morbidity. However, specific prevalence was not reported but 
associations between the “maternal and neonatal complications” and violence 
against women was reported in this study (Romero-Gutiérrez 2011). The associations 
are reported and commented upon at the end of this results section.  
 
Stewart et al used the HIV status of women (10.8%) as a measure of physical 
morbidity in 583 women, and reported that 17.2% of women “had a child die” and 
15.4% of women had “complications in previous pregnancy” (Stewart 2014).  
 
Surkan et al conducted secondary data analysis of a database of 39,000 women and 
describe the types and prevalence of physical morbidity as gastroenteritis (22.1%); 
anaemia (18.7%); severe headache (14.2%); urinary tract infection (6.0%); 
pneumonia (4.9%); stress incontinence (3.2%); reproductive infection (2.5%); 
prolapse (2.2%); and continuous dripping of urine (0.33%) (Surkan 2017).  
 
Ukachukwe et al conducted a retrospective case note review of 1716 women and 
described the types and prevalence of physical morbidity as genital tract trauma 
(90.6%), urinary tract infection (14.5%) and HIV positive status (3%) (Ukachukwe 
2009).  
 
Wado et al measured mid-upper arm circumference as a possible measurement of 
physical morbidity in 622 pregnant women. The mean birth weight of the newborn 
baby were also reported as an indirect measure of possible physical morbidity in the 
mother. In this study, 17.0% of women had a baby with a low birth weight and 68.1% 
of women had a mid-upper arm circumference less than 23cms, suggestive of 
maternal malnutrition (WHO 1995, Wado 2014)  
 




Waqas et al measured the following as possible measures of physical morbidity in 
500 women: previous Caesarean section (27.2%), previous abortion (22.0%), previous 
episiotomy (16.2%), and previous miscarriage (8.8%) (Waqas 2015).  
 
Zafar et al used self-reported symptoms and signs elicited on clinical examination, 
bundled to reflect infectious and non-infectious physical morbidity in 3459 women 
across two countries (Malawi and Pakistan) (Zafar 2015).  
 
Types and prevalence of physical non-infectious morbidity in 1732 women assessed 
in Malawi included: anaemia (39.5%); nausea and vomiting (19.1%); antepartum 
haemorrhage (3.1%); asthma (1.0%); pre-eclampsia (0.2%); and epilepsy (0.3%) (Zafar 
2015). All women denied incontinence and 10% of women reported a previous 
pregnancy complication (Zafar 2015). Overall, in 1732 women assessed in Malawi, 
when symptoms and signs elicited on clinical examination were bundled, 28.8% of 
women had one non-infective morbidity, 1.2% had two non-infective morbidities; 
and 0.2% had three non-infective morbidities (Zafar 2015).  
 
Types and prevalence of physical non-infectious morbidity in 1727 women assessed 
in Pakistan included: anaemia (35.3%); nausea and vomiting (18.8%); incontinence 
(4.7%); antepartum haemorrhage (4.1%); asthma (1.4%); pre-eclampsia (0.8%); 
epilepsy (0.8%); (Zafar 2015). Overall, in 1727 women assessed in Pakistan, when 
symptoms and signs elicited on clinical examination were bundled, 34.4% of women 
had one non-infective morbidity, 6.9% had two non-infective morbidities and 1.8% 
had three non-infective morbidities (1.8%) (Zafar 2015). Overall, 1 in 5 women in 
Pakistan reported a previous pregnancy complication (Zafar 2015). 
 
Types and prevalence of physical infectious morbidity in 1732 women assessed in 
Malawi included: HIV positive status (16.0%); malaria (8.2%); possible sexually 
transmitted infection (7.5%); possible urinary tract infection (5.4%); fever (2.4%); and 
suspected TB (0.8%) (Zafar 2015). Overall, in 1732 women assessed in Malawi, when 




had one infective morbidity, 5.4% had two infective morbidities and 1.3% had three 
infective morbidities (1.3%) (Zafar 2015). 
 
Types and prevalence of physical infectious morbidity in 1727 women assessed in 
Pakistan included: possible STI (14.9%); suspected TB (10.0%); possible UTI (8.2%); 
HIV positive status (6.3%); fever (3.1%); malaria (2.7%); and hepatitis (1.6%) (Zafar 
2015). Overall, in 1727 women assessed in Pakistan, when symptoms and signs 
elicited on clinical examination were bundled, 21.1% of women had one infective 
morbidity, 6.4% had two infective morbidities and 4.1% had three infective 
morbidities (Zafar 2015).  
 
The authors of the Zafar et al study highlighted that as a combined study sample 
(Malawi and Pakistan), multiple morbidities were uncommon in women (<10%), 
(Zafar 2015).  
 
Table 2.6 summarises the reported prevalence for each reported physical morbidity 
in the included studies. All studies reported more than one type of physical morbidity. 
The different types of physical morbidity are categorised as those relating to the (1) 
woman (2) fetus/neonate or (3) as “other” descriptions or measures. For ease of 

















Table 2.6: Summary table of prevalence of physical morbidity  






related to the 
women 
Abdominal pain 17.0 
Abnormal vaginal discharge 25.0 
Abortion  1.0; 22.0 
Anaemia  18.7; 19.0; 35.3; 39.5; 
52.0 
Antepartum haemorrhage 3.1; 4.1; 31.0 
Asthma  1.0; 1.4 
Bacterial vaginosis 31.0 
Breast problems  5.0 
Burning during urination 2.0 
Caesarean section  1.7; 24.4; 27.2  
Candida 7.0 
Continuous dripping of urine  0.33 
Dysuria 10.0 
Epilepsy  0.3; 0.8  
Episiotomy  16.2  
Febrile symptoms 6.0 
Fever  2.4; 3.1; 13.1  
Gastroenteritis  22.1 
Genital tract trauma  90.6 
Gestational diabetes  51.0* 
Hepatitis  1.6  
HIV positive  3.0; 6.3; 10.8; 16.0 
Hypertension  13.0 
Incontinence 0.0; 1.0; 4.7 
Malaria  2.7; 8.2; 15.9 
Mid; upper arm circumference 
<23cms (maternal malnutrition)  
68.1  
Miscarriage  8.8 
Nausea and vomiting  18.8; 19.1  
Nitrites in urine 4.0 
Pneumonia 4.9 
“Poor/bad global health” 3.8 
Pre-eclampsia  0.2; 0.8  
Premature rupture of the membranes 0.1 
Preterm labour 30.3 
Prolapse  2.2 
Reproductive infection  2.5 
Severe anaemia 5.0 
Severe headache  14.2 
Sexually transmitted infection 7.5; 14.9 
Stress incontinence  3.2 




Tuberculosis (suspected) 0.8; 10.0 
Urinary leakage 1.0 
Urinary tract infection 5.4; 6.0; 8.2 14.5  
Specific 
condition 
related to the 
fetus/neonate 
Neonatal death  3.7; 17.2; 25.0 
Low birth weight 7.0; 7.1; 17.0  
Preterm labour 30.3 
Preterm birth  6.9 






Antenatal hospitalization  55.4  
At least one self-reported physical 
complaint  
44.0 
Genital infections (vaginal discharge)  8.0 
Gynaecological problems (genital 
infection, uterine prolapse, cystocele, 
complications of episiotomy) 
22.0 
Gynaecological and obstetric 
problems (sexual problems, uterine 
prolapse, and infected episiotomy)  
10.0 
Infective morbidity - 
One condition 
21.1; 25.9  
Infective morbidities - 
Two conditions 
5.4; 6.4 
Infective morbidities - 
Three conditions 
1.3; 4.1 
Medical condition diagnosed by a 
healthcare provider  
60.0 
More than one medical condition 
diagnosed by a healthcare provider 
9.0 
Multiple morbidities  <10.0 
Non-infective morbidity - 
one condition 
28.8; 34.4 
Non-infective morbidities -two 
conditions 
1.2; 6.9 
Non-infective morbidities -three 
conditions 
0.2; 1.8 
Previous pregnancy complication  0.0; 15.4; 20.0 
“Problems” in the antepartum stage  46.3 
“Problems” at delivery  35.1 
“Problems” in the postpartum stage 30.5 
*in pre-selected population of women with gestational diabetes. 
 
Table 2.6 shows that there is a wide range of different types of physical morbidity 
assessed in the included studies, with wide ranges of prevalence for some conditions. 
Some descriptions of physical morbidity were described as aggregates or a 




summative condition, for example, in one study gynaecological problems included 
“genital infection, uterine prolapse, cystocele, bad repair of an episiotomy”. Only one 
study used antenatal hospitalisation as a “proxy” for physical morbidity. The 
difference in the prevalence of physical morbidities may be due to different data 
collection tools; different population groups; and assessment at different stages of 
the pregnancy. These factors are explored in the discussion section of this chapter.  
 
In this part of the results section so far, the types of physical morbidity and the 
prevalence of the types of physical morbidity described in the included studies have 
been reported.  
 
In the following section of this results section, the data collection tools used, and 
prevalence of psychological maternal morbidities reported in the included studies are 
described. The associations between the different types of maternal morbidity are 
described separately at the end of the results section of this chapter.  
 
Psychological morbidity  
In total, 14 studies assessed psychological morbidity and depression was the most 
commonly assessed aspect of maternal mental health. Of these 14 studies, three 
assessed anxiety and depression (Karmalianai 2009, Nasreen 2011, Stewart 2014). 
One study assessed “distress” (Prost 2012), and one study assessed depression and 
psychological distress (Rees 2016).  
 
Across the 14 studies that assessed psychological morbidity, twelve internationally 
recognised data collection tools were used either alone or in combination with other 
data collection tools. A table of the data collection tools used in the included studies, 
with an explanation of the purpose, the country of origin, the author and date of first 
publication of the data collection tool is displayed in Table 2.7. Many of the data 
collection tools used to assess psychological morbidity were originally developed in 





Two studies stated clearly that the authors used a locally adapted and validated 
version of the Edinburgh Postnatal Depression Score (EPDS) (Nasreen 2011, Tsai 
2016). In other studies, there was little if any, information regarding the process of 
translation and back-translation of established data collection tools. The quality of 
the translation is therefore uncertain in studies, and this impacts the validity of the 
data collected in this way.  
 
 




Table 2.7: Description of data collection tools used in included studies to assess psychological morbidity 









1. Aga Khan University 
Anxiety and Depression 
Scale  
AKUADS  The Aga Khan University Anxiety and Depression Scale is an indigenous 
screening scale developed at the Aga Khan University, Karachi, Pakistan. 
AKUADS is in Urdu, a language which is widely understood and spoken in 
Pakistan and India. It has been developed from a list of complaints 
collected by a retrospective file review of symptoms mentioned in Urdu by 
patients of anxiety and depression coming to the Community Health 
Center (CHC) of AKU. It is a 25-item questionnaire which includes 12 
psychiatric and 13 somatic symptoms. It is a differential scale which is rank 
ordered for severity and inquiries about the presence and severity of 
psychiatric and somatic symptoms of anxiety and depression over a period 
of last two weeks. It has been validated in a community setting in Pakistan 
(Ali 1988). 
Pakistan, 
Ali 1988  
2. Clinical Interview 
Schedule-Revised  
CIS-R  The Clinical Interview Schedule-Revised can be used to assess common 
mental disorders. In the CIS-R, 14 different symptom groups are enquired 
after in the previous month, focusing on symptoms experienced within 
the last week. The 14 symptoms enquired are: (1) somatic symptoms; (2) 
fatigue; (3) sleep problems; (4) irritability; (5) physical health worries; (6) 
depression; (7) depressive ideas; (8) worry; (9) anxiety; (10) phobias; (11) 
panic; (12) compulsive behaviours; (13) obsessive thoughts; (14) 
forgetfulness/concentration problems. Scores on each symptom group 
ranged from 0 to 4 (and 0 to 5 for depressive ideas), with higher scores 







3. Edinburgh Postnatal 
Depression Scale 
EPDS The 10-question Edinburgh Postnatal Depression Scale is a valuable and 
efficient way of identifying patients at risk for perinatal depression. The 
EPDS is easy to administer and has proven to be an effective screening 
tool. Mothers who score above 13 are likely to be suffering from a 
depressive illness of varying severity. The EPDS score does not override 
clinical judgment. A careful clinical assessment should be carried out to 
confirm the diagnosis. The scale indicates how the mother has felt during 
the previous week. In doubtful cases, it may be useful to repeat the tool 
after two weeks. The scale will not detect mothers with anxiety neuroses, 
phobias or personality disorders (Cox 1987).  
UK, 
Cox 1987 
4. Harvard Trauma 
Questionnaire 
HTQ The Harvard Trauma Questionnaire is a checklist that enquires about a 
variety of torture, and traumatic events, as well as the emotional 
symptoms considered to be uniquely associated with trauma, post-
traumatic stress disorder (Mollica 1992). 
USA,  
Mollica 1992 
5. Kessler-10 item 
psychological distress 
scale 
K-10 This is a 10-item questionnaire intended to yield a global measure of 
distress based on questions about anxiety and depressive symptoms that 




6. List of Threatening 
Experiences 
questionnaire 
LTE-Q List of Threatening Experiences questionnaire includes a subset of 12 life 





Depression Rating scale  
MADRA The Montgomery–Åsberg Depression Rating Scale (MADRS) is a ten-item 
diagnostic questionnaire which psychiatrists use to measure the severity 









PHQ-9 The Patient Health Questionnaire (PHQ) has nine questions and is used to 
make criteria-based diagnoses of depressive and other mental disorders 
commonly encountered in primary care (Spitzer 1992). 
USA,  
Spitzer 1992 






SRQ-20 The Self-Reporting Questionnaire is a 20-item self-report screening tool 
developed by the World Health Organization specifically for the LMIC 
primary healthcare setting. It employs a yes/no answer format and is 
designed to detect non-specific psychological distress, including suicidal 





10. State-Trait Anxiety 
Inventory 
STAI The State Anxiety Scale evaluates the current state of anxiety, asking how 
respondents feel “right now,” using items that measure subjective feelings 
of apprehension, tension, nervousness, worry, and activation/arousal of 
the autonomic nervous system. The STAI has 40 items, 20 items allocated 




11. Structured Clinical 
Interview for the 
Diagnostic and Statistical 
Manual of Mental 
Disorders, 4th Edition 
SCI- DSM IV DSM-IV codes are the classification found in the Diagnostic and Statistical 
Manual of Mental Disorders, 4th Edition, Text Revision, also known as 
DSM-IV-TR, a manual published by the American Psychiatric Association 
that includes all currently recognized mental health disorders (American 






12. WHO version of the  
Centre for 
Epidemiological Studies 
Depression scale  
CES-DR The 20 items in CESDR scale measure symptoms of depression in nine 
different groups as defined by the American Psychiatric Association 
Diagnostic and Statistical Manual, fifth edition. It is a 20-item measure 
that asks caregivers to rate how often over the past week they 
experienced symptoms associated with depression, such as restless sleep, 







Prevalence of psychological morbidity  
In the following results section, the data collection tools used and prevalence of 
psychological morbidity reported are described for each included study.  
 
Assarag et al adapted questions from a WHO report in 2001. Questions used to 
identify psychological morbidity included screening for symptoms such as “feeling 
negative about yourself, crying easily, decreased interest or pleasure in daily 
activities” in the last two weeks that represented a change from normal (Assarag 
2013). Assarag et al reported that 10% of women reported mental distress (anxiety, 
unexplained crying, nervousness) (Assarag 2013).  
 
Brittain et al used the EPDS score to measure psychological morbidity and reported 
19% of 623 HIV positive pregnancy women had a EPDS score ≥10 and 11% had a EDPS 
score ≥13 (Brittian 2017). Chersich et al used ICD-10 definitions for mild and major 
depression and reported 2% of 500 postnatal women had major depression (Chersich 
2009). Faisal-Cury et al used the Clinical Interview Schedule-Revised version and 
reported a prevalence of common mental disorders as 20.2% in 831 pregnant women 
(Faisal-Cury 2009). 
 
Karmaliani et al used the Aga Khan University Anxiety Depression Scale to assess 
psychological distress and reported that 18% of 1368 pregnant women had anxiety 
and/or depression (Karmaliani 2009). Hanlon et al used the Self-Reporting 
Questionnaire-20 Items (SRQ-20) to assess symptoms of antenatal common mental 
disorders and used the List of Threatening Experiences (LTE) questions to assess 
stressful life events during pregnancy for 1065 women (Hanlon 2009). Women were 
asked whether they were worried about the forthcoming delivery. High symptom 
levels (SRQ scores ≥6) were present in 128 women (12.0%), low symptoms (SRQ 
scores 1–5) were present in 634 women (59.5%) and no symptoms (SRQ = 0) in 303 
(28.5%) of women (Hanlon 2009).  
 




Nasreen et al used the EPDS to measure depression and reported a EDPS score ≥10 
in 18% of 720 pregnant women (Nasreen 2011). The authors stated that the EPDS 
questionnaire had previously been validated for use in Bangladesh using the national 
language (Gausia 2007). In this study, Nasreen et al also used the State-Trait Anxiety 
Inventory (STAI) to assess general anxiety and reported anxiety in 29% of 720 
pregnant women (Nasreen 2011). Natasha et al used the Montgomery–Åsberg 
Depression Rating Scale (MADRS) to assess depression and reported 18.3% of 748 
pregnant women were depressed (Natasha 2015). Prost et al used Kessler-10 item 
scale to measure psychological distress and reported 11.5% of 5801 women had 
symptoms of distress (Kessler score >15).  
 
Rees et al used a combination of three data collection tools: the EPDS, the Kessler-10 
item scale and the Harvard Trauma Questionnaire to assess different types of 
psychological morbidity (Rees 2016). In 1672 women, 19.7% had a EPDS score ≥13; 
6.3% had a Kessler (K10) score ≥30; 5.7% had post-traumatic stress disorder score ≥2; 
and overall, 24.1% had symptoms of any type of mental distress (Rees 2016).  
 
Shamu et al assessed 842 women using the WHO version of the Center for 
Epidemiologic Studies Depression Scale (CES-D) and reported one in five postnatal 
women (21.4%) met the diagnostic criteria for postnatal depression symptomatology 
whilst 21.6% reported postpartum suicide thoughts and 4% reported suicide 
attempts (Shamu 2016). 
 
Stewart et al measured psychological morbidity using validated local versions of the 
Self-Reporting Questionnaire (SRQ). In a sub-sample, Diagnostic Statistical Manual 
(DSM)-IV diagnoses of major and minor depressive disorders were made using the 
Structured Clinical Interview for DSM-IV. In this study, 10.7% of 538 pregnant women 
reported major depression and 10.4% reported minor depression (Stewart 2014). 
 
Surkan et al conducted secondary data analysis on a database of 39,000 women to 
assess postpartum depressive symptoms based on questions about the women’s 





created their own five-item scale based on items modified from the Patient Health 
Questionnaire (PHQ-9) and the CES-D (Surkan 2017). A standard suicidal ideation 
question was also added. Independent translation and back translation was used and 
the items were piloted in focus group discussions to ensure their adequate 
translation, cultural relevance, and understandability. The five-item scale included: 
feeling sad all the time; becoming more forgetful; crying all the time; having thoughts 
of hurting oneself; and not wanting to bathe or eat for several days (Surkan 2017). 
Using these questions, 13.5% of 39,000 women experienced high depressive 
symptoms (3–5 symptoms) (Surkan 2017). 
 
Tsai et al used the Xhosa version of the EDPS to screen for depression in 1328 women 
and reported 39.5% of women screened positive for depression. It is not clear what 
the cut off score for depression was used in this study (Tsai 2016).  
 
Ukachukwu et al used their own questionnaire to extract data from medical case 
notes and reported that psychological disorders constituted 5.3% of reported 
postpartum complications among 1716 women (Ukachukwu 2009).  
 
Zafar et al used the EPDS questionnaire to assess depression (as a cut off score >9) 
and reported depression in 2.6% of women in Malawi and 26.9% of women in 
Pakistan (Zafar 2015). 
 
Table 2.8 below displays the summary of reported prevalence of psychological 
morbidity in the included studies. Different types of psychological morbidity with 
varying severity were assessed in the included studies, with wide ranges of 
prevalence for some conditions. Different studies used various cut-off scores to 
indication depression in the EPDS and to indicate distress in the Kessler scale. Some 
descriptions of psychological morbidity were described as aggregates or a summative 
condition, for example, terms such as “common mental disorders” and “symptoms 
of any mental distress” were used to report prevalence.  
 
 




Table 2.8: Summary table of prevalence of psychological morbidity 
Psychological morbidity (author description) 
 
Reported prevalence (%) 
Anxiety  Anxiety 29.0 
Depression “Depression” 13.5; 18.3; 21.4; 39.5 
EPDS score >9 2.6; 26.9 
EPDS score ≥10 18.0; 19.0 
EPDS score ≥13 11.0; 19.7 
Minor depression 10.4 
Major depression 2.0-10.7 
Suicidal 
ideation 
Postpartum suicide thoughts 21.6 
Attempted suicide 4.0 
Distress Distress (Kessler score >15) 11.5 
Distress (Kessler score >30) 6.3 
Post-traumatic stress disorder 
score ≥2 
5.7 
Stress High symptom levels 
(SRQ scores ≥6) 
12.0 
Low symptoms 
(SRQ scores 1–5) 
59.5 
No symptoms 




Anxiety and/or depression 18.0 
Mental distress 
(anxiety, unexplained crying, 
nervousness) 
10.0 
“Common mental disorders” 20.2 
Psychological disorders 5.3 







In this part of the results section so far, the data collection tools used, the types of 
psychological morbidity and the prevalence of the types of psychological morbidity 
described in the included studies have been reported. There is a wide range of 
symptoms and signs considered to be “psychological morbidity” and in addition, 
definitions of psychological morbidity vary. Finally, different data collection tools with 
different cut-off point, even for the same tool have been used to denote 
“depression”.  
 
In the following part of this results section, the data collection tools used, and 
prevalence of social morbidities related to maternal ill-health during and after 
pregnancy reported in the included studies is described. The associations between 
the different types of maternal morbidity are described separately at the end of the 
results section of the chapter.  
 
Social morbidity 
In total, 20 studies assessed at least one form of social morbidity. The most commonly 
assessed type of social morbidity was domestic violence in 12 studies (Chersich 2009, 
Karmaliana 2009, Hassan 2014, Hanlon 2009, Nasreen 2011, Ntaganir 2008, Romero-
Gutiérrez 2011, Rees 2016, Shamu 2014, Shamu 2016, Stöckl 2010, Tsai 2016). 
Substance misuse was assessed in six studies, mostly alcohol abuse (Faisal-Cury 2009, 
Isaken 2015, Hassan 2014, Hanlon 2009, Prost 2012, Wong 2017). Different forms of 
social morbidity were also assessed in three studies (Brittian 2017, Wado 2014, 
Waqas 2015). These different types of social morbidity included measures of social 
support and unplanned pregnancy.  
In the following part of the results section of this chapter, each form of social 
morbidity is described, including the data collection tool used, and the prevalence 








Domestic violence  
A total of 12 studies assessed domestic violence, and there were various types of data 
collection tools used and described. Most authors used their own definitions and 
questions to screen for domestic violence and other authors used all or part of 
internationally recognised questionnaires. A table of the three data collection tools 
used in the included studies, with an explanation of the purpose, the country of 
origin, the author and date of first publication of the data collection tool is displayed 







Table 2.9: Description of data collection tools used in included studies to assess social morbidity  
Data collection tool to 
assess psychological 
morbidity 





Details  Country of 
origin, author, 
date  
Index of Spousal Abuse  Domestic 
violence 
ISA  The Index of Spousal Abuse (ISA) is a 30-item self-report scale 
developed to measure the severity of physical and non-physical 




Severity of Violence 
against Women scale 
Domestic 
violence 
SVAWS  The Severity of Violence Against Women Scales (SVAWS) is a 46-
item scale to assess the frequency and severity of physical 
aggression against women by their male partners. The main 
purpose of the SVAWS is to tap, in a comprehensive manner, 
the psychological effects of intimate partner abuse. This scale 
has subscales that differ in the degree of severity (i.e., threats of 
violence, acts of violence, and sexual aggression). These scales 
can be further categorized into nine dimensions with each item 





country study on 
Women’s Health 






The WHO have developed an extensive questionnaire consisting 
of a household questionnaire, and a woman’s questionnaire. 
The woman’s questionnaire has 12 sections to obtain details 
about the woman and her community, her general and 
reproductive health, her financial autonomy, her children, her 
partner, her experiences of partner and non-partner violence, 
and the impact of violence on her life. This questionnaire was 
used in the WHO multi-country study WHO Multi-country study 
on Women’s Health and Domestic Violence against Women in 
2005 (WHO 2005).  
WHO,  
Geneva 2005 




Prevalence of domestic violence 
The prevalence of domestic violence and data collection tools used (if any) are 
described below for included studies. 
 
Chersich et al did not describe the source of questions used to assess domestic 
violence but reported 21% of 500 women self-reported intimate partner violence 
(Chersich 2009). Karmaliana et al used their own questions to assess domestic 
violence and 15% of women reported physical and/or sexual abuse and 30% of 
women reported verbal abuse in this study (Karmaliana 2009).  
 
Hassan et al developed their own screening questions regarding sexual abuse by a 
partner, and defined a woman with at least one positive response to any of the 
questions regarding physical, emotional or sexual violence as a “woman experiencing 
violence” (Hassan 2014). In this study, 72% of 1300 women self-reported that they 
had experienced intimate partner violence during their last pregnancy (Hassan 2014). 
Hanlon et al used their own questions and reported that 2.3% of 1065 women self-
reported physical assault during pregnancy (Hanlon 2009). 
 
Nasreen used their own questions to assess intimate partner violence and reported 
that 79.2% of 720 women had experienced forced sex; 33.8% of women reported 
multiple acts of physical violence; and 18.1% had experienced physical violence 
during pregnancy (Nasreen 2011). Ntaganir et al used their own questions to assess 
intimate partner violence and reported 35.4% of 600 women reported intimate 
partner violence in the past 12 months (Ntaganir 2008).  
 
Romero-Gutiérrez et al used the Index of Spousal Abuse (ISA) and the Severity of 
Violence against Women scale (SVAW) to assess domestic violence and reported that 
43.8% of 1623 women self-reported violence during pregnancy. Of these women 
79.1% experienced mild violence and 20.9% experienced severe violence (Romero-
Gutiérrez 2011). Rees et al used the WHO measurement to assess intimate partner 





did not feel respected. Overall, in this study 30.6% of women reported severe 
psychological abuse; 6.2% reported physical abuse and 19.5% reported both physical 
and psychological abuse (Rees 2016).  
 
Shamu et al used the WHO measurement to assess intimate partner violence and 
reported that 60% of 842 women reported at least one episode of physical, sexual or 
emotional intimate partner violence in the past 12 months (Shamu 2014). The same 
authors state that 65.4% of women reported any form of intimate partner violence 
in another publication (Shamu 2016). Stöckl et al categorised a woman as having 
experienced violence during pregnancy if she answered yes to the question “Was 
there ever a time when you were beaten or physically assaulted by (any of) your 
partner(s) whilst you were pregnant?”. Based on this question 19% of women 
reported having experienced violence during pregnancy (Stöckl 2010). 
 
Tsai et al enquired about the “frequency with which a woman’s current or previous 
intimate partner had, during the past 12 months, slapped or thrown anything at her; 
pushed or shoved her; hit her with a fist or another object; or threatened or attacked 
her with a gun, knife, or other weapon”. Responses were scored on a four-point Likert 
type scale ranging from 1 (“never”) to 4 (“many”). At this baseline assessment of this 
study, the prevalence of intimate partner violence varied and was reported as a range 
of 4.4-30.2% in 1328 pregnant women (Tsai 2016).  
 
Table 2.10 displays the summary of reported prevalence of social morbidity in the 
form of domestic violence reported in included studies. Different types of domestic 
violence with varying severity were assessed in the included studies, with wide ranges 
of prevalence for some conditions. Some descriptions of domestic violence were 
described as aggregates or a summative condition, for example, terms such as 
“multiple acts of physical violence”, “physical and/or sexual abuse”, and “physical 









Table 2.10: Summary table of prevalence of social morbidity (domestic violence)  
Social morbidity  Reported prevalence (%)  
One form of 
domestic 
violence 
Disrespect  32.9 
Forced sex 79.2 
Intimate partner 
violence 
21.0; 35.4;  




Verbal abuse  30.0 
Violence  
(no details of type)  
43.8 
Combination 
of types of 
domestic 
violence 
At least one form of 
physical, emotional or 
sexual violence  
60.0; 72.0 
Multiple acts of physical 
violence 
33.8 




psychological abuse  
19.5 
 
Substance misuse  
A total of seven studies assessed one or more forms of substance misuse and four 
different types of internationally recognised data collection tools were used. A table 
of the three data collection tools used in the included studies, with an explanation of 
the purpose, the country of origin, the author and date of first publication of the data 
collection tool is displayed in Table 2.11. All were developed in English and validated 






Table 2.11: Description of data collection tools used in included studies to assess social morbidity  
Data collection tool to 
assess psychological 
morbidity 





Details  Country of 
origin, author, 
date  
Alcohol Use Disorders 
Identification Test 
Alcohol use AUDIT  The full AUDIT provides 10 alcohol identification questions, and 
is a simple method of screening for excessive drinking and to 
assist in brief assessment. It can help identify excessive drinking 
as the cause of the presenting illness. It provides a framework 
for intervention to help risky drinkers reduce or cease alcohol 
consumption and thereby avoid the harmful consequences of 
their drinking. The AUDIT also helps to identify alcohol 
dependence and some specific consequences of harmful 
drinking (Babor 2001). 
WHO, 
Switzerland,  
Babor 2001  
Maternity Social 
Support Index 
Social support  MSSI  The Maternal Social Support Index is a 21-item questionnaire 
designed to quickly assess qualitative and quantitative aspects 
of a mother's social support (Pascoe 1988).  
USA,  
Pascoe 1988 
Social Provisions Scale  Social support  SPS To examine the degree to which respondent’s social 
relationships provide various dimensions of social support. The 
instrument contains 24 items, four for each of the following: 
attachment, social integration, reassurance of worth, reliable 
alliance, guidance, and opportunity for nurturance. Half of the 
items describe the presence of a type of support and the others 









Chersich et al used the Alcohol Use Disorders Identification Test (AUDIT) tool for 
harmful alcohol use and reported that less than 10% of 500 women reported any 
alcohol use during or after pregnancy (Cherscih 2009). Faisal-Cury et al used their 
own questions to assess alcohol and tobacco use, did not report the actual 
prevalence but did report that substance misuse was higher in women with common 
mental disorders (Faisal-Cury 2009). Hassan et al assessed tobacco use in 1300 
women and reported that 52.6% of pregnant women were smokers (Hassan 2014). 
Hanlon et al used their own questions to assess substance misuse and reported that 
5.0% of women used alcohol weekly or more, and 12.9% of women used “khat” (a 
local plant stimulant), weekly or more (Hanlon 2009). Isaken et al conducted a 
secondary data analysis of a database of 34,090 women and reported that alcohol 
consumption in women during pregnancy decreased from 49.5% in 2000 to 21.5% in 
2010 (Isaken 2015). Prost et al used their own questions to assess alcohol use and 
reported that 43.9% of 5801 women used a local form of alcohol “handia” in 
pregnancy (Prost 2012). Wong et al used the AUDIT tool to assess alcohol misuse and 
reported that among 625 HIV positive women, 21% reported alcohol-related harm 
and 16% reported risky alcohol use (Wong 2017). 
 
Table 2.12 displays the summary of reported prevalence of social morbidity in the 
form of substance misuse in included studies. Different types of substances were 
assessed in the included studies, with wide ranges of prevalence for alcohol use.  
 
Table 2.12: Summary table of prevalence of social (substance use) morbidity  
Substance misuse (author description) Reported prevalence (%)  
Alcohol  Alcohol use  5.0; 10.0; 21.5; 43.9; 49.5 
 Alcohol-related harm 21.0 
 Risky alcohol use  16.0 
Stimulants “Khat” (stimulant)  12.9 











Other forms of social morbidity assessed 
Wado et al used the Maternity Social Support Scale (MSSS) to assess social support 
but did not report prevalence (Wado 2014). Waqas et al used the Social Provision 
Scores (SPS) to assess social morbidity but did not report prevalence. They did report 
that 73.0% of women had an unplanned pregnancy (as a suggested form of possible 
social morbidity) (Waqas 2015). 
 
Associations between types of morbidity 
Overall, most (18) studies reported on associations (or not) between the two or more 
types of maternal morbidity, as defined for this systematic review. Studies used the 
odds ratio, adjusted odds ratio, risk ratio and logistic regression, univariate and/or 
multivariate analysis to present the strength of the associations.  
 
One study assessed the association between physical infectious and social morbidity 
(Shamu 2014). Seven studies assess associations between physical medical/obstetric 
and psychological morbidity (four studies report association that were statistically 
significant; three report association that were not) (Table 2.13). Three studies assess 
the association between physical medical/obstetric and social morbidity (Hassan 
2014, Romero-Gutiérrez 2011, Surkan 2017). Five studies assess the association 
between psychological and social morbidity (Karmalian 2009, Nasreen 2011, Rees 
2016, Tsai 2016, Stockl 2010). One study assessed the association between adverse 
pregnancy outcomes and psychological morbidity as the main finding (Prost 2012).  
 
Table 2.13 reports the details of associations between the different types of 
morbidity and the strength of these associations. For ease of readability, the main 
associations are presented below. More details for each study are in Summary Table 
in Appendix 1 and Appendix 2.  
 
Shamu et al reported that positive HIV status was associated with domestic violence 
(Shamu 2014). Surkan et al reported (in models adjusted for sociodemographic 




factors and co-morbidities), all postpartum illnesses were associated with an 
increased relative risk of depressive symptoms by 6 months postpartum (Surkan 
2017). The risk ratio for each postpartum physical illness is in Table 2.13. Zafar et al 
reported that complications during a previous pregnancy, infective morbidity, intra 
or postpartum haemorrhage were associated with psychological morbidity in both 
Malawi and Pakistan (Zafar 2015). Other associations are detailed in Table 2.13.  
 
Faisal-Cury et al reported that obstetric complications were independently 
associated with common mental disorders during pregnancy; but were not 
associated with risk of preterm birth or low birth weight. Karmaliana et al reported 
that psychological distress was associated with an unwanted pregnancy (as a possible 
measure or proxy for social morbidity). Hanlon et al reported that increasing levels of 
antenatal common mental disorders symptoms were associated both with prolonged 
labour >24 hours and delayed initiation of breast-feeding (Hanlon 2009).  
 
Nasreen et al reported that partner violence showed strong associations with 
depression and anxiety (Nasreen 2011). Natasha et al reported no statistically 
significant association between depression and gestational diabetes (Natasha 2015). 
Prost et al reported that an unwanted pregnancy, small perceived infant size and a 
stillbirth or neonatal death were all independently associated with an increased risk 
of psychological distress in the postnatal stage (Prost 2012). The loss of an infant or 
an unwanted pregnancy increased the risk of psychological distress considerably 
(Prost 2012). Rees et al reported that for women who reported four or more 
traumatic events, and either physical abuse alone or in combination with severe 
psychological abuse, there was a 10-fold increase in depressive and other mental 
health symptoms (Rees 2016).   
 
Tsai et al reported that after multivariable adjustment, intimate partner violence 
intensity had a strong and statistically significant association with depression 
symptom severity (Tsai 2016). Wado et al reported that an unwanted pregnancy, 
prenatal depression and social support were associated with low birth weight (Wado 






with less social support, abortion, Caesarean delivery and unplanned pregnancies 
(Waqas 2015). Wong et al reported that thoughts of self-harm were likely in younger 
women with HIV, compared to older women with HIV (Wong 2017).  
 
Hassan et al reported a significant association between domestic violence and 
preterm labour, Caesarean section, antenatal hospitalization and vaginal bleeding 
(Hassan 2014). Romero-Gutiérrez et al reported that women who had obstetric 
complications were more likely to have experienced domestic violence. Women who 
experienced sexual violence were more likely to report maternal complications, and 
women who experienced psychological violence were more likely to report neonatal 
complications (Romero-Gutiérrez 2011). The odds ratios were not reported for these 
associations. Stöckl et al reported that women were more likely to drink alcohol 
during their last pregnancy if they had experienced violence during pregnancy. 
Violence during pregnancy was also associated with having had a child or infant that 
died. Violence during any pregnancy was not significantly associated with ever having 
had a miscarriage, or low birthweight of the last-born child (Stöckl 2010).  





















In models adjusted for sociodemographic factors and co-morbidities, all postpartum 
illnesses were associated with an increased relative risk of depressive symptoms by 6 
months postpartum. These morbidities included uterine prolapse (RR 1.20, 95% CI 
1.04–1.39), urinary tract infection (RR 1.24, 95% CI 1.11–1.38), stress related 
incontinence (RR 1.49, 95% 1.33–1.67), simultaneous SRI and continuously dripping 
urine (RR 1.60–2.96), headache [RR 1.20 (95% CI 1.12–1.28)], convulsions (RR 1.67, 
95%CI 1.36–2.06), night blindness (RR 1.33, 95% CI 1.19–1.49), anemia (RR 1.38, 95% CI 
1.31–1.46), pneumonia (RR 1.24, 95% CI 1.12–1.37), gastroenteritis (RR 1.24, 95% CI 







Multivariate logistic regression showed that for Malawi, after controlling for parity and 
pregnancy stage, antepartum bleeding increased the odds of psychological morbidity 
5-fold (OR: 5.01; 95% CI 1.60, 15.70; p=0.006). Infective morbidity (i.e. for each 
additional infective morbidity) showed more than 2.5-fold increase in the odds of 
having psychological morbidity (OR: 2.58; 95% CI 1.92, 3.47; p=0.000). For Pakistan, 
results show a 56% increase in odds of psychological morbidity due to increasing 
burden of infective morbidity (OR: 1.56; 95% CI 1.36, 1.79; p = 0.000), and 78% 
increased odds due to increasing burden of non-infective morbidity (OR: 1.78; 95% CI 
1.51, 2.11; p = 0.000), when controlling for the effect of complication during a previous 
pregnancy. Complications during a previous pregnancy, infective morbidity (p <0.001), 
intra or postpartum haemorrhage (p<0.02) were associated with psychological 












Age at current pregnancy and at first delivery, not having friends in the community, 
living in a crowded household, lower occupational status and history of previous 
psychiatric treatment was all independently associated with increased prevalence of 
common mental disorders. Current obstetric complications were independently 
associated with common mental disorders. Common mental disorders during 
pregnancy was not associated with risk of preterm birth (adjusted OR:1.03, 95% CI: 





Common mental disorders during pregnancy was not associated with risk of preterm 






Psychological distress was associated with husband unemployment (p = 0.032), lower 
household wealth (p = 0.027), having 10 or more years of formal education (p = 0.002), 





Increasing levels of antenatal common mental disorders symptoms were associated 
both with prolonged labour (>24 h) (SRQ 1-5: RR 1.4; 95% CI 1.0-1.9, SRQ >or= 6: RR 





Women’s literacy, poor household economy, poor relationship with husbands, and 











Unwanted pregnancy for the mother, small perceived infant size and a stillbirth or 
neonatal death were all independently associated with an increased risk of 
psychological distress. The loss of an infant or an unwanted pregnancy increased the 
risk of distress considerably (AORs: 7.06 95% CI: 5.51-9.04 and 1.49, 95% CI: 1.12-
1.97respectively. 










For any mental distress, the adjusted odds ratios for four or more traumatic events 
and severe psychological abuse was 3.60 (95% CI 2.08-6.23); for four or more 
traumatic events and physical abuse 7.03 (95% CI 3.23-15.29); and for four or more 
traumatic events and severe psychological and physical abuse the adjusted OR was 
10.45 (95% CI 6.06-18.01). Of women who reported four or more traumatic events, 
and either physical abuse alone or in combination with severe psychological abuse, 











After multivariable adjustment, intimate partner violence intensity had a strong and 






Results of unadjusted log-binomial regression showed that unwanted pregnancy, 
prenatal depression and social support were associated with LBW. The relationship 
between antenatal depressive symptoms and LBW was mediated by the presence of 
social support, while the association between LBW and unwanted pregnancy remained 





Inferential analysis revealed that higher HADS scores were significantly associated with 
lower scores on the SPS, rural background, history of harassment, abortion, Caesarean 
delivery and unplanned pregnancies (P <.05). Social support (SPS score) mediated the 



















A significant association was found between intimate partner violence and preterm 
labour [adjusted odds ratio (adjOR) 1.54, 95% confidence interval (CI) 1.16-2.03], 
caesarean section (adjOR 11.84, 95% CI 6.37-22.02), antenatal hospitalization (adjOR 






Maternal complications were higher in women who experienced violence (30.2% vs 
23.6%, p=0.004). Women who experienced sexual violence had more maternal 
complications (43.2%), and women who experienced psychological violence had more 
neonatal complications (54.2%). 
Stöckl 2010 Tanzania Household 
survey 
Women's odds of drinking during their last pregnancy were significantly increased if 
they had experienced violence during pregnancy. Violence during pregnancy was also 
associated with having had a child or infant that died.  




2.5 Discussion  
A systematic review of the literature was conducted to assess studies that have 
measured the prevalence of and/or associations between at least two types of 
maternal morbidity in LMIC.  
 
Statement of principal findings 
The main finding is that there is evidence of a high burden of ill-health related to 
and/or aggravated by pregnancy reported by, and/or confirmed by clinical 
examination and investigations, during and after pregnancy in women in several 
LMIC. There is emerging evidence of association between the different types of 
maternal morbidity. However, a wide variety of tools and assessment stages are 
used, making comparison difficult, and an estimation of overall burden of maternal 
morbidity cannot be estimated from existing studies.  
 
Study design  
Of the 26 included studies, the majority were cross sectional studies that collected 
primary data from women during and after pregnancy by face-to-face interview 
and/or clinical assessment of the women.  
 
Three studies used existing databases to describe estimates of maternal morbidity 
(Isaken 2015, Surkan 2017, Tsai 2016). The use of databases to identify and estimate 
maternal morbidity can have many strengths and advantages. Such data involves 
generally large populations of women, is comprehensive in nature and often covers 
a longer period of time. For secondary data analysis, the data is often readily 
available, (usually electronically) and secure for referencing. However, in the absence 
of a validated set of uniform identification criteria for maternal morbidity, the 
nomenclature, types and severity of maternal morbidity is difficult to measure with 
confidence in a standardised way. Furthermore, since the databases were not 
primarily designed to collect data regarding maternal morbidity, there is a risk that 






be included in the original data collection tool and therefore not entered into the 
database.  
 
A cross sectional study design was employed to collect primary data regarding 
maternal morbidity in most of the studies reviewed. This study design is simple, 
relatively cheap and appropriate for face-to-face interviews (Mann 2003). A cross 
sectional study design can determine prevalence. However, using a method and 
approach that allows for important comparisons across and between settings is 
important. 
 
Collection of primary data was the most common approach with nearly all studies 
collecting self-reported data in face-to-face interviews with women during and after 
pregnancy. In three studies, women were also examined and basic investigations 
were performed.  
 
In terms of geographical distribution, similar numbers of studies collected primary 
data in low income countries, and in middle income countries. This pattern suggests 
that in the absence of robust electronic data collection systems and databases, 
researchers based in LMIC tend to employ primary data collection using self-
reporting symptoms, for studies on maternal morbidity. There was no mention in any 
study if electronic data collection was used. The strength of primary data collection 
can be that the participating woman has an opportunity to self-report their 
symptoms, have a clinical assessment performed and data collected to identify and 
then to provide care or refer on if any health problems are detected.  
 
Given the lack of resources in many LMIC settings, the research team may have spent 
more time with the women and may have then had the opportunity to provide 
“better than average” care allowing for correct diagnosis of women’s health needs, 
and providing appropriate treatment or referral. This may result in “better” or higher 
estimates of maternal morbidity than if retrospective self-reported or documented 
symptoms and signs are elicited. 




The sample size in most of the studies in this review was less than 750 women. 
Limiting factors have included the cost and technical expertise required of healthcare 
providers or research assistants in LMIC to fully assess maternal morbidity during and 
after pregnancy. For a more accurate measurement of maternal morbidity, a larger 
sample size and a multi-country approach is required. Ultimately, population level 
data on maternal morbidity would be ideal, but this would be difficult to capture by 
primary data collection.  
 
Of the studies, that collected primary data, most (19/21) assessed women during 
pregnancy at one point of time. Less studies (6/21) assessed women after pregnancy. 
It would be beneficial to assess women at different stages of pregnancy. This would 
help to compare prevalence of maternal morbidity during and after pregnancy and 
allow to assess if morbidity changes during pregnancy and/or over time. In addition, 
the burden and type of maternal morbidity can be expected to be different; for 
example, maternal morbidity detected in the early antenatal stage may be different 
to that in the late antenatal stage, and likewise for the various postnatal stages.  
 
Types of maternal morbidity assessed  
There were many varied and different types of physical, psychological and social 
morbidity assessed in the included studies, with wide ranges of prevalence of and/or 
association between different types of maternal morbidity. Table 2.8, Table 2.10, and 
Table 2.12 have displayed the best estimates available for the maternal morbidities 
assessed in the studies included in this review. Although maternal morbidity is known 
to be under-reported in LMIC, these estimates show widespread ill-health.  
 
HIV was assessed in six studies; anaemia in five studies, malaria in three studies, and 
tuberculosis in two studies. Considering that some LMIC are endemic areas for these 
conditions, this was a surprising finding. This finding suggests that assessment of 
burden of HIV, malaria and anaemia are often conducted as separate singular studies 






pregnancy. This may because studies that these morbidities are assessed in isolated 
in the literature. 
 
There was a lack of standardisation of definitions and data collection tools used to 
measure different types of physical morbidity. The EPDS was the most common 
validated data collection tool to assess psychological morbidity in the included 
studies, but with different cut-off scores used to determine the risk of “depression” 
or not. A variety of different validated data collection tools were used to assess 
domestic violence and substance misuse as components of social morbidity. Many 
descriptions of physical, psychological and social morbidity were described as 
aggregates or summative measures, limiting the comparability of the reported 
prevalence. Aggregation or comparison of data is problematic because of the 
differences in methodology and tools, and because data is situation specific. Hence 
the estimates of the prevalence of maternal morbidity at best portray local or 
regional specific situations. 
 
  




Strengths and weaknesses of the study 
To the best of the lead researcher’s knowledge, this is the first systematic review to 
assess the prevalence of maternal morbidity (physical, psychological, social) and/or 
associations between two of more types of maternal morbidity in women in LMIC.  
 
Limitations 
In the following sections, the main limitations are discussed. The following are 
highlighted; sample size of included studies, recall bias, self-reported subjective 
symptoms and quality assurance of translation of validated data collection tools are 
discussed.  
 
Sample size  
This review did not include studies if the sample size was less than 500 women, of 
which there were 14 studies excluded. The details of these studies have been 
included for reference in Appendix 5, Table A and Table B.  Furthermore, only studies 
that assessed women within 12 weeks postnatal were included. As a result, maternal 
morbidity prevalence in smaller studies and that first developed or manifested 
beyond 12 weeks postnatal was not assessed.  
 
Recall bias  
Many included studies relied on recall of health problems or complications by women 
over various ranges of time. A few studies asked women to recall information 
regarding complications in previous pregnancies and in one study, women were 
interviewed after birth and were asked to remember symptoms over the course of 
their pregnancy (Prost 2012). When a woman is asked to remember complications 
over a longer time frame, there is a higher risk of recall bias and women may not be 
able to provide a complete account of events during and after pregnancy.  
 
Recall bias is a common issue in studies that use self-reporting and is a type of 






be unintentional due to a woman’s poor or incomplete memory recall, or it can 
be intentional, for example, because the women felt embarrassed or uncomfortable 
to report psychological ill-health (for example, severe depression and suicidal 
ideation) (Sedgwich 2012). There may have been higher levels of responder bias in 
studies assessing maternal morbidity that assesses potentially sensitive or socially 
unacceptable conditions, for example domestic violence. Responder bias may 
contribute to pre-existing belief systems, for example women may not report 
different types of maternal morbidity as these conditions are concerned “normal” or 
there may be a belief that complaining of the symptom may pre-empt ill-health in 
the specific cultural setting (Sedgwich 2012). The reported prevalence based on recall 
must be interpreted with caution.  
 
As an example, a study included in this review by Stewart et al compared self-
reported data collected through interviews with that extracted from women’s clinical 
records to examine concordance regarding their study participants’ maternal 
morbidity conditions (Stewart 2014). They highlighted the weakness of interview-
based diagnosis, showing that women’s response to questions to elicit morbidity 
could not compare to the “gold-standard” diagnosis as recorded in case notes 
(Stewart 2014). The authors concluded that interviews may only be useful to 
determine prevalence of symptoms of interest but not clinical diagnosis (Stewart 
2014). This review highlights the further need to correlate what women recall 
compared to accurately documented clinical diagnosis extracted, for example from 
medical records.  
 
Self-reporting symptoms 
In studies included in this review, much of the primary data collected was largely 
symptom based rather than “diagnosed” maternal morbidity conditions per se. In this 
review, only three studies triangulated self-reported symptoms with findings from 
clinical examination and/or basic investigations. This may mean that the assessment 
of prevalence of ill-health is over-estimated, as most prevalence estimate were based 




on women’s subjective self-reporting, rather than a confirmed clinical diagnosis. The 
issues regarding the “validity” of subjective self-reporting is important as it relates to 
the WHO definition of maternal morbidity, that is “any health condition that is 
attributed to or aggravated by pregnancy and childbirth which has a negative impact 
on the woman’s wellbeing” (Firoz 2013). For example, a woman may feel “well” and 
state that she feels that there is no health condition having a negative impact on her 
wellbeing. However, after a healthcare provider conducts a clinical examination and 
basic investigations, the woman may be diagnosed with pre-eclampsia. Conversely, 
for example, a woman may report nausea and vomiting that is having a significant 
negative impact on her wellbeing but when a healthcare provider conducts a clinical 
examination and basic investigations, all parameters are normal. The limitations of 
self-reporting are well recognised but it could be argued that these are signs and 
symptoms which women themselves consider as significantly contributing to “non-
health” or associated with adverse pregnancy outcome. This requires further 
exploration. This review highlights the need to further explore the experiences of 
women with regards to their understanding of ill-health during and after pregnancy, 
compared to a clinical condition diagnosed as ill-health by a healthcare provider. 
 
Data collection tools  
No study included in this review described or used an internationally recognised data 
collection tool to assess physical morbidity. Each author group described and 
measured physical morbidity in different ways. A variety of internationally recognised 
data collection tools were used to assess psychological and social morbidity, but most 
were developed in English and validated in high income country settings, but have 
been used for studies in low and middle-income countries. The translation and back-
translation versions of standardised data collection tools were mentioned in a few 
studies but the quality assurance of the translation and validation is uncertain for 
every setting. 
 
Furthermore, in several of the included studies, the authors emphasised that if the 






clinical setting, it should be administered by a general healthcare provider under the 
supervision and support of a specialised psychiatric nurse and/or psychiatrist. Many 
of the authors highlighted that the data collection tools used to assess psychological 
and social morbidity, are not designed to be “diagnostic” and that no checklist should 
replace the role of a healthcare provider trained in diagnosing and treating each 
specific type of maternal morbidity.  
 
There is a need to use standardised tools and cut-off scores and definitions with 
correct translation, ensuring relevance in (all) settings and at each stage during and 
after pregnancy that is feasible for use at primary and secondary healthcare level.  
 
Summary  
In this review, the estimated prevalence of different types of physical, psychological, 
and social maternal morbidity were not based on standardised, well documented and 
transparent methodologies and tools, and therefore have limited usefulness and 
validity for informing efforts to address the global burden of maternal morbidity 
during and after pregnancy (Gülmezoglu 2004, Chou 2016). The findings of this 
systematic review would suggest that three major issues have limited valid, routine, 
and comparable measurements of maternal morbidity to date (Chou 2016). These 
are the lack of: 
a) common definitions and identification criteria for different types of physical, 
psychological, and social maternal morbidity, 
b) standardised and validated data collection tools that can be used in different 
languages and at all levels of healthcare: community, primary, secondary and 
tertiary healthcare levels, 
c) validation of self-reported measurements of maternal morbidity 
(experienced by women themselves) compared to clinical assessment, 
investigations and diagnosis determined by a healthcare provider.  
 




Implications for research  
The findings of this review have research implications and contributes to the ongoing 
debate on the need for an internationally accepted assessment methodology to 
assess maternal morbidity. As a reflection of the new concept of maternal morbidity, 
only two of the studies in this review used the term “maternal morbidity”. To date a 
range of methods and tools have been used to assess maternal morbidity in different 
languages, in different settings across different LMIC, each with their strengths and 
weaknesses. The validity of many of the standardised data collection tools used in 
LMIC is unknown and the quality of translation, acceptability and feasibility of 
standardised data collection tools is uncertain. 
 
Unanswered questions and future research 
The review highlights significant discrepancy in the literature concerning how 
different types of maternal morbidity are measured and defined. There is a need for 
a validated data collection tool that allows for consistent standardised measurement 
of maternal morbidity across settings and time. This literature review illustrates that 
there is a need to agree on a framework and system for measuring maternal 
morbidity that is useable and applicable across different country and income settings. 
The new WHO definition of maternal morbidity in principle provides such a 
framework, but challenges remain to map out comprehensive, feasible and 
acceptable assessment stages, approaches and tools.  
 
The findings of this systematic review of the literature highlights the limitations of 
various methods and measurements that have previously been used to assess 
different types of maternal morbidity in different LMIC to assess components of 
maternal morbidity. The maternal morbidity estimates generated using these 
methodologies and tools, while useful as a guide, are not truly representative of the 
burden and range of maternal morbidity conditions that have a negative impact on a 







To date, the measurements that have reported prevalence of different types of 
maternal morbidity are not based on standardised, well documented, and 
transparent methodologies. Comprehensive and routine measurements of maternal 
morbidity are necessary to inform policy and program decisions and resource 
allocations that will also help to improve maternal health and well-being and to 
decrease long-term suffering and disability. Improved systems of the measurement 
of maternal morbidity will also allow for comparison of the burden across settings 
within and between countries.  
 
The lessons learnt in the efforts to measure maternal mortality previously may 
provide useful insights to improve how maternal morbidity is assessed in LMIC. For 
example, it may not be feasible to use the exact same approach across all countries, 
but having an internationally agreed standardized method and data collection tool 
could then be adopted and adapted by countries based on their level of technological 
development and affordability at costs they can afford.  
 
  




2.6 Chapter summary  
This chapter has presented a systematic review of studies that have measured the 
prevalence of and/or associations between different types of maternal morbidity in 
women in LMIC. This chapter has described how the systematic review of literature 
as conducted starting with the conceptualisation of maternal morbidity and the 
categories selection into types or components including physical, psychological and 
social morbidity. A total of 26 studies met the inclusion criteria and the main findings 
are presented and discussed using a narrative synthesis, alongside summary tables.  
This chapter has positioned the objective of this research project in the context of 
available evidence, critically appraised methods used, presented the main findings, 
as well as strengths and weaknesses and implications for research have been given. 









CHAPTER 3: METHODOLOGY  
3.1 Introduction  
In this chapter, the approach used to measure maternal morbidity using physical, 
psychological and social health in a comprehensive and standardised way in women 
during and after pregnancy at different healthcare levels in India, Pakistan, Kenya, 
Malawi is described. 
 
At the start of this chapter firstly, the positionality of the research project and author 
contribution is considered. This chapter then describes the study design, study 
settings, study population and sampling. How the sample size is determined and the 
data collection tool and the process of piloting is described. This chapter describes 
the process of data collection, processing, cleaning, coding and analysis. This chapter 
concludes with how the quality of the data was assured and ethical considerations 
are described and addressed. 
 
3.2 Positionality of researcher 
At the time of writing, the lead researcher was a Senior Specialist Registrar in 
Obstetrics and Gynaecology and was undertaking a four year “Out of Programme in 
Research” placement at the Centre of Maternal and Newborn Health (CMNH) at the 
Liverpool School of Tropical Medicine (LSTM). At the time of writing, the lead 
researcher was a full-time member of staff at CMNH-LSTM, as a Clinical Research 
Associate and qualifications included BSc Med Sci, MBChB, MRCOG, PgCert. Before 
this research placement, the lead researcher had worked as a full-time volunteer 
doctor with Voluntary Services Overseas in South Ethiopia, East Africa for one year.  
 
At CMNH-LSTM, the lead researcher led, developed and delivered the maternal 
morbidity research project that comprises this PhD project. The lead researcher co-
ordinated and supervised all the research activities. It is noted that as a medical 
doctor, the lead researcher may have a bias towards over-medicalisation of health. 




The lead researcher conducted the following activities: 
 
• Developing the study protocol 
• Performing the systematic literature review 
• Supporting ethical approval in each country  
• Developing training manuals for research assistants and supervisors  
• Piloting and refining the data collection tool 
• Training data collectors /research assistants and research supervisors  
• Quality assurance of the translation and delivery of the data collection tool  
• Chairing weekly research meetings with research supervisors and team 
members 
• Monitoring and supervising the data collection process  
• Writing the data analysis plan 
• Leading the cleaning, processing, coding of the datasets 
• Conducting basic data analysis  
• Conducting the univariate and multivariate analysis, with the support of a 
senior statistician 
• Presenting the results of each country 
• Interpreting the results of each country 
• Discussing the meaning of the results and implications for further research 
• Writing and submitting the manuscripts for publication  
 
For this large multi-country maternal morbidity project, other members of the 
CMNH-LSTM team contributed. Professor Nynke van den Broek conceived the study 
idea, study design, and data collection tool. Dr Sunday Ajadi obtained ethical approval 
from LSTM and started the ethical approval process in each country. Fiona Dickinson 
formatted the data collection tool for electronic data collection onto hand held 
tablets. Dr Barbara Madaj supervised and monitored data collection remotely for 
each country. Professor Pratima Mittal supervised data collection in India, Professor 
Shamsa Rizwan in Pakistan, Dr Pamela Godia in Kenya, and Dr Sarah Bar-Zeev in 






Formic®. Dr Mamuda Aminu and Katrin Metsis imported electronic data from email 
attachments, cleaned, processed, coded part of the datasets. Dr Bethany Levick 
conducted preliminary univariate and multivariate analysis. Dr Sarah White checked 
all basic and advanced data analysis and performed further analysis.  
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Research questions  
In this research study, there were four research questions, that are answered in the 
results chapter and explained in the discussion chapter.  
Table 3.1: Research questions for the study  
Number  Research question 
1. What is the prevalence of maternal morbidity and what types of ill-
health (symptoms, signs and investigations) contribute to maternal 
morbidity? 
2. What is the prevalence of maternal morbidity at different stages of 
pregnancy? 
3. Is there an association between the different types of maternal 
morbidity and age, socioeconomic status, educational level, number of 
previous pregnancies, and/or adverse maternal or neonatal outcomes 
in the most recent pregnancy? 
4. Is there an association between the different types of morbidity, 
defined as infectious, medical/obstetric, psychological and social 
morbidity?  
 
3.3 Study design  
To answer research question number one and two, this research study employed an 
observational descriptive cross-sectional study. The data collection tool was 
administered to women attending for routine antenatal or postnatal care or birth at 
selected healthcare facilities in India, Pakistan, Kenya and Malawi. The survey 
involved the administration of a questionnaire in a face-to-face interview, clinical 
examination and urine and serological investigations, to obtain information on 
women’s subjective and objective health during and after pregnancy. A cross-
sectional study design was chosen in order to compare different population groups 
at a single point in time, and to allow for comparison of many different variables 
within the same time (Mann 2003). Cross sectional surveys using questionnaires are 






descriptive research (Mann 2003). The methods are presented here following the 
STROBE guidelines for reporting cross sectional studies (Elm 2007). 
A cross-sectional study design was used in this study to make comparisons across the 
following five assessment stages, during and after pregnancy (Table 3.2). 
 
Table 3.2. Definitions of assessment stages  
Number Stage Abbreviation Time frame 
1. Early 
antenatal 
EAN ≤ 20 weeks’ gestation of pregnancy* 
2. Late 
antenatal 
LAN >20 weeks gestation of pregnancy* 
3. Delivery 
 
DEL  ≤ 24 hours from time of childbirth 
4. Early 
postnatal 
EPN from day 1-7 (>24 hours up ≤ day 7) from 
time of childbirth 
5. Late 
postnatal  
LPN from week 2-12 (>day 7 and ≤ week 12) 
from time of childbirth 
*For the antenatal assessments, gestation was calculated based on the women’s last menstrual period 
or the results of a dating scan, if available.  
 
3.4 Study settings  
This study was conducted in two countries in South Asia (India and Pakistan) and two 
countries in sub-Saharan Africa (Kenya and Malawi). Malawi and Pakistan were 
purposively chosen as a previous maternal morbidity baseline survey has been 
conducted in these settings by the research team at CMNH-LSTM (Zafar 2015). Kenya 
and India were selected opportunistically by the research team at CMNH-LSTM to 
include one further country from sub-Saharan Africa and Asia to enable comparisons 
between the study populations in Malawi and Pakistan. Countries were also chosen 
due to poor maternal health indicators and to reflect the diversity of epidemiology 
with regards to the prevalence of HIV, TB, syphilis and malaria. Table 3.3 displays the 




total population, life expectancy at birth (years) for females and the proportion of 
women who attend for at least one ANC visit in each country study setting. 
The following table contain information derived from the World Health Statistics 
document 2016 (WHO 2016). The original source of information is given in the 
footnotes of the two following tables.  
Table 3.3: Background country details for study settings  
Background Date of 
reference  




2015 1311051 188925 46050 17215 7313015 
Life expectancy 
at birth (years) 
femaleb 
2015 69.9 67.5 65.8 59.9 73.7 
Healthy life 
expectancy at 
birth (years)b  
2015 59.5 57.8 55.6 51.2 63.1 
At least one 
antenatal visit 
(%)c 
2015 75 73 92 96 83 
a World Population Prospects, the 2015 revision (WPP2015). New York: United Nations DESA, 
Population Division. 
b WHO annual life tables for 1985–2015 based on the World Population Prospects on the data held in 
the WHO Mortality Database and on HIV mortality estimates prepared by UNAIDS.  
c World Health Statistics. Geneva: World Health Organization; 2015. Available at: 
http://www.who.int/gho/publications/world_health_statistics/2015/en/ 
 
Table 3.4 presents health indicators used to monitor the SDG for each study country 












Indicators  India Pakistan Kenya Malawi Global 
Ensure significant 
mobilization of resources 
from a variety of sources, 
including through 
enhanced development 
cooperation, in order to 
provide adequate and 
predictable means for 
developing countries, in 
particular least-developed 
countries, to implement 
programmes and policies 
to end poverty in all its 
dimensions 
1.a 2015 1.a.2 Proportion of total 
government spending on 
essential services 




(GGHE) as % of general 
governmentd 
5.0 4.7 12.8 16.8 n/a 
By 2030, reduce the 
global maternal mortality 
ratio to less than 70 per 
100 000 live births 
3.1.1 2015 Maternal mortality ratio 
(per 100 000 live births)e  
174 178 510 634 216 
3.1.2 2005-
2016 
Proportion of births 
attended by skilled health 
personnel (%)f  
81 52 62 90 78 
By 2030, end preventable 
deaths of newborns and 
children under 5 years of 
age, with all countries 
3.2.1 2015 Under-five mortality rate 
(per 1000 live births)g  
47.7 81.1 49.4 64.0 42.5 
3.2.2 2015 Neonatal mortality rate 
(per 1000 live births)g  
27.7 45.5 22.2 21.8 19.2 




aiming to reduce neonatal 
mortality to at least as 
low as 12 per 1,000 live 
births and under-5 
mortality to at least as 
low as 25 per 1,000 live 
births 
By 2030, end the 
epidemics of AIDS, 
tuberculosis, malaria and 
neglected tropical 
diseases and combat 
hepatitis, water-borne 
diseases and other 
communicable diseases 
3.3.1 2015 New HIV infections 
among adults 15–49 years 
old (per 1000 uninfected 
population)h 
0.11 0.16 3.52 3.82 0.5 
3.3.2 2015 TB incidence (per 100 000 
population)i  
217 270 233 193 142 
3.3.3 2015 Malaria incidence (per 
1000 population at risk)j  
18.6 8.6 166.0 188.8 94.0 
3.3.4 2015 Infants receiving three 
doses of hepatitis B 
vaccine (%)k  
87 72 89 88 84 




497396247 31056287 13642040 11426323 1591109130 
By 2030, reduce by one 
third premature mortality 
from non-communicable 
diseases through 
prevention and treatment 
3.4.1 2015 Probability of dying from 
any of CVD, cancer, 
diabetes, CRD between 
age 30 and exact age 70 
(%)m  






and promote mental 
health and well-being 
3.4.2 2015 Suicide mortality rate (per 
100 000 population)m  
15.7 2.1 6.5 5.5 10.7 
Strengthen the prevention 
and treatment of 
substance abuse, 
including narcotic drug 
abuse and harmful use of 
alcohol 
3.5.2 2016 Total alcohol per capita 
(≥15 years of age) 
consumption (litres of 
pure alcohol), projected 
estimatesn 
5.0 0.2 4.4 2.4 6.4 
By 2030, ensure universal 
access to sexual and 
reproductive health-care 
services, including for 
family planning, 
information and 
education, and the 
integration of 
reproductive health into 




Proportion of married or 
in-union women of 
reproductive age who 
have their need for family 
planning satisfied with 
modern methods (%)o  
63.9 47.0 75.4 73.6 76.7 
3.7.2 2005-
2014 
Adolescent birth rate (per 
1000 women aged Male 
Female Both sexes 15–19 
years)p 
28.1 44.0 96.0 143.0 44.1 
d WHO Global Health Expenditure Database [online database]. Geneva: World Health Organization (http://apps.who.int/nha/ database/Select/Indicators/en). Global and 
regional aggregates are unweighted averages.  
e WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Trends in maternal mortality: 1990 to 2015. Estimates by WHO, UNICEF, UNFPA, 
World Bank Group and the United Nations Population Division. Geneva: World Health Organization; 2015.  
f WHO global database on maternal health indicators, 2016 update [online database]. Geneva: World Health Organization (http://www.who.int/gho/maternal_health/en/).  
g Levels & Trends in Child Mortality. Report 2015. Estimates Developed by the UN Interagency Group for Child Mortality Estimation. New York (NY), Geneva and 
Washington (DC): United Nations Children’s Fund, World Health Organization, World Bank and United Nations; 2015. 
h UNAIDS/WHO estimates; 2015. 




i Global tuberculosis report 2015. Geneva: World Health Organization; 2015 (http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1). 
j World Malaria Report 2015. Geneva: World Health Organization; 2015 (http://www.who.int/malaria/publications/world-malariareport-2015/report/en). 
K WHO/UNICEF coverage estimates 2014 revision. (http://www.who.int/immunization/monitoring_surveillance/routine/coverage/en/index4.html). 
l Global Health Observatory [website]. Geneva: World Health Organization (http://www.who.int/gho/en/), and the Preventive Chemotherapy and Transmission Control 
(PCT) databank. Geneva: World Health Organization (http:// www.who.int/neglected_diseases/preventive_chemotherapy/databank/en/). 
m Global Health Estimates 2013: Deaths by Cause, Age and Sex, Estimates for 2000–2012. Geneva: World Health Organization; 2014 
(http://www.who.int/healthinfo/global_burden_disease/en/).  
n WHO Global Information System on Alcohol and Health [online database]. Geneva: World Health Organization; 2015 
(http://apps.who.int/gho/data/node.main.GISAH?showonly=GISAH). 
o World Contraceptive Use 2016. New York (NY): United Nations, Department of Economic and Social Affairs, Population Division; 2016. Forthcoming. Regional aggregates 
are estimates for the year 2015, taken from model-based estimates and projections of family planning indicators 2015. New York: United Nations, Department of Economic 
and Social Affairs, Population Division; 2015 (http://www.un.org/en/development/desa/population/ theme/family-planning/cp_model.shtml). 














India is a lower-middle-income country and one of the most populous countries in 
the world, with an estimated population of 1.3 billion (WHO 2017e). India is a federal 
union of states comprising 28 states and seven union territories. The states and union 
territories are further subdivided into 640 districts (Census of India 2011). The MMR 
in India is 174 per 100,000 with wide disparities across the states (WHO 2015a). 
Skilled birth attendance is 81% and neonatal mortality rate (NMR) is 27.7per 1000 
live births. (WHO 2015c). India does not have the highest rates of MMR and NMR 
globally, but it does have the highest absolute numbers of women and newborn 
babies who die per year (WHO 2015c). With regard to healthcare coverage and 
uptake, the proportion of women who attend for at least one ANC visit is 75% and 
skilled attendance at birth (or institutional delivery) is 81% (WHO 2015c). This study 
was conducted in the Department of Obstetrics in Safdarjung Hospital, in New Delhi, 
the capital of India and this selection was opportunistic. The Safdarjung Hospital is a 
1600-bed tertiary level healthcare facility and is one of the largest public government 
hospitals in New Delhi, India. It serves as a referral centre for several public and 



















Figure 3.1: Map of India 
 
 
(Source of map: https://www.readmeindia.com/india-maps/2016) 
 
Table 3.5: Study site in India  
Country  Regions District Healthcare 
facility 
(HCF) level  















Pakistan is a lower-middle income country with an estimated population of 188 
million (WHO 2017f). Pakistan is divided into four provinces and 102 districts. The 
MMR for Pakistan is 178 per 100,000 live births with skilled birth attendance 
estimated to be 52% (WHO 2017d). The neonatal mortality rate is 45.5 per 1,000 live 
births (WHO 2017c). With regard to healthcare coverage and uptake, the proportion 
of women who attend for at least one ANC visit is 73% and skilled attendance at birth 
(or institutional delivery) is 52.0% (WHO 2015c). 
The study was carried out in the Punjab province and Islamabad Capital Territory (ICT) 
situated in the north of Pakistan. These provinces were purposively selected to 
include both urban and rural women seeking care at primary or secondary level 
healthcare facilities. Two hospitals in the ICT and three district hospitals for three 
districts in Punjab were chosen purposively. Five primary level health centres were 
selected using simple random sampling from all the primary rural health centres that 
refer to the selected secondary level healthcare facilities included in this study in the 
Attock district of Punjab.  








Table 3.6: Study sites in Pakistan  




Rawalpindi Secondary  Pakistan Railway Hospital 




Secondary  District Headquarter Hospital 
Attock  
Tehsil Headquarters Hospital 
Hassan Abdal 
Tehsil Headquarters Hospital 
Fateh Jang 
Primary  Rural Health Centre Maghian 
Rural Health Centre Bahter Tehsil  
Rural Health Centre Chhab 
Rural Health Centre Rango Tehsil 
Hazro 









Kenya is a low-income country with an estimated population of 46 million (WHO 
2017g). The MMR is estimated 510 per 100,000 livebirths and skilled birth attendance 
rate is 62% (WHO 2017c). The neonatal mortality rate is 22.2 per 1,000 live births 
(WHO 2017c). With regard to healthcare coverage and uptake, the proportion of 
women who attend for at least one ANC visit is 92% and skilled attendance at birth 
(or institutional delivery) is 62.0% (WHO 2015c). 
Kenya is divided into eight geopolitical regions: Central, Coast, Eastern, Nairobi, North 
Eastern, Nyanza, Rift Valley and Western provinces (Figure 3.3). The study was 
carried out in three secondary level and six primary level healthcare facilities in the 
Central region of Kenya. In each district, the main hospital was purposively selected 
and in addition two health centres which referred to this hospital were selected using 
simple random sampling, to reflect a cross-section of two levels of healthcare 
(primary and secondary). For the purposes of this study, these facilities consisted of 
three clusters of three healthcare facilities in which each cluster included a district-
level healthcare facility or above and two primary health facilities which refer to it.  
Figure 3.3: Map of Kenya  
 




Table 3.7: Study sites in Kenya  
Country  Regions District HCF level  Name of facility  




Nyeri Provincial General 
Hospital  
Primary Naromoru Health Centre 
Endarasha Health Centre 
Murang’a Secondary  Murang'a County Referral 
Hospital 
Primary Kandara Sub-County Hospital 
Kigumo Sub-County Hospital 
Kiambu Secondary  Kiambu Hospital 
Primary  Githunguri Health Centre 
Karuri Health Centre 
 
Malawi 
Malawi is a low-income country with an estimated population of 17 million (WHO 
2017h). The MMR is 634 per 100,000 with an estimated 90% of women delivering at 
health centres with skilled birth attendants (WHO 2017c). The NMR is estimated at 
21.8 deaths per 1,000 live births (WHO 2015a). With regard to healthcare coverage 
and uptake, the proportion of women who attend for at least one ANC visit is 96% 
and skilled attendance at birth (or institutional delivery) is 90.0% (WHO 2015c). 
 
The country is divided into three regions: the northern, central and southern regions. 
There is a total of 28 districts in the country. Six are in the northern region, nine in 
the central region and 13 are in the southern region (Figure 3.4)  
 
The study was carried out in three secondary level and six primary level healthcare 
facilities in Malawi (Table 3). These facilities consist of three clusters of three 
healthcare facilities in which each cluster includes a district secondary level 
healthcare facility and two primary health facilities which refer to it. For Malawi, in 






secondary) the main hospital was purposively selected and in addition, two health 
centres which referred to this hospital were selected using simple random sampling. 
Figure 3.4: Map of Malawi  
 
Table 3.8: Study sites in Malawi 
Country  Region District HCF level  Name of healthcare facility  
Malawi  South  Blantyre  
 
Secondary  Limbe Health Centre 
Primary Ndirande Health Centre  
Bangwe Health Centre 
Mulanje  
 
Secondary  Mulanje District Hospital 
Primary  Chonde Health Centre  
Mulomba Health Centre  
Mwanza Secondary  Mwanza District Hospital 
Primary  Thambani Health Centre  
Tulonkhondo Health Centre  
 




Summary of study sites 
Overall, the study population was from a total of 12 secondary and 17 primary care 
level facilities across the four countries (Table 3.9). 
Table 3.9: Details of study sites and healthcare level  
Country  Region District Healthcare 
Level  
Name of health care facility  





Rawalpindi Secondary  Pakistan Railway Hospital 




Secondary  DHQ Hospital Attock  
THQ Hospital Hassan Abdal 
THQ Fateh Jang 
Primary  RHC Maghian 
RHC Bahter Tehsil  
RHC Chhab 
RHC Rango Tehsil Hazro 
RHC Domail 




Nyeri Provincial General 
Hospital  
Primary Naromoru Health Centre 
Endarasha Health Centre 
Murang’a Secondary  
 
Murang'a County Referral 
Hospital 
Primary Kandara Sub-County Hospital 
Kigumo Sub-County Hospital 
Kiambu Secondary  Kiambu Hospital  
Primary  Githunguri Health Centre 
Karuri Health Centre 
Malawi  South  Blantyre  
 
Secondary  Limbe Health Centre 
Primary Ndirande Health Centre  
Bangwe Health Centre 
Mulanje  
 
Secondary  Mulanje District Hospital 
Primary  Chonde Health Centre  
Mulomba Health Centre  
Mwanza Secondary  Mwanza District Hospital 
Primary  Thambani Health Centre  
Tulonkhondo Health Centre  








Study population  
The study involved consenting pregnant women and women who were within 12 
weeks of childbirth attending for maternity care at the selected study healthcare 
facilities. 
Inclusion criteria 
All women who attended for routine antenatal or postnatal care or birth at the study 
healthcare facilities, were eligible for inclusion. 
 
Exclusion criteria 
Women who are too ill to participate were excluded. These criteria excluded women 
with altered conscious level, admission to high dependency unit or intensive care 
unit, as this population of women represent those with a severe acute maternal 
morbidity. Women below the age of consent for sex in each study setting were 
excluded: India (18); Kenya (18) and Malawi (16). There is no age of consent in 
Pakistan, as all sexual activity outside of marriage is illegal. The minimum age of 




Data was collected for this study was conducted for one year in 2015.  
 
Sampling procedure 
Research question number two was: “What is the burden of maternal morbidity at 
different stages of pregnancy?” To answer the question, women were recruited at 
five stages of pregnancy along the antenatal and postnatal continuum of pregnancy 
and childbirth. For this study, the five stages of pregnancy have been displayed in 
Table 3.2.  
  




Sample size calculation  
 
The formula:     was used to calculate the sample size, where n = 
sample size, p = estimated prevalence, Z (for a 95% confident interval) = 1.96 and ME 
= margin of error (0.05).  
 
However, there are currently no estimates of comprehensive maternal morbidity 
rates in the study countries, so ‘p’ is unknown. Extrapolating ‘p’ from the prevalence 
of a range of common and less common maternal morbidity conditions such as 
anaemia, eclampsia, syphilis and obstetric fistula and, the values of n, as shown below 
(with ME of 5% at 95% confidence interval) 
Anaemia ‘p’ = 0.5   
Eclampsia ’p’ = 0.05  
Syphilis ‘p’ = 0.02  
Fistula  ‘p’ = 0.002   
Based on these calculations, using a value of 50% (estimated prevalence of anaemia 
in pregnancy), a sample size of 384 is required to estimate proportions with a margin 
of error not exceeding 5%, using a 95% confidence level. Since estimation is required 
for five assessment stages, this number of women will be interviewed for each of the 
five stages bringing the total required sample size to 1920 participants. With sample 
sizes of 384 and for comparable reasons, 1,500 women per assessment stage, the 
margin of error for estimation of various proportions without accounting for 
clustering is as indicated in the Table 3.10.  
Table 3.10: Estimated margin of error 
Proportion: 0.50 0.20 0.10 0.05 0.02 0.002 
ME if n=384 0.05 0.04 0.03 0.022 0.014 NA 
ME if n=1500 0.025 0.02 0.015 0.011 0.007 0.002 
 
If the design effect resulting from use of cluster sampling is 1.5 and the sample size 
576 is the lowest, the prevalence that can be expected to be detected (95% chance 






doubled (for example combining the early and late postnatal samples to estimate 
obstetric fistula) to give a sample size of 1152, the lowest prevalence would be 4 per 
1000. To detect a prevalence of 2 per 1000 a sample size of 3000 is required. With 
the assistance of a senior statistician, the sample size per country was calculated as 
2880.  
 
In Pakistan, Kenya and Malawi for each of the five assessment stages, the sample size 
was a minimum of 576 women across two levels of healthcare facility (primary and 
secondary) selected by stratified cluster sampling. In India, as the study was 
conducted in one facility (secondary level) a cluster sampling approach was not 
required, giving an amended sample size of 1900 with a minimum of 380 women per 
assessment stage. This sample size had 95% power to detect the presence of any 
morbidity with a prevalence greater than 1%.  
 
3.5 Data collection tool 
For this study, a data collection tool that was developed with inputs from the WHO 
Maternal Morbidity Working Group in line with the agreed criteria for maternal 
morbidity (Chou 2016). The maternal morbidity assessment tool used in this study 
included the following sections displayed in Table 3.11 and Appendix 6. 
 
Table 3.11: Sections of the data collection tool 
1. Identification of research assistant, date of interview and site of healthcare 
facility 
2. Social, economic and demographic items 
3. History of previous pregnancies and maternal and/or adverse neonatal 
outcomes 
4. Obstetric interview with questions regarding current symptoms and extent 
to which women feel bothered by these 
5. Mental health (past seven days) 
6. Quality of life (past three months) 
7. Risk factors to pregnancy (drugs, substance abuse and domestic violence) 
(past three months) 




8. Clinical examination including general, obstetric and pelvis (if clinically 
indicated) 
9. Urinary and serological investigations including haemoglobin, C-Reactive 




All women were administered the same questionnaire (Appendix 6). The obstetric 
examination part of the questionnaire was not required and therefore not completed 
for women who were assessed in the postnatal stages. 
Variables  
Demographics factors assessed including age, marital status, occupation and 
educational level.  
Socioeconomic status  
Socioeconomic status (SES) was measured using an amended Kuppuswamy’s scale in 
India and Pakistan (Sharma 2014). The Kuppuswamy’s scale is a composite score of 
education and occupation of the head of the family along with the monthly income 
of the family. This scale classifies the study populations into SES categories. However, 
the income ranges in the scale lose their relevance following the depreciation in the 
value of the country’s currency; and therefore, at the time of development of the 
tool, the most updated version of the scale was used (Bairwe 2013, Sharma 2014). 
For the purposes of this study, we used women as head of household. Wealth index 
was derived using principal component analysis for Malawi and Kenya (Braun 2006, 
Vyas 2006).  
 
A systematic screening of current physical symptoms was assessed using a total of 76 
questions. The severity of each symptom was assessed on a scale of how much the 
symptom bothers the woman. The 76 questions covered five main organ systems and 
one group was miscellaneous: cardiopulmonary, gastrointestinal, musculoskeletal, 
uro-gynaecology, obstetric and breast, and miscellaneous (dermatology, endocrine, 







Psychological health  
Psychological health was assessed using the 10-question EPDS (Cox 1987). The EPDS 
is a valuable and efficient screening tool to identifying women at risk for depression 
and/or suicidal ideation (Gibson 2009). The EPDS is easy to administer and has proven 
to be an effective screening tool, validated for both HIC and LMIC (Gibson 2009). The 
EPDS is a screening tool that be conducted in complement to a clinical assessment to 
confirm a diagnosis. The EDPS indicates how the woman has felt during the previous 
week. The EDPS will not detect women with anxiety neuroses, phobias or personality 
disorders. Women who score above 10 are likely to have symptoms of depression. 
Women who score above 13 are likely to be suffering from a depressive illness of 
varying severity (Cox 1987). The last question asks regarding thoughts of self-harm 
and the authors of the EPDS recommend that this question can be used to detect 
women with suicidal ideation.  
 
For the purposes of this study psychological ill-health was defined as an EPDS score 
of >10 and/or thoughts of self-harm.  
Table 3.12: Example of how to ask one of the questions from the EPDS 
“As you are pregnant or have recently had a baby, we would like to know how you 
are feeling. Please check the answer that comes closest to how you have felt in the 
past 7 days, not just how you feel today. Here is an example, already completed”. 
• I have felt happy:  
• Yes, all the time; Yes, most of the time; No, not very often; No, not at all. 
This would mean: “I have felt happy most of the time during the past week.” 
 
Quality of life 
Eight questions regarding quality of life (QOL) and satisfaction with health were 
derived from the WHO QOL Spirituality, Religiousness and Personal Beliefs (SRPB) 
questionnaire (WHO 2002). The WHO QOL SRPB questionnaire produces a quality of 
life profile, derived from four domain scores. The four domain scores indicate an 
individual's perception of quality of life, with higher domain scores correlating with 




higher quality of life (WHO 2002). Two items can be examined separately and these 
were included in this study questionnaire: overall perception of quality of life and 
overall perception of their health (WHO 2002).  
 
Table 3.13: Example of how to ask one of the questions from the quality of life 
assessment 
“The following questions ask how you feel about your quality of life, health, or 
other areas of your life. I will read out each question to you, along with the 
response options. Please choose the answer that appears most appropriate. If you 
are unsure about which response to give to a question, the first response you think 
of is often the best one. Please keep in mind your standards, hopes, pleasures and 
concerns. We ask that you think about your life in the last four weeks.” 
• How satisfied are you with your health? 
• Very satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied and 
very dissatisfied 
This would mean: “I am very dissatisfied with my health.” 
 
Domestic violence  
The UN define domestic violence as "any act of gender-based violence that results in, 
or is likely to result in, physical, sexual or mental harm or suffering to women, 
including threats of such acts, coercion or arbitrary deprivation of liberty, whether 
occurring in public or in private life” (UN 1993). The “Hurt, Insulted, Threatened, 
Screamed at” (HITS) questionnaire was used to assess domestic violence firstly from 
the husband or partner and adapted to be used to assess domestic violence from 







Table 3.14: Example of how to ask one of the questions from the HITS 
questionnaire 
“How often does your partner: physically hurt you, insult you or talk down to you, 
threaten you with harm, and scream or curse at you?”  
Women respond to each of these items with a 5-point frequency format: never, 
rarely, sometimes, fairly often, and frequently.  
Score values could range from a minimum of 4 to a maximum of 20. 
 
The HITS questionnaire is not the first, short domestic violence screening tool to be 
developed for outpatient clinical settings. Other short instruments, such as the Abuse 
Assessment Screen (McFarlane 2001), have been developed for the same purpose, 
but the HITS instrument is as effective and shorter than others. The HITS 
questionnaire has only four items, two each that address verbal and physical 
aggression (Sherin 1998).  
Substance misuse 
WHO developed the Alcohol, Smoking and Substance Involvement Screening Test 
(ASSIST) in 1997 in response to the public health burden associated with psychoactive 
substance use worldwide. The ASSIST has since undergone significant testing to 
ensure that it is feasible, reliable, valid, flexible, comprehensive and cross-culturally 
relevant, and able to be linked to brief interventions (WHO 2008). The ASSIST was 
developed principally for use in primary health care settings to identify substance use 
that is not dependent, but still causing harm to an individual. The ASSIST is an 
interviewer-administered questionnaire and screens for all levels of problem or risky 
substance use (WHO 2008). A risk score is provided for each substance, and scores 
are grouped into low, moderate or high risk. The risk score determines the level of 
intervention (treatment as usual, brief intervention or referral to specialist 
treatment). The revised version of the ASSIST v2.0 consisted of eight questions 
covering tobacco, alcohol, cannabis, cocaine, amphetamine-type stimulants 
(including ecstasy), inhalants, sedatives, hallucinogens, opioids and “other drugs”, 
that could be answered by individuals in around 10 minutes.  For the purposes of this 




study four questions from the “Alcohol, Smoking and Substance Involvement 
Screening Test (ASSIST)” questionnaire was included (WHO 2008).  
Table 3.15: Example of how to ask one of the questions from the ASSIST 
questionnaire 
“Thank you for agreeing to take part in this brief interview about alcohol, tobacco 
products and other drugs. I am going to ask you some questions about your 
experience of using these substances in the past three months. While we are also 
interested in knowing about your use of various substances, please be assured that 
information on such use will be treated as strictly confidential. 
In the past three months, how often have you used the substances you mentioned: 
Never, Once or Twice, Monthly, Weekly, Daily or Almost, Daily.” 
 
Clinical assessment 
All consenting women were offered full clinical observations: pulse rate, respiratory 
rate, blood pressure, and oral temperature were measured and the conjunctiva, 
sclera, breast, abdomen (general and obstetric) and pelvis (speculum and digital 
vaginal examination if clinically indicated) were examined.  
Investigations  
Urine assessment  
Urinalysis was performed using Multistix 10 SG®. These reagent strips are firm plastic 
strips to which are affixed several separate reagent areas. Multistix 10 SG® strips 
provide tests for glucose, bilirubin, ketones, specific gravity, blood, pH, protein, 
urobilinogen, nitrite, and leukocytes in urine. Test results may provide information 
regarding the status of carbohydrate metabolism, kidney and liver function, acid-base 
balance, and urinary tract infection.  
 
Serological assessments  
A simple finger prick test was used to obtain one capillary (<0.5ml) of blood for use 






and HIV (SD BIOLINE HIV/Syphilis Duo®) and C-reaction protein (QuickRead®). All 
laboratory investigations were all provided by the research team and all research 
assistants were trained to conduct the investigations using the exact same method 
of testing. The Hemocue® and QuickRead® machines were calibrated as per operating 
instructions in each study setting by specially trained research supervisors to ensure 
the readings were accurate.  
Haemoglobin 
Haemoglobin was measured using a hand held Hemocue® machine as this device has 
been used extensively across LMIC to measure haemoglobin. It is portable, easy to 
use, does not require a laboratory and is relatively inexpensive. The HemoCue® device 
requires a small drop of capillary or venous blood and provides an immediate 
numerical haemoglobin value. Many studies have examined the accuracy and 
precision of HemoCue® results compared with automated haematology analysers in 
different adult populations (Nkrumah 2011, Adams 2017, Hinnouho 2017).  
Malaria 
The Humasis® malaria plasmodium falciparum/Pan antigen test is a rapid diagnostic 
test, that detects the specific antigen, HRP-II (Histidin-rich protein-II) to plasmodium 
falciparum and the specific antigen in common, pLDH (plasmodium lactate 
dehydrogenase), to plasmodium vivax, plasmodium ovale and plasmodium malaria 
(Mouatcho 2013). Using the test principle of HRP-II for plasmodium falciparum, the 
test demonstrates a sensitivity of 99.5% and specificity of 99.5% and the result is 
available within 10 minutes (Mouatcho 2013). 
HIV and Syphilis  
The SD BIOLINE HIV/Syphilis Duo® is a common rapid diagnostic test that uses enzyme 
immunoassay and polymerase chain reaction to allow for simultaneous detection of 
HIV-1/2 and syphilis antibodies test using one device. One droplet of blood is 
required, easily obtained by finger-prick. The results of both tests are available within 
15 minutes. When compared to other single rapid diagnostic test kits, the sensitivity 
and specificity for HIV diagnosis has been reported as 100% and 99.96–100% 
respectively (Shakya 2016). The sensitivity and specificity for syphilis diagnosis has 




been reported as 95.5% and 99.9% respectively (Shakya 2016). As with all tests for 
HIV, a positive test must be repeated using a different kit to rule out a false positive. 
 
C-Reactive Protein  
C‐reactive protein (CRP) is an acute‐phase protein secreted by the liver in response 
to inflammation. It is not specific for infection but is a marker used for the diagnosis 
of many infective and inflammatory conditions. During infectious or inflammatory 
disease states, CRP levels rise rapidly and when the inflammation or tissue 
destruction is resolved, CRP levels fall, making it a useful baseline measure for control 
of infection and a marker for monitoring treatment (Jain 2011, WHO 2014). 
 
There are several point-of-care quantitative testing kits available for measuring CRP: 
(1) NycoCard by Axis-shield (2) QuickRead by Orion Diagnostica (3) Afinion by Axis-
sheild and (4) Smart 546 by Eurolyser. In this study, QuickRead machine was used as 
it is portable, easy to use, does not require a laboratory or specialised skills to use the 
machine, and can be performed on a finger-prick sample of capillary blood. The 
results are reliable and of high quality comparable to laboratory tests and provide a 
range of less than five and up to 200 mg/L. Results are available within two minutes 
and the accuracy has been shown to be comparable to laboratory measurements of 
CRP (Diar 2012, Ivaska 2015). 
 
There is lack of literature regarding the appropriate cut-off points of CRP in women 
at different assessment stages, during and after pregnancy and there is no literature 
regarding this from LMIC.  There is currently lack of agreed reference standards on 
what is a normal and what is an abnormal CRP level at different stages of pregnancy 
and after childbirth (Trochez-Martinez, 2007). The WHO report that normal CRP 
levels in a general population are less than 10 mg/L (WHO 2014) and the reported 
normal CRP level in a non-pregnant woman is 0.2–3.0 mg/L.  In UK clinical practice  
an abnormal CRP is considered greater than 5 mg/L.  As labour and childbirth is a 
physiological inflammatory state, a higher CRP cut-off of 10 was used within 24 hours 






a “raised CRP” was defined as >5mg/L at each assessment stage, apart from at 
delivery (within 24 hours of childbirth) where raised CRP was defined as >10mg/L. 
 
In this research project, due to logistical and financial constraints, CRP was performed 
on a sub-sample of the study populations attending for care at secondary level 
healthcare facilities in Malawi and Pakistan. All women in the study populations in 
Kenya and India had their CRP performed. 
 
3.6 Training of research team  
All research assistants were invited to be data collectors if they were skilled birth 
attendants (doctors, medical officers, nurses and midwives) actively involved in the 
routine antenatal and postnatal care of women at the selected healthcare facilities 
and were competent in history taking, clinical assessment, blood sampling and 
completion of paper or electronic questionnaires.  
 
In Pakistan, Kenya and Malawi, research assistants were reimbursed for their time 
for each woman recruited to the study with a completed questionnaire. Research 
assistants used their routine working hours to invite women to take part in the study 
and recruited women from the antenatal outpatient clinic, postnatal outpatient 
clinic, or the family planning outpatient clinic, where they were working as healthcare 
providers. A sub-sample (<10%) of women were recruited from the antenatal or 
postnatal wards of the healthcare facility, where they were either awaiting childbirth 
or discharge. Each woman was given a written information leaflet and an 
appointment was arranged to meet with the women at a time that suited the women, 
outside normal working hours to ensure that routine maternity care was not 
interrupted. 
 
All research assistants in Pakistan, Kenya and Malawi completed the research 
consultation and questionnaire outside their routine work hours, during their 
lunchbreak or evenings or when they had a rest day. In India, four female doctors 




were employed as full-time research assistants for six months for the purposes of this 
study and women were recruited to this study as part of their routine day-to-day 
work.  
 
All research assistants and supervisors were trained using standardised training 
manuals and workshops at the start of the research programme in each country by 
the lead researcher. Induction and theoretical training of all research assistants and 
supervisors took place in a lecture theatre or conference room for three days in each 
study setting (Appendix 7). For the first and second day PowerPoint presentations 
were used to introduce each session, with question and answer sessions and detailed 
discussion sessions. Day three involved supervision of research assistants practicing 
and undertaking informed consents from women, conduction of the interviews, 
performing clinical examination and completing the paper or electronic data 
collection tool (Appendix 6).  
 
All research assistants were supervised taking blood samples and conducting the 
rapid diagnostic testing prior to the start of data collection. The Hemocue® and 
QuickRead® machines, and all rapid diagnostic tests were purchased in Liverpool and 
distributed to each study site to ensure all women’s samples were tested with the 
same machines and rapid diagnostic test kits. The Hemocue® and QuickRead® 
machines were calibrated as per operating instructions in each study setting by 
specially trained research supervisors.  
 
During data collection, all research assistants were supervised by an in-country 
research supervisor, who worked as a collaborator for the purposes of this research 
study. After initial training and supervision, all research activities were co-ordinated 
and supervised by the lead researcher remotely in Liverpool. If there was a need (for 
example, problems sending electronic data in Pakistan), the lead researcher travelled 








Introducing the tool 
During the three-day training sessions, all research assistants were trained to 
approach women and to give them written and verbal information regarding the 
study including a brief overview of the research aims and objectives (Appendix 8 and 
9). Each research assistant was trained to introduce themselves using their name, 
title, role and responsibility, including primary place of work. The expectations at 
each stage of the consultation (interview, examination and investigation) were 
carefully explained to the women. All research assistants were trained to pause to 
ensure that their explanation was clearly understood and allowed time for questions 
and comments to clarify. All research assistants were trained to reassure women that 
they could decline or discontinue the study at any point without any consequence. 
There was no payment to the women for the completion of the interview.  
 
Obtaining consent  
Each research assistant was trained to obtain informed consent. It was emphasised 
that obtaining consent occurs in two stages: (1) time for women to read the 
information leaflet to ensure full understanding of the women, allowing time for 
questions and comments about any aspect of the study and (2) signing the consent 
form by signature in the appropriate space. If a woman was illiterate, the information 
form was read to her by the research assistant and the women used her thumb print 
to indicate written consent. Another signed copy of the consent form was offered to 
the women, as her own copy. 
 
All women were administered the same questionnaire in a face-to-face interview 
(Appendix 6). The obstetric examination part of the questionnaire was not required 
and therefore not completed for women who were assessed postnatally and who had 
given birth.  
 
Women were approached in the outpatient clinics and inpatient wards of each health 
care facility. Recruitment took place sequentially until the target sample size for each 




assessment stage was reached in each study healthcare facility. All women were 
interviewed in the local language spoken both by the women and the trained 
research assistant. All women who consented to take part in the study were 
interviewed and had a full clinical examination and urine and serological 
investigations performed by the trained healthcare provider, in their capacity as a 
research assistant. After training, the average interview lasted 45 minutes, with an 
average of 15 minutes for examination and taking of samples for investigations. Data 
was collected using a standardised structured questionnaire.  
 
Definitions of conditions were given 
Explanation of what conditions were being screened for was given during the training 
to ensure standardisation across settings. Internationally agreed definitions of 
conditions were used.  
 
Clinical examination 
All research assistants were trained to conduct systematic examination of the 
conjunctiva and sclera, pulse rate, respiratory rate, temperature, blood pressure, 
breasts and abdomen in the same way. All research assistants were trained to 
conduct pelvic examination (external, internal digital and speculum examination) if 
clinically indicated, for example, vaginal discharge, abnormal vaginal bleeding. All 
research assistants were trained to ensure confidentially and provide privacy to the 
best of their ability in accordance with local setting standards. All research assistants 
were trained to expose only the part of the body to be examined at a time in a 
systematic approach. All research assistants were trained to ensure that women were 
aware that they could opt out of the examination at any point and to document this 
discussion on the consent form. All research assistants were trained on how to 
accurately enter the clinical findings details into the appropriate section of the data 









Specific training of the research assistants 
All research assistants were trained to be courteous and gentle to each woman, to 
welcome them with a smile and introduce themselves and any other member on the 
team; to listen to the woman’s individual concerns and to provide a full explanation 
of the clinical assessment. All attempts were made to ensure a private room was 
available for the examination or an area was cornered off by a screen for the whole 
consultation. Adequate privacy and confidentially was emphasised. All research data 
assistants were trained not to conduct the interview unless these pre-requisites are 
in place and that the woman felt comfortable with the local set up in the healthcare 
facility. All research assistants were trained on how to deal with any maternal 
morbidity detected during the data collection process, how to discuss any abnormal 
finding with the women, and to provide care themselves or to refer to another 
member of the clinical team in that healthcare facility. All research assistants were 
trained to document the reason for referral in the questionnaire. For any detected 
cases of morbidity that were “new” or for which the research assistant was unsure 
whether the morbidity was being managed by the routine clinical team, all research 
assistants were trained to discuss each case with a senior staff member identified in 
each health care facility and/or research supervisor. The roles and responsibilities 
were clearly set out to each research assistant (Table 3.14) and standardised training 
was provided in each study setting for each group of research assistants and their 
supervisors. 
Table 3.16: Roles and responsibilities of research assistants 
1. Give verbal information regarding the project in lay language. 
2. Give and explain written information and gain informed consent.  
3. Conduct face-to-face interviews with women at different stages of 
pregnancy.  
4. Perform obstetric examination on pregnant women and basic clinical 
examination on postnatal women. 
5. Perform basic obstetric investigations, including urinalysis; rapid diagnostic 
testing for haemoglobin HIV, malaria, syphilis and CRP. 
6. Ensure all questionnaires are completed correctly and accurately on the 
hand held computerised device (or on paper if using paper questionnaire).  




7. Ensure the computerised devises (or paper questionnaires) are kept safe 
and stored securely in an agreed space. 
8. Endorse and display the core values of patient privacy and confidentiality 
and good medical practice. 
9. Respect the values and culture of the woman. 
10. Support maternity care provision as required when on site for data 
collection. 
11. Refer women involved in the study to higher level healthcare providers in 
the study setting if any new maternal morbidity is discovered.  
12. Attend training and orientation at the beginning of the study. 
13. Other duties related to the study as may be assigned by the research 
supervisor.  
 
Research supervision  
One research supervisor was recruited per secondary level healthcare facility per 
country and trained in each study setting to provide regular supervisory visits to all 
research assistants (Table 3.17). 
Table 3.17: Roles and responsibilities of research supervisors  
1. Visit and introduce the study to healthcare facilities. 
2. Supervisory visits to study sites. 
3. Track and monitor progress of the equal recruitment of women across five 
assessment stages, with a minimum of 576 women per assessment stage 
(380 per assessment stage in India). 
4. To ensure accurate and timely payment of research assistants. 
5. To supervise 10% of interviews to ensure quality assurance. 
6. To conduct regular calibration of the machines used to test haemoglobin and 
CRP for quality assurance. 
7. To clarify any concerns or questions that the research assistants may have. 
8. To motivate the research assistants to continue data collection in their 
facility. 
9. To collect the completed paper questionnaires in Malawi. 







Figure 3.5 outlines the study management arrangements with roles and 
responsibilities at each level. The study was coordinated by the lead researcher in 
Liverpool with in-country research supervisors directly supervising data collection 
and facilitating the sending of the data to Liverpool.  





























- Tracking progress in data collection  
- Contributing to data cleaning/ entry/ 
analysis 
- Facilitating logistics  
- Report writing  
 
Weekly:  
- Skype/ telephone meetings with study team  




- In-country study team Skype meetings with 













- Communicate with lead researcher weekly 
by email regarding process 
- Skype meetings to discuss and resolve 








- Supervision of collection of iPads and 
consent forms every day 
- Completion of data handover forms 
- Secure storage of consent forms 
Weekly: 
- Observe at least three data collection 
sessions 
- Note, document and communicate on 
progress 
- Support data collection  








Verification of completed data collection tools 
All research supervisors were trained to document and monitor the rate of refusal, 
partially completed forms, duration of data collection and any practical problems and 
challenges encountered for the research assistants in each study setting and this 
information was discussed weekly with the lead researcher in Liverpool. 
 
Pilot Study 
A pilot study was undertaken in each study setting to validate the effectiveness of the 
data collection tool and to field test the feasibility and acceptability of the data 
collection tool and to check the questions were understood as meant (in all settings) 
in English and after translation into local language. The pilot test was used to assess 
the flow, limitations, or weaknesses within the questionnaire and to enable necessary 
revisions to be made prior to the implementation of the full study. Ten women were 
involved in the pilot-test in each study setting (40 women in total). Woman were 
recruited according to the inclusion criteria for the main study. The pilot test 
highlighted the need for a standardised explanation to women for certain symptoms 
and procedures. Based upon initial field experience in all four countries, the 
questionnaire was revised to improve the quality and clarity. Examples are presented 
















Table 3.18: Pilot testing amendments  
No. Issue and resolution  
1. An introductory statement was introduced to each new section of the 
questionnaire to ensure a better understanding for the woman of what to 
expect.  
2. A standardised reference list of explanation of words or phrases considered 
ambiguous by the research assistants was developed to ensure uniform 
understanding of questions. WHO international definitions were given to 
clarity for example: stillbirth (24 or 28 weeks), antenatal haemorrhage 
(amount). 
3. Questions considered to be potentially sensitive were introduced in more 
detail to ensure the women was at ease; for example: questions regarding 
domestic violence and thoughts of self-harm. 
4. The HITS questionnaire to assess domestic violence was expanded to assess 
domestic violence perpetrated by the husband/partner and/or family 
members.  
5. Some questions screening for symptoms were re-structured so that the flow 
of questioning was smoother. 
6. During the pilot study, some study sites faced a problem with electronic data 
collection due to due to lack of availability of internet access. Portable 3G 








3.7 Data collection  
 
Data management 
The process of data collection was the same in India, Pakistan and Kenya but different 
in Malawi. Due to lack of internet capacity in the study settings in Malawi, paper 
questionnaires were developed and formatted for use with Formic® for paper-based 
data collection in Malawi. The same questionnaire was formatted with Filemaker® 
for electronic data collection using hand held devices (iPads®) in India, Pakistan and 
Kenya.  
 
Formic® data collection 
Formic® software is a means of processing paper-based data collection forms 
electronically via an optical scanner.  Once the paper questionnaires were completed 
and returned to the main office in Malawi, they are scanned into the Formic® 
software programme that can read the handwriting and process it into a digital 
format suitable for analysis with Excel software. This has the advantage of being a 
low-tech solution at the point of data collection, whilst allowing for relatively rapid 
processing of large amounts of data into an electronic format for analysis. 
 
Filemaker® data collection 
An electronic version of the questionnaire was formatted using Filemaker® software 
and downloaded onto iPads®. Hand held devices were programmed with 
FilemakerGo® software. All iPads were programmed with restrictive access for use of 
the internet, personal email or other programmes out with the scope of this study. 
Each iPad® was engraved with the LSTM logo and a tracking device was set up to 
enable monitoring of the location of the iPad® using remote location software. Each 
iPad® had a specific security code known only to the research assistant and their 
supervisor. Each iPad® was set up with a unique email account. At a designated time, 




each week, the completed questionnaires were either uploaded directly to a remote 
server or sent by email using 3G or Wi-Fi connections to Liverpool.  
 
In India, electronic data was sent from the hand-held tablet using a 3G internet 
connection to a central server set up by an external company in Liverpool. For 
electronic data collection in Pakistan and Kenya, electronic data was sent from the 
electronic hand-held tablet as an email attachment using 3G internet connection to 
an email account set up in Liverpool. The data was downloaded from each email 
attachment and imported into an Excel file for cleaning and storage.  
 
Prior to data collection in each country internet connectivity was mapped out for 
each study setting. Prior to training of research assistants, sim cards were purchased 
in-country by the lead researcher, configured and activated to ensure 3G internet 
connection for each hand-held tablet. In Pakistan, there was no internet connectivity 
in several rural study sites. In these cases, data was stored on the hand-held tablets 
and the in-country research supervisor would collect the tablets on a weekly basis 
and use a Wi-Fi connection in the urban setting to send the data by email attachment.  
 
For the electronic data collection, it was possible to review the time spent to 
complete each questionnaire and the time data was sent by email. This helped with 
the quality assurance of the data collection process and to monitor the number of 
women recruited per assessment stage per country remotely from Liverpool also.  
 
All study materials including the iPads® were distributed to the research assistants. 
Each research assistant, research supervisor and/or head of facility signed a handover 
of equipment form and accepted the responsibility of the storage and use of the 
iPads. It was agreed that if the iPads were damaged or missing, it was the 
responsibility of the in-country research team to replace them. Each iPad® was 
password protected and all data management complied with standard operating 








Storage and distribution of data collection materials in study sites  
All study materials were stored in a designated office within each healthcare facility. 
From there, research assistants collected the iPads daily and returned the completed 
consent forms for filing. All research assistants were trained with regards to the 
utmost importance of security and privacy. Locked cabinets accessible only to the 
research team were used to store the study materials including completed consent 
forms. In Malawi, completed paper forms were stored in locked purpose-built 
cupboards before being transported to the CMNH-LSTM office in Lilongwe and 
scanned to Liverpool monthly.  In Liverpool, the data was then scanned into the 
Formic® scanner and downloaded onto Excel software where it is stored and cleaned. 
 
Electronic data collected in India, Pakistan and Kenya was either uploaded directly to 
the remote server or sent by email attachment by research assistants to an email 
account based in CMNH-LSTM. The data is imported into an Excel file, checked for 
duplication, and missing information or incomplete entries by the research team at 
CMNH-LSTM. The lead researcher in Liverpool monitored the electronic data 
uploading, importing and maintenance of database and data cleaning of database on 
a weekly basis.  
 
Data storage  
Once data was received by the research team in Liverpool, data was cleaned and 
coded in four separate Excel files, one per country. A data dictionary was used to 
code each variable, to enable summative assessments for example, socio-economic 
status, and EPDS, HITS and ASSIST scores.  
 
Once all data had been cleaned and coded for each country, Excel files were merged 
to create one large database. Basic analysis was conducted using SPSS and advanced 
analysis was conducted using STATA® software. Standardised operating protocols 
were used for all data collection, cleaning and monitoring of data as per the institute 
guidelines.  




All data was treated confidentially and electronic data was password protected and 
only accessible to the research team. To protect privacy and confidentiality, a unique 
identification number was allocated to each completed the questionnaire. Names 
were not included in the database. All standard procedures to ensure high quality 
data collection, processing, storage and analysis were employed, according to LSTM 
institutional protocols. Raw data has been stored and will remain protected for at 




Descriptive statistical analysis was used to describe frequency, mean, median. Data 
analysis was conducted using the software programs SPSS® v22 and STATA® version 
12.1. Occurrence of each symptom and sign was individually evaluated.  Where 
possible, documentation of symptoms, signs and investigations were “triangulated” 
and grouped as indicative of specific maternal morbidities e.g. headache, visual 
disturbances, upper abdominal pain, raised blood pressure plus proteinuria indicative 
of pre-eclampsia.  A reported symptom of a productive cough of more than two 
weeks, was used to indicate either a possible chest infection or suspected TB.  
 
Definitions 
At the time of writing, there are no WHO recommendations on the use of different 
haemoglobin cut-off points for anaemia by stage of pregnancy, but it is recognized 
that during the second trimester of pregnancy, haemoglobin concentrations 
decrease slightly due to haemodilution. In absence of alternative cut-offs and for the 
purposes of this study, anaemia was classified as per WHO, as haemoglobin less than 
110 g/l (WHO 2011b). Anaemia is further classified and presented as mild (100-109 
g/l); moderate (70-99 g/l); and severe <70 g/l) (WHO 2011b) to illustrate differences 
in severity of anaemia in the five different assessment stages, during and after 
pregnancy. Hypertension was classified as BP ≥140/90 (Brown 2001). Pre-eclampsia 
was defined as BP ≥140/90, and proteinuria (Pr++ on urinalysis) after 20 weeks’ 






reported bleeding per vaginum during pregnancy and/or had this confirmed on 
examination. Incontinence was defined as a woman who self-reported any 
incontinence of urine and/or had this confirmed on examination.  
The Systematic Inflammatory Response Syndrome (SIRS) (Balk 2014) was adapted by 
the lead researcher to define possible early infection as the presence of two or more 
of the following:  
(1) T>38 °C or <36°C,  
(2) PR >90 beats per minute;  
(3) RR >20 breaths per minute or  
(4) Raised CRP  
 
For the purposes of this study, a raised CRP was defined as >5mg/L at each 
assessment stage, apart from at delivery where raised CRP was defined as >10mg/L. 
For the purposes of this research project individual conditions were then aggregated 
into different types of maternal morbidity: physical; psychological; and social. 
Summative physical morbidity was defined as (1) infectious or (2) medical/obstetric. 
Infectious physical morbidity included: HIV, malaria, syphilis, possible chest infection, 
and a SIRS score of ≥2. Medical/obstetric morbidity included: anaemia, hypertension, 
pre-eclampsia, antenatal haemorrhage and incontinence.  Psychological morbidity 
was defined as an EPDS score of ≥10 and/or thoughts of self-harm. Social morbidity 
was defined as women reporting any domestic violence (HITS score >4) and/or any 
substance misuse.  
Statistical methods  
A p-value of <0.05 was used to determine statistical significance and estimates 
provided with 95% confidence intervals. Odds Ratios (OR) were estimated using 
univariate and multivariate logistic regression models for binary and categorical 
variables. Variables statistically significant in univariate analyses were considered for 
inclusion in multivariable analyses. Likelihood ratio tests were used to compare 
logistic regression models.  





To examine evidence of associations between morbidities, loglinear models were 
used. Firstly, exploration of associations between countries were performed to assess 
whether there was evidence of heterogeneity between countries using loglinear 
models. The following variables were included in the fullest possible loglinear model: 
country and infectious, medical/obstetric, psychological and social morbidity. All 
possible interactions, up to the five-way interaction between country and each of the 
four morbidities were explored.  All interactions involving country were then 
eliminated from the model and a likelihood ratio test was used to compare the sub-
model with the full model and thereby testing for evidence of heterogeneity in effect 
between countries.  
 
For each country, strength of associations of all the different types of interactions 
between the four different types of morbidities were explored using a loglinear 
model. For each country, firstly the full model was fitted using all main effects of the 
four morbidities and all the possible interactions. Terms which were not statistically 
significant at the 5% level were then eliminated from the model to identify the 
simplest sub-model which was not a significantly poorer fit. In the final set of 
analyses, only two-way interactions were considered. Those that were not 
statistically significant were eliminated from the model, to identify the simplest sub-
model which was not a significantly poorer fit of the model with two-way interactions 
only.  
Unless otherwise stated, all percentages reported use the total sample size for the 
relevant country. Where a substantial proportion of women had data missing for a 











3.8 Ethical considerations  
This study involved face-to-face interviews, clinical examination and basic laboratory 
investigations conducted in one consultation with women during or after pregnancy. 
Key ethical concerns associated with the study are presented in Table 3.19. 
 
Table 3.19: Ethical considerations for this research project  
Number Ethical consideration  
1. Length of the questionnaire and potentially sensitive nature of some of the 
questions e.g. domestic violence 
2. Clinical examination and investigations performed on women who may 
not have complained of any symptoms 
3. The implications of HIV and syphilis testing for the women themselves 
regarding partner notification 
4. Ensuring privacy for the women during interviews and examination  
5. Confidentiality of data collected from women 
6. Providing care for cases of morbidity detected during the study  
7. Disruption of services at healthcare facility where the study was 
conducted  
8. Collecting information that is part of routine ANC and PNC as a researcher, 
rather than a healthcare provider 
 
The following steps were taken to address these concerns:  
1. Length of the questionnaire and potentially sensitive nature of some of the 
questions e.g. domestic violence 
Local healthcare providers were trained to be efficient and concise and observe the 
skips in the questionnaire to avoid asking irrelevant questions whilst administering the 
questionnaire. All research assistants were trained on the approach to ask sensitive 
questions and how to handle any concerns raised by the items in the questionnaire and/ 
or finding of examination and investigations. The length of interview did vary depending 
on whether significant maternal morbidity was uncovered. This did mean that more 




time was required to counsel and refer the woman onto another care giver as necessary 
if morbidity was detected.  
 
2. Clinical examination and investigations performed on women who may not 
have complained of any symptoms 
To address concerns about examination and carrying out tests in the absence of any 
perceived symptoms, explanations were provided to women that the examination and 
investigations are not different from the assessments provided for women as part 
routine maternity care. Research assistants emphasised the potential benefits of 
detecting ill-health that the woman did not recognise, for example pre-eclampsia. 
Opportunities were provided and women were made aware of options to decline any 
part of the examination and investigations they find uncomfortable without any 
repercussions.  
 
3. The implications of HIV and syphilis testing for the woman and partner 
notification.  
All women were invited to consider undertaking a voluntary HIV and syphilis rapid 
diagnostic test. If the woman declined the test this decision was respected.  If the 
women freely accepted to partake in the rapid diagnostic testing of both HIV and 
syphilis, further in-depth pre-test counselling and consenting was undertaken in 
accordance with local protocols. All research assistants were trained to ensure that 
all women were made fully aware of the implications of the results of the HIV test. 
The national guidelines for each country provided detailed standards and protocols 
for disclosure of HIV status and partner notification and accordingly the research 
assistants were trained to assess the women’s views and ability regarding disclosure 
of this information to the women’s husband. All research assistants were trained to 
recommend to the women that the husband should attend the healthcare facility as 
soon as possible to undergo testing also. All research assistants were trained to 
conduct a second confirmatory test for the women using another test method in the 
local laboratory to ensure the accuracy of any HIV positive result. Confidentiality was 







All research assistants were staff members of the healthcare facility that the women 
are interviewed in and they, therefore, were available to counsel, support, monitor 
and follow up the women post-test as per national guidelines recommendations. If 
the research assistants felt this counselling was beyond their capacity, the research 
assistant was trained to ensure that the woman and her husband were referred to 
the most senior local healthcare provider for further follow up of the management 
of HIV and/or syphilis. 
 
4. Privacy for women during interviews and examination  
To protect privacy and confidentiality, a unique identity number was allocated to each 
questionnaire. Names and addresses were not recorded anywhere in the 
questionnaire or any data collection form connected to women. Data collection 
whether during interviews or clinical examination were in private and all samples 
collected for investigations were treated with confidentiality in line with local 
guidelines. If any need occurred to refer a woman for further treatment, local 
guidelines were followed to ensure that information was given on a need to know 
basis only. 
 
5. Confidentiality of data collected from women 
All data collected was treated confidentially whether on paper or electronic format. 
No one had access to the data other than the study staff. Paper formats were filed 
under lock and key and electronic data were password protected only accessible to 
the research team. Data was used only for the study and names of women were not 
recorded.  
 
6. Providing care for cases of morbidity detected during the study  
The research team were trained and oriented to support the provision of care while 
collecting data. Any new morbidity detected was recorded in the woman’s medical 
records and discussed with the appropriate healthcare provider who was responsible 
for the ongoing care of the women.  
 




7. Disruption of services at service delivery points where the study was 
conducted  
In Pakistan, Kenya and Malawi, research assistants were reimbursed for their time 
for each woman recruited to the study with a completed questionnaire. Research 
assistants used their routine working hours to invite women to take part in the study. 
Each woman was given a written information leaflet and an appointment was 
arranged to meet with the women at a time that suited the women, outside normal 
working hours to ensure that routine maternity care was not interrupted. All research 
assistants in Pakistan, Kenya and Malawi completed the research consultation and 
questionnaire outside their routine work hours, during their lunchbreak or evenings 
or when they had a rest day. In India, four female doctors were employed as full-time 
research assistants for six months for the purposes of this study and women were 
recruited to this study as part of their routine day-to-day work. 
 
Health promotion  
As part of the training, all research assistants were trained and encouraged to counsel 
the women regarding general well-being in pregnancy, birth spacing and general 
reproductive health promotion throughout the interview.  
 
Disclosure of domestic violence  
All research data collectors were trained extensively to approach these questions 
with sensitivity and to counsel women per the options available to them to make an 
informed choice of action. For example, written and verbal information was offered 
regarding non-governmental organisations in the area, who could provide support 
for women suffering from domestic violence. In many cases, the research assistants 
were also full-time members of staff in the healthcare facilities that the women were 
attending and, therefore, they were available to offer further counselling, support 










Preliminary feedback was given to in-country collaborators. Final results of this study 
will be published in peer review journals. Copies of the published work will be made 
available to all heads of each healthcare facility for distribution to research 
supervisors and research assistants involved in this study. 
 
Ethical approval  
 
LSMT granted full ethical approval (LSTM14.025). Ethical approval was obtained from 
each country specific research ethics committee (Table 3.1). Written informed 
consent was obtained from each woman who participated in the study. 
Table 3.20: Ethical approval from each country research committee  
Country Research committee  Reference number 
India Research and Ethics Committee, Vardhman 
Mahavir Medical College and Safdarjung 




Pakistan National Bioethics Committee, Islamabad 4-87/14/NBC-
159/RDC/1850 
Kenya Kenyatta National Hospital and University of 
Nairobi, Ethics and Research Committee, 
Nairobi 
P574/09/214 
Malawi  The College of Medicine Research and Ethics 








3.9 Chapter summary 
This chapter has described the approach used to measure maternal morbidity using 
physical, psychological and social health in a comprehensive and standardised way in 
women during and after pregnancy at different healthcare levels in India, Pakistan, 
Kenya, Malawi. The positionality of the lead researcher and contribution was 
considered. The study design, study settings, study population and sampling was then 
described. How the sample size was determined and the data collection tool and the 
process of piloting was described. This chapter described the process of data 
collection, processing, cleaning, coding and analysis. This chapter concluded with 
how the quality of the data was assured and ethical considerations were described 








CHAPTER 4: RESULTS ONE 
4.1 Introduction 
This is the first of four chapters that report on the results of this research project. The 
four chapters that present the main results of the research study, are structured in 
sequence to address each main research question. For the purposes of this thesis, 
results for the study settings are presented per country in the following sequence: 
India, Pakistan, Kenya and Malawi. Where appropriate, results are presented as a 
combined study population.  
 
In this chapter, the prevalence and types of ill-health (symptoms, signs and 
investigations) that contribute to maternal morbidity are described per country study 
population and as a combined study population. 
 
• Chapter 5, the second results chapter, presents the prevalence of maternal 
morbidity per assessment stage of pregnancy per country and as a combined 
study population.  
• Chapter 6, the third results chapter, presents the factors associated with 
maternal morbidity per country. 
• Chapter 7, the fourth results chapter, presents the associations between 
different types of maternal morbidity per country.  
 
Results are presented in a narrative text accompanied by tables and figures. Where 
supplementary information is necessary, this is presented in the appendices. At the 
end of each results chapter, the main findings are summarised and compared to 
published literature. Further positioning of the findings from all the results chapters 
are further compared to available literature in the main discussion chapter of this 
thesis in more detail.  
 
 





In this research study, there were four research questions.  
Table 4.1: Research questions for the study  
Number  Research question 
1. What is the prevalence of maternal morbidity and what types of ill-
health (symptoms, signs and investigations) contribute to maternal 
morbidity? 
2. What is the prevalence of maternal morbidity at different stages of 
pregnancy? 
3. Is there an association between the different types of maternal 
morbidity and age, socioeconomic status, educational level, number of 
previous pregnancies, and/or adverse maternal or neonatal outcomes 
in the most recent pregnancy? 
4. Is there an association between the different types of morbidity, 
defined as infectious, medical/obstetric, psychological and social 
morbidity?  
 
In this chapter, research question one is addressed. For standardisation, study 
populations are described firstly for India, Pakistan, Kenya and then Malawi 
throughout. When describing the study populations from each country, for 
standardisation, the country name is used. This does not mean that the study 
population from each country is representative of the remainder of the country.  
 
Unless otherwise stated, all percentages reported use the total sample size for the 
relevant country. Where a substantial proportion of women (more than 10%) had 
data missing for a variable, this is stated in a footnote, but for ease of readability, the 











4.2 Study population 
A total of 11454 women across four LMICs were assessed: India (2,099; 18.3%), 
Pakistan (3,287; 28.7%), Kenya (3,145; 27.5%) and Malawi (2,923; 25.5%). Table 4.2 
displays the study sites, the healthcare level and number of women recruited per 
study site across the four LMIC. 
Table 4.2: Number of women recruited per health facility per country and total. 
Country  Region District Healthcare 
Level  
Name of health 




India New Delhi New Delhi Secondary  Safdarjung 
Hospital  
2,099 

























Primary  RHC Maghian 
RHC Bahter Tehsil  
RHC Chhab 









    TOTAL 3,287 





General Hospital  
356 
 




















Kiambu Secondary  Kiambu Hospital 330 










    TOTAL  3,145 
Malawi  South  Blantyre  
 
Secondary  Limbe Health 
Centre 
1,073 









Secondary  Mulanje District 
Hospital 
740 







Mwanza Secondary  Mwanza District 
Hospital 
135 
Primary  Thambani Health 
Centre  
Tulonkhondo 




    TOTAL  2,923 
TOTAL NUMBER OF WOMEN INCLUDED ACROSS FOUR COUNTRIES  11454 
DHQ -District headquarter, THQ-Tehsil headquarter, RHC-Rural health centre 
 
This study was a cross sectional study. The minimum sample size in Pakistan, Kenya 
and Malawi was estimated as 2880, with a minimum sample size for each of the five 
assessments stages of 576. In India, the study was conducted in one facility 
(secondary level) giving an amended sample size of 1900 with a minimum of 380 
women per assessment stage.  
 
Some research assistants across the four LMIC collected more data from women at 
various assessment stages. Instead of discarding this data, all data was included in 
the final analysis. Similar proportions of women were recruited for each assessment 
stage from each country setting with more women recruited from late antenatal and 







Table 4.3: Women recruited per healthcare facility level per assessment stage per 














n % n % n % n % n % 
Stage of pregnancy  
Early 
antenatal 
416 19.8 607 18.5 592 18.8 589 20.2 2204 19.2 
Late 
antenatal 
397 18.9 768 23.4 684 21.7 576 19.7 2425 21.2 
Delivery 423 20.2 654 19.9 592 18.8 581 19.9 2250 19.6 
Early 
postnatal 
432 20.6 618 18.8 620 19.7 594 20.3 2264 19.8 
Late 
postnatal 
431 20.5 640 19.5 657 20.9 583 19.9 2311 20.2 
Healthcare facility level  
Second-
ary 
2099 100 1740 52.9 1686 53.6 1,948 66.6 7473 66.7 
Primary 0 0 1547 47.1 1459 46.4 975 33.4 3981 33.3 
 
Overall, more women, 7473 (66.7%) were assessed in secondary healthcare facilities 
(those provided comprehensive emergency obstetric care), compared to primary 
level (those provided basic emergency care), 3,981 (33.3%). In India, one large 
teaching secondary level healthcare facility was included in the study, and hence, 
100% of women in this study population in India were from secondary level 
healthcare facility. In Pakistan, 52.9% of women were recruited from a secondary 
level healthcare facility and 47.1% of women were recruited from a primary level 
healthcare facility. In Kenya, 53.6% of women were recruited from a secondary level 
healthcare facility and 46.4% of women were recruited from a primary level 
healthcare facility. In Malawi, 66.6% of women were recruited from a secondary level 
healthcare facility and 33.4% of women were recruited from a primary level 
healthcare facility.  





Overall, the refusal rate was low and this main reason for giving refusal was mainly 
due to the woman reporting a lack of time. The refusal rate was 1.1%, 2.5%, 1.7% and 
2.1% for India, Pakistan, Kenya and Malawi respectively. Overall, following 
recruitment and after taking a clinical history, 150 women (1.3%) declined clinical 
examination and 138 women (1.2%) declined laboratory investigations. There was no 
difference in the percentage of women who declined clinical examination and 
investigations across the four LMIC.  
 
In the following tables and, percentages reported are derived from the number of 




Overall, 12.7% of the combined study population were adolescents (<20 years at time 
of assessment) (Table 4.4 and Figure 4.1). The mean standard deviation (SD) age at 
recruitment was 26 (5.9) years and broadly similar across the countries: India 26 (3.7), 
Pakistan 27 (6.1), Kenya 26 (5.9) and Malawi 24 (6.5). There were higher numbers of 
teenage pregnancies in Malawi (26.8%) and Kenya (10.5%) compared to Pakistan 
(9.1%) and India (2. 8%).More women in Malawi and Kenya were younger compared 
to India and Pakistan, with the majority aged 20-24 years in Malawi (26.7%) and in 
Kenya (33.7%). Women in India and Pakistan were older with the majority aged 25-
29 years (46.3%) and (31.0%) respectively. In Pakistan, there were more women 







Table 4.4: Percentage of women per categorical age per country and per total 
*Percentages reported are derived from the number of women who responded. 
 
 

































<20 20-24 25-29 30-34 ≥35
Category  India Pakistan Kenya Malawi Total 
Number of 
women 
2,099 3,287 3,145 2,923 11,454 
Percentage* % % % % % 
Age category (years) 
<20 2.8 9.1 10.5 26.8 12.7 
20-24 36.5 21.3 33.7 26.7 28.9 
25-29 46.3 31.0 27.2 26.9 31.8 
30-34 12.7 25.3 18.4 12.6 17.8 
≥35 1.7 13.3 10.2 7.0 8.8 
TOTAL  100 100 100 100 100.0 




Marital status  
Overall, 93.2% of women assessed were married and 5.4% were single. Overall, 1.3% 
of women did not answer or were widowed. There were more single women in Kenya 
(15.9%) and Malawi (4.0%), compared to India (0.2%) and Pakistan (0.2%) (Table 4.5). 
 















n % n % n % n % n % 
Single 4.0 0.2 7.0 0.2 501 15.9 116 4.0 628 5.4 
Married 2094 99.8 3267 99.4 2573 81.8 2748 94.0 10682 93.2 
Other  1.0 0.1 13 0.4 71 2.3 59 1.9 144 1.3 
Total 2099 100 3287 100 3145 100 2923 100 11454 100 
 
Level of formal education completed  
Overall, 19.4% of women had no education, 37.4% completed primary level, 27.7% 
completed secondary level and 15.0% completed post-secondary level education 
(Table 4.6 and Figure 4.2). The highest percentages of women with no education level 
completed was in in Malawi (36.2%) and then Pakistan (30.2%). More women were 
educated to graduate level in India (24.8%). Overall, there were more educated 
women in Kenya (97.6%) compared to the other country settings. The median (IQR) 
number of years of formal education was 10 (7-12) in India, 5 (0-10) in Pakistan, 12 



























n %* n %* n %* n %* n %* 
No level 
completed  
111 5.2 955 30.2 74 2.4 1,055 36.2 2195 19.4 
Primary 812 38.7 911 28.7 1,363 43.5 1,202 41.3 4288 37.9 
Secondary 653 31.1 683 21.6 1,253 39.9 547 18.8 3136 27.7 
Post-
secondary 
522 24.8 616 19.5 445 14.2 107 3.7 1690 15 
*Percentages reported are derived from the number of women who responded 
 





























None Primary Secondary Post-secondary





Overall, 9.7% of women were in the 5th quintile (lower), 11.8% in the 4th quintile, 
26.9% in the 3rd quintile, 30.3 % in the 2nd and 13.5% in the 1st quintile (upper) SES 
level (Table 4.7). Overall, most women (30.3%) were in the 2nd/upper middle SES 
level. 
In India and Pakistan, an adapted Kuppuswamy’s score was used to assess SES and 
hence the calculations are comparable. More women were in the upper (1st quintile) 
SES level in Pakistan (15.2%) compared to India (0.4%). More women were in the 
upper lower (2nd quintile) SES level in India (59.5%) compared to Pakistan (35.1%). 
More women were in the middle (3rd quintile) SES level in Pakistan (45.1%) compared 
to India (28.5%). More women were in the upper lower (4th quintile) and lower (5th 
quintile) SES level in India (9.1% and 2.5%) compared to Pakistan (3.7% and 0.7%) 
(Table 4.7). 
Due to the relative nature of the calculation of SES in Kenya and Malawi (wealth 
index), similar proportions of women were split into the five quintiles with the top 
20% of the highest wealth index level in the 5th quintile, the next 20% in the 4th 
quintile and so forth. The measure of SES was not an absolute measure of SES in this 
setting but enabled aggregation of women in different wealth quintiles for 
comparison in further analysis. In Kenya, 28.4% of women did not answer all the 
questions required to calculate wealth index and therefore this data was missing. 























n %* n %* n %* n %* n %* 




9 0.4 501 15.2 448 14.2 591 20.2 1549 13.5 
2nd 
quintile 
1248 59.5 1153 35.1 452 14.4 613 21.0 3466 30.3 
3rd 
quintile 
599 28.5 1484 45.1 450 14.4 547 18.7 3080 26.9 
4th 
quintile 




53 2.5 25 0.7 451 14.4 583 19.6 1112 9.7 
*Percentages reported are derived from the number of women who responded 
 
Number of previous pregnancies  
For standardisation, the term “pregnancy” is used to represent a birth (including 
livebirth and stillbirth) after 28 weeks. Overall, 13.7% of women had no previous 
pregnancy, 35.2% had one previous pregnancy, and most (45.9%) had two to four 
previous pregnancies. A small subsample 5.2% had at least five or more previous 
pregnancies (Table 4.8).  
 
In India, 45.6% of women had one previous pregnancy; 39.3% % of women had two 
to four previous pregnancies’ 14.6% had no previous pregnancy and 0.5% had five or 
more previous pregnancies. In Pakistan, 50.5% of women had two to four previous 
pregnancies; 29.0% had one previous pregnancy, 11.8% had no previous pregnancy 
and 8.7% had five or more previous pregnancies. In Kenya, 43.6% of women had two 




to four previous pregnancies, 3% had one previous pregnancy, 15.9% had no previous 
pregnancy and 1.9% had five or more previous pregnancies. In Malawi, 48.1% of 
women had two to four previous pregnancies, 31.0% had one previous pregnancy, 
12.9% had no previous pregnancy and 8.0% had five or more previous pregnancies. 
Higher proportions of women were multiparous (P2-4) in Pakistan (50.5%) and 
Malawi (48.1%), compared to Kenya (43.6%) and India (39.3%). Similar percentages 
of women were grand multiparous (P≥5) in Malawi (8.0%) and Pakistan (8.7%). The 
highest percentage of women with one previous pregnancy was in India (45.6%). 
(Table 4.8 and Figure 4.3). 














Parity n %* n %* n %* n %* n %* 
0 285 14.6 353 11.8 486 15.9 375 12.9 1499 13.7 
1 893 45.6 865 29.0 1175 38.6 901 31.0 3834 35.2 
2-4 770 39.3 1508 50.5 1326 43.6 1398 48.1 5002 45.9 
≥5 9 0.5 258 8.7 56 1.9 232 8.0 555 5.2 
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4.3 Self-reported measures of health 
Overall, 8.0% of women were very satisfied, 69.8% were satisfied, 17.5% were neither 
satisfied or dissatisfied, 4.0% were dissatisfied and 0.2% were very dissatisfied with 
their health. Overall, most women (77.8%) were very satisfied or satisfied with their 
health. More women were very satisfied in Malawi (22.5%) and more women were 
satisfied (80.2%) in Kenya, compared to the other country settings. In Pakistan, 7.7% 
of women were dissatisfied and 0.4% were very dissatisfied with their health. In India, 
21.6% of women were neither satisfied or dissatisfied with their health (Figure 4.4). 
 















































Quality of life 
Overall, most women (73.9%) reported a very good or good quality of life. More 
women reported a very good quality of life in Malawi (21.4%) and more women 
reported a good quality of life in (77.5%) in Kenya. More women reported poor (6.4%) 
or very poor (0.6%) quality of life in Pakistan. In India, 32.5% of women reported 
neither a good or poor quality of life. The results for reporting of quality of life are 
like satisfaction with health (Figure 4.4 and 4.5).  
 
Figure 4.5: Quality of life per percentage of women per country and per total 
 
 
Number of symptoms  
A detailed clinical history was obtained. Almost three quarters of all women, (8,425; 
73.5%) reported at least one clinical symptom with a median (IQR) of 4.2 (0-27) 
symptoms per woman. Women in Pakistan and India most frequently reported 
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Table 4.9: Categories of symptoms per country and per total  












n %* n %* n %* n %* n %* 
Current physical symptoms 
None 199 9.5 258 7.9 1228 39.1 1344 46.0 3029 26.4 
1-3 1036 49.4 710 21.6 1148 36.5 1201 41.1 4095 35.7 
≥4 864 41.2 2319 70.6 769 24.4 378 12.9 4330 37.8 
*Percentages reported are derived from the number of women who responded 
 
Overall 26.4% of women did not report any symptoms and, overall 73.5% of women 
reported at least one symptom. Overall, 15.5% of women reported one symptom, 
13.3% reported two and 44.7% reported three or more symptoms (Figure 4.6). 
In India, more women (49.4%) reported one to three symptoms, 41.2% of women 
reported four or more symptoms and 9.5% of women denied any symptoms. In 
Pakistan, more women (70.6%) reported four or more symptoms, 21.6% of women 
reported one to three symptoms and 7.9% women denied any symptoms. 
In Kenya, more women (39.1%) denied any symptoms, 36.5% of women reported one 
to three symptoms and 24.4% of women reported four or more symptoms. In 
Malawi, more women (46.0%) denied any symptoms, 41.1% of women reported one 
to three symptoms and 12.9% of women reported four or more symptoms.  
Overall, more women did not report any symptoms in Malawi (46.0%) and Kenya 
(39.1%). More women reported four or more symptoms in Pakistan (70.6%) and India 







Figure 4.6: Percentage of women reporting symptoms (none, one, two, or three or 
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Organ systems  
Overall 8425 (73.5%) of women reported at least one symptom. These 8425 women 
reported a combination of 43706 symptoms. More women reported symptoms in 
Pakistan (62.6%) compared to Kenya (14.3%), India (13.2%) and Malawi (9.6%).  
 
When categorised by organ system, overall symptoms were most frequently related 
to the gastrointestinal tract (23.9% of all symptoms reported) followed by obstetric 
and breast (16.7%), uro-gynaecological (16.1%) cardiopulmonary (15.5%), 
musculoskeletal (12.8%) and miscellaneous (including immunology, dermatology, 
and endocrine) (15.0%). There were slight variations in the trend but the commonest 
was gastrointestinal symptoms in all four countries followed by cardiopulmonary 
symptoms in Malawi and Kenya, uro-gynaecological in Pakistan, and obstetric or 








Figure 4.7: Number of symptoms reported by women by organ system, by country 





















































Severity of symptoms  
 
Of all the symptoms reported per country, more women reported more severe 
symptoms in Pakistan compared to the other country settings, where women 
reported that symptoms bothered them “moderately” (35.0%) and “a lot” (35.0%). 
Women in Malawi (50%) and Kenya (40%)reported that their symptoms bothered 
them “not at all”. The results for reporting of number of symptoms are in line with 
the reporting of severity of symptoms (Figure 4.6 and Figure 4.8).  
 
Figure 4.8: Severity of symptoms per country and per total (n=8425) 
 
 
Clinical examination  
Overall, following recruitment and after taking a clinical history, 150 women (1.3%) 
declined clinical examination and 138 women (1.2%) declined laboratory 
investigations. Overall, 28.7% of women had no abnormality on clinical examination. 
Overall, 37.4% of women had one abnormal finding, 16.3% had two abnormal 















































Figure 4.9: Number of abnormal clinical examinations per percentage of women 
per country and per total  
 
 
In India, 43.1% of women (had one abnormal finding, 32.2% of women had no 
abnormality, 18.2% had two abnormal findings and 6.5% had three or more abnormal 
findings on clinical examination. In Pakistan, 43.2% of women had three or more 
abnormal findings, 23.3% of women had no abnormality, 17.3% had one abnormal 
finding and 16.2% had two abnormal findings on clinical examination. 
 
In Kenya, 52.3% of women had one abnormal finding, 20.5% of women had two 
abnormalities, 17.8% had no abnormal findings and 9.4% had three or more 
abnormal findings on clinical examination. In Malawi, 44.1% of women had no 
abnormal findings, 39.9% of women had one abnormality, 10.5% had two abnormal 



































0 1 2 ≥3




Of all the country settings, more women (43.2%) had three or more abnormal 
findings on clinical examination in Pakistan, and more women (44.1%) had no 
abnormal findings on clinical examination in Malawi. These abnormal findings are 
described in further detail in the following sections. 
 
4.4 Clinical observations  
 
Table 4.10 shows the percentage of women assessed with abnormal ranges of basic 
clinical observations per country and per total. Overall a large proportion of women 
assessed (42.3%) had an abnormal respiratory rate (RR≤8 or RR≥20). Overall 7.0% had 
an abnormal temperature (T≤35 or T≥38.0°C); 6.2% an abnormal diastolic blood 
pressure (≤45 or ≥90 mmHg); 5.8% an abnormal systolic blood pressure (≤90 or ≥140 
mmHg); and 4.5% an abnormal pulse rate (PR≤50 or PR≥100 beats per minute).  
 
In India, 15.2% of women (15.2%) had an abnormal temperature; 3.0% an abnormal 
diastolic and 2.5% an abnormal systolic blood pressure; 0.7% an abnormal pulse rate 
and 0.1% an abnormal respiratory rate. In Pakistan, 39.0% of women (39.0%) had an 
abnormal respiratory rate, 11.6% an abnormal diastolic blood pressure; 10.6% an 
abnormal temperature; 7.3% an abnormal systolic blood pressure, and 1.8% an 
abnormal pulse rate.  
 
In Kenya, 72.7% of women (72.7%) had an abnormal respiratory rate, 7.6% an 
abnormal systolic blood pressure; 7.3% an abnormal pulse rate, 4.3% an abnormal 
diastolic blood pressure, and 1.2% an abnormal temperature. In Malawi, 43.2% of 
women had an abnormal respiratory rate, 7.4% an abnormal an abnormal pulse rate, 








Table 4.10: Abnormal ranges of clinical observations per country and per total  
Country 
 
India Pakistan Kenya Malawi Total 
Number of women 
assessed * 
 
2099 3287 3145 2923 11454 
Clinical examination - general 
Variable Definition 
 
% % % % % 









































India Pakistan Kenya Malawi Total 
Number of women assessed * 
 
2099 3287 3145 2923 11454 





% % % % % 
General Conjunctival 
pallor 
40.9 43.9 6.1 4.7 23.0 
 
Sclera 0.7 3.5 0.1 0.0 1.2  
Goitre 0.2 6.3 0.2 0.2 2.0  
Peripheral 
pitting oedema  




0.3 5.7 0.3 0.5 1.9 
 Total 45.0 73.3 9.3 6.3 33.5 
Skin Skin rashes 3.5 9.2 1.4 0.7 3.7  
Skin ulcers 0.2 2.4 0.2 0.0 0.8  
Skin lump or 
growth  
0.4 5.7 0.8 0.2 2.0 
 
Total 4.1 17.3 2.4 0.9 6.5 
Oral cavity Bleeding gums 0.8 14.5 5.3 0.1 6.0  
Oral thrush 0.3 9.3 0.5 0.3 3.0  
Mouth ulcers 1.6 9.3 0.3 0.1 3.1  
Total  2.7 33.1 6.1 0.5 12.1 
Breast Cracked 
nipples 








1.3 11.1 1.0 0.8 3.9 
 
Abscess 0.3 0.9 0.2 0.3 0.4  
Lump 1.2 0.8 0.6 0.3 0.7  
Total  6.4 45.7 3.8 2.7 16.0 
Abdominal Abnormal 
tenderness 
25.7 17.9 2.4 1.3 10.9 
 
Abnormal mass 0.1 6.3 0.2 0.0 1.9  
Total  25.8 24.2 2.6 1.3 12.8 
*Percentage with abnormal findings calculated as proportion of those who consented to the 
examination. Proportion of total (n= 11 454) who provided consent for general examination 98.7%; 








In total, 73.1% of women had one or more abnormal findings at clinical examination 
(Table 4.11). The most common findings were; conjunctival pallor (23.0%), breast 
problems (16.0%), gum and oral cavity problems (12.1%), and abdominal tenderness 
(10.9%) (Table 4.11). Overall, more women (33.5%) had an abnormal clinical finding 
on general examination. Overall, 16% of women had breast, 12.8% abdominal, 12.1% 
mouth, and 6.5% abnormal skin findings.  
 
In India, 45.0% of women had an abnormal clinical finding on general examination, 
with 40.9% of all women noted to have conjunctival pallor. In India, 25.7% of women 
had abdominal, 6.4% breast, 4.1% skin and 2.7% mouth abnormal findings. In 
Pakistan, 73.3% of women had abnormal clinical findings on general examination, 
with 43.9% of all women noted to have conjunctival pallor. In Pakistan, 24.2% of 
women had abdominal, 45.7% breast, 17.3% skin and 33.1% mouth abnormal 
findings.  
 
In Kenya, 9.3% of women (had abnormal clinical findings on general examination, 
with 6.1% of all women noted to have conjunctival pallor. In Kenya, 6.1% of women 
had mouth, 3.8% breast, 2.6% abdominal, and 2.4% skin abnormal findings. In 
Malawi, 6.3% of women had abnormal clinical findings on general examination, with 
4.7% of all women noted to have conjunctival pallor. In Malawi, 2.7% of women had 
breast, 1.3% abdominal, 0.9% skin and 0.5% mouth abnormal findings (Table 4.11).  
 
Vaginal examination  
Vaginal examination was only offered and consent obtained, if clinically indicated. 
Overall, perineum examination was indicated and performed in 54.9% (6,288) of 
women and speculum examination in 22.3% (2,555) of women.  
 
Perineum examination was indicated and performed in more women in Pakistan, 
Kenya and Malawi compared to India.  Overall, 25.9% of women had perineal 
problems (vaginal tears, excoriation, swelling), and 3.3% were noted to have leakage 




of urine. This is equivalent to an overall estimated prevalence of 15.5% for perineal 
morbidity across the four countries but noted to be particularly high among women 
in Pakistan (Table 4.12).  
 




India Pakistan Kenya Malawi Total 
Number of women 
assessed * 
 
2099 3287 3145 2923 11454 
Clinical Examination - Perineum and speculum examination * 
Number of women with 
indication and assessed 
563 2654 2225 846 6288 
Perineum %** %** %** %** %**  
Leakage of 
urine 
0.0 7.1 0.6 0.5 
3.3 
 
Excoriation  0.0 12.0 0.5 2.2 5.5  
Swelling  1.2 18.2 1.1 3.2 8.7  
Tear  0.7 18.0 5.9 7.0 10.7  
Sub-Total  1.9 55.3 8.1 12.9 28.2 
Proportion of total 
number of women 
included in study 
0.5 44.6 5.7 3.7 15.5 
Number of women with 
indication and assessed 
365 1729 316 154 2555 








2.2 15.1 33.4 1.3 14.8 
 
Sub-Total  14.0 58.6 50.6 53.9 51.2 
Proportion of total 
number of women 
included in study 
2.4 30.8 5.1 2.8 11.4 
*Vaginal examination was only offered and consent obtained if clinically indicated; for perineum 
examination 54.9% of women; for speculum examination 22.3% of women. **Percentages reported 
are derived from the number of women who had the examination performed.  
 
Speculum examination was only offered, and consent obtained, if clinically indicated. 
Overall, speculum examination was indicated and performed in 22.3% (2,555) of 






Pakistan (52.6%) compared to India (17.4%), Kenya (10.0%) and Malawi (5.3%). 
Overall, 51.2% of women assessed had an abnormal finding on speculum 
examination. 
 
In India, 14.0% of women who had speculum examination had an abnormal finding 
with the commonest finding being abnormal vaginal discharge (11.8% of all women 
assessed). In Pakistan, 58.6% of women who had speculum examination, had an 
abnormal finding with the commonest finding being abnormal vaginal discharge 
(43.5% of all women assessed). 
 
In Kenya, 50.6% of women who had speculum examination had an abnormal finding 
with the commonest finding being abnormal bleeding (33.4% of all women assessed). 
In Malawi, 53.9% of women who had speculum examination had an abnormal finding 
with the commonest finding being abnormal vaginal discharge (52.6% of all women 
assessed). There was an overall estimated prevalence of 11.4% for vaginal morbidity 
across the four countries but prevalence was particularly high among women in 
Pakistan. Overall, 36.4% of women examined by speculum were noted to have 
abnormal vaginal discharge and vaginal bleeding was confirmed in 14.8% giving an 
overall estimated prevalence of between 2.4 and 5.1% in India, Kenya and Malawi 
but up to 30.8% among women in Pakistan (Table 4.12).  
 
Point-of-care investigations 
Overall, 26.5% of women did not have abnormal findings from investigations, and 
overall, 73.5% of women did have at least one abnormal investigation. Overall, 47.2% 
of women had one, 23.0% had two and 3.3% had three or more abnormal 
investigations (Figure 4.10).  
In India, 42.9% of women had one abnormal investigation, 35.3% had two and 21.4% 
had no and 0.4% had three or more abnormal investigations. In Pakistan, 57.9% of 
women had one abnormal investigation, 24.4 had none, 16.1% had two and 1.6% had 
three or more abnormal investigations. In Kenya, 46.9% of women (46.9%) had one 




abnormal investigation, 32.1 had none, 18.6% had two and 2.4% had three or more 
abnormal investigations. In Malawi, 38.5% of women had one abnormal 
investigation, 26.9% had two, 26.5% had none and 8.1% had three or more abnormal 
investigations. Overall, 26.5% of women had no abnormal investigations, and more 
women had no abnormal investigations in Kenya (32.1%). Overall, 23.0% of women 
had two abnormal investigations, with more women with two abnormal 
investigations in India (35.3%) compared to Pakistan (16.1%), Kenya (18.6%) and 
Malawi (26.9%). 
Figure 4.10: Percentage of women with abnormal laboratory investigations (none, 










































4.5 Infectious morbidity  
Overall, 4.8% of women tested positive for HIV, 2.7% for malaria and 0.9% for syphilis. 
In India, the percentage of women with HIV, malaria and syphilis was very low (0.1%, 
0.1% and 0.0%) respectively. In Pakistan, the percentage of women with HIV, malaria 
and syphilis was very low (0.3%, 0.0% and 0.0%) respectively. In Kenya, the percent 
of women with HIV was 3.6% and malaria and syphilis was low (0.2% and 0.3%) 
respectively. Overall, HIV positive status was highest in Malawi (14.5%) as was 
malaria (10.4%) and syphilis (3.4%) (Table 4.13).  
 
Table 4.13: Infectious conditions identified per country and per total  
Country 
 
India Pakistan Kenya Malawi Total 
Number of women* 2099 3287 3145 2923 11454 
 % % % % % 
INFECTIOUS MORBIDITY 
Condition Definition  
HIV  Positive 0.1 0.3 3.6 14.5 4.8 
Malaria  Positive 0.1 0.0 0.2 10.4 2.7 
Syphilis  Positive 0.0 0.0 0.3 3.4 0.9 
*Percentages reported are derived from the number of women who had the investigation performed. 
 
Table 4.14: SIRS identified per country and per total  
Country 
 
India Pakistan Kenya Malawi Total 
Number of women* 2099 3287 3145 2923 11454 
 % % % % % 
INFECTIOUS MORBIDITY 
 SIRS** 13.8 11.2 36.5 28.7 23.1 




66.9 91.5 47.9 43.1 42.9 
 




*Percentages reported are derived from the number of women who had the investigation performed. 
**Amended SIRS score any two of the following: PR>90 bpm; RR>20 per min; T<36°C or T>38°C; Raised 
CRP mg/L 
 
Overall 23.1% of women had a SIRS score of ≥2. More women had a SIRS score of ≥2 
in Kenya (36.5%) Malawi (28.7%), compared to India (13.8%) and Pakistan (11.2%). 
Overall, in 2336 women with a SIRS score of ≥2, based on symptoms, clinical 
examination and/or investigation findings, a source could be identified in 1002 
(42.9%) women (Table 4.14). Of women with a SIRS score of ≥2, more women had an 
identifiable source of possible infection in Pakistan (91.5%), India (66.9%), Kenya 
















Figure 4.11: Possible identifiable source of infection in women with SIRS score of 
≥2, per country and per total  
 
 
Overall, of women with a SIRS score of ≥2, and using triangulation of data of 
symptoms, signs and/or investigations, identifiable possible sources of early infection 
included gastroenteritis (18.8%), lower respiratory tract infection (13.0%), sexually 
transmitted infection (10.1%), urinary tract infection (9.6%), mastitis (7.4%), upper 
respiratory tract infection (4.4%), endometritis (2.0%), chorioamnionitis (1.6%) and 

























India Pakistan Kenya Malawi Total
>
No source Identifiable source




Table 4.15: Possible causes of infection in women identified with a SIRS score of 
≥2 for all countries combined  
Possible source of infection  
(if any) 
Women with a SIRS score ≥2 
n %* 
No source 1334 57.1 
Possible source of infection 
based on symptoms and/or 
clinical examination findings  
1002 
42.9 
Chorioamnionitis 39 1.6 
Endometritis  46 2.0 
Mastitis 174 7.4 
Lower respiratory tract infection  307 13.0 
Upper respiratory tract infection  103 4.4 
Gastroenteritis 439 18.8 
Sexually transmitted infection 252 10.1 
Urinary tract infection  225 9.6 
Wound infection  15 0.6 
TOTAL  2336 100 







4.6 Medical and obstetric morbidity  




India Pakistan Kenya Malawi Total 
Number of women 2099 3287 3145 2923 11454 
Medical/ obstetric 
morbidity 
% % % % % 

























5.3 8.2 5.2 0.6 4.9 
Proportion of women with 
>1 medical and/or obstetric 
condition 
61.1 69.3 25.2 41.0 45.5 
 
 
Overall, 47.9% of women were diagnosed with anaemia. Overall, 4.9% of women 
were diagnosed with antenatal haemorrhage, 3.6% urinary incontinence, 2.4% 
hypertension, and 0.6% pre-eclampsia. In India, 61.2% of women were diagnosed 
with anaemia, 5.3%were diagnosed with antenatal haemorrhage, 1.7% urinary 




incontinence, 1.5% hypertension, and 0.1% pre-eclampsia. In Pakistan, 68.7% of 
women were diagnosed with anaemia, 9.6% were diagnosed with urinary 
incontinence, 8.2% antenatal haemorrhage, 4.8% hypertension, and 1.5% pre-
eclampsia. In Kenya, 23.9% of women were diagnosed with anaemia, 5.2% were 
diagnosed with antenatal haemorrhage, 1.6% urinary incontinence, 1.8% 
hypertension, and 0.4% pre-eclampsia. In Malawi, 41.0% of women were diagnosed 
with anaemia, 1.5% were diagnosed with urinary incontinence, 0.8% hypertension, 
0.6% antenatal haemorrhage and 0.3% pre-eclampsia (Table 4.16). 
 
Figure 4.12: Severity of anaemia (if any) identified per country and per total  
 
 
Overall, 47.4% of women were anaemic. Overall, anaemia was most common in 
women in Pakistan (67.8%) and India (60.4%), compared to Kenya (23.8%) and 
Malawi (40.4%). More women had moderate anaemia in Pakistan (38.2%) and India 
(32.9%), compared with Malawi (17.9%) and Kenya (11.1%). More women had severe 
anaemia in Pakistan (2.5%) and India (2.4%) compared to Kenya (1.2%) and Malawi 
















































4.7 Psychological Morbidity  
Psychological morbidity was assessed as part of the clinical history. Psychological 
morbidity (EDPS ≥10) was noted in 1 in 4 women (25.1%). More women had an EDPS 
≥10 in Pakistan (47.3%) compared to India (19.8%), Malawi (16.4%) and Kenya 
(13.5%). Overall, 15.2% of women reported thoughts of self-harm. More women 
reported thoughts of self-harm in Pakistan (29.8%) compared to India (15.6%), 
Malawi (10.1%) and Kenya (4.5%) (Table 4.17). Figure 4.13 displays these trends 
visually. 
 
Table 4.17: Psychological morbidity per country and per total  
Category India Pakistan Kenya Malawi Total 
Number of 
women 
2099 3287 3145 2923 11454 
 % % % % % 
PSYCHOLOGICAL MORBIDITY 
EDPS ≥10 19.8 47.3 13.5 16.4 25.1 
Thoughts of 
self-harm 
15.6 29.8 4.5 10.1 15.2 








4.8 Social morbidity  
 
Domestic violence  
Overall 3,887 women (33.9%) reported domestic violence (HITS >4). More women 
reported domestic violence in Pakistan (56.0%), India (39.7%), compared to Kenya 
(21.7%) and Malawi (18.2%). Overall, domestic violence was commonly reported 
from the husband (26.3%) than from another family member (15.8%). Domestic 
violence was commonly reported perpetrated by the husband in India (38.6%), 
Pakistan (37.4%), compared to Kenya (18.3%) and Malawi (13.6%). More women 
reported domestic violence perpetrated by family members in Pakistan (31.8%) 









































Overall 8.9% of women reported higher levels domestic violence (HITS score >10). 
More women reported higher levels of domestic violence in Pakistan (21.7%), 
compared to India (6.1%), Malawi (4.7%) and Kenya (3.2%). Overall, higher levels of 
domestic violence were commonly reported from husbands (6.0%) than from 
another family members (3.4%).  
 
Table 4.18: Severity of domestic violence from husband/partner, and/or family, 







Category  India Pakistan Kenya Malawi Total 
 
Number of women 2099 3287 3145 2923 11454 












39.7 56.0 21.7 18.2 33.9 
Husband 38.6 37.4 18.3 13.6 26.3 
Family 












6.1 21.7 3.2 4.7 8.9 
Husband 5.1 12.5 2.4 3.0 6.0 
Family 
2.7 7.5 0.5 2.6 3.4 




Figure 4.14: Severity of domestic violence perpetrated by husband/partner, or 



































HITS score >4 Husband and/or family
HITS score >4 Husband
HITS score >4 Family
HITS score >10 Husband and/or family
HITS score >10 Husband






Substance use  
Use of alcohol, sedatives or inhalants was not common, with an overall 6.5% of 
women reporting using any of these substances over the three months prior to the 
time of assessment. More women reported using alcohol, sedatives, inhalants or 
tobacco over the past three months in India (2.7%) and Kenya (2.0%) compared to 
Malawi (1.7%) and Pakistan (0.2%). Overall, 1.7% of women had an ASSIST score of 
>4 indicating that they would benefit from an intervention for substance use. More 
women scored an ASSIST score of >4 in Malawi (2.8%), Pakistan (1.5%), Kenya (1.4%) 
compared to India (0.8%) (Table 4.20). 
 




The following histogram (Figure 4.1) displays the visual trend of quality of life, 
satisfaction with health, number of symptoms, number of abnormal clinical 
examinations, and number of abnormal laboratory investigations as percentage of 
women assessed by country and per total.
Category  India Pakistan Kenya Malawi Total 
 
Number of women 2099 3287 3145 2923 11454 
 % % % % % 
Substance misuse 
Use of alcohol 
sedatives, inhalants, 
tobacco in last three 
months 
2.7 0.2 2.0 1.7 6.5 
Intervention 
recommended 
(ASSIST score >4) 
0.8 1.5 1.4 2.8 1.7 




Figure 4.15: Histogram of quality of life, satisfaction with health, number of symptoms, number of abnormal clinical examinations, and 



















































































































































Very satisfied Very good - - - 
 





Neither good nor 
poor 
1 1 1 
 




Very poor ≥3 ≥3 ≥3 
 
 
Overall, despite most women reporting a good quality of life (75.9%) and satisfaction 
with health (78.2%), almost three out of four women reported at least one symptom 
(73.5%), had at least one abnormal finding on clinical examination (71.3%) or had at 
least one abnormal finding on simple laboratory investigation (73.5%).  
 









Figure 4.16: Venn diagram for number of women with no morbidity; or infectious, 





Overall, most women (8,834; 77.1%) had at least one type of morbidity and a very 
small number of women (138; 1.2%) had all four types of morbidity (Figure 4.13). 
Overall, more women had a medical or obstetric morbidity (48.5%), social morbidity 
(35.9%), infectious morbidity (25.6%) or psychological morbidity (25.1%) compared 







4.9 Chapter summary  
Overall, despite most women reporting a good quality of life (75.9%) and satisfaction 
with health (78.2%), almost three out of four women reported at least one symptom 
(73.5%), had at least one abnormal finding on clinical examination (71.3%) or had at 
least one abnormal finding on simple point-of-care investigation (73.5%).  
 
Overall, 1 in 4 women (25.1%) reported psychological morbidity on screening and 
more than 1 in 3 women (36.6%) reported social morbidity (domestic violence and/or 
substance misuse) with 15.6% of women reporting both psychological and social 
morbidity.  
 
Women in Pakistan tended to report more physical, psychological, and social ill-
health. Of all women tested, 47.4% of women were anaemic with the highest 
prevalence among women from India and Pakistan.  
 
Using an amended SIRS score, 23.1% of women had possible early signs of infection; 
in 43% of cases, a source could be identified which (based on symptoms and clinical 
examination) was most frequently gastroenteritis followed by lower respiratory tract, 
sexually transmitted or urinary tract infection or mastitis. The prevalence of HIV, 
malaria, and syphilis was below 5% in all settings except Malawi. Overall, one or more 
infectious condition was identified in 25.6% of women, one or more medical or 
obstetric condition in 45.5%.  
 
  




4.10 Chapter summary in relation to literature 
Summative morbidity  
As this is the first study to assess the prevalence of physical, psychological and social 
components of ill-health comprehensively at five different assessment stages in four 
LMIC, there is little data in the literature against which to compare the overall 
summative burden of maternal morbidity. There are early reports of population 
surveys or health camps which tried to identify maternal ill-health in Uganda and 
Egypt (Ugandan Ministry of Health 1994, Osman-Hassan 1995). The community 
based-survey in Egypt reported up to 82.8% of women having morbidity before, 
during or after pregnancy respectively (Osman-Hassan 1995). One prospective study 
followed up 280 women in rural India for 5 years and reported pregnancy related 
morbidity in 30% of women (Bhatia 1995). In Kenya, 53% of women assessed for 
postnatal morbidity reported feeling “unwell” and 37% had experienced a “health 
problem” since childbirth (Chersich 2009). In a more recent study, 44% of women 
reported at least one self-reported physical complaint (Assarag 2013). In another 
study, 50.0% of 1,732 women in Malawi and 53.0% of 1,727 women in Pakistan had 
a least one medical/obstetric morbidity (infective or non-infective) but this relied 
only on solicited symptoms and limited clinical examination (Zafar 2015). Only one of 
the previous studies included social and psychological aspects of ill-health, along with 
physical measures of ill-health (Chersich 2009). In this PhD study, across the four 
countries, 77.1% of women had at least one type of morbidity. This may be because 
the assessment of ill-health was very comprehensive including self-reported 
symptoms, in combination with detailed clinical examinations and investigations. 
Furthermore, in this study all aspects of ill-health were assessed (infectious, 
medical/obstetric, psychological and social ill-health), in line with the current 
definition of maternal morbidity. Other studies have largely measured only one or 
two types of morbidity and this may explain the lower reported prevalence of 
morbidity in many of these studies.  
 
With regards to self-reported perception of health, few women reported a poor or 






health (21.8%), despite having morbidity on further questioning and examination. 
However, this prevalence of poor perceived health is more than the prevalence of 
what other studies have reported. For example, as part of the overall assessment of 
ill-health in Ethiopia, 3.8% of 1065 pregnant women reported “poor/bad global 
health” (Hanlon 2009). The findings in this PhD study suggests that self-perceived ill-
health is not simply a result of physical change during and after pregnancy but is 
influenced by a woman’s understanding of health, her social support and/or social 
desirability bias in responding to such questions (Graham 2016). The understanding 
of women’s perception of health and how this is reported warrants further research.  
 
Infectious morbidity  
 
With regards to infectious morbidities, the overall prevalence of HIV was 4.8%, and 
this is much higher than the global HIV prevalence of 0.8% among adults and the 
global estimate of new HIV infections among adults 15-49 years old as 0.5 per 1000 
uninfected population (WHO 2017i, WHO 2016c). This finding may be higher than the 
global prevalence of HIV, as settings with known high prevalence of HIV (for example 
Malawi) were included in this overall estimated. Similarly, overall 2.7% of women 
were positive for malaria and 0.9% for syphilis. The prevalence of HIV, malaria, and 
syphilis are context specific. The findings from this PhD study for the prevalence in 
each country were comparable (Table 3.4).   
 
Possible chest infection/tuberculosis was much lower than estimated global and 
national prevalence (Table 3.4) and this may be due to the lack of sensitivity of the 
screening question that was used to detect possible chest infection/tuberculosis. In 
this PhD study, 23.1% of women scored ≥2 using our amended SIRS score (CRP 
instead of WCC). This amended score has not been used in any other study and there 
is lack of data of the prevalence and significance of women with a SIRS score ≥2 in 
LMIC settings. However, the finding is very similar to a clinical audit in a HIC setting 
where 23.1% of 225 pregnant women with confirmed infection had a SIRS score ≥2 
(Richardson 2017). It is noted however, that the definitions of a “raised CRP” in this 




PhD study used low cut-offs levels (>5mg/L and >10mg/L within 24 hours of 
childbirth); and this may have resulted in an over-estimation of women with possible 
infection. Caution in interpretation of the sensitivity and specificity of these results 




In this study the overall prevalence of anaemia was 47.9%, a higher prevalence 
compared to the global estimated prevalence of anaemia during pregnancy (38.2%) 
(WHO 2015d). Country specific prevalence of anaemia and the severity are similar to 
national prevalence (WHO 2015d). In this study, hypertension was diagnosed in 2.4% 
of women; a smaller prevalence compared to the estimated prevalence of 3.6 to 9.1 
% in HIC (Roberts 2011); and pre-eclampsia was diagnosed in 0.6% of women; a 
smaller prevalence compared to the estimated global prevalence of 4.6% (Abalos 
2013). This may be because the study population in each setting were women 
attending for antenatal or postnatal care, and they may have received anti-
hypertensive medication to treat their hypertension or pre-eclampsia. In this study, 
urinary incontinence was diagnosed in 3.6% of women; a similar finding to other 
studies that reported urinary incontinence as part of an overall assessment of 
maternal morbidity, with estimates ranging from 1.0 to 4.7% in LMIC settings 
(Assarag 2013, Chersich 2009, Surkan 2017). The understanding of the type, severity 
and impact on a woman’s well-being regarding incontinence requires further 
research. Antepartum haemorrhage was reported by 4.9% of women, a comparable 
finding to other studies in LMIC, that reported prevalence of antepartum 
haemorrhage as 1.2 to 5.5% (Chufamo 2015, Zafar 2015, Takai 2017).  
 
Psychological morbidity  
In this PhD study, 25.1% of women reported a EPDS ≥10. This finding is similar to 
studies from LMIC that report the prevalence of pregnant or postpartum women with 
an EPDS ≥10 as 13.5 to 39.5% (Brittain 2017, Nasreen 2011, Rees 2016, Tsai 2016). In 






similar to prevalence ranges (5.0-18.0%) reported in a systematic review of 17 studies 
from HIC and LMIC (Lindahl 2005). These findings are also corroborated by more 
recent studies from other LMICs, with reported suicidal ideation and thoughts of self-
harm prevalence rates ranging from 6.3 to 14% (Gausia 2009; Huang 2012; Zhong 
2015). The reasons why women report such burden of psychological morbidity, and 
interventions to address these health needs across different country settings, 
requires further research. 
 
Social morbidity, domestic violence 
In this PhD study, overall 33.9% of women reported at least one form of domestic 
violence, and this could have been physical or verbal abuse. This finding is 
comparable to that of one study that assessed maternal morbidity after childbirth in 
women in Kenya that reported 39.4% of women had been coerced into sex, and 19% 
had been pushed or physical hit by an intimate partner (Chersich 2009). This 
prevalence of domestic finding from this PhD is higher than overall findings reported 
in the WHO multi-country study on domestic violence against women, that found in 
most settings, the prevalence of physical intimate partner violence in pregnancy 
ranged between 4% and 12% (WHO 2013c). Other clinical studies found higher 
prevalence of physical domestic violence in Egypt (32%), followed by India (28%), 
Saudi Arabia (21%) and Mexico (11%) (WHO 2013c); and clinical studies from Africa 
reported prevalence rates of 23–40% for physical, 3–27% for sexual and 25–49% for 
emotional intimate partner violence during pregnancy (WHO 2013c).  The findings of 
a high prevalence of domestic violence in this PhD study, may be due to women being 
asked questions regarding physical and verbal forms of domestic violence, not just 
from the partner/husband but from other family members also.  
 
Social morbidity, substance misuse 
 In this PhD study, 6.5% of women reported any substance misuse during and after 
pregnancy. This summative finding includes the misuse of tobacco, alcohol, illicit 
drugs and stimulants and suggests that overall, as a summative measure, substance 




misuse is not a common problem in women in these settings. There is little 
information available on the extent of substance use among pregnant women in LMIC 
settings. The global prevalence of women using alcohol during pregnancy has been 
reported as 9·8% (Popova 2017). Similarly, one study that assessed maternal 
morbidity after childbirth in 500 women, reported that overall 8% of women had 
drank alcohol during pregnancy or whilst breastfeeding (Chersich 2009). The overall 
prevalence of tobacco use in women during pregnancy is LMIC settings has been 
estimated as 2.6% (Caleyachetty 2014); and the limited data available indicate that 
between 3.6 to 8.8% of pregnant women use illicit substances in South Africa 
(Petersen 2014).   
 
Further reflections of the main findings from this chapter in relation to other 









CHAPTER 5: RESULTS TWO  
5.1 Introduction 
This is the second of four chapters that report on the results of this research project. 
The four chapters that present the main results of the research study, are structured 
in sequence to address each main research question. For the purposes of this thesis, 
results for the study settings are presented per country in the following sequence: 
India, Pakistan, Kenya and Malawi. Where appropriate, results are presented as a 
combined study population. In this chapter, the prevalence of maternal morbidity per 
assessment stage of pregnancy per country and as a combined study population is 
presented. Results are presented in a narrative text accompanied by tables and 
figures. Where supplementary information is necessary, this is presented in the 
appendices.  
Background 
In this research study, there were four research questions.  
Table 5.1: Research questions for the study  
Number  Research question 
1. What is the prevalence of maternal morbidity and what types of 
ill-health (symptoms, signs and investigations) contribute to 
maternal morbidity? 
2. What is the prevalence of maternal morbidity at different stages 
of pregnancy? 
3. Is there an association between the different types of maternal 
morbidity and age, socioeconomic status, educational level, 
number of previous pregnancies, and/or adverse maternal or 
neonatal outcomes in the most recent pregnancy? 
4. Is there an association between the different types of morbidity, 
defined as infectious, medical/obstetric, psychological and social 
morbidity?  
 




In this chapter, results are presented to address the following research question: 
“What is the prevalence of maternal morbidity at different stages of pregnancy?” In 
this research study for standardisation the following abbreviations and stages of 
pregnancy are presented in Table 5.2.  
 
Table 5.2: Definitions of assessment stages  
Number Stage Abbreviation Time frame 
1. Early 
antenatal 
EAN ≤20 weeks’ gestation of pregnancy* 
2. Late 
antenatal 
LAN >20 weeks gestation of pregnancy* 
3. Delivery 
 
DEL  ≤24 hours from time of childbirth 
4. Early 
postnatal 
EPN from day 1–7 (>24 hours up ≤day 7) 
from time of childbirth 
5. Late 
postnatal  
LPN from week 2–12 (>day 7 and ≤week 
12) from time of childbirth 
*For the antenatal assessments, gestation was calculated based on the women’s last menstrual period 








5.2 Study population per assessment stage  
In this chapter, results are presented using the combined dataset, which includes all 
four countries. If there are significant differences between the countries, these are 
highlighted in the narrative text. 
 
Table 5.3: Number of women in the study per assessment stage, per country and 














n % n % n % n % n % 








397 18.9 768 23.4 684 21.7 576 19.7 2425 21.2 
Delivery 
 








431 20.5 640 19.5 657 20.9 583 19.9 2311 20.2 
 
This study was designed as a cross sectional study. The target size for each 
assessment stage was the sample size divided by the five assessment stages. Some of 
the research assistants across the four LMIC collected more data from women at 
various assessment stages. Instead of discarding this data, all data was included in 
the final analysis. Similar proportions of women were recruited for each assessment 
stage from each country setting with more women recruited from the late antenatal 
and late postnatal stages due to over-recruitment (Table 5.3).  
 
  




5.3 Self-reported health  
Overall, the responses of women to questions regarding their quality of life and their 
satisfaction with health were similar across all five assessment stages (Figure 5.1). 
Overall, most women across all assessment stages agreed that they had a good 
quality of life and were satisfied with their health. Between 18.6% and 23.1% of all 
women, responded that they neither agreed or disagreed that they had a good 
quality of life. This was highest (23.1%) in the late antenatal stage (Figure 5.1). 
Between 19.0% and 23.5% of all women, responded that they neither agreed or 
disagreed that they were satisfied with their health. This was highest (23.5%) in the 
late antenatal stage. The trend for satisfaction was in line with how women reported 
their quality of life, with similar percentage across the five assessment stages (Figure 
5.1).  
 
Figure 5.1 Quality of life and satisfaction with health per assessment stage, per 
total  
 










































































Self-reported number of symptoms per assessment stage per total  
 
Figure 5.2 shows as a combined cohort, the responses of women when screened for 
different types of symptoms covering six organ systems using 76 screening questions. 
More women did not report any symptoms in the late postnatal stage (37.9%), 
compared to the early antenatal (27.9%), early postnatal (25.3%), late antenatal 
stages (23.0%) and within 24 hours of delivery (18.3%). Similar percentages of women 
reported the same numbers of symptoms across all five assessment stages, with 
small variations only. For example, the percentage of women reporting three 
symptoms was 11.4%, 10.5%, 11.1%, 12.4% and 9.2% throughout the continuum of 
pregnancy from early antenatal to late postnatal stage (Figure 5.2). 43.1% of women 
(reported at least four symptoms at the late antenatal stage. 81.7% of women 
reported at least one symptom within 24 hours of childbirth. Overall, 24.1% of 
women reported at least four symptoms in the late postnatal assessment stage. The 
mean number of symptoms were similar across all five assessment stages (EAN 3.4, 
DEL 3.8, EPN 3.8, LPN 3.2) with a slight increase in the late antenatal stage (4.8).  
 




Figure 5.2: Percentage of all women with no symptoms and one or more 











































































Severity of symptoms per assessment stages per total  
Figure 5.3: Severity of symptoms reported for all women who reported symptoms 
per assessment stage, per total. 
 
 
Figure 5.3 shows as a combined cohort and the percentage of all women assessed, 
whether they report symptoms and if so, the severity of symptoms reported per 
assessment stage. Overall, 11454 women reported 43,706symptoms in total. Of all 
the symptoms reported, similar proportions of women reported the same scale of 
severity of symptoms across the five assessment stages. For example, the percentage 
of women reporting that their symptoms were bothering them a lot was similar 
(12.6%, 13.0%, 12.2%, 11.1%) throughout the continuum of pregnancy from early 
antenatal to late postnatal stage with a slightly higher proportion within 24 hours of 
delivery (16.6%). Similar proportions of women also reported the same scale of 
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33.9%) throughout the continuum of pregnancy from the early antenatal to late 
postnatal stage with a slightly lower proportion in late postnatal (26.2%) (Figure 5.3). 
 
Severity of symptoms per assessment stage per country  
 
In India, a large proportion of women reported that their symptoms bothered them 
only “slightly” across all five assessment stages, with the highest percentage of 
women reporting this within 24 hours of childbirth (66.9%).  (Figure 5.4).  
 
In Pakistan, a large proportion of women reported that their symptoms bothered 
them “a lot” over the five assessment stages with 42.8% of women reported that 
their symptoms bothered them “a lot” within 24 hours of childbirth; 39.9% in the 
early antenatal, 38.0% in the early postnatal and 33.0% in the late postnatal stages 
(Figure 5.4). 
 
In Kenya, a larger proportion of women denied any symptoms/or if they reported a 
symptom, it “did not bother them at all” across the five assessment stages, with the 
highest percentage of women reporting this in the late postnatal stage (65.0%). 
 
Similar to Kenya, in Malawi, a large proportion of women denied any symptoms; or if 
they reported a symptom, it did not bother them “at all”, with the highest percentage 

































































































































India Pakistan Kenya Malawi
None/Not at all Slightly Moderately A lot




Categorises of morbidity  
For the purposes of this research project, maternal morbidity was defined as: 
(1) physical  
(2) psychological  
(3) social  
 
Summative physical morbidity was defined as (1) infectious or (2) medical and 
obstetric.  
5.4 Infectious morbidity  
In this study, infectious physical morbidity that could be measured included: HIV, 
malaria, syphilis, possible chest infection/TB, and a SIRS score of ≥2. Table 5.4 
presents infectious morbidity identified per assessment stage for all countries 
combined and percentages are derived using the number of women who responded 
per assessment stage.  
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a Where data were missing for a condition, the condition was regarding as being absent for purposes of deriving 
morbidities % missing was: HIV 9.7%, malaria 5.3%, syphilis 8.9%, screening for chest infection/TB 2.0%. 
b CRP was not measured at some primary level facilities in Malawi and Pakistan. Only participants for whom a CRP 
result was obtained are included in these statistics. 
 
The CRP levels were highest in the early postnatal stage (19), then within 24 hours of 
delivery (15), in the late postnatal (10), early antenatal (7), and late antenatal stages 
(6).  This trend was similar across all four countries (Table 5.5). The percentage of 
women with possible early signs of infection (using the score of SIRS ≥2) were highest 
in the early postnatal (26.1%) and in the late antenatal (25.1%) stages. There were 
similar percentages of women with possible early signs of infection in the early 
antenatal (21.0%), within 24 hours of delivery (21.0%) and late postnatal (21.3%) 
stages.  
 
Figure 5.5 further displays the percentage of women as a combined total cohort with 
infectious morbidity per assessment stage, and percentages are derived using the 
number of women who responded per assessment stage.




















EAN LAN DEL EPN LPN EAN LAN DEL EPN LPN EAN LAN DEL EPN LPN EAN LAN DEL EPN LPN EAN LAN DEL EPN LPN



























Similar proportions of women were HIV positive across all five assessment stages 
with the highest percentage of women in the early postnatal stage (5.4%) (Table 5.4 
and Figure 5.5). Overall, the highest percentage of women who women tested 
positive for malaria in the early antenatal stage (3.9%), and this percentage generally 
decreased as the pregnancy continued (Table 5.4 and Figure 5.5).  
 
Overall, the highest percentage of women tested positive for syphilis in the early 
antenatal stage (1.6%) and this percentage decreased as the pregnancy continued 
and after delivery with the lowest percentage at the late postnatal (0.5%) stage. 
Compared to the other assessment stages, more women reported a productive cough 
of more than two weeks suggestive of a possible chest infection/TB at the late 
antenatal stage (1.0%).  
 
The percentages of women with malaria and syphilis were highest in the early 
antenatal stage, and decreased across the continuum of pregnancy (Figure 5.5). 
 
Overall, and as a combined measure, 30.5% of women were diagnosed with at least 
one infectious morbidity in the early postnatal stage, 30.1% in the late antenatal, 
27.3% in the early antenatal, and 25.8% in the early postnatal stage. Within 24 hours 
of childbirth 25.8% of women were diagnosed with at least one infectious morbidity. 
Country specific tables for infectious morbidity per assessment stage are displayed in 
Table 5.5. The percentages and trends of each infectious morbidity were generally 
similar across all four countries, although differences are highlighted in the text 
below the table. Percentages are derived using the number of women who 
responded per assessment stage. 
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a Where data were missing for a condition the condition was regarding as being absent for purposes of deriving 
the percentage. 
b CRP was not measured at some primary level facilities in Malawi and Pakistan. Only participants for whom a CRP 
result was obtained are included in these statistics. 
 
As a combined cohort, the median CRP level was 10 with an interquartile range (IQR) 
of 5-23. Across the four countries, the highest median levels of CRP were highest in 
Malawi (18.5; IQR 9-35) and then Pakistan (10; IQR 6-17), Kenya (8; IQR 5-19) and 
India (9; IQR 5-21). Across all four countries, CRP levels tended to be highest in the 
early postnatal stage, then within 24 hours of delivery, and then in the late postnatal, 
early antenatal, and late antenatal stages (Table 5.5). As a combined cohort, the 
highest percentage of women with SIRS≥2 was in the early postnatal stage. This trend 
was similar for women in Kenya and Malawi.  In India, of those who did have SIRS ≥2, 
the largest percentage was in the late antenatal compared to the early postnatal in 
the overall cohort. This was similar to the trend of women with SIRS≥2 in Pakistan 
also (Table 5.5).  
 
As a combined measure, the highest percentage of women were diagnosed with at 
least one infectious morbidity in the early postnatal stage. This trend was similar in 
Kenya. In India and Pakistan, the highest percentage of women were diagnosed with 
at least one infectious morbidity in the late antenatal stage. In Malawi, the highest 
percentage of women were diagnosed with at least one infectious morbidity in the 
early antenatal stage. 
 
Figure 5.6 displays these trends visually, displaying the number of women with any 







Figure 5.6: Number of women with any infection morbidity per assessment stage, 
per total and per country 
 
there was a much higher burden of infectious morbidity in the Kenya and Malawi, 
compared to India and Pakistan. Figure 5.6 demonstrates that this burden of 
infectious morbidity is identified across all five assessments stages with the highest 
percentage of women overall with infectious morbidity in the late antenatal stage. 
 
5.5 Medical/obstetric morbidity  
In this study medical/obstetric morbidity that could be measured included: anaemia, 
hypertension, pre-eclampsia, antenatal haemorrhage and urinary incontinence.  
Table 5.7 presents medical/obstetric morbidity per assessment stage per total and 










Total India Paksitan Kenya Malawi
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stage per total. Percentages are derived using the number of women who responded 
per assessment stage. 
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*It is noted that haemoglobin levels decrease as pregnancy continues due to haemodilution. The WHO definitions of anaemia 
have been used here to display the severity of anaemia across the assessment stages of pregnancy. 
Overall, as a combined cohort, the percentage of women with anaemia was highest 
in the early postnatal (53.6%) and late antenatal (50.6%) stages. There were similar 
percentages of women with anaemia in the early antenatal (40.8%) and late postnatal 
(42.6%) stages. Within 24 hours of delivery the percentage of women with anaemia 
was 48.7%. Table 5.7 displays that most of the anaemia was either mild (Hb 10-
10.9g/l) or moderate (Hb 70-99 g/l) at each assessment stage. The percentage of 
women with severe anaemia (Hb <70 g/l) was highest in the early postnatal (2.8%) 
and the late antenatal stage (1.9%). There were similar percentages of women with 
severe anaemia in the late antenatal stage (1.9%) and within 24 hours of delivery 
(1.8%). There were similar percentage of women with severe anaemia in the early 
antenatal (1.2%) stage and within 24 hours of delivery (1.0%). More women were 
diagnosed with anaemia and with severe anaemia in India and Pakistan compared to 
Kenya and Malawi.  
 
Overall, 4.6% of women were diagnosed with hypertension in the late antenatal stage 
and 1.5% of women were diagnosed in early antenatal stage. This could represent 
women with pre-existing hypertension. The percentage of women diagnosed with 
hypertension decreased along the continuum of pregnancy to 3.6% within 24 hours 
of childbirth, 2.9% in the early postnatal and 2.1% in the late postnatal stage. This 
trend may indicate that women with hypertension are identified during antenatal 
care and receive appropriate treatment, resulting in a decrease in women with 
hypertension along the continuum of pregnancy. 
 
In the late antenatal stage, 2.1% of women were diagnosed with pre-eclampsia. The 
percentage of women were diagnosed with pre-eclampsia decreased to 0.8% within 
24 hours of childbirth and 0.7% in the early postnatal stage (Table 5.6 and Figure 5.7).   
 
This trend may indicate that women with pre-eclampsia were identified during 
antenatal care and/or during childbirth, and received appropriate treatment. 




However, this trend may also simply reflect the physiological resolving of pre-
eclampsia after childbirth (Magowan 2014).  
 
Overall, the highest percentage of women who were diagnosed with urinary 
incontinence was in the late antenatal stage (6.6%) (Table 5.6 and Figure 5.7). Similar 
proportions of women were diagnosed with urinary incontinence in the early 
antenatal (3.0%) and the late postnatal (3.3%) stages, and within 24 hours of 
childbirth (3.1%). Overall, 1.9% of women were diagnosed with urinary incontinence 
in the early postnatal stage.  
 
Overall, 6.3% of women were diagnosed with antenatal haemorrhage in the early 
antenatal and 3.0% in the late antenatal stage.  
 
Overall, as a combined cohort 50.0% of women had at least one medical/obstetric 
morbidity. The highest percentage of women who had at least one medical/obstetric 
morbidity was in the early postnatal stage (55.0%), followed by the late antenatal 
(54.8%), within 24 hours of childbirth (50.4%), early antenatal (45.3%) and then late 
postnatal stage (44.0%) (Table 5.5). 
 
Figure 5.7 displays visually the percentage of women as a combined total cohort with 
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Country specific tables for medical/obstetric morbidity per assessment stage are 
displayed in Table 5.8. Table 5.9 presents further information on the severity of 
anaemia per assessment stage per country. Percentages are derived using the 
number of women who responded per assessment stage. 
 
The percentages and trends of each medical/obstetric morbidity were similar across 
all four countries, although differences are highlighted in the text below the table. 
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140 
(10.2%) 











































































n/a n/a n/a 
7 
(0.6%) 











































































n/a n/a n/a 
7 
(0.6%) 






















































































































































































































































































Overall, the highest percentage of women with anaemia was in the early postnatal 
stage, and this trend was similar in India, Kenya and Malawi. In Pakistan, the highest 
percentage of women with anaemia was in the late antenatal stage (76.8%).  
Overall, the highest percentage of women with hypertension was in the late 
antenatal stage and this was the same trend across all four countries. Overall, the 
highest percentage of women with pre-eclampsia was in the late postnatal stage, and 
this trend was similar for Pakistan, Kenya and Malawi. In India, the highest 
percentage of women with pre-eclampsia was in the early postnatal stage (0.2%). 
Overall, the highest percentage of women with urinary incontinence was in the late 
antenatal stage and this trend was similar across all four countries. Overall, the 
highest percentage of women with antenatal haemorrhage was in the early antenatal 
stage, and this was the same trend across all four countries.  
 
Overall, the highest percentage of women who had at least one medical/obstetric 
morbidity was in the early postnatal stage, and this was similar for women in India 
and Kenya. The highest percentage of women who had at least one medical/obstetric 
morbidity was in the late antenatal stage in Pakistan and Malawi.  
 
Summative physical morbidity  
Furthermore, as a summative measure, Figure 5.8 displays the number of women 
with any physical morbidity (infectious and medical/obstetric combined) per 
assessment stage, per total and per country. 
 
Overall, more women were diagnosed with physical morbidity in the late antenatal 
and early postnatal stage, compared to within 24 hours of delivery and in the late 
postnatal and early antenatal stages  
 
In India, Kenya and Malawi, more women had a physical morbidity in the early 
postnatal stage, compared to Pakistan, where women had more physical morbidity 
in the late antenatal stage.  





Figure 5.8: Number of women with any physical morbidity (infectious and 
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5.6 Psychological morbidity  
Psychological morbidity was defined as an EPDS score of ≥10 and or thoughts of self-
harm. Overall 25.1% of women scored positive for depression (EPDS score of ≥10) 
and 15.2% of women self-reported thought of self-harm (Table 5.10). More women 
reported psychological morbidity in Pakistan and India, compared to Kenya and 
Malawi. Depression was the commonest form of psychological morbidity along each 
assessment stage, with the highest percentage of women reporting depression in the 
early antenatal stage. However, across the five assessment stages, the highest 
percentage of women who self-reported thoughts of self-harm was in the early 
antenatal stage (17.6%) (Table 5.10). 
 











































































Individual psychological morbidities per assessment stage are presented in Table 
5.11 for each country. Percentages are derived using the number of women who 
responded per assessment stage. 
 
  




Table 5.11: Psychological morbidity of women per assessment stage per country 
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Overall, 25.1% of women scored positive for psychological morbidity using the EPDS. 
The proportion of women with psychological morbidity was much higher in Pakistan 
(49.3%compared to India (22.5%), Malawi (17.3%) and Kenya (14.6%).There were 
similar proportions of women who reported any psychological morbidity across the 
continuum of pregnancy. Overall, women reported psychological morbidity in the 
following stages: late antenatal (29.7%), within 24 hours of delivery (28.0%), early 
postnatal (26.1%), late postnatal (24.9%) and least in the early antenatal stage 
(24.6%). The overall trend in psychological morbidity was similar in India and Pakistan 
also (Table 5.11).  
 
In India, women reported psychological morbidity in the following stages: late 
antenatal (29.2%), within 24 hours of delivery (24.1%), early postnatal (22.9%), late 
postnatal (22.0%), and least in the early antenatal stage (14.4%) (Table 5.11). 
 
 In Pakistan, similar percentages of women reported psychological morbidity across 
all five assessment stages, along the continuum of pregnancy: early antenatal stage 
(48.9%), late antenatal (49.3%), within 24 hours of delivery (49.4%), early postnatal 
(49.8%) and late postnatal (49.2%).  
 
This trend was like Kenya, where more women reported psychological morbidity in 
the following stages: late antenatal (18.4%), within 24 hours of delivery (16.0%), early 
antenatal (15.9%), early postnatal (13.2%) and least in the late postnatal stage (9.1%) 
(Table 5.11) 
 
This trend was different in Malawi, where the proportions of women who reported 
psychological morbidity were similar across all five assessment stages: within 24 
hours of delivery (18.9%), late postnatal (18.0%), late antenatal (17.4%), early 
postnatal (16.8%) and least in the early antenatal stage (15.4%).  
 




These differences in the numbers of women who reported any psychological 
morbidity per assessment stage, per country and per total are displayed visually in 
(Figure 5.9).  
 
Figure 5.9: Number of women with any psychological morbidity per assessment 
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5.7 Social morbidity  
Social morbidity was defined as women reporting any domestic violence (HITS score 
>4) and or any substance misuse. Table 5.12 displays domestic violence (from 
husband and/or family) per assessment stage for the combined cohort of women. 
Percentages are derived using the number of women who responded per assessment 
stage. 
Table 5.12: Social morbidity (domestic violence) in women per assessment stage 
and per total 












Number of women* 2204 2425 2250 2264 2311 11,454 







































































































Overall 3883 (33.9%) women reported domestic violence (HITS >4) from their 
partner/husband and or family members; and the highest percentage of women who 
reported any domestic violence was in the late antenatal stage (40.3%), then the 
early postnatal stage (34.0%), within 24 hours of delivery (33.6%), the late postnatal 









Overall 969 women reported domestic violence (HITS>10) from their 
husband/partner and/or family members. Women reported higher levels of domestic 
violence in the following stages: late antenatal (28.6%), early postnatal (19.3%), 
within 24 hours of delivery (18.0%), late postnatal (17.5%) and least in the early 
antenatal stage (16.6%). Overall, the proportion of women who reported higher 
levels of domestic violence peaked in the late antenatal stage (Table 5.8). 
 
The trend for any domestic violence was in line with that of severity of domestic 
violence from the husband/partner and/or domestic violence from family across all 
five assessment stages.  
 
There was not a wide variation in the percentage of women who reported higher 
levels of domestic violence (HITS >10) across the continuum of pregnancy. More 
women reported higher levels of domestic violence in the late antenatal stage in 
India, Pakistan and Kenya, compared to Malawi where more women reported higher 
levels of domestic violence in the late postnatal stage (Table 5.12) 
 
Table 5.13 presents social morbidity (domestic violence) per assessment stage per 
country. Percentages are derived using the number of women who responded per 
assessment stage. 
 
The trend for any domestic violence was in line with that of the severity of domestic 
violence from the husband/partner and domestic violence from family across all five 
assessment stages and the trend was similar across all four countries. Where there 











Table 5:13: Social morbidity (domestic violence) of women in per assessment 
stage, per country 












Total number of 
women* 
2204 2425 2250 2264 2311 11,454 






















































































































































































































































































































































































The proportion of women reporting domestic violence was much higher in Pakistan 
(55.9%) compared to India (37.9%), Kenya (21.6%), and Malawi (18.2%) (Table 5.13). 
 
There was not a huge variation in the percentage of women who reported any 
domestic violence (HITS >4) or severe (HITS >10) across the continuum of pregnancy. 
More women reported domestic violence in the late antenatal stage in Pakistan, 
Kenya and Malawi, compared to India, where more women reported domestic 
violence in the early postnatal stage.  
 
The proportion of women reporting domestic violence was much higher in Pakistan 
(617; 63.7%) compared to Malawi (137; 14.1%), India (127; 13.1%), Kenya (88; 9.1%).  
 
The trend for any domestic violence was in line with that of severity of domestic 
violence from the husband/partner and/or domestic violence from family across all 







There was not a wide variation in the percentage of women who reported higher 
levels of domestic violence (HITS >10) across the continuum of pregnancy. More 
women reported higher levels of domestic violence in the late antenatal stage in 
India, Pakistan and Kenya, compared to Malawi where more women reported higher 
levels of domestic violence in the late postnatal stage (Table 5.13). 
 
The main difference noted was that the highest percentage of women reporting more 
severe domestic violence from family members was within 24 hours of childbirth and 
this trend was similar across all four countries.  
 
Substance misuse per assessment stage 
Table 5.14 presents social morbidity as substance misuse, per assessment stage per 
total. Percentages are derived using the number of women who responded per 
assessment stage. 
Overall, 672 (5.9%)  women reported substance misuse, of which 202 (1.8%) required 
intervention. The highest percentage of women who reported substance misuse and 
who required intervention was in the late postnatal stage (6.8% and 2.2% 
respectively) (Table 5.14).  
 
Table 5:14: Social morbidity (substance misuse) per assessment stage, per total 













Number of women* 2204 2425 2250 2264 2311 11,454 
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Table 5.15 presents social morbidity as substance misuse, per assessment stage per 
country. Percentages are derived using the number of women who responded per 
assessment stage.  
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Overall, the proportions of women reporting substance use was highest in Pakistan 
(8.9%) compared to Kenya (6.6%) Malawi (4.6%) and India (1.7%) (Table 5.9). 
 
Overall women reported substance misuse in the following stages:) late postnatal 
(6.8%), early postnatal (6.5%), early antenatal (6.1%), within 24 hours of childbirth 
(5.4%) and late antenatal (4.6%%). The highest percentage of women who reported 
substance use in India and Pakistan was in the early postnatal stage (2.8% and 12.0% 
respectively).  The highest percentage of women who reported substance use in 
Kenya was in the late postnatal stage (9.6%) and in Malawi was within 24 hours of 
childbirth (5.3%). 
 
Summative social morbidity  
Overall and as a combined measure, social morbidity was defined as women 
reporting any domestic violence and/or substance misuse. Table 5.16 displays 
women with any social morbidity per assessment stage per total. Overall, 4193 
(36.6%) women reported social morbidity, and the highest percentage of women 
who reported any social morbidity was in the late antenatal stage (42.5%) (Table 
5.16). This trend was similar to that in Pakistan, Kenya and Malawi; but different to 
India where the highest percentage of women who reported any social morbidity was 
in the early postnatal stage (45.1%) (Table 5.16).  
 




Table 5.16: Social morbidity (any domestic violence and/or substance misuse) per 
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The trends of social morbidity (any domestic violence and/or substance misuse) per 







Figure 5.10 Number of women with any social morbidity per assessment stage, 
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5.9 Summative morbidity  
Table 5.17 presents women with any morbidity per assessment stage, per country 
and per total. Percentages are derived using the number of women who responded 
per assessment stage. 
 
Overall, 8889 (77.6%) women reported any morbidity. The proportion of women 
reporting any morbidity was much higher in Pakistan (89.5%%) compared to India 
(83.5%), Malawi (71.8%%), and Kenya (66.5%%). 
 
Of all women assessed, the highest percentage of women who had any morbidity 
(infectious, medical/obstetric, psychological, social) was in the late antenatal stage 
(81.1%); then early postnatal stage (80.3%), within 24 hours of childbirth (78.9%). 
Similar percentage of women had any morbidity in the early antenatal (73.5%) and 
the late postnatal stage (73.8%).  
 
Similar to the overall cohort, the highest percentage of more women who had any 
morbidity was in the late antenatal stage in Pakistan (91.9%) and Kenya (73.2%). In 
India and Malawi, the highest percentage of women who had any morbidity was just 
similar more in the early postnatal stage (87.5% and 73.6% respectively) compared 
to the late antenatal stage in each country (Table 5.17).   
 























n %* n %* n %* n %* n %* 








































































*Percentages are derived using the number of women who responded per 
assessment stage. ** The percentages in the total row are derived using the number 
of women who responded per country sample size.  




Figure 5.11: Number of women with any morbidity per assessment stage, per total 
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5.10 Chapter summary in relation to literature 
Summative morbidity  
There is a lack of studies that have assessed two or more types of morbidity in women 
at different stages of pregnancy in LMIC settings. Three. In Kenya, Chersich et al 
collected data from the women at three postnatal stages: early (4-12 weeks), middle 
(12-24weeks) and late (24-26 weeks) after childbirth in Kenya (Chersich 2009) and 
measured infectious, medical/obstetric, psychological and social morbidity. In 
Malawi and Pakistan, Zafar et al used a cross sectional survey to assess women at 
three different assessment stages, both during (early and late antenatal) and after 
pregnancy and measured infectious, medical/obstetric and psychological morbidity 
(Zafar 2015). In India, Prost et al assessed women in the postnatal stage and asked 
women to recall medical/obstetric morbidity or complications experienced during 
pregnancy, at delivery and after childbirth (Prost 2012).  
 
In this PhD study, women’s perception of health with regards to quality of life and 
satisfaction with health was similar along all five assessment stages. No other study 
that has assessed maternal morbidity has assessed women’s perception of health at 
five different stages of pregnancy.  In Ethiopia, Hanlon et al also used a variety of 
measures to assess physical morbidity in 1065 pregnant women, and reported 3.8% 
of women reported “poor/bad global health” at one stage during pregnancy (Hanlon 
2009). This finding is similar to this PhD study, in that4.0 % of women were 
dissatisfied with their health and this percentage varied slightly across the stages of 
pregnancy (5.1% in the early antenatal and 4.8% in the late antenatal stage). This 
finding would suggest that there is a small sub-group of women who are dissatisfied 
with their health at different stages of the pregnancy, and that there is no specific “at 
risk” time, when higher percentages of women report dissatisfaction with their 
health. 
 




In this PhD study, 45.3% of women reported at least one morbidity in the early 
antenatal, late antenatal stage (54.8%); at delivery (50.4%); and in the early (44.0%) 
and late postnatal stage (50.0%). This finding would suggest that women have ill-
health along the continuum of pregnancy, and not at one specific time. In a study that 
sought to assess maternal morbidity in India, Prost et al assessed women in the 
postnatal stage and asked women to recall complications; 46.3% of women recalled 
“problems” during pregnancy; 35.1% at delivery; and 30.5% in the postpartum stage 
(Prost 2012). The higher prevalence of morbidity reported in this PhD study may be 
because the data collection tool used was very comprehensive and included variables 
to assess four types of morbidity, along with self-reporting symptoms and clinical 
examinations and investigations.  
 
Infectious morbidity  
Infective morbidity is traditionally considered to be more of a concern after 
pregnancy, where it is labelled “puerperal sepsis” (RCOG 2012). However, one of the 
main findings of this PhD study is that overall, using an amended SIRS score, similar 
proportions of women were diagnosed with possible early signs of infection from the 
early stage of pregnancy (21.0%), along the continuum of pregnancy and childbirth 
(25.1 to 21.3%) and up to 12 weeks postnatal (23.1%).   
 
In the Zafar et al study, the highest percentage of women with “fever of unknown 
origin” was in the late antenatal stage in Malawi (3.5%) and in the early antenatal 
stage in Pakistan (3.6%) (Zafar 2015). In the Chersich et al study, women were not 
assessed during pregnancy and 6% of women reported febrile symptoms at 4-12 
weeks; 11% at 12-24 weeks and 13% at 24-26 weeks after childbirth in Kenya 
(Chersich 2009).  As previously highlighted in Chapter 4, section 4.10, the higher 
prevalence of infectious morbidity in this PhD study may be due to a more 
comprehensive measurement of infectious in combination to the use of a low cut-off 
level for “raised CRP”, may have resulted in an overestimated of women with a SIRS 







Other studies have used CRP as a marker for possible infection in women during 
pregnancy. It is well recognised that CRP levels vary depending on whether a woman 
is pregnant or not, and the stage of pregnancy (Trochez-Martinez 2007). Overall, CRP 
is useful as an indicator of possible infection but is not sensitive to indicate what type 
of infection could be present.  With a higher cut-off level of CRP, specificity would be 
increased but sensitivity would be lower. In a non-pregnant woman, a normal CRP is 
0.2–3.0 mg/L (Abbassi-Ghanavati 2009). There are no standardised ranges for a 
normal CRP level in a pregnant woman in the first trimester. In this PhD study, the 
median CRP was 7 with an interquartile range of 5 to 13 in the early antenatal stage; 
the median CRP was 6 (IQR 5-12) in the late antenatal stage; and the median CRP was 
highest in the late postnatal stage, 19 (IQR 8-44). The reported normal CRP range is 
wide in a pregnant female population (0.4–20.3 mg/L) in the second trimester; and 
the third trimester is 0.4–8.1 mg/L (Abbassi-Ghanavati 2009). However, it is difficult 
to fully compare the levels of CRP as there is currently lack of agreed reference 
standards on what is a normal and what is an abnormal CRP level in women at 
different stages of pregnancy and after childbirth; and what levels of CRP are 
sensitive and specific to indicate infection (Trochez-Martinez 2007). It is noted that 
although CRP may be useful to indicate infection, a one-off reading should not be 
interpreted in isolation. The interpretation of a CRP level is more useful when used 
in compliment to other clinical parameters (RCOG 2012). Most of the research to 
date, that has explored CRP levels during and after pregnancy are related to the use 
of CRP to diagnose chorioamnionitis in pregnant women with premature prelabour 
rupture of membranes.  In one recent study, women in the late antenatal stage of 
pregnancy (31 to 34 weeks gestation) with PPROM with no clinical signs of infection 
had a median CRP of 4.9 with a range of 0.1 to 59.1 (Musilova 2017a). The median 
CRP of women with PPROM along with signs of infection was 6.9 with a range of 0.4 
to 113 (Musilova 2017a).  
 
With regards to the prevalence of malaria and syphilis, the prevalence of these 
conditions was highest in the early antenatal stage, suggesting that with screening 
these conditions are detected and treated and therefore the trend decreases along 




the continuum of pregnancy. This is a similar finding to Zafar et al where the highest 
percentage of women with malaria was in the early pregnancy stage in Malawi (8.8%) 
and Pakistan (2.1%); and a similar finding to a study in Kenya, 2% of women were 
diagnosed with malaria at each assessment stage after childbirth; and 2% of women 
were diagnosed with syphilis 24-26 weeks and 1% were diagnosed with syphilis at 12-
24 weeks after childbirth (Chersich 2009).In this PhD study, detection of HIV was 
highest in the early postnatal stage (5.4%) This is a similar finding to that of the Zafar 
et al study where the highest percentage of women diagnosed with HIV was in the 
postnatal stage in Malawi (16.5%) and Pakistan (7.0%).These findings would suggest 
perhaps that these women did not attend for and/or receive screening during 
antenatal care but attended for delivery at the healthcare facility and were screened 
for HIV prior to discharge.  
 
Medical/obstetric morbidity  
 
In this PhD study, the severity of anaemia increased as the pregnancy continued and 
the highest percentage of women with moderate and severe anaemia was in the 
early postnatal stage; and this trend was similar in the four LMIC settings.  This finding 
is in line with the clinical fact that haemoglobin levels decrease during pregnancy due 
to haemodilution, and then most women lose some blood during childbirth. In other 
studies, the highest percentage of women with anaemia was in the late antenatal 
stage in Malawi (41.1%) and Pakistan (39.3%). In Kenya, the highest percentage of 
women with anaemia (61.0%) was at 12-24 weeks after childbirth (Chersich 2009). 
However, this study did not assess women during pregnancy. This highest percentage 
of women diagnosed with antepartum haemorrhage was in the early antenatal stage 
(6.3%), and this bleeding tended to have resolved later in pregnancy.  This finding is 
comparable to that of the Zafar et al study, where the highest percentages of women 
with antepartum haemorrhage was in the late antenatal stage in Malawi (1.5%) but 
highest in the early antenatal stage in Pakistan (4.6%). The reasons of why some more 








In this PhD study, the highest percentage of women with hypertension, pre-
eclampsia, urinary incontinence was in the late antenatal stage. This is in keeping 
with clinical evidence of higher prevalence of these conditions later in pregnancy.   
 
Pre-eclampsia was detected more in the late antenatal stage in this PhD study and 
this is similar to the findings in Malawi (0.2%) and Pakistan (1.3%) (Zafar 2015). In this 
PhD study, the highest percentage of women urinary incontinence was in the late 
antenatal stage, and this may be due to stress incontinence due to the increased 
abdominal pressure of the baby. However, in the Zafar et al study, the highest 
percentage of women reporting incontinence (urine or faeces) was in the postnatal 
stage in Malawi (0.9%) and Pakistan (4.7%) (Zafar 2015); the reason for this may be 
due to transient incontinence related to perineal trauma that occurred during 
childbirth.  
 
Psychological morbidity  
Psychological morbidity is traditionally considered to be more of a concern after 
pregnancy, where it is labelled “postnatal depression”. However, one of the main 
findings of this study is that overall, similar proportions of women are reporting 
psychological morbidity (including symptoms of depression and self-harm) from the 
early stage of pregnancy (24.6%), along the continuum of pregnancy and childbirth 
(29.7 to 24.9%) and up to 12 weeks postnatal (26.7%). In another study, in Malawi 
and Pakistan, more women reported psychological morbidity in the postnatal stage 
(Zafar 2015). In Malawi, the proportion of women with psychological morbidity 
increased across the stages of pregnancy in Malawi (1.2%, 3.2% and 3.6%) and in 
Pakistan (25.8%, 26.9% and 28.1%).  
 
The findings of the prevalence of psychological morbidity from this PhD study are 
higher prevalence compared to the global estimates of 10% of women during 
pregnancy and 13% of women after childbirth being affected by psychological ill-
health (WHO 2017, maternal mental health). The findings from the PhD study are 




more compared to a systematic review of studies from LMIC settings where 
psychological morbidity affected 15.6% of women during pregnancy and 19.8% after 
pregnancy (Fisher 2012). Another review reported higher prevalence of 1 in 4 women 
in LMIC settings reported depression during pregnancy and 1 in 5 reported 
depression after pregnancy (Gelaye 2013). The authors of the review suggest that the 
figures in LMIC settings are twice the rate of women in high income countries, and it 
is suggested that psychological ill-health in general is not reported, infrequently 
recognised and under-treated in many LMIC (Fisher 2012). The reasons why women 
in LMIC settings are reporting psychological morbidity at different stages of 
pregnancy, requires further research to understand how to address these health 
needs, both during pregnancy and after childbirth.  
 
Social morbidity  
 
In this PhD study, more women reported substance misuse in the early stage of 
pregnancy or after childbirth, compared to the late antenatal stage, suggesting that 
women understood the harmful effects of substance misuse to the developing baby 
with more women tending to stop misusing substances as the pregnancy progressed.  
However, high proportions of women reported domestic violence from the early 
stage of pregnancy (29.8%), along the continuum of pregnancy and childbirth (40.3 
to 34.0%) and up to 12 weeks after childbirth (33.9%). This urgently requires 
interventions to prevent and stop this practice in these settings. The finding that 
domestic violence occurs after childbirth is similar to the study by Chersich et al in 
which women reported domestic violence (physical (23.3%), sexual (56.9%) and 
substance misuse (11%) at 12-24 weeks after childbirth in Kenya (Chersich 2009). 
 
Summary  
The overall findings from this chapter would suggest that overall the burden of 
disease is not simply at one “high risk” stage of pregnancy, but that women report 






pregnancy. Further reflections of the main findings from this chapter in relation to 
other literature are given in the discussion chapter of this thesis. 
  




CHAPTER 6: RESULTS THREE  
6.1 Introduction  
This is the third of four chapters that report on the results of this research project. 
The four chapters are structured in sequence to address each main research 
question. In this chapter age, socioeconomic status, educational level, number of 
previous pregnancies, and/or adverse maternal or neonatal outcomes in the most 
recent pregnancy are assessed to determine any association with maternal 
morbidity. Results are described per country in univariate and multivariate analysis.  
Factors examined include: 
• Age 
• Socioeconomic status 
• Educational level  
• Number of previous pregnancies  
• Adverse maternal outcome in the most recent pregnancy 
• Adverse neonatal outcome in the most recent pregnancy 
 
These factors were chosen by the lead researcher as they are recognised to influence 
a woman’s health risk index from a clinical point of view, and are factors recognised 
to be associated with maternal mortality in LMIC (Alvarez 2009). 
 
For the purposes of this thesis, results for the study settings are presented per 
country in the following sequence: India, Pakistan, Kenya and Malawi. Results are 
presented in a narrative text accompanied by tables and figures. Where 









In this research study, there were four research questions.  
Table 6.1: Research questions for the study  
Number  Research question 
1. What is the prevalence of maternal morbidity and what types of ill-
health (symptoms, signs and investigations) contribute to maternal 
morbidity? 
2. What is the prevalence of maternal morbidity at different stages of 
pregnancy? 
3. Is there an association between the different types of maternal 
morbidity and age, socioeconomic status, educational level, number 
of previous pregnancies, and/or adverse maternal or neonatal 
outcomes in the most recent pregnancy? 
4. Is there an association between the different types of morbidity, 
defined as infectious, medical/obstetric, psychological and social 
morbidity?  
 
In this chapter, results are presented to address the research question: “Is there an 
association between the different types of maternal morbidity and age, 
socioeconomic status, educational level, number of previous pregnancies, and/or 
adverse maternal or neonatal outcomes in the most recent pregnancy?”. 
 
The different types of morbidity include the following: 
• Physical (infectious) 
• Physical (medical/obstetric) 
• Psychological  









Definitions of types of morbidities  
As set out in the chapter three, that described the methodology, summative physical 
morbidity is defined as (1) infectious or (2) medical/obstetric. Infectious morbidity 
can include: HIV, malaria, syphilis, possible chest infection, and a SIRS score of ≥2. 
Medical/obstetric morbidity can include: anaemia, hypertension, pre-eclampsia, 
antenatal haemorrhage and incontinence. Psychological morbidity is defined as an 
EPDS score of ≥10 and/or thoughts of self-harm. Social morbidity is defined as a 
woman reporting any domestic violence (HITS score >4) and or any substance use.  
 
Table 6.2: Definitions of maternal morbidity 
PHYSICAL MORBIDITY NON-PHYSICAL MORBIDITY 































For this study, all women were asked questions regarding adverse maternal 
outcomes in the most recent pregnancy and/or adverse neonatal outcomes in the 
most recent pregnancy. Table 6.3 and Table 6.4 lists the ranges of maternal and 
adverse neonatal outcomes explored. These outcomes are not definitive and this is 
highlighted as a limitation in the discussion chapter of this thesis.   
 
For the tabulations of the univariate and multivariate analysis, the reference category 
are women who did not report maternal or newborn adverse outcomes in the most 










Table 6.3: Adverse maternal outcomes in most recent pregnancy  
Adverse maternal outcome Definition/explanation of question  
1. Caesarean section wound 
infection  
Any concerns with the Caesarean section scar, 
for which a woman has visited a healthcare 
provider and received antibiotics. 
2. Complications of 
episiotomy  
Dehiscence/breakdown of the episiotomy 
wound; any concerns with the episiotomy for 
which the women has visited a healthcare 
provider and received antibiotics. 
3. Complications of 
instrumental delivery  
Third or fourth degree tears, internal spiral 
vaginal lacerations, failed instrumental delivery. 
4. General/spinal/epidural 
anaesthetic complications 
Aspiration pneumonia, dural headache, total 
spinal, spinal cord infection. 
5. Vesico-vaginal fistula  Connection between the bladder and the 
vagina resulting in leakage of urine. 
6. Recto-vaginal fistula  Connection between the rectum and the vagina 
resulting in leakage of faecal matter. 
7. Uterine inversion An acute obstetric emergency occurring when 
the placenta fails to detach from the uterus and 
traction on the placenta pulls on the inside 
surface, and inverts the uterus. 
8. Postpartum haemorrhage Bleeding from the genital tract >500mls 
9. Antepartum 
haemorrhage  
Any bleeding from the genital tract during 
pregnancy from the stage of viability  











Table 6.4: Adverse neonatal outcomes in most recent pregnancy  
Adverse neonatal outcome  Definition / explanation of question 
1. Stillbirth Baby is born dead from the stage of viability (>28 
weeks in LMIC). 
2. Neonatal death Death of baby from birth to 28 days. 
3. Low birth weight baby <2.5kg at birth. 
4. Preterm delivery <37 weeks’ gestation at birth. 
5. Macrosomia >4.0kg at birth. 
6. Microcephaly An abnormally small head due to failure of brain 
growth caused by intrauterine infections (such as 
rubella, cytomegalovirus, and toxoplasmosis), 
intrauterine chemical exposure (such as in fetal 
alcohol syndrome), chromosome abnormalities 
and genetic syndromes. 
7. Newborn eye infection  Any eye infection in the newborn. 
8. Newborn blindness Any detected blindness in the newborn. 
 
In the analysis presented in chapter four, there were significant differences between 
the countries with regards to prevalence of age, parity, SES, HIV, and malaria. For this 
reason, the results in this chapter are reported per country as the associations were 
not appropriate to analyse with regards to the combined countries total cohort. 
Nearly all women (93.2%) were married and therefore marital status was not used as 
a factor.  
 
The associated factors results are reported per type of morbidity (infectious, 
medical/obstetric, psychological and social) per country (India, Pakistan, Kenya and 
Malawi) for univariate analysis. Key socio-economic and obstetric variables were 
included in the univariate analysis as these factors are clinically recognised to be 








Table 6.5: Factors examined for association with maternal morbidity  
Factors examined included: 
• Age 
• Socioeconomic status 
• Educational level  
• Number of previous pregnancies  
• Adverse maternal outcomes in the most recent pregnancy 
• Adverse neonatal outcomes in the most recent pregnancy 
 
There were no elimination criteria, and therefore, all factors were also included in 
the multivariate analysis. The associated factors are reported per type of morbidity 
per country in multivariate analysis. For all results, statistically significant differences 
are highlighted and odd ratios, 95% confidence intervals and p-values are presented. 
The results reported are tabulations, univariate and multivariate associations 
between the type of morbidity and each associated factor. 
1. Cross tabulations of the associated factors with the morbidity class were 
conducted.  
2. Univariate analysis was conducted for each associated factor with the type of 
morbidity for each country. 
For the results reported in this chapter, colour is used to highlight significant findings.  
Table 6.6: Explanation of colour coding for results tables  
Colour Code  
Blue  Reference category  
Green  Women are less likely to report this type of morbidity  
Light orange  Women are more likely to report this type of morbidity  
 
For associations related to the age factor, all women were compared to women in 
the age range 20-<25 as this was considered the most representative. The age range 
15-<20 years was not considered as the reference category as this would suggest that 
adolescents were the most typical group to compare the other age groups against. 




6.2 India: Univariate analysis  
All results for univariate analysis for the study population are displayed in Table 6.7.  
 
Age 
There were similar percentage of women across the different age categories for all 
four types of morbidity in India. There are no statistically significant differences 
between the age groups for medical/obstetric or psychological morbidity. When 
compared to women in the age range 20-<25 years of age, women in the age range 
≥35 years of age were more likely to report infectious morbidity OR 2.63 (1.17-5.90) 
p-value 0.02. Compared to women in the age range 20-<25 years of age, women in 
the age range 25-<30 and 30-<35 years of age were more likely to report social 
morbidity OR 1.61 (1.33-1.96) p-value 0.00 and 1.85 (1.37-2.50) p-value 0.00 
respectively.  
 
Socioeconomic status  
When compared to women in the lower SES category, women in the upper middle 
and upper SES categories were more likely to report social morbidity: OR 0.17 (0.04-
0.72) p-value 0.02 and OR 0.19 (0.04-0.87) p-value 0.03 respectively. 
 
Educational level completed  
When compared to women with no education level, women who had completed 
primary level education were less likely to report social morbidity OR 0.56 (0.38-0.84) 
p-value 0.00. Compared to women with no education level, women who had 
completed secondary level education were less likely to report medical/obstetric 
morbidity OR 0.61 (0.39-0.94) p-value 0.03. Compared to women with no education 
level, women who had completed tertiary level education were less likely to report 
medical/obstetric morbidity OR 0.55 (0.35-0.85) p-value 0.01, and social morbidity 
OR 0.46 (0.31-0.70) p-value 0.00; and more likely to report psychological morbidity 







Number of previous pregnancies  
Overall, there are no statistically significant differences between the number of 
previous pregnancies and infectious or psychological morbidity. However, compared 
to women with no previous pregnancy (primigravida), women with one previous 
pregnancy were more likely to report medical/obstetric OR 2.27 (1.72-2.99) p-value 
0.00 and less likely to report social morbidity OR 0.74 (0.56-0.97). Compared to 
women with no previous pregnancies (primigravida), there are no statistically 
significant differences between women with two-four (P2-4) or five or more previous 
pregnancies (P≥5) and medical/obstetric, infectious, psychological or social 
morbidity.  
 
Mothers with an adverse outcome in the most recent pregnancy  
When compared to women with no adverse maternal outcomes in the most recent 
pregnancy, women with an adverse maternal outcome in the most recent pregnancy, 
were more likely to report medical/obstetric (OR 1.96 (1.36-2.80) p-value 0.00), 
psychosocial (OR 1.45 (1.02-2.07) p-value 0.04), and social morbidity (OR 1.60 (1.17-
2.17) p-value 0.00) in the index pregnancy.  
 
Mothers with an adverse neonatal outcome in the most recent 
pregnancy  
When compared to women with no adverse neonatal outcome in the most recent 
pregnancy, women with an adverse neonatal outcome in the most recent pregnancy, 
were more likely to report medical/obstetric (OR 1.40 (1.07-1.83) p-value 0.02) and 
psychosocial morbidity (OR 3.90 (2.97-5.12) p-value 0.00, but were less likely to 
report infectious morbidity (OR 0.48 (0.31-0.73) p-value 0.00). 




Table 6.7: India: Univariate analysis 
COUNTRY PHYSICAL MORBIDITY NON-PHYSICAL MORBIDITY 
Variable / 
category 
MEDICAL/OBSTETRIC INFECTIOUS PSYCHOLOGICAL SOCIAL 
n % OR (95% CI) n % OR (95% CI) n % OR (95% CI) n % OR (95% CI) 
Age 
15 - < 20  50 4 1.60 (0.93-2.77) 14 5 1.46 (0.79-2.70) 15 4 1.01 (0.55-1.82) 16 2 0.57 (0.32-1.02) 
20 - < 25 510 41  122 42  178 4  284 34  
25 - < 30 539 43 0.95 (0.79-1.16) 119 4 0.89 (0.67-1.16) 157 39 0.78 (0.61-0.98) 410 49 1.61 (1.33-1.96) 
30 - < 35 138 11 1.05 (0.77-1.42) 28 10 0.84 (0.51-1.30) 44 11 0.91 (0.63-1.31) 109 13 1.85 (1.37-2.50) 
≥35  20 1 1.57 (0.69-3.58) 9 3 2.63 (1.17-5.90) 9 2 1.66 (0.74-3.71) 13 1 1.57 0.75-3.32) 
Socio-economic status 
Lower (V) 7 1  1 0  1 0   1  
Upper Lower (IV) 
838 65 0.49 (0.10 - 2.35) 225 75 
1.63 (0.20-
13.09) 254 61 1.89 (0.24-15.17) 618 73 0.43 (0.11-1.74) 
Lower Middle (III) 347 27 0.42 (0.09-2.06) 59 20 0.90 (0.11-7.36) 126 30 2.22 (0.27-17.88) 178 21 0.22 (0.05-0.89) 
Upper Middle (II) 72 6 0.33 (0.07-1.66) 13 4 0.86 (0.10-7.42) 22 5 1.57 (0.19-13.20) 34 4 0.17 (0.04-0.72) 
Upper (I) 18 1 0.20 (0.04-1.06) 4 1 0.80 (0.08-8.13) 12 3 3.00 (0.34-26.60) 12 1 0.19 (0.04-0.87) 
Level of education completed 
None 79 6 
 
 






Primary  511 40 0.69 (0.45-1.06) 121 40 0.75 (0.45-1.25) 104 25 0.76 (0.44-1.31) 309 36 0.56 (0.38-0.84) 
Secondary  392 31 0.61 (0.39-0.94) 86 28 0.65 (0.38-1.10) 160 39 1.68 (0.98-2.86) 305 36 0.80 (0.54-1.20) 
Tertiary  300 23 0.55 (0.35-0.85) 74 25 0.71 (0.41-1.21) 133 32 1.77 (1.03-3.04) 176 21 0.46 (0.31-0.70)  
Number of previous pregnancies 
None  133 10.9  48 16.0  64 16  128 16  
1 563 46.3 2.27 (1.72-2.99) 152 50.7 1.01 (0.71-1.45) 174 4 0.84 (0.60-1.16) 336 41 0.74 (0.56-0.97) 
2-4 563 46.3 4.00 (0.82-19.59) 98 32.7 0.72 (0.49-1.05) 157 40 0.88 (0.64-1.23) 354 43 1.04 (0.79-1.37) 
≥5 7 0.6 0.88 (0.69-1.10) 2 0.7 1.41 (0.28-7.00) 2 1 0.99 (0.20-4.87) 6 1 2.45 (0.60-10.00)  
Adverse outcome 
Mother 141 13 1.96 (1.36-2.80) 22 9 0.75 (0.47-1.19) 47 14 1.45 (1.02-2.07) 95 14 1.60 (1.17-2.17) 






India: Multivariate analysis  
 




When compared to women in the age range 20-<25 years, women in the age range 
15-<20 years were less likely to report social morbidity OR 0.51 (0.28-0.93) p-value 
0.03. When compared to women in the age range 20-<25 years, women in the age 
range 25-<30 years and 30-<35 years were more likely to report social morbidity, and 
the risk increased as age increased: OR 1.48 (1.19-1.85) p-value 0.00, OR 1.69 (1.21-
2.37) p-value 0.00 respectively. There are no statistically significant differences 
between age and psychological morbidity. When compared to women in the age 
range 20->25 years, women in the age range ≥35 years were more likely to report 
infectious morbidity 3.03 (1.24-7.39) p-value 0.01. 
 
Socioeconomic status  
There are no statistically significant differences between SES and medical/obstetric, 
infectious, psychological morbidity on multivariate analysis. When compared to 
women in the lower SES category, women in the upper middle SES category were less 
likely to report social morbidity OR 0.20 (0.04-0.94) p-value 0.04.  
 
Educational level completed  
There are no statistically significant differences between education level completed 
and infectious or psychological morbidity. When compared to women with no 
educational level completed, women with primary, secondary and tertiary education 
were more likely to report medical/obstetric morbidity OR 1.84 (1.37-2.47) p-value 
0.00 and OR 2.60 (1.72-3.92) p-value 0.00 respectively.  
 




When compared to women with no educational level completed, women with 
primary and secondary education were less likely to report social morbidity and this 
decreased with level of education: OR 0.66 (0.49-0.89) p-value 0.01; OR 0.60 (0.39-
0.91) p-value 0.02 respectively.  
 
Number of previous pregnancies  
There are no statistically significant differences between number of previous 
pregnancies and medical/obstetric, infectious, or social morbidity on multivariate 
analysis. When compared to women with no previous pregnancies, women with two 
to four pregnancies, and women with five or more pregnancies were more likely to 
report psychological morbidity and this likelihood increased with the number of 
pregnancies: OR 2.23 (1.20-4.14) p-value 0.01 and OR 2.53 (1.33-4.81) p-value 0.00.  
 
Mothers with an adverse outcome in the most recent pregnancy  
When compared to women with no adverse maternal outcomes in the most recent 
pregnancy, women with an adverse maternal outcome were more likely to report 
medical/obstetric and social morbidity: OR 1.87 (1.17-2.99) p-value 0.00 and OR 1.89 
(1.25-2.87) p-value 0.00.  
 
Mothers with an adverse neonatal outcome in the most recent 
pregnancy  
There are no statistically significant differences between women with adverse 
neonatal outcomes for the newborn in the most recent pregnancy and 
medical/obstetric or social morbidity on multivariate analysis. When compared to 
women with no neonatal adverse outcomes in the most recent pregnancy, women 
with an adverse neonatal outcome were less likely to report infectious morbidity OR 
0.48 (0.27-0.87) p-value 0.01. When compared to women with no newborn adverse 
outcomes in the most recent pregnancy, women with a newborn adverse outcome 







Summary box: India  
Factor Associations with morbidity  
Age When compared to women in the age range 20-<25 
years, women in the age range 15-<20 years were 
less likely to report social morbidity; women in the 
age range 25-<30 years and 30-<35 years were more 
likely to report social morbidity; and women in the 
age range ≥35 years were more likely to report 
infectious morbidity.  
Socioeconomic status When compared to women in the lower SES 
category, women in the upper middle SES category 
were less likely to report social morbidity. 
Educational level  Women with primary and secondary education 
were more likely to report medical/obstetric 
morbidity and less likely to report social morbidity.  
Number of previous 
pregnancies  
When compared to women with no previous 
pregnancies, women with two to four pregnancies, 
and women with five or more pregnancies were 
more likely to report psychological morbidity and 
this likelihood increased with the number of 
pregnancies. 
Adverse maternal 
outcome in the most 
recent pregnancy 
Women with an adverse maternal outcome were 
more likely to report medical/obstetric and social 
morbidity.  
Adverse neonatal outcome 
in the most recent 
pregnancy 
Women with an adverse neonatal outcome were 
less likely to report infectious morbidity. Women 
with an adverse neonatal outcome were more 
likely to report psychological morbidity. 
 




Table 6.8: India: Multivariate analysis  
COUNTRY INDIA 
Variable  PHYSICAL MORBIDITY NON-PHYSICAL MORBIDITY ANY MORBIDITY 
 MEDICAL/OBSTETRIC INFECTIOUS PSYCHOLOGICAL SOCIAL  
 OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value  
Age            
15- <20  1.84 (1.01-3.32) 0.05 1.33 (0.71-2.50) 0.38 0.98 (0.53-1.82) 0.95 0.51 (0.28-0.93) 0.03 1.09 (0.50-2.40) 0.82 
20 - <25 Reference 
25 - <30 0.84 (0.67-1.05) 0.13 0.88 (0.66-1.19) 0.41 0.72 (0.55-0.94) 0.02 1.48 (1.19-1.85) 0.00 0.85 (0.62-1.15) 0.28 
30- <35 0.84 (0.60-1.18) 0.32 0.87 (0.54-1.40) 0.56 0.87(0.57-1.32) 0.50 1.69 (1.21-2.37) 0.00 0.87 (0.54-1.40) 0.58 
≥35  1.21 (0.51-2.89) 0.67 3.03 (1.24-7.39) 0.01 1.50 (0.61-3.65 0.38 1.64 (0.73-3.68) 0.23 1.42 (0.40-5.09) 0.59 
SES 
Lower (V)  Reference 
Upper Lower  0.69 (0.14-3.55) 0.66 1.75(0.20-14.9) 0.61 1.91 (0.21-17.52 0.57 0.52 (0.12-2.24) 0.38 1.04 (0.12-9.02) 
 
0.97 
Lower Middle 0.67 (0.13-3.45) 0.63 0.97 (0.11-8.50) 0.98 1.99 (0.21-18.47) 0.55 0.23 (0.05-1.00) 0.05 0.43 (0.05-3.82) 0.45 
Upper Middle  0.54 (0.10-2.93) 0.48 0.89 (0.10-8.38) 0.92 1.42 (0.15-13.86) 0.76 0.20 (0.04-0.94) 0.04 0.36 (0.04-3.30) 0.36 
Upper (I) 0.31 (0.05-1.83) 0.20 0.51 (0.04-6.08) 0.60 1.68 (0.16-17.53) 0.66 0.20 (0.04-1.03) 0.05 0.23 (0.02-2.23) 0.20 
Level of education completed 
None Reference 
Primary  1.84 (1.37-2.47) 0.00 0.99 (0.67-1.46) 0.95 0.98 (0.68-1.39) 0.90 0.66 (0.49-0.89) 0.01 1.40 (0.94-2.09) 0.10 
Secondary  2.60 (1.72-3.92) 0.00 0.62 (0.36-1.06) 0.08 1.11(0.67-1.86) 0.68 0.60 (0.39-0.91) 0.02 1.98 (1.14-3.46) 0.02 
Tertiary  3.60 (0.68-19.0) 0.13 0.81 (0.13-5.02) 0.82 1.09 (0.18-6.45) 0.93 1.28 (0.28-5.92) 0.75 2.08 (0.23-19.0) 0.52 
Number of previous pregnancies 
None  Reference 
1 0.75 (0.46-1.21) 0.23 0.74 (0.42-1.29) 0.29 1.03 (0.55-1.92) 0.93 0.87 (0.56-1.36) 0.54 0.76 (0.38-1.52) 0.44 
2-4 0.72 (0.44-1.17) 0.18 0.67 (0.37-1.19) 0.17 2.23 (1.20-4.14) 0.01 1.45 (0.92-2.28) 0.11 1.48 (0.72-3.02) 0.29 
≥5 0.73 (0.43-1.22) 0.23 0.88 (0.48-1.62) 0.69 2.53(1.33-4.81) 0.00 1.07 (0.66-1.73) 0.79 1.37 (0.65-2.87) 0.41 
Adverse outcome 
Mother 1.87 (1.17-2.99) 0.01 0.91 (0.49-1.70) 0.77 1.49 (0.92-2.42) 0.10 1.89 (1.25-2.87) 0.00 9.06 (2.20-37.3) 0.00 






6.3 Pakistan: Univariate analysis  
 
All results for univariate analysis for the study population are displayed in Table 6.9. 
 
Age 
There were no statistically significant differences between the age groups and the 
likelihood of medical/obstetric or social morbidity. When compared to women in the 
age range 20-<25 years of age, women were more likely to report infectious 
morbidity in the age range ≥35 years of age OR 1.49 (1.03-2.17) p-value 0.04. When 
compared to women in the age range 20-<25 years of age, women were more likely 
to report psychological morbidity across three age categories: in the age ranges 25-
<30 years OR 1.33 (1.09-1.61) p-value 0.00; 30-<35 years OR 1.24 (1.01-1.53) p-value 
0.04; and ≥35 years OR 1.41 (1.09-1.82) p-value 0.01.  
 
Socioeconomic status  
When compared to women in the lower SES category, women of all other SES 
categories were less likely to report psychological morbidity. When compared to 
women in the lower SES category, women in the upper middle SES category were less 
likely to report social morbidity OR 0.57 (0.33-0.98) p-value 0.04. 
 
Educational level completed  
There are statistically significant differences between the educational level 
completed and the likelihood of reporting or being diagnosed with all four types of 
morbidities: medical/obstetric; infectious; psychological and social morbidity. When 
compared to women with no education level, women were less likely to report 
medical/obstetric morbidity across all other educational levels: primary OR 0.77 
(0.61-0.98) p-value 0.03; secondary OR 0.64 (0.51-0.79) p-value 0.00, and tertiary OR 
0.67 (0.54-0.84) p-value 0.00. When compared to women with no education level, 
women were less likely to report infectious morbidity with secondary OR 0.57 (0.42 -
0.77) p-value 0.04. When compared to women with no education level, women were 




less likely to report psychological morbidity across all other educational levels: 
primary OR 0.73 (0.59-0.91) p-value 0.00; secondary OR 0.38 (0.31-0.47) p-value 0.00; 
and tertiary OR 0.33 (0.27-0.41) p-value 0.00. When compared to women with no 
education level, women were less likely to report social morbidity across all other 
educational levels: primary OR 0.73 (0.58-0.91) p-value 0.00; secondary OR 0.62 
(0.50-0.76) p-value 0.00; and tertiary OR 0.43 (0.35-0.54) p-value 0.00.  
 
Number of previous pregnancies  
There are statistically significant differences between number of previous 
pregnancies and the likelihood of reporting or being diagnosed with 
medical/obstetric, infectious, psychological and social morbidity. When compared to 
women with no previous pregnancies (primigravida), women with one previous 
pregnancy were more likely to report social morbidity OR 1.45 (1.13-1.86) p-value 
0.00. When compared to women with no previous pregnancy (primigravida), women 
with two to four pregnancies (P2-4) were more likely to have medical/obstetric OR 
1.78 (1.24-2.55) p-value 0.00); infectious OR 1.49 (1.02-2.19) p-value 0.04; 
psychological OR 1.88 (1.48-2.39) p-value 0.00; and social morbidity OR 1.78 (1.41-
2.25) p-value 0.00. When compared to women with no previous pregnancy 
(primigravida), women with five or more pregnancies (P≥5) were more likely to have 
medical/obstetric morbidity (OR 1.82 (1.46-2.26) p-value 0.00; infectious (OR 1.68 
(1.03-2.75) p-value 0.04); or report psychological OR 3.11 (2.23-4.33) p-value 0.00 
and social morbidity OR 1.68 (1.22-2.33) p-value 0.00.  
 
Mothers with an adverse outcome in the most recent pregnancy 
When compared to women with no adverse maternal outcomes in the most recent 
pregnancy, women with an adverse maternal outcome were more likely to have 
medical/obstetric (OR 2.61 (2.08-3.29) p-value 0.00); infectious (OR 4.03 (C3.20-5.08) 
p-value 0.00); and to report psychosocial OR 5.14 (4.17-6.32) p-value 0.00); and social 







Mothers with an adverse neonatal outcome in the most recent 
pregnancy 
When compared to women with no neonatal adverse outcome in the most recent 
pregnancy, women with an adverse neonatal outcome were more likely to report 
medical/obstetric morbidity (OR 2.03 (1.59-2.60) p-value 0.00), infectious (OR 3.60 
(2.83-4.59) p-value 0.00), psychosocial (OR 3.23 (2.60-4.02) p-value 0.00) and social 
morbidity OR 2.42 (1.92-3.04) p-value 0.00.  




Table 6.9: Pakistan: Univariate analysis 
COUNTRY PHYSICAL MORBIDITY NON-PHYSICAL MORBIDITY 
Variable / category MEDICAL/OBSTETRIC INFECTIOUS PSYCHOLOGICAL SOCIAL 
n % OR (95% CI) n % OR (95% CI) n % OR (95% CI) n % OR (95% CI) 
Age 
15 -<20  
113 
 
5 0.76 (0.54-1.07) 13 3 
0.63 (0.34-1.17) 
79 6 0.98 (0.71-1.37) 98 5 0.78 (0.56-1.09) 
20 -<25 485 23 1.00 76 20 1.00 307 21 1.00 420 23 1.0 
25 -<30 698 33 1.22 (0.98-1.51) 136 36 1.35 (1.00-1.82) 490 34 1.33 (1.09-1.61) 603 34 1.12 (0.92-1.36) 
30 -<35 541 26 1.19 (0.97-1.49) 95 25 1.19 (0.87-1.64) 369 26 1.24 (1.01-1.53) 456 25 1.04 (0.81 -1.28) 
≥35  250 12 1.24 (0.93-1.65) 54 14 1.49 (1.03-2.17) 184 12 1.41 (1.09-1.82) 213 12 1.03 (0.80-1.34) 
Socio-economic status 
Lower (V)  48 2 1.00 5 1 1.00 42 3 1.00 43 2 1.00 
Upper Lower (IV) 
527 23 0.76 (0.43-1.36) 91 23 1.61 (0.63-4.10) 364 23 0.49 (0.29-0.83) 483 24 0.86 (0.50-1.46) 
Lower Middle (III) 1205 53 0.80 (0.46-1.40) 225 56 1.78 (0.71-4.49) 860 55 0.54 (0.32-0.90) 1065 54 0.81 (0.48-1.36) 
Upper Middle (II) 405 18 0.79 (0.44-1.41) 71 18 1.65 (0.64-4.25) 236 15 0.37 (0.22-0.63) 310 16 0.57 (0.33-0.98) 
Upper (I) 94 4 1.07 (0.54-2.13) 10 2 1.04 (0.34-3.19) 52 3 0.39 (0.21-0.73) 79 4 0.88 (0.47-1.65) 
Level of education completed 
None 721 37 1.00 153 41 1.00 589 43 1.00 663 39 1.00 
Primary  381 19 0.77 (0.61-0.98) 78 21 0.88 (0.66-1.19) 293 22 0.73 (0.59-0.91) 337 20 0.73 (0.58-0.91) 
Secondary  453 23 0.64 (0.51-0.79) 67 18 0.57 (0.42-0.77) 261 19 0.38 (0.31 -0.47) 398 23 0.62 (0.50-0.76) 
Tertiary  415 21 0.67 (0.54-0.84) 77 21 0.75 (0.56-1.01) 215 16 0.33 (0.27-0.41) 306 18 0.43 (0.35-0.54) 
Number of previous pregnancies 
None  229 11.2 1.05 (0.81-1.36) 34 9 1.00 121 9 1.00 169 10 1.00 
1 568 27.8 1.25 (0.98-1.59) 119 30 1.51 (1.01-2.25) 339 25 1.25 (0.96-1.61) 492 28 1.45 (1.13-1.86) 
2-4 1047 51.3 1.78 (1.24-2.55) 206 52 1.49 (1.02-2.19) 743 55 1.88 (1.48-2.39) 932 53 1.78 (1.41-2.25) 
≥5 197 9.7 1.82 (1.46-2.26) 39 10 1.68 (1.03-2.75) 159 12 3.11 (2.23-4.33) 156 9 1.68 (1.22-2.33) 
Adverse outcome 
Mother 499 28 2.61 (2.08-3.29) 176 48 4.03 (3.20-5.08) 460 37 5.14 (4.17-6.32) 498 32 4.15 (3.30-5.21) 






Pakistan: Multivariate analysis 
 




There are no statistically significant differences between age and any type of 
morbidity on multivariate analysis.  
 
Socioeconomic status  
There are no statistically significant differences between SES and medical/obstetric 
morbidity. When compared to women in the lower SES category, women in the upper 
middle and upper SES were more likely to report infectious morbidity and this risk 
increased as the SES increased: OR 3.67 (1.19-11.3) p-value 0.02 and 4.18 (1.13-15.4) 
p-value 0.03 respectively. The 95% CI are wide for each odds ratio. Conversely, when 
compared to women in the lower SES category, women were less likely to report 
psychological morbidity in all other categories of SES, but the risk was not consistent 
in either direction. When compared to women in the lower SES category, women in 
the upper middle category were less likely to report social morbidity OR 0.33 (0.13-
0.84) p-value 0.02. 
 
Educational level completed  
When compared to women with no educational level completed, women with 
secondary education were less likely to report medical/obstetric morbidity OR 0.52 
(0.33-0.83) p-value 0.01. When compared to women with no educational level 
completed, women with primary and secondary level education were more likely to 
report social morbidity OR 1.40 (1.03-1.92) p-value 0.03 and OR 1.63 (1.06-2.49) 0.03. 
There was no consistent direction of association across the types of morbidity.  
 






Number of previous pregnancies  
There were statistically significant differences between number of previous 
pregnancies and medical/obstetric, infectious, psychological and social morbidity on 
multivariate analysis. When compared to women with no previous pregnancy, 
women with two to four pregnancies were less likely to have medical/obstetric 
morbidity OR 0.72 (0.55-0.94) 0.01. When compared to women with no previous 
pregnancy, women with two to four pregnancies or five or more pregnancies were 
less likely to report infectious morbidity OR 0.56 (0.39-0.53) 0.00 and OR 0.60 (0.41-
0.87) 0.01. When compared to women with no previous pregnancy, women with one 
previous pregnancy, two to four pregnancies or five or more pregnancies were less 
likely to report psychological and social morbidity. 
 
Mothers with an adverse outcome in the most recent pregnancy 
When compared to women with no adverse maternal outcomes in the most recent 
pregnancy, women with an adverse maternal outcome were more likely to report all 
four types of morbidity: medical/obstetric, infectious, psychological and social 
morbidity.  
 
Mothers with an adverse neonatal outcome in the most recent 
pregnancy  
When compared to women with no adverse neonatal outcomes in the most recent 
pregnancy, women with an adverse neonatal outcome were more likely to report all 













Summary box: Pakistan  
Factor Associations with morbidity  
Age No statistically significant difference. 
Socioeconomic status When compared to women in the lower SES category, 
women in the upper middle and upper SES were more 
likely to report infectious morbidity; women were less 
likely to report psychological morbidity in all other 
categories of SES; and women in the upper middle 
category were less likely to report social morbidity. 
Educational level  When compared to women with no education, 
women with primary and secondary level education 
were more likely to report social morbidity.; and 
women with secondary education were less likely to 
report medical/obstetric morbidity. 
Number of previous 
pregnancies  
When compared to women with no previous 
pregnancy, women with two to four pregnancies 
were less likely to report medical/obstetric morbidity; 
women with two to four pregnancies or five or more 
pregnancies were less likely to report infectious 
morbidity; women with one previous pregnancy, two 
to four pregnancies or five or more pregnancies were 
less likely to report psychological and social 
morbidity.  
Adverse maternal 
outcome in the most 
recent pregnancy 
When compared to women with no adverse maternal 
outcome, women with an adverse maternal outcome 
were more likely to report medical/obstetric, 
infectious, psychological and social morbidity. 
Adverse neonatal 
outcome in the most 
recent pregnancy 
When compared to women with no adverse neonatal 
outcome, women with an adverse neonatal outcome 
were more likely to report medical/obstetric, 
infectious, psychological and social morbidity.  




Table 6.10: Pakistan: Multivariate analysis 
COUNTRY PAKISTAN 
Variable  PHYSICAL MORBIDITY NON-PHYSICAL MORBIDITY ANY MORBIDITY 
 MEDICAL/OBSTETRIC INFECTIOUS PSYCHOLOGICAL SOCIAL  
 OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value  
Age            
15- <20  0.81 (0.54-1.22) 0.31 0.51 (0.24-1.06) 0.07 0.85 (0.57-1.29) 0.45 0.88 (0.59-1.31) 0.53 0.96 (0.52-1.77) 0.89 
20 - <25 Reference 
25 - <30 1.00 (0.78-1.29) 0.99 1.26 (0.90-1.77) 0.18 1.13 (0.88-1.45) 0.33 1.12 (0.88-1.43) 0.34 1.18 (0.80-1.73) 0.41 
30- <35 0.93 (0.70-1.24) 0.62 1.10 (0.75-1.61) 0.63 0.91 (0.69-1.20) 0.50 0.92 (0.71-1.21) 0.57 0.90 (0.59-1.38) 0.64 
≥35  0.91 (0.64-1.30) 0.60 1.39 (0.90-2.16) 0.14 0.97 (0.69-1.36) 0.86 0.92 (0.66-1.28) 0.63 1.45 (0.79-2.65) 0.23 
SES 
Lower (V)  Reference 
Upper Lower  0.87 (0.40-1.91)  0.74 2.38 (0.79-7.14) 0.12 0.33 (0.15-0.72)  0.01 0.76 (0.36-1.61) 
 
0.48 0.61 (0.14 2.68 
 
0.52 
Lower Middle  0.87 (0.40-1.88) 0.72 2.77 (0.94-8.18) 0.07 0.39 (0.18-0.85) 0.02 0.74 (0.36-1.55) 0.43 0.68 (0.16-2.93) 0.61 
Upper Middle  0.73 (0.33-1.62) 0.44 3.67 (1.19-11.3) 0.02 0.29 (0.13-0.64) 0.00 0.52 (0.24-1.11) 0.09 0.53 (0.12-2.30) 0.40 
Upper (I) 0.68 (0.26-1.76) 0.43 4.18 (1.13-15.4) 0.03 0.19 (0.07-0.51) 0.00 0.33 (0.13-0.84) 0.02 0.40 (0.08-2.03) 0.27 
Level of education completed  
None Reference  
Primary  0.72 (0.52-1.00) 0.05 0.99 (0.60-1.63) 0.97 0.87 (0.63-1.22) 0.43 1.40 (1.03-1.92) 0.03 0.80 (0.50 1.29)  0.36 
Secondary  0.52 (0.33-0.83) 0.01 0.72 (0.39-1.33) 0.29 0.99 (0.64-1.54) 0.97 1.63 (1.06-2.49) 0.03 0.56 (0.27-1.14) 0.11 
Tertiary  0.89 (0.49-1.62) 0.71 0.73 (0.35 1.51) 0.39 1.70 (0.99-2.93) 0.05 1.31 (0.78-2.20) 0.32 0.92 (0.34-2.47) 0.87 
Number of previous pregnancies  
None  Reference  
1 0.87 (0.65-1.15) 0.33 0.85 (0.61-1.19) 0.34 0.66 (0.51-0.85) 0.00 0.70 (0.54-0.91) 0.01 0.56 (0.35-0.88)  0.01 
2-4 0.72 (0.55-0.94) 0.01 0.56 (0.39-0.80) 0.00 0.42 (0.32-0.53) 0.00 0.71 (0.55-0.91) 0.01 0.50 (0.32-0.76) 0.00 
≥5 0.79 (0.60-1.05) 0.10 0.60 (0.41-0.87) 0.01 0.39 (0.30-0.51) 0.00 0.58 (0.45-0.76) 0.00 0.53 (0.34-0.84) 0.01 
Adverse outcome  
Mother 2.21 (1.59-3.07) 0.00 3.04 (2.26 4.10) 0.00 4.48 (3.35-6.01) 0.00 4.41 (3.21-6.07) 0.00 4.84 (2.30-10.2)  0.001 






6.4 Kenya: Univariate analysis 
 
All results for univariate analysis for the study population are displayed in Table 6.11.  
 
Age  
When compared to women in the age range 20-<25 years of age, women were more 
likely to report psychological morbidity in the age ranges 15-<20 years and 30-35 
years OR 1.67 (1.22-2.28) p-value 0.00 and OR 1.54 (1.14-2.08) p-value 0.00.  
 
Socioeconomic status  
There are statistically significant differences between SES and the likelihood of 
medical/obstetric, infectious, psychological and social morbidity. When compared to 
women in the lower SES category, women in the upper lower and the middle 
categories were less likely to have medical/obstetric morbidity OR 0.60 (0.45 - 0.79) 
p-value 0.00 and OR 0.73 (0.56-0.95) p-value 0.02 respectively. When compared to 
women in the lower SES category, women in the upper middle and the upper 
categories were more likely to have infectious morbidity OR 1.40 (1.10-1.78) p-value 
0.01 and OR 1.39 (1.09-1.76) p-value 0.01 respectively. When compared to women 
in the lower SES category, women in the all SES categories were less likely to report 
psychological morbidity. When compared to women in the lower SES category, 
women in the upper lower and upper SES categories were less likely to report social 
morbidity but women in the middle SES category were more likely to report social 
morbidity. 
Educational level completed  
When compared to women with no education level, women were more likely to have 
infectious morbidity with secondary OR 2.08 (1.22-3.55) p-value 0.01, and tertiary OR 
2.04 (1.17-3.55) p-value 0.01 education levels. When compared to women with no 
education level, women were less likely to report psychological morbidity with 
primary OR 0.34 (0.21-0.57) p-value 0.00; secondary (OR 0.30 (0.18-0.50) p-value 
0.00; and tertiary OR 0.26 (0.15-0.47) p-value 0.00 education levels. 





Number of previous pregnancies  
When compared to women with no previous pregnancy (primigravida), women with 
one previous pregnancy were more likely to have infectious morbidity OR 1.38 (1.11-
1.73) p-value 0.00  
 
Mothers with an adverse outcome in the most recent pregnancy 
When compared to women with no adverse maternal outcomes in the most recent 
pregnancy, women with an adverse maternal outcome were more likely to have 
infectious morbidity 3.31 (2.14-5.10) p-value 0.00 and social morbidity OR 2.08 (1.24-
3.48) p-value 0.01. 
 
Mothers with an adverse neonatal outcome in the most recent 
pregnancy  
When compared to women with no adverse neonatal outcomes in the most recent 
pregnancy, women with an adverse neonatal outcome were more likely to have 
medical/obstetric OR 1.98 (1.46-2.68) p-value 0.00 and infectious OR 1.45 (1.08-1.95) 






Table 6.11: Kenya: Univariate analysis 
COUNTRY PHYSICAL MORBIDITY NON-PHYSICAL MORBIDITY 
Variable / category MEDICAL/OBSTETRIC INFECTIOUS PSYCHOLOGICAL SOCIAL 
n % OR (95% CI) n % OR (95% CI) n % OR (95% CI) n % OR (95% CI) 
Age 
15 -<20  113 14 098 (0.76-1.26) 162 13 0.94 (0.75-1.18) 76 18 1.67 (1.22-2.28) 115 15 1.12 (0.87-1.45) 
20 -<25 270 34 1.00 395 33 1.00 115 27 1.00 247 32 1.00 
25 -<30 201 26 0.98 (0.80-1.20) 310 26 1.00 (0.83-1.21) 99 24 1.11 (0.83-1.48) 204 26 1.06 (0.86-1.32) 
30 -<35 126 16 0.88 (0.70-1.12) 216 18 1.08 (0.88-1.34) 87 21 1.54 (1.14-2.08) 131 17 1.03 (0.81-1.31) 
≥35  75 9 1.10 (0.83-1.48) 124 9 1.29 (0.99-1.68) 42 10 1.41 (0.96-2.07) 78 10 1.23 (0.91-1.65) 
Socio-economic status 
Lower (V)  164 22 1.00 206 19 1.00 109 27 1.00 149 21 1.00 
Upper Lower (IV) 
108 15 0.60 (0.45-0.79) 180 16 0.85 (0.66 - 1.09) 76 19 0.67 (0.49-0.93) 113 16 0.72 (0.55-0.96) 
Lower Middle (III) 133 18 0.73 (0.56-0.95) 215 19 1.03 (0.81-1.31) 71 18 0.58 (0.42-0.81) 200 28 1.47 (1.14-1.90) 
Upper Middle (II) 157 21 0.93 (0.72-1.21) 253 23 1.40 (1.10-1.78) 71 18 0.60 (0.43-0.83) 138 19 0.90 (0.68-1.17) 
Upper (I) 170 23 1.06 (0.82-1.37) 249 23 1.39 (1.09-1.76) 78 19 0.67 (0.49-0.92) 119 17 0.75 (0.57-0.99) 
Level of education completed 
None 19 2 1.00 19 2 1.00 24 6 1.00 21 3 1.00 
Primary  322 41 0.90 (0.52-1.53) 491 40 1.63 (0.96-2.78) 192 45 0.34 (0.21-0.57) 372 48 0.95 (0.56-1.59) 
Secondary  336 43 1.06 (0.62-1.81) 524 43 2.08 (1.22-3.55) 156 37 0.30 (0.18-0.50) 299 38 0.79 (0.47-1.33) 
Tertiary  113 14 0.99 (0.56-1.73) 184 15 2.04 (1.17-3.55) 50 12 0.26 (0.15-0.47) 90 12 0.64 (0.37-1.12) 
Number of previous pregnancies 
None  114 14.7 1.00 164 14 1.00 71 18 1.00 112 15 1.00 
1 289 37.3 1.06 (0.83-1.36) 486 41 1.38 (1.11-1.73) 138 34 0.78 (0.57-1.06) 269 35 0.99 (0.77-1.27) 
2-4 352 45.4 1.18 (0.93-1.50) 507 43 1.22 (0.98-1.51) 183 45 0.94 (0.70-1.26) 363 48 1.26 (0.99-1.61) 
≥5 20 2.6 1.81 (1.01-3.26) 23 2 1.37 (0.78-2.41) 13 3 1.77 (0.90-3.45) 15 2 1.22 (0.65-2.29) 
Adverse outcome 
Mother 45 7 3.31 (2.14-5.10) 40 4 1.33 (0.87-2.05) 20 6 2.08 (1.24-3.48) 19 3 0.83(0.50-1.40) 
Baby  76 11 1.98 (1.46-2.68) 93 9 1.45 (1.08-1.95) 39 12 1.78 (1.22-2.58) 53 8 1.13 (0.81-1.57) 
 




Kenya: Multivariate analysis 
 




When compared to women in the age range 20-<25 years of age, women were more 
likely to report psychological morbidity in the age ranges 15-<20 years OR 1.66 (1.17-
2.35) p-value 0.00; and 30-<35 years OR 1.48 (1.05-2.08 p-value 0.03. There were no 
statistically significant differences between age and medical/obstetric, infectious or 
social morbidity on multivariate analysis.  
 
Socioeconomic status  
When compared to women in the lower SES category, women in the upper lower and 
lower middle were less likely to report medical/obstetric morbidity and this risk 
increased as SES increased: OR 0.62 (0.46-0.79) p-value 0.00 and 0.72 (0.55-0.95) p-
value 0.02 respectively. When compared to women in the lower SES category, 
women in the lower middle and middle SES categories were less likely to report 
psychological morbidity OR 0.70 (0.50-0.98) p-value 0.04 and OR 0.63(0.45-0.89) p-
value 0.01.  
 
Educational level completed  
There are no statistically significant differences between level of education 
completed and medical/obstetric, infectious or social morbidity. When compared to 
women with no educational level completed, women with primary, secondary and 
tertiary education were less likely to report psychological morbidity and this 










Number of previous pregnancies  
When compared to women with no previous pregnancy (primigravida), women with 
one previous pregnancy or two to four pregnancies were less likely to report 
psychological morbidity OR 0.69 (0.49-0.99) p-value 0.04 and 0.57 (0.35-0.94) p-value 
0.03 respectively. There are no statistically significant differences between the 
number of previous pregnancies and medical/obstetric, infectious or social morbidity 
on multivariate analysis.  
 
Mothers with an adverse outcome in the most recent pregnancy 
When compared to women with no adverse maternal outcomes in the most recent 
pregnancy, women with an adverse maternal outcome were more likely to report 
medical/obstetric morbidity OR 2.95 (1.67-5.20) p-value 0.00.  
 
Mothers with an adverse neonatal outcome in the most recent 
pregnancy  
When compared to women with no adverse neonatal outcomes in the most recent 
pregnancy, women with an adverse neonatal outcome were more likely to report 
medical/obstetric morbidity OR 2.00 (1.36-2.94) p-value 0.00.  
  





Summary: Kenya  
Factor Associations with morbidity  
Age When compared to women in the age range 20-<25 
years, women were more likely to report 
psychological morbidity in the age ranges 15-<20 
years and 30-<35 years. 
Socioeconomic status When compared to women in the lower SES category, 
women in the upper lower and lower middle SES 
category were less likely to report medical/obstetric 
morbidity; and women in the lower middle and 
middle SES category were less likely to report 
psychological morbidity. 
Educational level  When compared to women with no education level 
completed, women with primary, secondary and 
tertiary education were less likely to report 
psychological morbidity. 
Number of previous 
pregnancies  
When compared to women with no previous 
pregnancies women with one previous pregnancy 
and women with two to four pregnancies were less 
likely to report psychological morbidity. 
Adverse maternal 
outcome in the most 
recent pregnancy 
When compared to women with no adverse maternal 
outcome, women with an adverse maternal outcome 
were more likely to report medical/obstetric 
morbidity. 
Adverse neonatal 
outcome in the most 
recent pregnancy 
When compared to women with no adverse neonatal 
outcome, women with an adverse neonatal outcome 








Table 6.12: Kenya: Multivariate analysis  
COUNTRY KENYA 
Variable  PHYSICAL MORBIDITY NON-PHYSICAL MORBIDITY ANY MORBIDITY 
 MEDICAL/OBSTETRIC INFECTIOUS PSYCHOLOGICAL SOCIAL  
 OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value  
Age            
15-<20  1.15 (0.87-1.51) 0.32 1.09 (0.84-1.42) 0.50 1.66 (1.17-2.35) 0.00 1.03 (0.77-1.38) 0.83 1.27 (0.96-1.68) 0.09 
20-<25 Reference 
25-<30 0.90 (0.71-1.14) 0.36 0.97 (0.78-1.20) 0.78 1.12 (0.82-1.55) 0.47 0.96 (0.76-1.23) 0.77 0.82 (0.65-1.03) 0.08 
30- <35 0.78 (0.60-1.03) 0.08 1.14 (0.89-1.46) 0.29 1.48 (1.05-2.08) 0.03 0.89 (0.67-1.17) 0.41 0.82 (0.63-1.06) 0.13 
≥35  0.99 (0.70-1.39) 0.94 1.38 (1.00-1.89) 0.05 1.24 (0.80-1.94) 0.33 1.02 (0.72-1.45) 0.90 1.27 (0.89-1.80) 0.19 
SES 
Lower (V)  Reference 
Upper Lower  0.60 (0.45-0.79) 0.00 0.87 (0.67-1.12) 0.29 0.70 (0.50-0.98) 0.04 0.76 (0.57-1.02) 0.07 0.66 (0.51-0.86) 0.00 
Lower Middle  0.72 (0.55-0.95) 0.02 1.04 (0.81-1.33) 0.79 0.63 (0.45-0.89) 0.01 1.54 (1.18-2.01) 0.00 1.10 (0.84-1.44) 0.48 
Upper Middle 1.00 (0.76-1.31) 0.98 1.33 (1.03-1.72) 0.03 0.72 (0.51-1.01) 0.06 1.05 (0.79-1.40) 0.74 1.06 (0.81-1.40) 0.67 
Upper (I) 1.16 (0.88-1.55) 0.30 1.35 (1.03-1.77) 0.03 0.78 (0.54-1.12) 0.18 0.86 (0.63-1.17) 0.35 1.03 (0.77-1.37) 0.86 
Level of education completed 
None Reference 
Primary  1.37 (0.76-2.47) 0.30 1.45 (0.83-2.52) 0.19 0.33 (0.19-0.56) 0.00 1.00 (0.57-1.75) 0.99 1.00 (0.58-1.73) 1.00 
Secondary  1.41 (0.77-2.56) 0.26 1.75 (1.00-3.06) 0.05 0.29 (0.17-0.51) 0.00 0.84 (0.48-1.48) 0.54 1.18 (0.67-2.06) 0.57 
Tertiary  1.20 (0.63-2.26) 0.58 1.49 (0.83-2.69) 0.19 0.25 (0.13-0.47) 0.00 0.70 (0.38-1.30) 0.26 1.02 (0.56-1.84) 0.95 
Number of previous pregnancies 
None  Reference 
1 1.10 (0.83-1.44) 0.51 1.36 (0.83-2.52) 0.02 0.69 (0.49-0.99) 0.04 0.82 (0.61-1.10) 0.18 1.01 (0.78-1.30) 0.96 
2-4 1.36 (0.92-2.02) 0.13 1.19 (1.00-3.06) 0.33 0.57 (0.35-0.94) 0.03 0.79 (0.53-1.19) 0.26 0.91 (0.62-1.33) 0.63 
≥5 1.91 (0.93-3.90) 0.08 1.31 (0.83-2.69) 0.43 0.87 (0.38-2.00) 0.74 0.81 (0.39-1.71) 0.59 1.19 (0.55-2.57) 0.66 
Adverse outcome 
Mother 2.95 (1.67-5.20) 0.00 1.17 (0.66-2.04) 0.59 1.63 (0.84-3.15) 0.15 0.78 (0.41-1.48) 0.44 1.33 (0.68-2.57) 0.40 
Baby  2.00 (1.36-2.94) 0.00 1.21 (0.83-1.76) 0.33 1.26 (0.78-2.03) 0.35 1.16 (0.77-1.74) 0.49 1.50 (0.96-2.33) 0.07 




6.5 Malawi: Univariate analysis  
 
All results for univariate analysis for the study population are displayed in Table 6.13.  
 
Age 
When compared to women in the age range 20-<25years of age, women in the age 
category 30-<35 years and ≥35 years were more likely to report infectious morbidity 
OR 1.34 (1.04-1.73) p-value 0.02 and OR 1.85 (1.33-2.58) p-value 0.00 respectively. 
When compared to women in the age range 20-<25years of age, women were less 
likely to report psychological morbidity in the age range ≥35 years OR 0.54 (0.35-0.98) 
p-value 0.04. When compared to women in the age range 20-<25years of age, women 
in the age category 30-<35 years of age were more likely to report social morbidity 
OR 1.41 (1.04-1.91) p-value 0.03. 
 
Socioeconomic status  
When compared to women in the lower SES category, women in the upper lower SES 
category were more likely to report medical/obstetric morbidity OR 1.27 (1.01-1.60) 
p-value 0.04. When compared to women in the lower SES category, women were 
more likely to report psychological morbidity in the middle (III) OR 1.52 (1.05-2.21) p-
value 0.03; upper middle (II) OR 2.63 (1.87-3.70) p-value 0.00; and upper (I) SES 
category OR 3.85 (2.76-5.36) p-value 0.00. When compared to women in the lower 
SES category, women were more likely to report social morbidity in the upper middle 
(II) OR 1.79 (1.33-2.40) p-value 0.00; and upper (I) SES category OR 2.20 (1.65-2.94) 
p-value 0.00. 
 
Educational level completed  
When compared to women with no education level, women were less likely to have 
infectious morbidity with secondary OR 0.67 (0.54-0.82) p-value 0.00; and tertiary 








Number of previous pregnancies  
There are statistically significant differences between number of previous 
pregnancies and the likelihood of reporting infectious, psychological and social 
morbidity. When compared to women with no previous pregnancy (primigravida), 
women with one previous pregnancy were more likely to report infectious OR 1.52 
(1.20-1.93) p-value 0.00; and psychological morbidity OR 1.67 (1.11-2.50) p-value 
0.01. When compared to women with no previous pregnancy (primigravida), women 
with two to four pregnancies (P2-4) were more likely to report medical/obstetric OR 
2.09 (9 1.50-2.92) p-value 0.00; infectious morbidity (OR 2.76 (1.89-4.03) p-value 
0.00); and psychological morbidity OR 1.68 (1.24-2.29) p-value 0.00). When 
compared to women with no previous pregnancy (primigravida), women with five or 
more pregnancies (P≥5) were less likely to report infectious morbidity OR 0.57 (0.46-
0.70) p-value 0.00. 
 
Mothers with an adverse outcome in the most recent pregnancy 
When compared to women with no adverse maternal outcomes in the most recent 
pregnancy, women with an adverse maternal outcome were more likely to report 
psychological OR 5.14 (4.17-6.32) p-value 0.00; and social morbidity OR 4.15 (3.30-
5.21) p-value 0.00. 
 
Mothers with an adverse neonatal outcome in the most recent 
pregnancy  
When compared to women with no adverse neonatal outcomes in the most recent 
pregnancy, women with an adverse neonatal outcome were more likely to report 
psychosocial morbidity OR 2.18 (1.24-3.84) p-value 0.00. 




Table 6.13: Malawi: Univariate analysis  
COUNTRY PHYSICAL MORBIDITY NON-PHYSICAL MORBIDITY 
Variable / category MEDICAL/OBSTETRIC INFECTIOUS PSYCHOLOGICAL SOCIAL 
n % OR (95% CI) n % OR (95% CI) n % OR (95% CI) n % OR (95% CI) 
Age 
15 -<20  244 23 1.20 (0.96-1.49) 240 21 1.09 (0.88-1.36) 79 18 0.78 (0.58-1.06) 104 20 1.02 (0.78-1.35) 
20 -<25 318 30 1.00 329 29 1.00 140 32  147 29  
25 -<30 278 27 0.98 (0.79-1.20) 290 26 1.00 (0.81-1.23) 126 29 1.02 (0.79-1.34) 144 28 1.14 (0.88-1.47) 
30 -<35 126 12 0.95 (0.73-1.23) 163 15 1.34 (1.04-1.73) 69 16 1.22 (0.88-1.68) 81 16 1.41 (1.04-1.91) 
≥35  78 8 1.27 (0.91-1.77) 97 8 1.82 (1.33-2.58) 19 4 0.59 (0.35-0.98) 38 7 1.26 (0.84-1.89) 
Socio-economic status 
Lower (V)  237 20 1.00 255 20 1.00 55 12 1.00 88 15 1.00 
Upper Lower (IV) 
282 24 1.27 (1.01-1.60) 275 22 1.07 (1.00-1.00) 58 12 1.02 (0.69-1.50) 86 15 0.93 (0.68-1.29) 
Lower Middle (III) 236 20 1.13 (0.90-1.44) 261 20 1.20 (1.17-1.17) 74 16 1.52 (1.05-2.21) 103 18 1.33 (0.97-1.81) 
Upper Middle (II) 232 19 0.97 (0.77-1.23) 259 20 1.04 (1.52-1.52) 125 26 2.63 (1.87-3.70) 140 24 1.79 (1.33-2.40) 
Upper (I) 213 18 0.86 (0.68-1.09) 227 18 0.84 (2.09-2.09) 165 35 3.85 (2.76-5.36) 162 28 2.20 (1.65-2.94) 
Level of education completed 
None 443 37 1.00 491 39 1.00 165 35 1.00 207 36 1.00 
Primary  500 42 0.98 (0.83-1.16) 543 43 0.95 (0.80-1.12) 187 39 0.99 (0.79-1.25) 223 39 0.93 (0.76-1.15) 
Secondary  209 18 0.85 (0.69-1.06) 201 16 0.67 (0.54-0.82) 104 22 1.27 (0.97-1.66) 126 22 1.23 (0.95-1.57) 
Tertiary  41 3 0.86 (0.57-1.29) 37 3 0.61 (0.40-0.92) 22 5 1.40 (0.85-2.30) 22 4 1.06 (0.65-1.74) 
Number of previous pregnancies 
None  154 12.9 1.00 136 11 1.17 (0.91-1.50) 33 7 1.00 57 10 1.00 
1 394 33.1 1.12 (0.87-1.42) 360 28 1.52 (1.20-1.93) 125 26 1.67 (1.11-2.50) 144 25 1.06 (0.76-1.48) 
2-4 537 45.1 0.90 (0.71-1.13) 649 51 2.09 (1.50-2.92) 294 62 2.76 (1.89-4.03) 324 57 1.68 (1.24-2.29) 
≥5 106 8.9 1.21 (0.87-1.68) 126 1 0.57 (0.46-0.70) 22 5 1.09 (0.62-1.91) 48 8 1.46 (0.95-2.23) 
Adverse outcome 
Mother 33 3 1.41 (0.87-2.29) 38 3 1.63 (1.00-2.66) 34 8 5.21 (3.19-8.50) 35 7 4.51 (2.76-7.36) 







Malawi: Multivariate analysis 
 




When compared to women in the age range 20-<25 years, women in the age range 
25-<30 years and ≥35 years of age were less likely to report psychological morbidity: 
OR 0.66 (0.50-0.89) p-value 0.01 and OR 0.43 (0.24-0.77) p-value 0.00. When 
compared to women in the age range 20-<25 years, women in the age range 15-<20 
years were more likely to report social morbidity OR 1.60 (1.16-2.21) p-value 0.00. 
 
Socioeconomic status  
When compared to women in the lower SES category, women in the upper lower 
were more likely to have medical/obstetric morbidity OR 1.45 (1.12-1.88) p-value 
0.00. When compared to women in the lower SES category, women in the upper 
middle and upper SES categories were more likely to report psychological morbidity 
and this likelihood increased as SES increased OR 3.42 (2.28-5.13) p-value 0.00 and 
5.90 (3.85-9.04) p-value 0.00 respectively. When compared to women in the lower 
SES category, women in the upper middle and upper SES categories were more likely 
to report social morbidity and this likelihood increased as SES increased, OR 1.89 
(1.35-2.66) p-value 0.00 and 2.59 (1.80-3.73) p-value 0.00 respectively.  
 
Educational level completed  
There are no statistically significant differences between level of education 
completed and medical/obstetric, infectious or social morbidity. When compared to 
women with no educational level completed, women with primary, secondary and 
tertiary education were less likely to report psychological morbidity and this generally 
decreased with level of education.  






Number of previous pregnancies  
There are no statistically significant differences between number of previous 
pregnancies and medical/obstetric, infectious or social morbidity on multivariate 
analysis.  
 
Mothers with an adverse outcome in the most recent pregnancy 
Compared to women with no adverse maternal outcomes in the most recent 
pregnancy, women with an adverse maternal outcome were more likely to report 
psychological morbidity OR 2.95 (1.46-5.96) p-value 0.00.  
 
Mothers with an adverse neonatal outcome in the most recent 
pregnancy  
There are no statistically significant differences between women with an adverse 
neonatal outcome in the most recent pregnancy and medical/obstetric, infectious, 







Summary box: Malawi  
Factor Associations with morbidity  
Age When compared to women in the age range 20-<25 
years, women in the age range 15-<20 years were 
more likely to report social morbidity; and women in 
the range 25-<30 years and ≥35 years of age were 
less likely to report psychological morbidity. 
Socioeconomic status When compared to women in the lower SES 
category, women in the upper lower were more 
likely to report medical/obstetric morbidity; women 
in the upper middle and upper SES category were 
more likely to report psychological morbidity; and 
women in the upper middle and upper SES category 
were more likely to report social morbidity.  
Educational level  When compared to women with no educational 
level completed, women with primary, secondary 
and tertiary education were less likely to report 
psychological morbidity. 
Number of previous 
pregnancies  
Not statistically significant.  
Adverse maternal 
outcome in the most 
recent pregnancy 
When compared to women with no adverse 
maternal outcomes in the most recent pregnancy, 
women with an adverse maternal outcome were 
more likely to report psychological morbidity. 
 Adverse neonatal 
outcome in the most 
recent pregnancy 
Not statistically significance. 




Table 6.14: Malawi: Multivariate analysis 
COUNTRY MALAWI 
Variable  PHYSICAL MORBIDITY NON-PHYSICAL MORBIDITY ANY MORBIDITY 
 MEDICAL/OBSTETRIC INFECTIOUS PSYCHOLOGICAL SOCIAL  
 OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value  
Age            
15- <20  1.12 (0.88-1.43) 0.35 1.30 (1.02-1.67) 0.03 1.46 (1.02-2.09) 0.04 1.60 (1.16-2.21) 0.00 1.43 (1.10-1.85) 0.01 
20 - <25 1.00  1.00  1.00  1.00  1.00  
25 - <30 1.05 (0.84-1.31) 0.65 0.89 (0.71-1.11) 0.29 0.66 (0.50-0.89) 0.01 0.85 (0.65-1.12) 0.26 0.93 (0.73-1.17) 0.52 
30- <35 1.00 (0.74-1.35) 1.00 1.10 (0.83-1.48) 0.50 0.73 (0.51-1.06) 0.10 0.95 (0.67-1.35) 0.78 1.09 (0.79-1.51) 0.60 
≥35  1.24 (0.84-1.84) 0.28 1.41 (0.95-2.08) 0.08 0.43 (0.24-0.77) 0.00 0.94 (0.59-1.51) 0.81 1.71 (1.06-2.75) 0.03 
Socioeconomic status 
Lower (V)  1.00  1.00  1.00  1.00  1.00  
Upper Lower  1.45 (1.12-1.88) 0.00 1.09 (0.84-1.41) 0.52 1.08 (0.69-1.69) 0.75 0.92 (0.64-1.32) 0.63 1.38 (1.05-1.81) 0.02 
Lower Middle  1.37 (1.05-1.79) 0.02 1.09 (0.84-1.42) 0.52 1.50 (0.97-2.32) 0.07 1.21 (0.85-1.73) 0.29 1.35 (1.02-1.79) 0.04 
Upper Middle  1.16 (0.89-1.52) 0.27 1.13 (0.87-1.47) 0.37 3.42 (2.28-5.13) 0.00 1.89 (1.35-2.66) 0.00 1.52 (1.14-2.02) 0.00 
Upper (I) 1.03 (0.76-1.38) 0.87 0.98 (0.73-1.31) 0.90 5.90 (3.85-9.04) 0.00 2.59 (1.80-3.73) 0.00 1.39 (1.02-1.90) 0.04 
Level of education completed 
None 1.00  1.00  1.00  1.00  1.00  
Primary  1.06 (0.88-1.29) 0.54 0.99 (0.82-1.20) 0.95 0.70 (0.53-0.92) 0.01 0.83 (0.65-1.06) 0.13 1.02 (0.82-1.25) 0.87 
Secondary  1.00 (0.77-1.30) 0.99 0.78 (0.60-1.01) 0.06 0.57 (0.40-0.81) 0.00 0.86 (0.62-1.18) 0.34 0.93 (0.70-1.23) 0.62 
Tertiary  1.23 (0.77-1.95) 0.39 0.67 (0.41-1.08) 0.10 0.42 (0.23-0.75) 0.00 0.52 (0.29-0.93) 0.03 0.90 (0.55-1.48) 0.68 
Number of previous pregnancies 
None  1.00  1.00  1.00  1.00  1.00  
1 1.13 (0.86-1.49) 0.38 1.07 (0.81-1.43) 0.62 1.43 (0.53-0.92) 0.15 1.00 (0.67-1.48) 0.99 1.18 (0.89-1.57) 0.26 
2-4 0.97 (0.65-1.45) 0.89 1.27 (0.84-1.90) 0.25 2.11 (0.40-0.81) 0.02 1.42 (0.83-2.42) 0.20 1.09 (0.71-1.68) 0.70 
≥5 1.27 (0.75-2.16) 0.37 1.32 (0.78-2.25) 0.30 1.12 (0.23-0.75) 0.79 1.27 (0.64-2.53) 0.49 1.14 (0.63-2.06) 0.67 
Adverse outcome 
Mother 1.69 (0.87-3.26) 0.12 2.34 (1.17-4.68) 0.02 2.95 (1.46-5.96) 0.00 2.77 (1.41-5.46) 0.00 4.72 (1.42-15.73) 0.01 
Baby  0.54 (0.28-1.07) 0.08 1.20 (0.64-2.25) 0.58 1.76 (0.86-3.60) 0.12 0.83 (0.39-1.76) 0.62 0.68 (0.34-1.39) 0.30 






6.6 Chapter summary in relation to literature 
In this chapter, several factors were explored to assess any association between 
socio-demographic considerations and poor outcomes in a previous pregnancy and 
types of maternal morbidity. Commonly, in many national demographic health 
surveys age, educational level, rural/urban residence status, marital status, and 
education, employment, and household wealth are assessed as factors that are 
considered to have an association with health and/or ill-health. There have been 
many studies that have assessed factors associated with maternal mortality and 
SAMM. For example, women with severe obstetric complications were poorer and 
less educated than were women with an uncomplicated childbirth in Burkina Faso 
(Filipp 2007). However, there is a lack of studies that have measured two or more 
types of morbidity as a summative measure, and assessed any socio-demographics 
factors with non-severe types of maternal morbidity.   
 
Age 
From a clinical perspective, the “extremes of ages”, those that are “too young or too 
old” are often considered “high risk” for morbidity, especially medical/obstetric 
morbidity (for example hypertension and/or pre-eclampsia) but this was not the main 
finding in this PhD study. In this PhD study, there were associations between age and 
different types of morbidity across three of the four LMIC settings, but the direction 
and strength of association were not consistent and this was an unexpected finding. 
As age increased women were more likely to report social morbidity in India and 
Malawi; were more likely to have infectious morbidity in India; These findings may be 
context specific and/or may be because an increase in age represents an increased 
exposure time to factors that contribute to different types of morbidity (for example, 
domestic violence, sexually transmitted infections. It is noted that as age increased 
women were more likely to report psychological morbidity in Kenya; but less likely to 
report psychological morbidity in Malawi. The reasons for these associations may be 
due to a difference in women’s understanding, perception and ability to disclose 








In this PhD study, there were associations between SES and three types of morbidity 
across three of the LMIC settings, but the direction and strength of association were 
not consistent. This was a surprising finding. It was expected in this study that as SES 
increased across all four LMIC settings, maternal ill-health would decrease. This 
reasons for this association were thought to be that as SES increased more women 
access care and afford treatments. This was the case in two settings, whereas SES 
increased women were less likely to report social and psychological morbidity in 
Pakistan; and less likely to report medical/obstetric and psychological morbidity in 
Kenya. However, as SES increased, women were more likely to have 
medical/obstetric, and report psychological and social morbidity in Malawi; and were 
more likely to have infectious morbidity in Pakistan.  The reasons for the different 
associations between SES and different morbidities require further research. It is 
further noted that SES is a challenging indicator to measure across different LMIC 
settings. Hence these results need to be interpreted with caution. There is also a need 
for an international agreed gold standard approach to the measurement of SES across 
LMIC settings.  
 
Education level  
It is often suggested that as educational level increases, women’s health should 
increase (Hahn 2015). However, as women’s awareness and health seeking decision 
making increases, and women may have less morbidity (because they access care) or 
more morbidity (as detection increases due to health seeking behaviour). In this PhD 
study, there were associations between educational level and three types of 
morbidity across all four LMIC settings, but the direction and strength of association 
were not consistent. This was an unexpected finding. As educational level increased, 
women were more likely to report medical/obstetric morbidity in India; and more 
likely to report social morbidity in Pakistan. This may be due to women having more 






confidence and understanding to know and report what is “normal” health and what 
is “abnormal” health during and after pregnancy. Conversely, as educational level 
increased, women were less likely to report medical/obstetric morbidity in Pakistan; 
less likely to report social morbidity in India; and less likely to report psychological 
morbidity in Kenya and Malawi. These reasons for these associations in these 
contexts require further research.  
 
Number of previous pregnancies  
It is often considered that the more pregnancies a woman has, the more morbidity a 
woman will “accumulate”, as each pregnancy can pose “risks” to the woman. This is 
not necessarily the case as suggested by the findings of this study, whereas the 
number of previous pregnancies increased in women in Pakistan, women were less 
likely to be diagnosed with medical/obstetric and infectious morbidity. However, 
women were more likely to report psychological morbidity in India and Malawi as the 
number of pregnancies increased and this may be due to the pressures and 
responsibilities associated with caring for more children. Conversely, as the number 
of pregnancies increased women were less likely to report psychological morbidity in 
Kenya. The reasons for these associations require further research. 
 
Previous adverse outcomes for the mother 
As part of a full systematic clinical consultation, women are asked regarding their 
previous obstetric history, as it is clinically considered that if a woman has had a 
previous adverse outcome, she would be at higher risk of having an adverse outcome 
in this pregnancy. The findings of this PhD support the direction of this assumption. 
Compared to women with no previous adverse outcomes for the mother, women 
with previous adverse outcomes were more likely to report medical/obstetric 
morbidity in India, Pakistan and Kenya; more likely to report psychological morbidity 
in Pakistan and Malawi; more likely to report infectious morbidity in Pakistan and 
more likely to report social morbidity in India and Pakistan. These findings would 
suggest that a previous adverse maternal outcome could have a significant impact on 




the morbidity a woman may experience in future pregnancies; and all women should 
be asked regarding their previous obstetric history to help “alert” healthcare 
providers to possible morbidity in any other pregnancy.  
 
Previous adverse outcome for the newborn baby 
 
Similar to previous adverse outcomes for the newborn baby, as part of a full 
systematic clinical consultation, women are asked regarding any complications with 
their newborn babies in their previous obstetric history, as it is clinically considered 
that if a woman has had a previous adverse outcome in her newborn, she would be 
at higher risk of having a neonatal adverse outcome in this pregnancy.  
 
Compared to women with no previous adverse outcomes for the newborn, women 
with previous adverse outcomes in the newborn were more likely to report 
medical/obstetric morbidity in Pakistan and Kenya; and more likely to report 
psychological, social and infectious morbidity in Pakistan. As highlighted above, these 
findings would also suggest that a previous adverse neonatal outcome could have a 
significant impact on the morbidity a woman may experience in future pregnancies; 
and that all women should be asked regarding the outcomes of their most recent 
pregnancy to help “alert” healthcare providers to possible morbidity in any other 
pregnancy. The reason why this association is significant in some settings and not in 
other settings requires further research.  
 
Further reflections of the main findings from this chapter in relation to other 












CHAPTER 7: RESULTS FOUR  
7.1 Introduction 
This is the last chapter that report on the results of this research project. The four 
results chapters are structured in sequence to address each main research question. 
For the purposes of this thesis, results for the study settings are presented per 
country in the following sequence: India, Pakistan, Kenya and Malawi. Where 
appropriate, results are presented as a combined study population.  
 
In this chapter, associations between the different types of morbidity, defined as 
infectious, medical/obstetric, psychological and social morbidity are described per 
country. Results are presented in a narrative text accompanied by tables and figures. 
Where supplementary information is necessary, this is presented in the appendices.  
 
7.2 Background  
There were four research questions. 
Table 7.1: Research questions for the study  
Number  Research question 
1. What is the prevalence of maternal morbidity and what types of ill-
health (symptoms, signs and investigations) contribute to maternal 
morbidity? 
2. What is the prevalence of maternal morbidity at different stages of 
pregnancy? 
3. Is there an association between the different types of maternal 
morbidity and age, socioeconomic status, educational level, number of 
previous pregnancies, and/or adverse maternal or neonatal outcomes 
in the most recent pregnancy? 




4. Is there an association between the different types of morbidity, 
defined as infectious, medical/obstetric, psychological and social 
morbidity?  
 
In this chapter, results are presented to address the research question: “Is there an 
association between the different types of morbidity, defined as infectious, 
medical/obstetric, psychological and social morbidity?” 
 
Table 7.2: Definitions of types of morbidities  
PHYSICAL MORBIDITY NON-PHYSICAL 

















• SIRS score 
of ≥2 
 















Summary of methodology for analysis  
For each country, strength of associations of all the different types of interactions 
between the four different types of morbidities were explored using a loglinear 
model. For each country, the full model was fitted using all main effects of the four 
morbidities and for all the possible interactions. Terms which were not statistically 
significant at the 5% level were then eliminated from the model to identify the 
simplest sub-model which was not a significantly poorer fit. In the final set of analyses 
only two-way interactions were considered. Those that were not statistically 
significant were eliminated from the model, to identify the simplest sub-model which 
was not a significantly poorer fit of the model with two-way interactions only. 
Likelihood ratio tests were used to compare models. Statistical significance was 
determined using the 5% significance level. Estimated odds ratios are reported with 






95% confidence interval. Table 7.3 provides the summary of the frequency of each 
morbidity by country. 
 












n % n % n % n % 
Infectious 302 14.4 402 12.2 1,219 38.8 1,278 43.7 
Medical/ 
obstetric 
1,283 61.1 2,279 69.3 791 25.2 1,200 41.1 
Psycho- 
logical 
415 19.8 1,554 47.3 424 13.5 478 16.4 
Social 849 40.5 1,980 60.2 787 25.0 582 19.8 
 
There are marked differences between countries regarding prevalence of the 
different types of morbidity. The most notable difference is the higher prevalence of 
reported psychological and social morbidity in women in Pakistan; and the higher 
prevalence of infectious morbidity diagnosed in women in Kenya and Malawi. These 
results were presented in detail in Chapter 4 and 5 of this thesis. 
  
Heterogeneity between countries 
Before considering associations between maternal morbidity per country separately, 
the combined cohort was considered. Analysis of the data for the four countries 
combined, using interactions no higher than two-way, found significant evidence of 
heterogeneity between countries in the associations between morbidities (X2=5,196, 
df=30, p<0.001). Therefore, no further analyses for the combined dataset were 
considered.  
 
To explore the strength of associations between the different types of morbidities, 
all possible combinations of interactions between morbidities were assessed for each 




country. Table 7.4 tabulates the frequency distribution of each possible combination 
of morbidities for each country. 
 
Table 7.4: Number of women with each combination of morbidity per country 





Social India Pakistan Kenya Malawi 
0 0 0 0 345 345 1052 823 
0 0 0 1 276 290 330 77 
0 0 1 0 62 112 97 35 
0 0 1 1 37 175 69 74 
0 1 0 0 469 468 241 520 
0 1 0 1 337 488 64 58 
0 1 1 0 156 277 52 28 
0 1 1 1 115 730 21 30 
1 0 0 0 65 23 549 431 
1 0 0 1 16 24 149 55 
1 0 1 0 12 13 63 63 
1 0 1 1 3 26 45 165 
1 1 0 0 128 44 252 416 
1 1 0 1 48 51 84 65 
1 1 1 0 13 25 52 27 
1 1 1 1 17 196 25 56 
0 = not present 
1 = present  
 






7.3 Two-way associations between maternal 
morbidities per country 
For each country, medical/obstetric morbidity was statistically significantly 
associated with psychological and infectious morbidity. These associations were all 
positive, with the exception that, in Malawi, the association between 
medical/obstetric and psychological morbidity was negative (Table 7.5).  
 
India  
In India, infectious morbidity was statistically significantly associated with 
psychological and social morbidity; these were negative associations. Women in India 
with infectious morbidity, were less likely to report psychological and social 
morbidity; OR 0.64 (0.46-0.90) p-value 0.01 and 0.52 (0.40-0.68) p-value <0.001 
respectively. In India, women with medical/obstetric morbidity were more likely to 
report infectious and psychological morbidity; OR 1.49 (1.15-1.94) p-value 0.003 and 
1.92 (1.52-2.44) p-value <0.001 respectively (Table 7.5). 
 
Pakistan  
In Pakistan, women with infectious morbidity more likely to have medical/obstetric 
OR 1.42 (1.10-1.83) p-value <0.001; and to report psychological OR 1.91 (1.52-2.39) 
p-value <0.001 and social morbidity OR 1.68 (1.32-2.13) p-value <0.001. In Pakistan, 
women with a psychological morbidity were more likely to have medical/obstetric 
morbidity OR 2.21 (1.88-2.59) p-value <0.001 and to report social morbidity OR 2.48 
(2.13-2.88) p-value <0.001. In Pakistan, women with medical/obstetric morbidity 
were more likely to report social morbidity OR 1.42 (1.21-1.66) p-value <0.001 also. 
Overall, in Pakistan, there were significant positive associations between all pair of 









In Kenya, women with a medical/obstetric morbidity were more likely to report 
infectious OR 2.10 (1.78-2.47) p-value <0.001; and psychological morbidity OR 1.78 
(1.43-2.21) p-value <0.001. In Kenya, women reporting psychological morbidity were 




In Malawi, women with an infectious morbidity were more likely to have 
medical/obstetric morbidity OR 1.38 (1.18.1.61) p-value <0.001; and to report 
psychological OR 2.45 (1.95-3.11) <0.001 and social morbidity OR 1.43 (1.15-1.78) p-
value 0.001. In Malawi, women with medical/obstetric morbidity were less likely to 
report psychological morbidity OR 0.50 (0.40-0.62) p-value <0.001 (Table 7.5). 
 
All associations between morbidities when two-way interactions were considered are 
summarised in (Table 7.5). 






Table 7.5: Estimated odds ratios and p-values for selected models using only two-way interactions, per country 
Interaction between 










OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value 
Infectious* 
medical/obstetric 
1.49 (1.15-1.94) 0.003 1.42 (1.10-1.83) <0.001 2.10 (1.78-2.47) <0.001 1.38 (1.18.1.61) <0.001 
Infectious* 
psychological 
0.64 (0.46-0.90) 0.01 1.91 (1.52-2.39) <0.001   2.45 (1.95-3.11) <0.001 
Infectious* 
Social 
0.52 (0.40-0.68) <0.001 1.68 (1.32-2.13) <0.001   1.43 (1.15-1.78) 0.001 
Medical/obstetric* 
psychological 
1.92 (1.52-2.44) <0.001 2.21 (1.88-2.59) <0.001 1.78 (1.43-2.21) <0.001 0.50 (0.40-0.62) <0.001 
Medical/obstetric* 
Social 
  1.42 (1.21-1.66) <0.001     
Psychological * 
Social 
  2.48 (2.13-2.88) <0.001 2.02 (1.63-2.51) <0.001 16.9 (13.4-21.4) <0.001 









df 1 0 3 1 




7.4 Three-way associations between maternal 
morbidities per country  
India 
In India, for women who report psychological morbidity, the strength of the 
association between infectious and medical/obstetric morbidity is less (OR 0.39 
(0.18-0.80) p-value 0.01); compared to women who do not report psychological 
morbidity. Similarly, in women with infectious morbidity, the strength of the 
association between medical/obstetric and psychological morbidity is less (OR 0.39 
(0.18-0.80) p-value 0.01); compared to women who do not have infectious morbidity.  
 
In India, for women who report social morbidity, the strength of the association 
between infectious and medical/obstetric morbidity is more (OR 2.03 (1.09-3.77) p-
value 0.03); compared to women who do not report social morbidity. Similarly, in 
women with infectious morbidity, the strength of the association between 
medical/obstetric and social morbidity is more (OR 2.03 (1.09-3.77) p-value 0.03); 
compared to women who do not report infectious morbidity. In India, for women 
who report social morbidity, the strength of the association between infectious and 
psychological morbidity is more (OR 2.66 (1.32-5.35) p-value 0.006); compared to 
women who do not report social morbidity. Similarly, in women who report 
infectious morbidity, the strength of the association between psychological and 
social morbidity is more (OR 2.66 (1.32-5.35) p-value 0.006) compared to women who 
do not have infectious morbidity (Table 7.6) 
 
Pakistan  
In Pakistan, for women who report social morbidity, the strength of the association 
between infectious and psychological morbidity is more (OR 2.11 (1.28-3.48) p-value 
0.004); compared to women who do not report social morbidity. Similarly, in women 
with infectious morbidity, the strength of the association between psychological and 
social morbidity is more (OR 2.11 (1.28-3.48) p-value 0.004) compared to women who 
do not have infectious morbidity. In Pakistan, for women who report psychological 






morbidity, the strength of the association between medical/obstetric and social 
morbidity is more (OR 1.50 (1.09-2.07) p-value 0.014); compared to women who do 
not report psychological morbidity. Similarly, in women with medical/obstetric 
morbidity, the strength of the association between psychological and social morbidity 
is more (OR 1.50 (1.09-2.07) p-value 0.014); compared to women who do not report 
medical/obstetric morbidity (Table 7.6) 
 
Kenya  
In Kenya, there were no associations between three-way interactions of the different 
types of maternal morbidities. 
 
Malawi 
In Malawi, for women who report psychological morbidity, the strength of the 
association between infectious and medical/obstetric morbidity is less (OR 0.46 
(0.30-0.72) p-value 0.001); compared to women who do not report psychological 
morbidity. Similarly, in women who report medical/obstetric morbidity, the strength 
of the association between psychological and infectious morbidity is less (OR 0.46 
(0.30-0.72) p-value 0.001); compared to women who do not report medical/obstetric 
morbidity. In Malawi, for women who report social morbidity, the strength of the 
association between medical/obstetric and psychological morbidity is less (OR 0.55 
(0.33-0.89) p-value 0.02); compared to women who do not report social morbidity. 
Similarly, in women with medical/obstetric morbidity, the strength of the association 
between psychological and social morbidity is less (OR 0.55 (0.33-0.89) p-value 0.02); 
compared to women who do not have infectious morbidity. 
 
When higher order interactions were considered for inclusion in models fitted, at 
least two of the three-way interactions were found to be statistically significant in 
each of India, Pakistan and Malawi (Table 7.6). By contrast, for Kenya, no higher order 
interactions statistically significantly improved the fit of the model. For India, the 
statistically significant three-way interactions were the three which include infectious 




morbidity. For Pakistan, the two statistically significant three-way interactions 
involved both psychological and social morbidity. For Malawi, the two statistically 
significant three-way interactions involved both medical/obstetric and psychological 
morbidity (Table 7.6)






Table 7.6: Estimated odds ratios and p-values for selected models using two- and three-way interactions, per countrya 
Interactions India (n=2099) Pakistan (n=3287) Kenya (n=3145) Malawi (n=2923) All countries combined 
































































































































0.014   
0.55  
(0.33-0.89) 
0.02   
Comparison with full modelb 
X2 3.97 0.14 4.02 0.26 12.08 0.15 1.11 0.78 1.87 0.60 
df 2 3 8 3 3 
Comparison with model selected using only two-way interactions 
X2 17.28 0.004 15.45 <0.001   18.83 <0.001  
df 5 2 0 3 




7.5 Chapter summary  
In this chapter associations between the different types of morbidity, defined as 




Country Two-way associations with different types of morbidity  
India Women with an infectious morbidity, were less likely to report 
psychological and social morbidity. Women with a 
medical/obstetric morbidity, were more likely to report infectious 
and psychological morbidity. 
Pakistan  Women with an infectious morbidity were more likely to report 
medical/obstetric, psychological and social morbidity. Women with 
a psychological morbidity were more likely to report 
medical/obstetric morbidity and social morbidity. Women 
reporting medical/obstetric morbidity were more likely to report 
social morbidity also.  
Kenya Women with a medical/obstetric morbidity were more likely to 
report infectious morbidity and psychological morbidity. Women 
reporting psychological morbidity were more likely to report social 
morbidity also.  
Malawi  Women with an infectious morbidity were more likely to report 
medical/obstetric, psychological and social morbidity. Women with 
a medical/obstetric morbidity were less likely to report 











7.6 Chapter summary in relation to literature 
In this study, women with infectious morbidity were more likely to report 
medical/obstetric, psychological and social morbidity in Pakistan, and Malawi; but 
less likely to report psychological and social morbidity in India.  In other studies, that 
have measured two or more types of morbidity, a positive HIV status (infectious 
morbidity) was associated with domestic violence (social morbidity) in Zimbabwe 
(Shamu 2014); and other infectious morbidity was associated with psychological 
morbidity in Malawi and Pakistan (Zafar 2015).  
 
Similarly, women with medical/obstetric morbidity were more likely to report 
infectious and psychological morbidity in India and Kenya and more likely to report 
social morbidity in Pakistan; but less likely to report psychological morbidity in 
Malawi. In other studies, that have measured two or more types of morbidity, all 
postpartum illnesses (infectious and medical/obstetric) were associated with an 
increased relative risk of psychological morbidity at 6 months postpartum in 
Bangladesh (Surkan 2017); and obstetric complications were independently 
associated with common mental disorders during pregnancy in Brazil (Faisal-Cury 
2010). Complications during a previous pregnancy and/or intra or postpartum 
haemorrhage were associated with psychological morbidity in Malawi and Pakistan 
(Zafar 2015). A significant association between medical/obstetric morbidity (preterm 
labour, Caesarean section, antenatal hospitalization and vaginal bleeding) and social 
morbidity (domestic violence) was reported in pregnant women in Iran (Hassan 
2014). Romero-Gutiérrez et al reported that women who had obstetric complications 
were more likely to have experienced domestic violence (social morbidity) in the 
postpartum stage of pregnancy in Mexico (Romero-Gutiérrez 2011).  
 
In this PhD study, women with psychological morbidity were more likely to report 
social morbidity in Pakistan and Kenya; and more likely to report medical/obstetric 
morbidity in Pakistan. Several studies that have assessed two or more types of 
maternal morbidity report associations between psychological and social morbidity. 




Partner violence (social morbidity) had strong associations with depression and 
anxiety (psychological morbidity) in pregnant women in Bangladesh (Nasreen 2011). 
Pregnant women who reported four or more traumatic events, and either physical 
abuse alone or in combination with severe psychological abuse, had a 10-fold 
increase in depressive and other mental health symptoms in Timor-Leste (Rees 2016). 
Intimate partner violence intensity had a strong and statistically significant 
association with depression symptom severity in pregnant women in South Africa 
(Tsai 2016).  
 
These findings, in keeping with the PhD study results, would suggest that different 
components of morbidity /components of ill-health may be inter-related or inter-
linked to other types of morbidity or ill-health in women during and after pregnancy.  
It is often suggested in a clinical setting, that co-morbidities exist together. That is, if 
a woman has one type of illness during and after pregnancy, she is often considered 
to be at higher risk for other ill-health. For example, women with diabetes tend to 
have more infections. It can be difficult to fully understand the relationship, if any, 
between different types of morbidity and whether any association is simply an 
overlap of ill-health or related to causality. This study has provided for the first time 
an exploration of associations between infectious, medical/obstetric, psychological 
and social morbidity. The reasons for the different directions in association, across 
the different LMIC settings require further research.  
 
Further reflections of the main findings from this chapter in relation to other 














CHAPTER 8: DISCUSSION  
8.1 Introduction  
In this chapter, the main results of the research project are discussed. This chapter 
begins with an overview of the structure of the chapter and the principal findings of 
the research project. Each research question is then considered for each category of 
type of maternal morbidity as a combined cohort (where feasible). The strengths and 
weaknesses of this research project are discussed; and main findings are compared 
to other studies and any differences in results are discussed. This chapter then 
describes the overall meaning of the study, and the implications for clinical practice. 
Recommendations are given and key future research priorities are suggested. The 
chapter ends with a summary conclusion. 
 
This research project has assessed maternal morbidity using a new assessment tool 
to determine the prevalence of and/or associations between four different types of 
maternal morbidity, at five assessment stages, during and after pregnancy, in 11454 
women across different settings in four LMIC: India, Pakistan, Kenya and Malawi.  
 
There are several possible approaches to the discussion of this research project; for 
example, main findings could be discussed per research question, or per type of 
maternal morbidity, or per country, or as a combined cohort. Findings could be 
compared between the study countries individually or discussed as a combined study 
population. For ease of readability and understanding, main findings are discussed as 
a combined cohort (where feasible) and the discussion chapter is structured in 










Statement of principal findings 
This section presents the main results of the research study, structured in sequence 
to address each key research question.  
 
Strengths and weaknesses of the study 
This section considers the strengths and weaknesses of the research study. This 
section also discusses the limitations of the research project in terms of study design, 
study settings, study population and sampling. The data collection tool, the process 
of data collection, cleaning, coding and analysis is critiqued. Finally, the quality of the 
data and the ethical issues relevant to the research project are discussed. 
 
Relationship of main findings to other studies 
This section compares the main findings of this research project to other studies that 
have measured the prevalence of and/or associations between two or more different 
types of maternal morbidity during and after pregnancy in women in LMIC. 
Similarities and differences of the main findings per type of maternal morbidity are 
interpreted in relation to the findings of other studies. 
 
Implications for clinicians and policymakers 
This section presents the meaning of the study and implications for clinicians and 
policy makers are given.  
 
Recommendations 
This section describes recommendations for clinical practice and for future research 
are described. A conclusion is at the end of the chapter.  
  







This is the first study to assess maternal morbidity using an integrated comprehensive 
approach to assess self-reported physical, psychological, and social ill-health, in 
combination with objective clinical and laboratory measurements in women during 
and after pregnancy across four LMIC. This multi-country study assessed maternal 
morbidity in 11454 women and provides baseline measurements of maternal 
morbidity that have been calculated using standardised methodology, enabling 
comparisons between different settings and countries. Non-severe maternal 
morbidity is a new concept internationally and this study addressed an important 
topic that to date has been poorly documented. Maternal morbidity represents a 
significant burden of ill-health for women during and after pregnancy.  
 
Research questions  
In this study, there were four research questions.  
Table 8.1: Research questions for the study  
Number Research question 
1. What is the prevalence of maternal morbidity and what types of ill-
health (assessed by symptoms, signs and investigations) contribute to 
maternal morbidity? 
2. What is the prevalence of maternal morbidity at different stages of 
pregnancy? 
3. Is there an association between the different types of maternal 
morbidity and age, socioeconomic status, educational level, number 
of previous pregnancies, and/or adverse maternal or neonatal 
outcomes in the most recent pregnancy? 
4. Is there an association between the different types of morbidity, 
defined as infectious, medical/obstetric, psychological and social 
morbidity? 
 




8.3 Main findings  
Research question one  
Research question one was “What is the prevalence of maternal morbidity and what 
types of ill-health (symptoms, signs and investigations) contribute to maternal 
morbidity?” 
 
In this study, 11454 women across four LMICs were assessed (India (2099), Malawi 
(2923), Kenya (3145), and Pakistan (3287)) with similar numbers of women assessed 
at each of the five stages of pregnancy. Despite most women reporting good quality 
of life (75.9%) and satisfaction with health (78.2%), almost three out of four women 
reported symptoms (73.5%), had abnormal findings on clinical examination (71.3%) 
or on simple laboratory investigation (73.5%).  
 
Overall, 27.9% of women were diagnosed with an infectious morbidity; and 48.5% 
were diagnosed with a medical/obstetric morbidity. Therefore, overall, 76.4% of 
women had at least one type of physical morbidity.  
 
Overall, 25.1% of women had psychological morbidity on screening with very high 
prevalence of domestic violence, particularly in Pakistan (47.3% of women). Overall, 
more than 1 in 3 women (36.6%) reported social morbidity, with 15.6% of women 
reporting both psychological and social morbidity.  
 
Overall, most women (77.1%) had at least one type of identifiable morbidity and a 
very small number of women (1.2%) suffered from all four types of morbidity which 
suggests that morbidity is not limited to a core “at risk” group of women. 
 
Women in Pakistan reported more symptoms of higher severity and were diagnosed 
with more physical morbidity and reported more psychological and social morbidity. 
Of all women tested, 47.4% of women were anaemic with the highest prevalence 
among women in Pakistan and India (67.7% and 60.4% of women respectively). 
Overall, using the amended SIRS score of ≥2, 23.1% of women had clinical signs of 






possible early infection. Of these women, 43.0% had an identifiable source of 
infection, more commonly gastrointestinal and lower respiratory tract infection. The 
prevalence of HIV, malaria, and syphilis was below 5% in all settings except Malawi. 
 
Research question two  
Research question two was “What is the prevalence of maternal morbidity at 
different stages of pregnancy?” 
 
In this study, overall and per country, 25% of women had at least one type of 
maternal morbidity across the five stages of pregnancy; and slightly more women 
reported or were diagnosed with more maternal morbidity in the late antenatal 
stage, compared to the other four assessment stages. 
 
For each type of morbidity, there were similar prevalence across the continuum of 
pregnancy, with the overall highest percentage of women with different types of 
maternal morbidity in the late antenatal stage There was however, a significant 
burden of maternal morbidity across all five stages of pregnancy, highlighting that 
there is not just one “at risk” stage for ill-health. This trend was similar across all the 
four LMIC.  
 
Research question three  
Research question three was “Is there an association between the different types of 
maternal morbidity and age, socioeconomic status, educational level, number of 
previous pregnancies, and/or adverse maternal or neonatal outcomes in the most 
recent pregnancy?” 
 
In this study, on multivariate analysis, age, socioeconomic status, educational level, 
number of previous pregnancies, and/or adverse maternal or neonatal outcomes in 
the most recent pregnancy were not associated with the same type of maternal 
morbidity across all four LMIC. Different factors were associated with different types 




of morbidity per country but there was no consistent direction of strength of 
association. Overall, more factors were associated with all four types of morbidity in 
Pakistan. 
 
Research question four  
Research question four was “Are there any associations between the different types 
of morbidity, defined as infectious, medical/obstetric, psychological and social 
morbidity?”  
 
In this study, there were associations between the different types of morbidity and 
these associations varied between the countries. For each country, women with 
medical/obstetric morbidity was more likely to report psychological and infectious 
morbidity. These associations were all positive, with the exception that, in Malawi, 
the association between medical/obstetric and psychological morbidity was 
negative. Women with an infectious morbidity were more likely to report 
medical/obstetric, psychological and social morbidity in both Pakistan and Malawi. 
Women with psychological morbidity were more likely to report social morbidity in 
Pakistan and Kenya. 
 
These findings suggest that the different components of maternal morbidity 
(physical, psychological and social aspects) are inter-linked and have an influence on 
the other components of health. However, the strength of the association between 
the different types of morbidity vary across settings.  
 
8.4 Strengths and limitations of the study 
In this section of the chapter the main strengths of the study are described. The 
limitations of the study are discussed with regards to the study design, study settings, 
study population, inclusion and exclusion criteria, and sampling procedure. The data 
collection tool used in this study is critiqued and suggestions for how to improve the 
data collection tool are discussed. The limitations of the categorisations of types of 
maternal morbidity are discussed.  






8.4.1 Strengths of the study 
This is the first study to assess maternal morbidity during and after pregnancy using 
an integrated comprehensive tool to provide primary data of self-reported physical, 
psychological, and social ill-health in combination with objective clinical and 
laboratory measurements performed by trained healthcare providers across 
different types of healthcare facilities in 11454 women in four different LMIC. This 
study provides new estimates of the prevalence of maternal morbidity during and 
after pregnancy, up to 12 weeks after birth.  
 
In this study, women’s reported signs and symptoms were triangulated with clinical 
examination and diagnostic tests that are expected to be available in the antenatal 
and postnatal care clinics in LMIC. The data collection tool used in this study for the 
identification of maternal morbidity was found to be easy to apply and acceptable at 
both primary and secondary care settings across the four LMIC, enabling more robust 
diagnosis of maternal morbidity. This study, includes both subjective (self-reported 
symptoms) and objective measures (examination and investigations) performed by 
trained healthcare providers, thus helping document as well as “validate” which 
areas of ill-health are considered important by women themselves (because they 
report the symptoms) as well as morbidity that can be “diagnosed” by a healthcare 
provider.  
 
8.4.2 Limitations of the study  
Study design  
This was an observational cross-sectional study and it was not possible to assess if  
maternal morbidity at one assessment stage of the pregnancy, was related to any 
adverse maternal or neonatal outcomes or ill-health during other stages of the 
pregnancy. It would be beneficial to conduct a prospective longitudinal cohort study, 
to assess the effect on pregnancy outcomes and change in health (if any) over the 
continuum of pregnancy.  




Study settings  
The study was conducted in multiple countries, which enabled comparison between 
settings. The selection of countries was both purposeful and opportunistic and 
included two countries from sub-Saharan Africa (Kenya and Malawi) and two from 
South East Asia (India and Pakistan). These countries were chosen to reflect the 
epidemiology of HIV, tuberculosis and malaria that are likely to be very different in 
sub-Saharan Africa compared to South East Asia. These four countries are not 
considered representative of LMIC in general and further research is needed to 
explore maternal morbidity in other settings.  
 
In this study, overall more women were assessed in a secondary (66.7%) compared 
to primary level (33.3%) healthcare facility. It is noted that this could represent a 
selection bias and that women who attend a secondary level healthcare facility may 
have been aware that they had more maternal morbidity and therefore sought higher 
level care, compared to women who choose to attend a primary healthcare level 
facility.  
 
In Pakistan, Kenya and Malawi several healthcare facilities were included across 
different regions, at both primary and secondary healthcare facility level. All the 
study population in India was recruited from one large public secondary level 
healthcare facility and hence there was no representation of women from a primary 
healthcare facility in India, and this study population is unlikely to be representative 
of other areas in the region. 
 
Sampling procedure  
This study used purposive sampling that represents convenience samples as opposed 
to population samples from a representative framework and hence is limited in terms 
of the sections of the population it represents. Furthermore, the sampling was not 
proportionated to population size. However, the aim of this study was not to conduct 
a study that was representative of the population of each country. This was a 
pragmatic study to assess the health needs of women accessing routine care, with a 






large sample size and statistical power to detect common conditions including those 
with an expected prevalence of up to 5%. 
 
Study population  
This study population included women during or after pregnancy who sought care 
and attended for antenatal, intrapartum or postnatal care in public primary or 
secondary level healthcare facilities across the four LMIC.  
 
With regard to healthcare coverage and uptake, globally, the proportion of women 
who attend for at least one ANC visit is 83%. Compared to the global estimate, a 
smaller proportion of women attend for at least one ANC visit in India (75%) and 
Pakistan (73%); and a larger proportion of women attend for at least one ANC visit in 
in Kenya (92%) and in Malawi (96%) (WHO 2016c). For skilled attendance at birth (or 
institutional delivery) globally, the estimate is 78%. Compared to the global estimate, 
a smaller proportion of women have skilled birth attendance in Pakistan (52%) and 
Kenya (62%), compared to India (81%) and Malawi (90%) (WHO 2016c). 
 
In this PhD study, overall, more women were recruited from a secondary, compared 
to a primary level healthcare facility and this may have resulted in a higher prevalence 
of morbidity in women, who may have sought care because they were unwell or had 
current complications due to pregnancy or childbirth. This study excludes women 
who did not seek care, who are based in the community setting and who may have a 
different perspective and burden of maternal morbidity. Thus, the prevalence of 
morbidity could be expected to be higher (for women who are ill but not able to 
access care) or lower (for women who feel well and do not see the need to access 
care). Most women were recruited from the outpatient clinics and the proportion of 
women who were inpatients at the time of assessment were less than 10% in each 
country setting. Of the antenatal women, most were inpatients waiting delivery by 
elective Caesarean section or induction of labour. Of the postnatal women, most 




were interviewed as inpatients prior to routine discharge. Neither of these groups of 
women were severely ill and all met the inclusion criteria of the study. 
 
Inclusion and exclusion criteria 
To include women who might be attending for “routine care”, the inclusion criteria 
were broad and only women who had an impaired consciousness level due to a 
possible SAMM were excluded. Women were not specifically screened to identify 
SAMM and therefore there may have been some women with SAMM in this study. 
For example, a woman who had a massive obstetric haemorrhage at delivery may 
have been recruited to the study whilst on the postnatal ward a few days later, and 
she may have been reporting symptoms related to the previous SAMM adverse 
event. Women with SAMM are generally only included in the group assessed within 
24 hours of delivery. However, it would have been beneficial to have had stricter 
exclusion criteria for this group.  
 
8.4.3 Limitations of the data collection tool  
The data collection tool used (Appendix 6) was a comprehensive tool with nine 
different sections and had been submitted to peer review including by all members 
of the WHO maternal morbidity working group as well as key stakeholders in each 
study country before use. This gave many opportunities to improve the tool to ensure 
that the tool was inclusive, applicable and considered feasible to administer. In this 
study, the full questionnaire took up to one hour to complete via a face-to-face 
interview, clinical examination and investigations. For further use in both a clinical 
and research capacity, it could be beneficial if this tool was shortened.  
 
In the following sections, the limitations of and suggested improvements to the data 
collection tool are described, including the measurement of SES; the descriptions and 
severity scale of adverse maternal and neonatal outcomes; how to assess symptoms; 
measurement of psychological morbidity; time-frame over which women are asked 
to recall morbidity; what examinations are conducted; and what further 
investigations could be included. 







Measurement of socioeconomic status   
In this study, women’s SES was assessed. However, SES is a complex factor and there 
is no standardised international way to measure SES across different LMIC. In this 
study, for Malawi and Kenya, principal component analysis was conducted to develop 
an amended wealth index with items from the DHS of each country. This was a 
relative measure of SES useful to categorise women but was not an absolute measure 
of wealth. It would be beneficial to have an internationally agreed comparable 
measure of SES across the different LMIC settings.  
 
Adverse maternal or neonatal outcomes  
In retrospect, the data collection tool included too many questions regarding 
previous pregnancies and outcomes including: number of all previous pregnancies, 
details of each pregnancy and adverse events for each pregnancy by each woman. 
This section could be shortened to include only the most recent pregnancy recalled 
and reported. In addition, the list of “adverse maternal outcomes” did not specify all 
possible adverse maternal outcomes that can occur during and/or after pregnancy, 
and did not differentiate regarding severity of adverse outcome (for example, severe 
uterine inversion compared to simple episiotomy wound infection). Similarly, for 
“previous neonatal adverse outcomes”, not all possible neonatal adverse outcomes 
were specified, nor was there any assessment of the severity of adverse outcome (for 
example, stillbirth compared to newborn eye infection). To improve the data 
collection tool, it would be beneficial to have a comprehensive reference list for both 
maternal and neonatal adverse outcomes that are important to document with an 
accompanying severity scale. This reference list would be best placed as an appendix 









Measurement of symptoms  
The data collection tool used in this study included a full systematic screening of 
physical symptoms using a total of 76 questions. The severity of each symptom was 
assessed on a scale of how much each symptom bothered the woman. For ease of 
flow of the questioning, it would be beneficial to re-categorise the sections into the 
groups described in the results section of this study, that is: cardiopulmonary, 
gastrointestinal, musculoskeletal, uro-gynaecology, obstetric and breast, and 
miscellaneous (dermatology, endocrine, neurological, immunology, ear-nose-
throat).  
Three symptoms were asked in a similar way and in the end, one question would have 
been sufficient. In this study, it was not possible to estimate the prevalence of women 
with postpartum haemorrhage accurately, as women were not able to “recall” or 
quantify their bleeding after birth. It is well recognised that visual estimation of 
bleeding is often an under-estimate, both from the women’s and the healthcare 
provider’s perspective (Prata 2010). Nevertheless, as postpartum haemorrhage is 
one of the major causes of maternal mortality and SAMM, it would be beneficial to 
introduce more questions that help women and healthcare providers better quantify 
bleeding after childbirth, in order to estimate the prevalence of maternal morbidity 
related to postpartum haemorrhage.  
Measurement of psychological health  
The data collection tool used the EPDS to measure psychological morbidity. The EPDS 
is easy to administer and has proven to be an effective screening tool, and has been 
previously been validated in 12 countries in 14 languages (Gibson 2009). However, a 
systematic review conducted in 2016 has indicated that current available Local 
Language Versions of the Edinburgh Postnatal Depression scales (LLV-EPDS) used in 
LMIC have some deficiencies in translation, cultural adaptation and validation 
processes (Shrestha 2016). This is a limitation of the EPDS, but there is an absence of 
a clear validated alternative questionnaire at present. In a clinical setting, it would be 
beneficial to use a shortened version of the EPDS; for example, using fewer questions 
compared to the ten questions in the current full version (Choi 2012). 






Standardised timeframe required for recall of morbidity  
In the data collection tool, four questions from the ASSIST questionnaire were 
embedded in the data collection tool to assess substance use; and the HITs 
questionnaire was used to assess domestic violence from the husband/partner 
and/or family. For both the ASSIST and HIT questions, the standard timeframe 
women were asked to consider was “in the past three months”. The questions from 
the WHO QOL SRPB questionnaire also asked women to reflect and report on their 
quality of life and satisfaction with health “over the past three months.” The EDPS 
questions asked women to report how they felt “over the past seven days.” It would 
be beneficial to have a more concise and standardised timeframe over which to ask 
women to self-report measure all types of maternal morbidity (physical, 
psychological and social) as a more accurate measure, for example “in the past seven 
days”. 
Investigations  
Not all possible morbidities, that could potentially have a negative impact on the 
woman, were included in the investigations; for example, assessment of gestational 
diabetes mellitus was not included in the data collection tool. Screening all women 
for gestational diabetes mellitus was considered, but at present there is no 
international consensus on how to do this as a one-point consultation for women 
who are pregnant. The gold standard to screen for gestational diabetes mellitus is an 
oral glucose tolerance test if a woman has at least one risk factor for gestational 
diabetes mellitus. This test requires preparation (fasting the night before the test) 
and takes on average three hours to perform and obtain results (NICE 2016).  
 
Investigations for important causes of infectious morbidity for example, tuberculosis 
and hepatitis B were also not included in this data collection tool. A more 
comprehensive list of investigations could be included if affordable and rapid 
diagnostic tests for these conditions were available in endemic areas in LMIC settings 
(WHO 2013b, Khuroo 2014). 
 




8.4.4 Data management  
Quality assurance  
Every effort was made to ensure all research assistants were trained, collected data 
and were supervised in a standardised way across all settings in all four LMIC. The 
competence of the research assistant as a healthcare provider may have influenced 
the reporting of findings detected on clinical examination; for example, doctors may 
be more experienced and skilled to conduct a more thorough clinical examination 
(including speculum examination), compared to nurse/midwives. However, all 
research assistants were also healthcare providers who were responsible for the 
delivery of routine antenatal and postnatal care.  
 
Data collection process   
In all four countries, the number of women recruited to the study were more than 
the minimum target sample size. Data was collected in batches by research assistants 
across the four LMIC. Towards the end of the data collection process, there was on 
occasion, a delay in communication regarding the number of women recruited per 
healthcare facility to the lead researcher based in Liverpool. Review and checking 
meant another slight delay was then encountered in relaying the information that 
the target size for the assessment stage for the overall country study population was 
achieved (or not) to the research supervisors and research assistants in each study 
setting. More detailed monitoring and evaluation from all in-country research 
supervisors would have been beneficial.  
 
This study was the first time the research team had used electronic data collection, 
and there were several challenges with the implementation of this process. It was 
not possible to have a secure internet connection to a remote server for electronic 
data collection in each setting. This would have enabled instant uploading of data 
which would have facilitated more efficient “real time” feedback of numbers of 
women recruited per assessment stage. In the study, there were problems with the 
remote servicer and therefore data was sent to Liverpool using email attachments. 






Once the data from both paper based and electronic data collection, was received by 
the research team in Liverpool, data was cleaned and coded in four separate Excel 
files and then merged to create one large database. It would be beneficial to have 
the same electronic data collection in each setting and a pre-designed large coded 
database set up prior to data collection, so all electronic data could be uploaded 
directly to this database, for a more efficient process.  
 
Ethical considerations 
There were no additional ethical concerns raised by women recruited in this study, or 
by research assistants or research supervisors in each study setting, compared to the 
ethical consideration described in the methodology chapter of this thesis.  
 
The low refusal rate in this PhD study, indicated that women welcomed an in-depth 
assessment of their health including all physical, psychological and social aspects. Very 
few women declined examination and investigations.  
 
No women refused to be tested for HIV. Few women received a new diagnosis of HIV 
this study. Many women who tested positive for HIV were aware of their status 
previously.  
Ensuring full privacy for women during interviews and examination was a challenge in 
some study settings given the low resource setting and it may have been beneficial to 











8.5 Categorisation of maternal morbidity  
Physical morbidity 
To date, there is no internationally agreed categorisation system for physical 
morbidity. Physical morbidity can be described and measured in different ways.  For 
example, physical morbidity can be measured by the number of symptoms reported 
by a woman; and/or the level of severity of the symptom as experienced by a woman; 
and/or a woman’s perception of the negative impact of the symptom on her well-
being and/or ability to function. 
Physical morbidity can also be described by the number of and the severity level of 
abnormalities detected by a healthcare provider when performing a clinical 
examination and/or blood and urine testing.  Or physical morbidity can be 
categorised only by conditions that use the findings from symptoms, signs and 
investigations to create a medical “diagnosis”, for example pre-eclampsia. 
At present, the current definition for maternal morbidity does not differentiate 
between ill-health from the perspective of the woman or from the perspective of the 
healthcare provider. It is debatable as which measurement of maternal morbidity 
more valid or more accurate.   
In this PhD study, physical maternal morbidity was reported firstly alongside the 
structure of a clinical consultation taking into consideration:  
• History -  number and severity of symptoms  
• Clinical examination- number of abnormal signs 
• Investigations – number of abnormal results on blood serology and urine analysis 
 
Secondly, reported symptoms, results of clinical examination, and laboratory 
investigation were combined where appropriate to determine or “diagnose” types of 
maternal morbidity. For the purposes of this PhD study, physical morbidity was 
categorised as (1) infectious or (2) medical/obstetric. Infectious physical morbidity 
included: HIV, malaria, syphilis, possible chest infection/suspected TB, and a SIRS 
score of ≥2. Medical/obstetric morbidity included: anaemia, hypertension, pre-






eclampsia, antenatal haemorrhage and incontinence. Standardised international 
definitions for each condition were used whenever possible.  
 
In the following section, the use of an amended SIR scale for the detection of possible 
early infection in this study is discussed.  
 
Challenges in the measurement of infectious morbidity  
One of the challenges to measure and describe the prevalence of infectious morbidity 
is the need for a standardised international definition and method to measure 
infection across different settings. There is often confusion regarding the definitions 
(and level of severity) of infection and sepsis (Table 8.2).  
Table 8.2: Definitions of infection and sepsis  
Definitions 
Infection: “the invasion of an organism's body tissues by disease-causing agents, 
that cause pathological conditions” (Medical dictionary 2017). 
Sepsis: “infection plus systemic manifestations of infection and severe sepsis can 
be defined as sepsis plus sepsis-induced tissue hypo perfusion or organ dysfunction 
(hypotension, arterial hypoxaemia, lactic acidosis, renal failure, liver dysfunction, 
coagulation abnormalities, mental status changes)” (RCOG 2012).  
Septic shock: “sepsis associated with hypotension despite intravenous fluid 
resuscitation leading to cell dysfunction and, if prolonged, cell death” (RCOG 2012). 
Puerperal sepsis: “infection of the genital tract occurring at any time between 
rupture of membranes or labour and the 42nd day post-partum associated with 
two or more of the following: pelvic pain, fever, abnormal vaginal discharge, 
abnormal smell of discharge, or delay in reduction in the size of the uterus” (RCOG 
2012).  
The major concern with infection during and after pregnancy is that this can develop 
and can become very severe very quickly. If signs of possible infection are detected 




and recognised early, action can be taken to prevent progression to more severe 
conditions. Survival rates in non-pregnant women following sepsis are related to 
early recognition and initiation of treatment (RCOG 2012).  
Using the Systematic Inflammatory Response Syndrome  
In high-income countries, for example the UK, sepsis during and after pregnancy has 
been of public health concern, for example, in 2015 sepsis was the main cause of 
maternal death in the UK (MBRRACE-UK 2016). This resulted in new public health 
policies and the “Surviving Sepsis” campaign to recognise “the sick woman” during 
and after pregnancy before undetected sepsis could progress and result in organ 
failure. Early warning scores included the SIRS score, alongside the Modified 
Obstetric Early Warning Score that have been used in a clinical setting for many years 
in the UK. However, there is ongoing debate regarding the parameters of SIRS for use 
in women during and after pregnancy. The difficult aspect of the recognition of 
possible early infection in pregnancy, is the differentiation of the measurements of 
SIRS from the normal physiological changes of pregnancy with which it overlaps.  
 
Some researchers have argued for customized SIRS parameters for a pregnancy 
population. Bauer conducted a systematic review in 2014 to establish the normal 
maternal range in healthy pregnant women for each component of the SIRS criteria 
and compared these ranges with existing SIRS criteria (Bauer 2014). In this systematic 
review, 88 studies including 8,834 women were reviewed (Bauer 2014). Overlap with 
SIRS criteria occurred in healthy pregnant women during the second trimester, third 
trimester, and labour for each of the SIRS criteria except temperature (Bauer 2014). 
Bauers et al concluded that the SIRS criteria can overlap with normal physiologic 
parameters during pregnancy and the immediate postpartum period; thus, 
alternative criteria should be developed to diagnose maternal sepsis (Bauer 2014).  
 
However, in 2016, Maguire et al examined the implications of customizing the SIRS 
criteria for physiologic changes of pregnancy for the diagnosis of maternal sepsis 
(Maguire 2016). The conclusion from this study was that in cases of confirmed 
maternal bacteraemia, customized SIRS criteria did not increase the rate of diagnosis 






of sepsis. The recommendation is this study was that prospective studies should 
investigate whether the introduction of customized SIRS criteria can improve clinical 
outcomes. (Maguire 2016).  
 
Using an amended SIRS score  
In this PhD study, the SIRS score was amended (using CRP instead of WCC) to describe 
women with possible clinical signs of infection. It was not the original intention at the 
time of planning this study to use the SIRS as a screening tool for women who have 
clinical signs of possible early infection, and WCC was not measured in any woman. 
This was an opportunistic adaption of the SIRS score at the time of data analysis, as 
“triangulation” of data using this clinical algorithm, is more useful that using CRP 
levels or temperature measurements alone, as a measure of possible infection in 
women during and after pregnancy.  
 
However, CRP has been shown to be more sensitive and specific than WCC in 
diagnosing infection, especially chorioamnionitis, against a background of premature 
prelabour rupture of membranes (Musilova 2017a); and it is also noted that during 
pregnancy, the maternal WBC count assessment has limited value owing to a broader 
range of reference values present across the trimesters than during non-pregnancy 
periods making the interpretation of WBC ranges difficult.  WCC count has therefore 
not been considered as a very useful marker for infection in women during and after 
pregnancy (Musilova 2017a). 
 
Some studies have compared the varying levels of CRP in response to inflammation 
or infection against WCC. In a study with a non-pregnant population, CRP had a higher 
sensitivity and specificity than white cell count and neutrophil count in the diagnosis 
of infection; and for every 1-mg/L increment in CRP, the risk of bacterial infection 
increased by 2.9% (Lui 2010). The authors concluded that CRP was a convenient and 
useful biomarker to predict early bacterial infection (Lui 2010). Two recent studies by 
the same researchers demonstrated that in a population of pregnant women with 




premature prelabour rupture of membranes, WCC showed poor diagnostic indices 
and CRP showed much better diagnostic indices for the identification of 
chorioamnionitis (Musilova 2017a, Musilova 2017b). The authors conducted that 
WBC count at the time of admission could not serve as a non-invasive screening tool 
for identifying infective complications in women with premature prelabour rupture 
of membranes, whereas CRP could be used (Musilova 2017a, Musilova 2017b). 
Therefore, in the absence of a widely accepted and validated method to diagnose 
women with infection, an amended SIRS score was used as a pragmatic measure of 
women with clinical signs of possible infection in this PhD study.  
 
Reference levels for C-Reactive Protein 
In this PhD study, a raised CRP was defined as >5mg/L at each assessment stage, apart 
from at delivery (within 24 hours of childbirth) where “raised CRP” was defined as 
>10mg/L. There is currently lack of agreed reference standards on what is a normal 
and what is an abnormal CRP level in women at different stages of pregnancy and 
after childbirth; and what levels of CRP are sensitive and specific to indicate infection 
(Trochez-Martinez 2007).  
 
In a non-pregnant woman, a normal CRP is 0.2–3.0 mg/L (Abbassi-Ghanavati 2009). 
There are no standardised ranges for a normal CRP level in a pregnant woman in the 
first trimester.   The reported normal CRP range is wide in a pregnant female 
population (0.4–20.3 mg/L) in the second trimester; and the third trimester is 0.4–
8.1 mg/L (Abbassi-Ghanavati 2009).  
 
There is also lack of an agreed range regarding the level of CRP that could indicate 
infection, and various researchers have used different thresholds. In one study with 
an (non-pregnant) elderly population, a CRP cut-off value of 60 mg/L had the best 
combination of sensitivity and specificity in the diagnosis of bacterial infection and 
the CRP levels were 21.3 ± 36.0 mg/L (mean ± SD) in the group with no infection (Lui 
2010).  
 






Most of the research that has investigated the use of CRP to diagnose infection in 
pregnant women has focused on complications of premature prelabour rupture of 
membranes, and the variation in the reported value of CRP for the diagnosis of 
chorioamnionitis is wide. 
 
A recent study with a relatively large cohort of pregnant women with preterm 
prelabour rupture of membranes, demonstrated that chorioamnionitis was 
associated with higher maternal serum CRP concentrations; and the maternal serum 
CRP cut-off value of 17.5 mg/L was the best level to identify the presence of both 
microbial invasion of the amniotic cavity and/or intra-amniotic inflammation, as part 
of the diagnosis of chorioamnionitis (Musilova 2017a). Previous researchers used two 
different CRP thresholds (12 mg/L and 20 mg/L) and considered an increasing value 
above 12 mg/L on two consecutive estimations as highly reliable for chorioamnionitis 
(Nowak 1998). Other researchers have proposed using higher CRP thresholds of 30, 
35 and 40 mg/L for single estimations to improve specificity but also accepted serial 
estimations of CRP of >20 mg/L as highly predictive of infection (Fisk 1987).   
 
The Royal College of Obstetricians and Gynaecologists (RCOG) in the UK, recommend 
that a CRP >7mg/L is an abnormal parameter in pregnancy women with suspected 
infection (RCOG 2012). However, in this guideline, the RCOG recommend that CRP 
levels are not interpreted in isolation but serve as complimentary adjunct to clinical 
examination (RCOG 2012). It is noted that the definitions of a “raised CRP” in this PhD 
study used low cut-offs levels (>5mg/L and >10mg/L within 24 hours of childbirth); 
and this may have resulted in an over-estimation of women with possible infection. 
Caution in interpretation of the sensitivity and specificity of these results are 
required. 
 
However, against the debate for the use of the exact criteria to use for SIRS; the use 
of CRP instead of WCC; and the cut-off levels for abnormal CRP levels in women 
during and after pregnancy, this PhD study suggests that there is a significant number 
of women who have possible signs of early infection. The definition and 




measurement of infection and sepsis in women during and after pregnancy requires 
further investigation; and the use of SIRS criteria as an early warning score for 
possible infection in women during and after pregnancy in LMIC requires further 
research. Furthermore, the definite level of CRP or a “raised CRP” that could indicate 
definite infection in women during and after pregnancy, and especially in LMIC 
settings, requires further research; and the use of role of CRP instead of WCC in the 
SIRS criterion needs further evaluation. 
 
Social morbidity 
For the purposes of this study, social morbidity was defined as domestic violence 
and/or substance misuse, as these are two important screening aspects of a social 
history of any clinical consultation and gives healthcare providers insight into how a 
woman’s social circumstances may have an influence on other components of health. 
This definition does not include of all types of social morbidity and does not include 
the impact of poverty, or other social determinants of health, for example, social 
exclusion and lack of social support (WHO 2015d).  
 
8.6 Discussion of main findings in relation to other 
studies 
In this chapter so far, an overview of the study has been given and results have been 
summarised and interpreted in sequence and relative to each research question. The 
strengths and limitations of the study have been described.  
 
In this section, the results of the study are linked to relevant research and any 
differences in results are discussed. For sake of readability, when referring to the 
findings of this research project, the term “this PhD study” is used.  
 
To the best of the lead researcher’s knowledge, this is the first study to assess 
physical, psychological and social maternal morbidity at five assessment stages. 
Comparison between the findings of this PhD study and with the findings of other 






studies is challenging, due to a lack of standardised definitions and methodology. 
Whilst, there are country or global estimates available for several single maternal 
morbidities (for example HIV, tuberculosis, malaria, anaemia), these are often based 
on relatively small sample sizes, non-specific regarding stage of pregnancy and/or 
have been defined using non -standardised, non-comparable methods.  
 
Most studies that have measured two or more types of maternal morbidity to date 
have used different definitions of conditions, different data collection tools, and do 
not include all types of physical, psychological and social morbidity, and/or do not do 
so for each of the different stages. 
 
In the following sections, for the sake of comparison, the prevalence of physical 
(infectious and medical/obstetric), psychological and social morbidity is compared to 
findings of studies that describe at least two or more maternal morbidities (as 
described in the systematic review chapter of this thesis) and/or the association 
between co-morbidities. The main findings of each results chapter have already been 
compared to literature in a summary at the end of the results chapters, and further 
interpretation and comparisons are given here also.  
 
To compare the findings of key individual maternal morbidities, data from the World 
Health Statistics, international WHO documents and/or recent systematic reviews 
using data from LMIC are used. 
 
In the following sections, the prevalence for each type of morbidity in this PhD study 
is compared against the prevalence described in the studies that were included in the 
systematic review of this thesis (Chapter 2). The similarities and differences in the 
main findings are reviewed and the reasons for the variations in the prevalence are 
given at the end of each section.  
 




Perception of health  
In this PhD study, despite most women reporting good quality of life (75.9%) and 
satisfaction with health (78.2%), almost three out of four women reported symptoms 
(73.5%), had abnormal findings on clinical examination (71.3%) or on simple 
laboratory investigation (73.5%).  There is lack of published literature regarding what 
women consider health and ill-health to be in general, and specifically during and 
after pregnancy in LMIC settings. Furthermore, there is lack of literature regarding 
how each type of non-severe maternal morbidity affects the woman’s wellbeing 
and/or “quality of life” and/or “satisfaction with health” and/or ability to function or 
complete her activities of daily living. These topics require further exploration by 
qualitative research, that is beyond the scope of this PhD study.  
 
8.6.1 Physical morbidity  
 
Physical morbidity can be described or measured in different ways: number of 
symptoms reported by a woman; and/or the level of severity of the symptom as 
experienced by a woman; and/or the number of abnormalities detected by a 
healthcare provider when performing a clinical examination and/or blood and urine 
testing; and/or by conditions that use the findings from symptoms, signs and 
investigations to create a medical “diagnosis”. Studies included in the systematic 
review used a variety of means to describe physical morbidity. In the following 
sections, each approach is commented upon and explanation for the variations in the 
prevalence are given at the end of this section.  
 
Self-reporting symptoms  
The earliest reported estimate of maternal morbidity in a LMIC, is from a prospective 
community based study among 280 women in rural India, who were followed for five 
years and visited monthly (Bhatia 1995). This study reported pregnancy related 
morbidity in 30% of women (Bhatia 1995). A larger cross-sectional community based 
study from India among 3600 women aged less than 35 years with at least one child 






under 5 years old found that 41% of women had experienced morbidity during the 
last pregnancy (Bhatia 1996). Postpartum morbidity was assessed by trained village 
workers in India in the first 28 days after delivery and estimated to occur in up to 
42.9% of women (Bang 2004). Assarag et al conducted a cross-sectional study of 1523 
postpartum women in Morocco and report that 44% of women expressed at least 
one complaint (Assarag 2013). When examined by a healthcare provider, 60% of 
women were considered to have a “medical diagnosis” (Assarag 2013). These 
estimates are much lower than the findings obtained in this PhD study, where almost 
three quarter of all women, (73.5%) reported at least one clinical symptom with a 
median (IQR) of 4.2 (0-27) symptoms per woman. In this PhD study, almost all women 
in Pakistan and India reported symptoms (92.1% and 90.4% of women respectively).  
 
One unpublished community based cross sectional survey was performed in 1995, in 
7325 households across one governate in Egypt and reported the burden of maternal 
morbidity based on women’s self-reported symptoms (Osman-Hassan 1995). Overall, 
82.8% of women reported morbidity in the antenatal period, 20.4% intrapartum, and 
19.1% postpartum (Osman-Hassan 1995). These findings are in line with this PhD 
study findings where similar percentages of women reported symptoms and were 
diagnosed with physical morbidity at all five stages of pregnancy with slightly more 
women reported symptoms in the late antenatal stage.  
 
Surkan et al conducted a secondary data analysis from a population based community 
trial among 39,000 rural married pregnant women in Bangladesh and reported the 
commonest prevalence of postpartum illness was gastroenteritis (22.1%), in line with 
this PhD study. An unpublished study from Uganda in 1993 among 1261 women in 
12 districts reported that 10.6% of women reported symptoms associated with pre-
eclampsia (Uganda Ministry of Health 1993). Fever (44.9%), excessive headaches 
(26.9%), severe vomiting (19.6%), and symptoms related to anaemia (19.0%) were 
the most frequently reported pregnancy related morbidities among women in 
Uganda (Uganda Ministry of Health 1993).  
 




In this PhD study, overall, when categorised by organ system, self-reported physical 
symptoms were most frequently related to the gastrointestinal tract (23.9% of all 
symptoms reported) followed by obstetric and breast (16.7%), uro-gynaecological 
(16.1%) cardiopulmonary (15.5%), musculoskeletal (12.8%) and miscellaneous 
(including immunology, dermatology, and endocrine) (15.0%). There were slight 
variations in the trend but the commonest category was gastrointestinal symptoms 
(all four countries), followed by cardiopulmonary symptoms (Malawi and Kenya), 
uro-gynaecological (Pakistan), and obstetric or breast related (India). 
 
Clinical examination  
In this PhD study, 73.1% of women had one or more abnormal findings at clinical 
examination. The most common findings were: conjunctival pallor (23.0%), breast 
problems (16.0%), gum and oral cavity problems (12.1%), and abdominal tenderness 
(10.9%). Overall, 25.9% of women had perineal problems (vaginal tears, excoriation, 
swelling), and 3.3% had leakage of urine. Similarly, overall 36.4% of women examined 
by speculum were noted to have abnormal vaginal discharge and 14.8% had 
abnormal vaginal bleeding. 
 
There is little literature to compare these findings to, because many of the studies 
that have assessed two or more maternal morbidities did not offer clinical 
examination but collected self-reported symptoms from women only. Previously, of 
the 21 studies included the systematic review that collected primary data (described 
in chapter two of this thesis), only three studies included clinical examination and 
investigations to assess maternal morbidity. The prevalence of the findings on clinical 
examination and investigations in these three studies are incorporated into the next 











8.6.3 Infectious morbidity  
HIV, malaria and syphilis  
In this study, overall, 4.8% of women tested positive for HIV, 2.7% for malaria and 
0.9% for syphilis. In India, the percentage of women with HIV, malaria and syphilis 
was 0.1%, 0.1% and 0.0% respectively. This was similar in Pakistan where the 
percentage of women with HIV, malaria and syphilis was 0.3%, 0.0% and 0.0% 
respectively. These findings are in line with the estimated national rates of HIV in 
India (0.11%) and Pakistan (0.16%) (WHO 2017c).  
 
In Kenya, the percentage of women with HIV was 3.6% and malaria and syphilis was 
low (0.2% and 0.3%) respectively. The prevalence of HIV is in line with the national 
rates of HIV in Kenya (3.5%). Overall, HIV positive status was highest in Malawi 
(14.5%) as was malaria (10.4%) and syphilis (3.4%). The prevalence of HIV in this study 
is four times more than the estimated national rates of HIV in Malawi (3.8%) (WHO 
2017c). 
 
In this PhD study, using an amended SIRS score, 23.1% of women had early signs of 
possible infection. In 43% of cases, a source could be identified which (based on 
symptoms and clinical examination) was most frequently gastroenteritis followed by 
lower respiratory tract, sexually transmitted or urinary tract infection or mastitis.  
 
Several studies in the systematic review reported possible infectious morbidity. The 
description and prevalence of infectious morbidity varied in nature and included the 
following: abnormal vaginal discharge (25.0%); bacterial vaginosis (31.0%); burning 
during urination (2.0%); candida (7.0%); febrile symptoms (6.0%); fever (2.4-13.0%); 
gastroenteritis (22.1%); hepatitis (1.6%); HIV (3.0-16.0%); malaria (2.7-15.9%); 
pneumonia (4.9%); reproductive infection (2.5%); sexually transmitted infection (7.5-
14.9%); trichomonas vaginalis (7.0%); suspected tuberculosis (0.8-10.1%); and 
urinary tract infection (5.4-14.5%) (Chapter 2).  
 




There is little prevalence of sepsis in women during and after pregnancy in LMIC.  One 
review estimated that the prevalence of sepsis ranged from 2.7 to 5.2 per 100 live 
births (Dolea 2003). Another review of hospital and community studies, estimated 
the prevalence of sepsis to be 4.4% of live births, giving an estimated number of 
puerperal sepsis cases of nearly 6 million per year globally (AbouZahr 2003).  
 
Previously, a community-based study in India reported the incidence of puerperal 
sepsis in the first week postpartum as 1.2% after home delivery, 1.4% after facility-
based delivery; and fever was reported in 4% of women (Iyengar 2012). Another 
study in India reported a high incidence of puerperal infections at home (10%) and of 
fever (12%), but the study uses broader definitions and followed women for only 28 
days (Bang 2004). 
 
It is recognised that estimating the prevalence of infection and sepsis is difficult to 
compare. This is may be because the aetiology and epidemiology of types of infection 
and sepsis vary across different settings; for example, related to lack of hygiene 
during delivery and/or due to high rates of co-infections, including sexually 
transmitted infections such as HIV.  
 
8.6.4 Medical and obstetric morbidity  
Anaemia 
In this PhD study, overall, 47.9% of women were diagnosed with anaemia (Hb 
<11.0g/dL). This finding is more than the 2011 global estimated prevalence of 
anaemia for pregnant women, 38.2% (95% CI: 33.5—42.6) (WHO 2015d). 
It is recognised that prevalence and severity of anaemia varies substantially across 
regions and countries. In this PhD study overall, anaemia was more common in 
women in Pakistan (67.8%) and India (60.4%), compared to Kenya (23.8%) and 
Malawi (40.4%). In studies included in the systematic review of this thesis, the 
reported prevalence of anaemia ranged from 18.7-52.0% across LMIC (Chapter 2, 
Table 2.6). 







It is estimated that severe anaemia, associated with a substantially increased risk of 
maternal mortality, ranges from 0.9% to 1.5% globally (WHO 2015d). In this PhD 
study, more women had severe anaemia in Pakistan (2.5%) and India (2.4%) 
compared to Kenya (1.2%) and Malawi (1.1%). 
In 2011, the WHO South-East Asia, Eastern Mediterranean and African Regions had 
the highest prevalence of anaemia (38.9% to 48.7% for pregnant women in these 
regions) (WHO 2015d). The countries with the lowest blood haemoglobin levels and 
highest prevalence of anaemia were in the WHO African Region and this was 
considered to be a reflection of the high prevalence of other conditions which can 
cause anaemia in this region, such as malaria, sickle cell anaemia and thalassaemia 
(WHO 2015d). The WHO report suggested that women in sub-Saharan Africa, 
represented the highest proportion of individuals affected with anaemia, at 62.3% 
(95% CI: 59.6-64.8) (WHO 2015d). However, these population estimates are based on 
mathematical modelling. In this PhD study, the prevalence and severity of anaemia 
was higher in Pakistan and India compared to Kenya and Malawi. This finding is 
different to that of the WHO estimates and may be due to the vegetarian dietary 
habits of women in South-East Asia.  The difference in prevalence of anaemia reflects 
the need for more robust primary data collection for anaemia as a component of 
maternal morbidity in LMIC.  
 
Antenatal haemorrhage 
In this PhD study 4.6% of women assessed during pregnancy, were diagnosed with 
antenatal haemorrhage. This finding is comparable to other studies in LMIC, where 
the prevalence of antepartum haemorrhage has been reported as 1.2-5.5% (Chufamo 
2015, Takai 2017).  Studies included in the systematic review of this thesis report a 
prevalence of antenatal haemorrhage as 3.1-39.5%. One systematic review reports a 
global prevalence of 0.5% for placenta previa, as a cause of antenatal haemorrhage 
(Cresswell 2013).  
 





In this study, overall 2.4% and 0.6% of women were diagnosed with hypertension and 
pre-eclampsia respectively. Studies included in the systematic review report 
prevalence of hypertension as 13.0% and pre-eclampsia as ranged between 0.2-0.8%. 
In the PhD study, more women were diagnosed with hypertension in Pakistan (4.8%). 
The prevalence of hypertension in Kenya was 1.8%, India 1.5% and Malawi 0.8%. The 
prevalence of pre-eclampsia in Pakistan was 1.5%, Kenya 0.4%, Malawi 0.3% and 
India 0.1%. 
One systematic review reported that the global prevalence of pre-eclampsia is 4.6% 
(Abalos 2013). The review finds evidence of regional variations, with sub-Saharan 
Africa having the highest incidence of pre-eclampsia (Abalos 2013). Hypertension and 
pre-eclampsia are more common among women in their first pregnancy, women who 
are obese, women with pre-existing hypertension, and women with diabetes. These 
characteristics are increasingly becoming more common in pregnant populations in 
LMIC.  
Incontinence 
In this study 16.1% of women reported an uro-gynaecological symptom and 3.6% 
were diagnosed with incontinence. Studies included in the systematic review report 
prevalence of incontinence as 1.0-4.7%. Our findings are comparable.  
However, there is little other information available on the incidence of incontinence 
in women in LMICs. Walker and Gunasekera (2011) find four studies of reproductive-
age women published between 1985 and 2010, in which the prevalence ranged from 
5-32%. Another systematic review calculates the mean pooled estimates for all types 
of incontinence during the first three months postpartum to be 33% for parous 
women and 29% for primigravida women (Thom 2010). Although the lead 
researchers of this paper attempted to obtain information for all countries, no papers 
from LICs were identified. 
Obstetric fistula is a well-recognised and documented condition resulting in the 
continuous loss of urine and/or faecal matter. In previous studies, continuous urinary 






incontinence has often been used to suggest vesico-vaginal fistula. A meta-analysis 
of the incidence of fistula in LMICs reported a pooled incidence of 0.09 (95% CI 0.01–
0.25) per 1,000 recently pregnant women (Alder 2013). Another meta-analysis of DHS 
data reported a lifetime prevalence of 3 cases per 1,000 women of reproductive age 
(95% CI 1.3–5.5) in sub-Saharan Africa (Maheu-Giroux 2015). In this PhD study, 0.33% 
of women reported continuous leakage of urine; these findings could be suggestive 
of vescio-vaginal fistula, but this may also represent an over-estimate. In this PhD 
study, women who reported continuous loss of urine did not have a methyl blue dye 
test performed to make a confirmed diagnosis.  
 
Comparison with studies that triangulated data  
There are few studies that have used clinical examination and investigations to 
triangulate data to aggregate measures, and to compare the summative findings of 
this PhD study with. 
 
In this study, the prevalence of summative physical morbidity is more, compared to 
the findings of Zafar et al who conducted a similar cross-sectional study to assess 
maternal morbidity in early pregnancy, late pregnancy and the postnatal stage 
among 3459 women in rural communities in Malawi (1732) and Pakistan (1727). In 
the study conducted by Zafar et al, 50.1% of women in Malawi and 53.0% of women 
in Pakistan were assessed to have at least one physical morbidity (infective or non-
infective). In this PhD study, 84.8% of women had physical morbidity in Malawi 
(43.7% infectious and 41.1% medical/obstetric); and 81.5% of women had physical 
morbidity in Pakistan (12.2% infectious and 69.3% medical/obstetric). 
 
Both infective (Pakistan) and non-infective morbidity (Pakistan and Malawi) was 
lower in the postnatal period than during pregnancy (Zafar 2015). These are similar 
findings to this PhD study, where overall (and in Malawi and Pakistan), the prevalence 
of physical morbidity, both infectious and medical/obstetric, was slightly more in the 
late antenatal stage. Very few women in this PhD study (1.2%) and less than 10%of 




women were identified to have multiple morbidities in the study conducted by Zafar 
et al (Zafar 2015).  
 
Variation in prevalence of physical morbidity  
In this PhD study, the overall prevalence of diagnosed physical morbidity was 76.4% 
women. This may be due to several possibilities. One reason may be because the data 
collection tool was very detailed and included extensive clinical examinations and 
investigations, more than any other study. As part of this PhD study, healthcare 
providers were trained that “if you don't ask for it or look for it, you won't find it” and 
this may have resulted in more detection of maternal morbidity.  
 
Another reason may be that this PhD study was conducted at the healthcare facility 
level and women may have sought care because they recognised that they had ill-
health. However, in these study settings, antenatal attendance is very common with 
women attending at least once in India (74%); in Pakistan (73%); in Kenya (94%) and 
in Malawi (95%) (WHO 2017c). Therefore, women recruited for this study were 
probably attending the healthcare facility for “routine care”. 
 
Another reason of the wide variations in the prevalence of physical morbidity is the 
way in which the morbidity is defined, described and measured. Different definitions 
are often used, different stages of pregnancy are assessed and are therefore non-
comparable across settings. Further studies, with more consistent and standardized 
classifications and methodological approaches are needed.  
 
8.6.4 Psychological Morbidity  
In the following section, the prevalence of psychological morbidity in this PhD study 
is compared to studies included in the systematic review and possible explanations 
for the variations are given at the end of this section. 
 
In this PhD study, psychological morbidity was assessed as part of the clinical history 
and depression (EDPS ≥10) was noted in 1 in 4 women (25.1%) with 15.2% of all 






women reporting thoughts of self-harm. Depression and self-harm were reported by 
more women in Pakistan, 47.3% and 29.8% respectively. The prevalence of 
depression in India was 19.8%, Malawi 16.4% and Kenya 13.5%. In India, Malawi, 
Kenya, 15.6%, 10.1 and 4.5% of women reported thoughts of self-harm respectively.  
 
In this PhD study, 47.3% of women in Pakistan and 16.4% of women in Malawi scored 
positive for depression. The finding of higher reporting in women in Pakistan as 
compared to women in Malawi, was similarly reported in the study by Zafar et al, 
where 25% and less than 5% of women reported symptoms of psychological 
morbidity in Pakistan and Malawi respectively (Zafar 2015). Zafar et al used the EDPS 
with a score of >9 to assess psychological morbidity in their study, whereas EDPS ≥10 
was used in this PhD study. 
Depression is a common cause of maternal ill-health, and many systematic reviews 
and meta-analyses have been conducted supported by large numbers of papers. 
However, a small proportion of these articles are from LMICs (Ngui 2010, Fisher 2016, 
Gelaye 2016).  In studies that have measured psychological morbidity as a component 
of maternal morbidity, the reported range of prevalence of depression ranges from 
13.5-39.5% and this finding is comparable to the 25.1% of women in this PhD study 
who scored EDPS ≥10.  
In Pakistan, Waqas et al conducted a cross sectional study in four teaching hospitals 
among 500 pregnant women in Lahore, and reported 31.8% of women were 
depressed, with 24.6% with borderline depression (Waqas 2015).  
 
In this PhD study, the prevalence of depression in India was 19.8%. This is in line with 
a study conducted by Nasreen et al, who report the prevalence of depression as 18% 
in a cross-sectional study among 720 pregnant women in rural communities in 
Bangladesh (Nasreen 2011), but is more than the 13.5% of women with high 
depressive symptoms (3–5 symptoms) from a secondary data analysis of a population 




based community trail among 39,000 married pregnant rural women in Bangladesh 
(Surkan 2017).  
 
In this PhD study, the prevalence of depression in women in Malawi was 16.4% and 
Kenya was 13.5%. Ukachukwu et al conducted a retrospective study of medical case 
notes among 1716 women to assess maternal morbidity in an urban hospital in 
Kenya, and reported psychological disorders constituted 5.3% of reported 
postpartum complications (Ukachukwu 2009). This rate is much less compared to the 
findings of this PhD study, and a limitation of this estimate is that information is only 
extracted from medical notes.  
 
In Zimbabwe, Shamu et al conducted a cross sectional study in six postnatal clinics in 
an urban setting among 842 woman who have given birth, and reported that one in 
five women 21.4% met the diagnostic criteria for postnatal depression 
symptomatology whilst 21.6% reported postpartum suicide thoughts (Shamu 2014).  
 
In Ethiopia, Wado et al conducted a prospective study among 622 pregnant women 
in rural communities and reported 20% of women assessed with depressive 
symptoms in pregnancy (Wado 2014). EPDS was not used. Tsai conducted a 
secondary data analysis of population based community study among 1328 pregnant 
women in South Africa and report at baseline assessment, 39.5% of women screened 
positive for depression using the EPDS (Tsai 2016). Wong et al conducted a cross 
sectional study among 625 HIV positive pregnant women in an urban setting in South 
Africa and reported 11% of women had EPDS scores suggesting probable depression, 
and 6% reported self-harming thoughts (Wong 2017). Faisal-Cury et al conducted a 
prospective study among 831 pregnant women attending antenatal clinics in primary 
care settings in Sao Paulo in Brazil. The prevalence of common mental disorders 
(anxiety and depression) ranged from 20.2% to 33.6% (Faisal-Cury 2010).  
 
In the following section, possible explanations for the variations in the reporting of 
the prevalence of psychological morbidity the studies described above as compared 
to this PhD study.  






Variations in prevalence of psychological morbidity  
There are many reasons for the variations in the reporting of the prevalence of 
psychological morbidity in this PhD study and the studies described above. It is 
thought that women in LMICs are more vulnerable to psychological ill-health due to 
contributing risk factors such as low socioeconomic status, unplanned pregnancies, 
and domestic violence, all of which can increase the likelihood of a woman 
developing psychological morbidity during or after pregnancy (Leigh 2008, 
Satyanarayana 2011).  
 
The reporting of a potentially sensitive subject such as depression and thoughts of 
self-harm depend on how screening questions are asked, by who, and what tool is 
used to assess symptoms. In the studies described above, there were several 
different definitions, screening questionnaires and data collection tools used to 
screen for symptoms suggestive of depression. Even when a standardised validated 
questionnaire was used, (for example, the EPDS), different cut-off scores were used 
to determine women at risk for depression. A systematic review of validation studies 
of the EDPS reported one challenge is the reported wide variety of cut-off points of 
the EDPS and highlighted that the EDPS may not be equally valid across all settings 
(Gibson 2009). These issues limit the accuracy and comparison of reported 
prevalence of depression.  
 
The stage of pregnancy (antenatal or postnatal) may contribute to the variation in 
the prevalence of psychological morbidity. Based three systematic reviews, these 
figures are estimated as 4.3%-25% of women during pregnancy; and 3.2%-48.0% of 
women following childbirth in LMIC (Sawyer 2010, Fisher 2012, Gelaye 2016). These 
results are in line with this PhD finding that depression was a significant problem 
along the continuum of pregnancy and women were not just “at risk” in the postnatal 
stage.  
 




A further difference in the reported prevalence of psychological morbidity is related 
to the study setting. For example, women may feel more at ease to share more 
information if there are alone in their own home, compared to at a busy secondary 
level healthcare facility. Previously, Zafar et al also suggested that the differences in 
prevalence of psychological morbidity may be in part to the way that data were 
collected; more private home setting in Pakistan compared to the more public less 
intimate, health centre in Malawi that could negatively affect disclosure (Zafar 2015). 
Zafar et al also suggested that women in Malawi are generally active in agricultural 
or other work and not confined to the home environment as much as women in 
Pakistan might be (Zafar 2015).  
 
Disclosure of potentially sensitive information by women is influenced by the degree 
of rapport, privacy, trust, confidentiality and time provided by the healthcare 
provider or data collector. The high reporting of psychological morbidity in this PhD 
may be because all data collectors were trained in respectful maternity care and good 
medical practice principles, to ensure a good rapport during the data collection 
process. Furthermore, all efforts were made by the research assistants to ensure that 
the face-to-face consultation, examination were almost always conducted in a 
private space and time was allocated.  
 
A further reason for the varied prevalence in psychological morbidity is that the 
understanding and possibly willingness to speak about “mental health and well-
being” varies between cultures and countries. For example, in Ghana psychological 
morbidity in women during and after pregnancy is considered a “spiritual issue” and 
women seek care from a religious leader as opposed to a healthcare provider (Ae-
Ngibise 2010). Zafar et al also suggested that in many African settings, admitting to 
problems or feelings of anxiety or worry may be associated with “wishing this upon 
oneself”. There are a variety of cultural and social practices and beliefs surrounding 
pregnancy which may contribute to or prevent anxiety and depression, as well and 
determine if and how a woman can express this (Zafar 2015). 
 






8.6.5 Social morbidity  
In this following section, the prevalence of social morbidity is described in relation to 
studies included in the systematic review in this thesis and possible explanations for 
the variations in the reporting of the prevalence of social morbidity is given at the 
end of this section.  
 
Domestic violence  
It is well recognised that domestic violence can often first occur, and increase in 
frequency and severity for women during and after pregnancy (McCauley 2017). 
Domestic violence occurs across all countries, cultures, religions, socioeconomic 
status and ages (WHO 2012b). In this PhD study, domestic violence as a component 
of social morbidity was assessed as part of the clinical history using the HITS 
questionnaires. In our study, overall 33.9% of women reported domestic violence 
(HITS score >4). This overall prevalence is in line with a recent WHO estimation that 
one in three women will suffering domestic violence during their lifetime worldwide 
(WHO 2012).  
 
In this PhD study, more women reported domestic violence in Pakistan (56.0%) and 
India (39.7%), compared to Kenya (21.7%) and Malawi (18.2%). Overall, domestic 
violence perpetrated by the husband (26.3%) was more commonly reported than 
from another family member (15.8%).  
The percentage of women who reported domestic violence perpetrated by the 
husband in India was (38.6%), Pakistan (37.4%), Kenya (18.3%) and Malawi (13.6%). 
More women reported domestic violence from family members in Pakistan (31.8%) 
compared to Malawi (12.5%), India (10.1%), and Kenya (6.0%).  These findings may 
reflect family living arrangements in these settings. For example, in Pakistan, it is 
common for women to live with their husband and his family, including all the in-law 
members of the family and it is recognised that domestic violence against pregnant 
women can be perpetrated from family members also (Ahmad 2005).  




In studies included in the systematic review, the prevalence of domestic violence 
ranged from 2.3-72.8% across different settings.  
Karmalini et al conducted a survey in an urban community in Hyderabad, Pakistan 
among 3324 pregnant women at 20–26 weeks gestation. In the six months prior to 
and/or during pregnancy, 51% reported experiencing verbal, physical or sexual 
abuse; and, 20% of women reported physical or sexual abuse alone. (Karmalini 2008). 
 
In Tanzania, 19% of ever-partnered, ever-pregnant women reported being physically 
assaulted during pregnancy by their partner (Stöckl 2010). Of those experiencing 
partner violence during pregnancy, 61% reported physical blows to the abdomen. In 
Rwanda, 35.1% of 600 women reported intimate partner violence in the last 12 
months (Ntaganir 2008). In Zimbabwe, 65.4% of 831 pregnant women reported any 
form of intimate partner violence (Shamu 2014). In South Africa, the prevalence of 
any intimate partner violence varied from 4.4–30.2% in a secondary analysis of 1328 
pregnant women (Tsai 2016). In Iran, 72.8% of pregnant women reported that they 
had experienced intimate partner violence during their last pregnancy (Hassan 2014). 
Substance use  
In this PhD study, overall 6.5% of women reporting using alcohol, sedatives. This was 
higher in India (2.7%) and Kenya (2.0%) compared to Malawi (1.7%) and Pakistan 
(0.2%). The trend of these findings is comparable to the national estimates of 
proportion of men and women who drink alcohol in India 5.0%, Kenya 4.4%, Malawi 
(2.4%) and Pakistan (0.2%) (World Health Stat 2015).  
 
Overall, 1.7% of women had an ASSIST score of >4 indicating that they would benefit 
from an intervention for substance use. More women scored an ASSIST score of >4 
in Malawi (2.8%), Pakistan (1.5%), Kenya (1.4%) compared to India (0.8%).  
 
Overall and per country, of all women who reported substance use, more than half 
did so in the early antenatal stage. There was not a large number (or variation in the 
percentage) of women who reported using any substances across the other four 






stages of pregnancy. This would suggest that women stop using these types of 
substances as the pregnancy progresses and this change in substance use continues 
in the postnatal stage (assessed up to 12 weeks after the end of the pregnancy). In 
the study, not clear if they change in substance misuse was sustainable over time, for 
example at one year postnatal.  
Only a few studies have included substance misuse as part of an assessment of 
maternal morbidity. In a secondary data analysis of a database of 34,090 women, the 
proportion of women reporting alcohol consumption during pregnancy decreased 
from was 21.5% in 2010 (Isaken 2015). In South Africa, among 625 women initiating 
anti-retroviral treatment, 16% reported risky alcohol use and 21 % alcohol-related 
harm (Wong 2015).  
Variation in the prevalence of social morbidity  
The reason for the wide variation in the reported prevalence of social morbidity may 
be in line with the reasons for the variation in physical and psychological morbidity. 
In all types of morbidity, different definitions and different data collection tools are 
used to measure maternal morbidity at different stages of pregnancy in different 
settings.  
 
With regards to social morbidity, for example, some studies assessing domestic 
violence included emotional abuse and others report on physical assault only; and 
some studies use the index pregnancy and others depend on recall of domestic 
violence in previous pregnancies. 
 
  




8.6.6 Factors associated with maternal morbidity  
In this PhD study, on multivariate analysis, age, socioeconomic status, educational 
level, number of previous pregnancies, and/or adverse maternal or neonatal 
outcomes in the most recent pregnancy were not associated with the same type of 
maternal morbidity across all four LMIC.  
 
Different factors were associated with different types of morbidity per country but 
there was no consistent direction of strength of association.  
 
It is difficult to compare the findings of the associations with and between maternal 
morbidities in this PhD study and other studies that have assessed two or more types 
of maternal morbidity.  
 
Assarag et al reported that women who were aged ≥30 years, employed, belonged 
to highest socioeconomic class, and had obstetric complications during birth or 
delivered in a private facility or at home were more likely to report a physical 
complaint postnatally in Morocco (Assarag 2013). Zafar et al reported that 
complications during a previous pregnancy, infective morbidity (p <0.001), intra or 
postpartum haemorrhage (p <0.02) were associated with psychological morbidity in 
rural communities in Malawi and Pakistan (Zafar 2015).  Wong et al reported that 
younger women reported more depressive symptoms. Reports of self-harming 
thoughts was 11 % in younger and 4 % in older women (p = 0.002) (Wong 2017).  
Stöckl et al reported that in a study in Tanzania, domestic violence was significantly 
associated with adverse maternal health behaviours and outcomes, including 
drinking during pregnancy, and having an adverse neonatal outcome (Stöckl 2010).  
It is difficult to compare to the strength of associations between different types of 
maternal morbidities in this PhD study and other studies described above due to 
different definitions, data collection tools and methodology used.  
 






8.6.7 Association between different types of maternal 
morbidity  
Associations between different types of maternal morbidity was assessed using 
two-way and three-way interactions per country.  
In this study, there were associations between the different types of morbidity and 
these associations varied between the countries.  
For each country, women with medical/obstetric morbidity was more likely to report 
psychological and infectious morbidity, apart from Malawi where the association 
between medical/obstetric and psychological morbidity was negative.  
Women with an infectious morbidity were more likely to report medical/obstetric, 
psychological and social morbidity in both Pakistan and Malawi. Women with 
psychological morbidity were more likely to report social morbidity in Pakistan and 
Kenya. 
These findings suggest that the different components of maternal morbidity 
(physical, psychological and social aspects) are inter-linked and have an influence on 
the other components of health. However, the strength of the association between 
the different types of morbidity vary across settings.  




8.7 Implications of findings and recommendations  
In this chapter so far, an overview of the study has been given, results have been 
summarised in sequence and relative to each research question and the strengths 
and limitations of the study have been described. The results of the study have been 
linked to relevant research and any differences in results have been discussed. 
 
 In this section, implications of the findings for clinicians and policymakers, and 
implications for research are discussed. Recommendations for clinicians and for 
future research are given at the end of this section.  
 
8.7.1 Implications for clinical practice and policy  
In this study, comprehensive assessments of maternal morbidity have been carried 
out in a variety of settings across four LMIC to measure maternal morbidity. This 
study provides primary data regarding women’s physical, psychological and social 
morbidity during and after pregnancy. Despite women reporting that they have a 
good quality of life and are satisfied with their health, there is evidence of a significant 
burden of ill-health (including infectious, medical/obstetric, psychological, and social 
morbidity) in women during pregnancy and up to 12 weeks postnatal. 
 
Globally, women are increasingly accessing antenatal care. At least 77% of women 
access antenatal care at least once in sub-Saharan Africa and Southeast Asia in 2015 
(WHO 2017c). More women are also accessing postnatal care (WHO 2017c). This PhD 
study suggest that there is currently a large burden of ill-health that is currently not 
detected in women during and after pregnancy. As women increasingly seek care at 
healthcare facilities, this represents a missed opportunity for healthcare providers 
working in LMIC, who are in a unique position with the potential to provide good 
quality care for women.  
 
In this study, a standardised model and criteria for assessment of maternal morbidity 
was applied in both primary and secondary level care settings alongside routine 
existing antenatal and postnatal care packages. This study shows that in principle, it 






is feasible and acceptable for healthcare providers in these settings to screen women 
for different types of ill-health during routine healthcare consultations using 
validated questions and point-of-care rapid diagnostic investigations that can be 
applied in low resource settings. The low refusal rate in this study suggests that 
women attending for care at primary and secondary level healthcare facilities in these 
study settings welcome such an assessment of their health. 
 
Overall, women report good quality of life and satisfaction with health, despite 
having a detectable morbidity on further screening. This finding would suggest that 
even if women self-report that they are “satisfied with their current health”, it is 
useful for healthcare providers to take the time to conduct a full systematic 
assessment of a women including full history, examination and basic investigations.  
 
Physical morbidity can be described or measured in different ways; for example, 
number and severity of self-reporting symptoms compared to number of abnormal 
examinations and investigations detected by a healthcare provider. An agreed 
classification of key physical maternal morbidities would be useful in a clinical setting. 
 
Anaemia and early infection represent a significant burden of ill-health. The definition 
and measurement of infection and sepsis, and the accuracy of SIRS criteria to 
diagnosis possible early infection requires further evaluation in LMIC. 
 
Simple diagnostic technology such as a battery operated Hemocue® to measure 
haemoglobin and urine dipsticks to measure proteinuria can be made available in 
these settings. In endemic areas, all women can be screened for HIV, malaria, syphilis 
using rapid diagnostic testing. This type of rapid diagnostic testing requires minimal 
infrastructure and equipment should be made available in these settings.  
 
There are important differences among the four countries (the much higher 
prevalence of HIV and malaria in Malawi and the much higher prevalence of 
psychological and social morbidity in Pakistan). Antenatal and postnatal care 




packages will need to be adapted as per country specific contexts burden of disease 
priorities.  
 
Currently, psychological morbidity is not screened for in most LMIC settings as part 
of routine antenatal or postnatal care. In our study 1 in 5 women reported to have 
psychological morbidity throughout the continuum of pregnancy and not just in the 
early postnatal stage. This PhD study shows that psychological morbidity represents 
a burden of ill-health. There is a need, not only to introduce screening, but also to 
provide appropriate management for psychological morbidity as a component of 
antenatal and postnatal care.  
 
As a component of social morbidity, domestic violence is significant problem for 
women during and after pregnancy in these study settings. Domestic violence is 
considered a taboo subject in many countries, resulting in a hidden burden of ill-
health in women. Healthcare providers in the antenatal clinic are likely to be the first 
professional contact that women experiencing domestic violence will encounter 
during her pregnancy (NICE 2015).  
 
WHO have produced clinical and policy guidelines on how to respond to women who 
report domestic violence during and after pregnancy, including identification, safety 
assessment and planning, communication and clinical skills, documentation and 
provision of referral pathways (WHO 2016). However, the WHO antenatal guidelines 
recommend that screening for domestic violence depends on the context. The 
current recommendation is that clinical enquiry about the possibility of domestic 
violence should be strongly considered at antenatal care contacts when assessing 
conditions that may be caused or complicated by domestic violence to improve 
clinical diagnosis and subsequent care, where there is the capacity to provide a 
supportive response (including referral where appropriate) and where the WHO 
minimum requirements are met (WHO 2016). 
 
The feasibility of implementation and acceptability of this recommendation for as a 
routine component of antenatal care packages across LMIC has been uncertain (WHO 






2016). Furthermore, the WHO antenatal guideline does not make a reference to 
domestic violence from other members of the family, apart from the partner. This 
PhD study shows that it is feasible for healthcare providers to ask women four 
questions to assess the level of domestic violence from both the partner/husband 
and/or family members during a routine antenatal or postnatal care consultation.  
 
There is a however need to explore potential interventions that can be integrated 
and implemented for women who report domestic violence from their partner 
and/or family members during and after pregnancy across different settings and 
LMIC.  
 
In this PhD study, substance use was not commonly reported in women during and 
after pregnancy in these settings. The WHO antenatal guidelines recommend that all 
women should be screened for substance use during pregnancy and that healthcare 
providers are advised to should ask all pregnant women about their use of alcohol, 
tobacco and other substances (past and present) and as early as possible in the 
pregnancy and at every antenatal care visit (WHO 2016). This PhD study would 
suggest that screening for substance misuse is less important in LMIC settings, 
compared to psychological and domestic violence screening. There may need to be a 
re-consideration of what is necessary and what is context specific on the basis on this 
PhD findings.  
 
Routine screening for psychological and social morbidity  
The detrimental impact of psychological and social morbidity on the overall health 
and well-being of mothers (and their babies) during and after pregnancy has resulted 
in public health policy in high income countries such as the United Kingdom (UK), 
where screening of depression and domestic violence is routinely conducted during 
and after pregnancy.  
 




In many high-income countries, specially trained midwives routinely assess, screen, 
support and provide further referral for women with psychological and social 
morbidity (NICE 2015). There is debate as to the cadre of healthcare providers most 
suitable to undertake routine screening for and manage psychological and social 
morbidity in LMIC (Rahman 2013, Gureje 2015). This study shows that with support 
and training, it is feasible and acceptable for the cadres of healthcare providers 
already providing routine antenatal and postnatal care in LMIC (nurse-midwifes, 
medical officers and doctors), to ask screening questions regarding psychological and 
social morbidity for women during and after pregnancy in these study settings. 
 
8.7.2 Implications for research  
In this section of the chapter, challenges and unanswered questions are discussed. At 




This study was carried out in public healthcare facilities in India, Pakistan, Kenya and 
Malawi and the findings cannot be assumed to be the same in other settings. There 
is a need to assess the views of community based women during and after pregnancy 
who may have different types of maternal morbidity. Their assessment of maternal 
morbidity would be important to understand their specific health needs and inform 
what aspects of antenatal and postnatal care are required in the community setting. 
 
Perception of health  
Overall, women report good quality of life and satisfaction with health, despite many 
women having at least one form of morbidity. There is a need for qualitative research 
to enable a better understanding of what women, their families and their healthcare 
providers consider to be maternal morbidity and to understand the cultural context 
of how women report and describe ill-health. 
 






Data collection tool for measurement of maternal morbidity 
There is a need for an internationally accepted and user-friendly data collection tool 
that can be used to measure maternal morbidity in a comprehensive and holistic 
manner. The data collection tool used in this study is lengthy and could be adapted 
and shortened for use: (1) in a clinical setting and (2) as a research tool to measure 
maternal morbidity (as an outcome measure). There is a need to refine and condense 
the current data collection tool, and to build expert consensus regarding the inclusion 
and weight given to each key variable. There is a need to explore whether 
discriminant analysis can be used to identify what variables should be included in the 
data collection tool to develop a more concise but still representative and composite 
maternal morbidity assessment tool and score. Further research is required to assess 
the applicability of this score as a health outcome measure and a strategic and 
programmatic key performance indicator in different health systems both in a clinical 
and research capacity.  
 
Routine screening for psychological and social morbidity  
In this PhD study, many healthcare providers screened women for psychological and 
social morbidity. However, screening for psychological and social morbidity is not 
part of routine maternity care in many LMIC settings. The establishment of such 
services requires the prioritisation of available resources and a change in the 
attitudes and practices of healthcare providers (McCauley 2017).  
 
The WHO have produced clinical and policy guidelines on how to screen and manage 
psychological and social morbidity during and after pregnancy (WHO 2013c). 
However, the feasibility of implementation and acceptability of such guidance in care 
packages in public healthcare facilities in LMIC, such as India, Pakistan, Kenya and 
Malawi are currently uncertain. There is a need to investigate knowledge, attitudes 
and perceptions regarding psychological and social morbidity during and after 
pregnancy among healthcare providers that provide routine maternity care across 
LMIC. In addition, further research regarding enabling factors and barriers to the 




provision of psychological and social morbidity, potential management options, and 
how to translate these recommendations into clinical practice would be beneficial. 
There is a need to explore how best to educate healthcare providers, women and the 
wider community about psychological and social morbidity in women during and 
after pregnancy. Future research is required to assess a shortened version of the 
EPDS or other types of shorten screening questions for psychological ill-health. A 
remaining challenge is lack of cross-culturally valid perinatal depression screening 
and diagnostic tools. There is a clear need to develop, refine and rigorously evaluate 
the predictive validity and reliability of depression assessment tools for women 
during and after pregnancy in LMIC.  
 
There is a need to further understand how psychological and social morbidity is 
experienced and understood within cultural contexts of LMIC to inform culturally and 
contextually appropriate interventions (McCauley 2017). The further development 
and implementation of culturally appropriate guidelines and interventions would be 
beneficial and result in better quality of maternity care. 
 
  






8.8 Recommendations for clinicians and policy makers  
 
1. Maternal morbidity represents a significant burden of ill-health and should 
not be ignored by clinicians and policy makers. 
 
2. There is a need for increased screening and management of physical, 
psychological and social morbidity during and after pregnancy.  
 
3. There is a need for an internationally agreed screening tool for maternal 
morbidity, including all components of physical, psychological and social 
morbidity, for use at different stages during and after pregnancy.  
 
4. It would be useful to reach agreement on a narrower definition of maternal 
morbidity mirroring that of maternal mortality and SAMM (e.g. limiting the 
timeframe in first instance to 42 days after the end of the pregnancy). This 
would enable more accurate comparisons across settings.  
 
5. There is a need to review and develop the content of current antenatal and 
postnatal care packages in LMIC and adapt these to ensure that care given is 
comprehensive and covers a woman’s physical, psychological and social 
health needs.  
 
6. Currently there is good coverage and uptake of antenatal care but content 
needs to be adapted to ensure good quality comprehensive care that is 
respectful, integrated and delivers physical, psychological and social care. The 
new WHO guidelines recommend that a woman should be reviewed eight 
times during her pregnancy. The emphasis seems to be on the frequency of 
visits with the aim to prevent neonatal complications. However, women need 
to be cared for in a holistic and comprehensive way and receive good quality, 
respectful maternity care at each contact. This implies the need to expand the 




content of current antenatal packages, with an agreed minimum content and 
agreed country specific additional content.  
 
7. Currently, there is poor uptake of postnatal care at healthcare facility and 
poor content of postnatal care packages. The provision of comprehensive 
postnatal care needs to link with the community and healthcare facility and 
focus on both the women and her baby together in an integrated way. There 
has been much focus in the postnatal stage to prevent neonatal mortality but 
there needs to be a renewed emphasis on both the general health and well-
being of a woman and her baby together.  
 
8. Despite women reporting that they are “satisfied with their health”, 
healthcare providers should still take the time to ask screening questions 
regarding symptoms and perform clinical examinations and basic 
investigations during and after pregnancy.  
 
9. Possible infection represents a burden of ill-health and all women should have 
basic observations performed at each contact during and after pregnancy, 
including pulse rate, respiratory rate, temperature to assess for possible early 
signs of infection. If facilities are available, a white cell count should be 
performed to apply the SIRS scale for possible early infection. 
 
10. Simple diagnostic technology such as a battery operated Hemocue® to 
measure haemoglobin and urine dipsticks to measure proteinuria should be 
made available in all settings to aid detection of physical morbidity. 
 
11. In endemic areas, all women can be screened for HIV, malaria, syphilis using 
rapid diagnostic testing.  
 
12. Rapid diagnostic testing for tuberculosis, Hepatitis B would be beneficial and 
should be incorporated in the data collection tool.  
 






13. There is a need for women to be screened for psychological morbidity at least 
one stage during pregnancy and after childbirth. The women should be 
counselled and asked to contact a healthcare provider if they notice a change 
in their symptoms regarding possible psychological morbidity. 
 
14. There is a need for women to be screened for domestic violence (perpetrated 
from a husband/partner and family members) at least one stage during 
pregnancy and after childbirth. The women should be counselled and asked 
to contact a healthcare provider if their circumstances change and they need 
help due to domestic violence.  
 
15. The number of times a woman needs to be screened for psychological and 
social morbidity during and after pregnancy needs further evaluation. 
 
16. There is a further need to explore potential interventions (counselling, 
support groups, educational material, legal advice) that can be integrated and 
implemented for women who report domestic violence from their partner 
and/or family members during and after pregnancy across different settings 
and LMIC.  
 
17. There is a need for increase in the capacity of healthcare providers with 
further education (and legal support) to enable healthcare providers to 
routinely screen for and manage psychological and social morbidity in 
different settings in LMIC.  
 
18. There is a need to increase services available to ensure health system 
readiness with appropriate management, referral systems for use when 
physical, psychological and social morbidity is detected.  
 




19. There is a need to shorten and adapt the data collection tool into a “maternal 
morbidity score” that can be used as an indicator to determine woman’s ill-
health and identify her health needs during and after pregnancy.  
 
 
8.9 Recommendations for research  
 
1. Maternal morbidity as a concept should be developed and used as an 
“outcome” evaluation measurement in maternal health interventions. 
 
2. There is a need to conduct a longitudinal observational study to assess if and 
how maternal morbidity changes over time during the continuum of 
pregnancy and after childbirth.  
 
3. There is a need to implement improved evidence-based antenatal and 
postnatal care packages. The findings from this PhD study can be used to 
inform and design targeted, effective antenatal and postnatal care packages 
effective to provide comprehensive care in a way that meets a woman’s 
health needs.  
 
 
4. There is a need to understand how infection and sepsis is defined and 
measured in women in LMIC during and after pregnancy. The use of SIRS 
criteria as an early warning score for possible infection requires further 
research. Furthermore, adapted SIRS criteria using CRP instead of WCC need 
further evaluation. 
 
5. There is a need to understand how best to screen and diagnose women for 
tuberculosis during and after pregnancy (for example, comparing the 
symptoms of productive cough for more than two weeks with microscopy 
and/or use of rapid diagnostic testing such as GeneXpert (WHO 2011c).  
 






6. There is a need to conduct a step wedge design study to assess whether the 
implementation of an intervention of improved evidence based 
comprehensive antenatal and postnatal care packages result in improved 
women health outcomes, in addition to the health of the newborn baby.  
 
7. There is a need to understand how healthcare providers can be best 
supported and enabled to provide comprehensive improved antenatal and 
postnatal care packages, beyond the provision of basic emergency care, that 
includes physical, psychological and social health assessment and 
management during and after pregnancy. 
 
8. There is a need for qualitative research to enable a better understanding of 
what women, their families and their healthcare providers consider to be 
maternal morbidity and to understand the cultural context of how women 
report and describe ill-health. 
 
9. Further research is required to assess how best clear effective referral 
pathways and support for women who report physical, psychological and 









CHAPTER 9: CONCLUSION  
9.1 Summary  
Despite women reporting that they have a good quality of life and are satisfied with 
their health, there is evidence of a significant burden of ill-health (including 
infectious, medical/obstetric, psychological, and social) in women during pregnancy 
and up to 12 weeks postnatal. Even though many women access care during 
pregnancy across LMIC, at present the available antenatal and postnatal care 
packages do not include comprehensive screening for all forms of ill-health. The focus 
till now has largely been on detection and prevention and treatment of HIV, malaria, 
and syphilis and on emergency preparedness for birth. Although laboratory screening 
for anaemia is advised, this is rarely implemented. Screening for psychological or 
social ill-health rarely happens. Furthermore, treatment pathways for women who 
do have identified health needs are often not in place or of very poor quality.  
 
This study demonstrates that women have health needs, beyond simply the physical 
aspects of health and includes psychological and social well-being. To support the 
current international priority that all women have the right to the highest attainable 
standard of health and well-being, current antenatal and postnatal care packages 
need to be adapted and improved to provide comprehensive, holistic care in a way 
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Appendix 1: Summary Table 1: reporting included studies, study design, country, setting, 
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Appendix 2: Summary Table 2: Included studies, data collection tools, types of maternal 
morbidity measured.  
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Appendix 3: Reasons for exclusion of papers at full text stage 
data extraction for the systematic review 
 
Reason for exclusion at full text  Number of papers 
excluded 
The outcome of interest was gynaecology 
conditions in a non-pregnant population 
12 
The outcome of interest was severe acute 
maternal morbidity  
2 
The outcome of interest was neonatal morbidity 
and not related to maternal morbidity 
2 
The outcome of interest was the health systems  1 
The outcome of interest was one maternal 
morbidity condition only 
6 
TOTAL  23 
 


































































































2 1 1 1 1 2 1 2 1 1 1 2 16 
2. Brittain 
2017 
1 1 1 1 1 1 1 1 1 1 1 1 12 
3. Chersich 
2009 












1 1 2 1 1 1 1 1 1 1 1 1 12 
7. Isaksen 
2015 
2 1 2 1 1 2 1 1 1 1 1 1 15 
8. Hassan 
2014 
1 1 1 1 1 1 1 1 1 1 1 0 11 
9. Hanlon 
2009 
1 1 0 1 1 0 1 1 1 1 1 1 10 








2 1 2 1 2 2 1 1 1 1 1 1 15 
11. Natasha 
2015 




2 1 2 1 2 2 1 1 1 1 1 1 15 
13. Prost 
2012 




1 1 1 1 1 0 0 1 1 1 1 0 9 
15. Rees 
2016 
2 1 2 1 1 2 1 2 1 1 1 2 17 
16. Shamu 
2014 
1 1 2 1 1 1 1 1 1 1 1 1 12 
17. Shamu 
2016 
1 1 2 1 1 1 1 1 1 1 1 1 12 
18. Stewart 
2014 
1 1 1 1 1 0 1 1 1 1 1 1 10 
19. Stöckl 
2010 
1 1 1 1 1 0 1 0 1 1 1 0 9 
20. Surkan 
2017 
2 1 2 1 1 1 1 1 1 1 1 1 13 
21. Tsai 
2016 




1 1 2 1 1 1 1 1 1 1 1 1 12 
23. Wado 
2014 
1 1 1 1 1 0 1 1 1 1 1 1 10 
24. Waqas 
2015 
1 1 1 1 1 0 1 0 1 1 1 0 9 






1 1 1 1 1 1 1 1 1 1 1 1 11 
26. Zafar 
2015 
2 1 2 2 1 2 1 2 1 1 1 2 18 
 
Adapted from Critical Appraisal Skills Programme (CASP 2015) 
*Variable of quality  Score per variable  
 No 0 
Yes -to an extent  1 
Yes-fully 2 
 
*Quality of study Score per variable  
Low <10 
Medium 10-17 













Appendix 5:  Details of papers excluded from systematic review  
 
Table A:  Details of excluded studies due to sample size <500 women including descriptions of study design, 
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Table B:  Excluded studies due to sample size < 500 women, with details of data collection tools, types of maternal 
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Appendix 6: Data collection tool  
 
The following section contains the paper version of the data collection tool that was 
used in the antenatal stages in Malawi. For India, Pakistan and Kenya, this data 
collection tool was formatted onto iPads® for electronic data collection. For women 
in the postnatal stages, all obstetric questions were not asked.  
 
  









































































Appendix 7: Training timetable for the maternal 
morbidity study research team 
Time Activity Mode 
8.15 -
9.00 
Registration   
9.00 - 
9.10 
Welcome and introductions 
Getting to know each other 




Training objectives and outline  Short presentation  
9.20 -
9.40 
Session 1: Introduction to the study  





Session 2: Obtaining informed consent 
- The participant information sheet  
- How to administer the participant 
information sheet 
- Signing the consent form 
Interactive lecture 







Session 3: Introduction to the maternal 
morbidity data collection tool 
Electronic data collections 
Explanation of each sections of the 
questionnaire 
How to navigate the questionnaire 
 
Interactive lecture 
Demonstration of the use of 





Session 4: Role play using 
questionnaire 
Obtaining consenting  
Administering the electronic 
questionnaire using the hand-held 
device 
Participants practice how to 
obtain consent and conduct a 
practice interview using the 




Lunch   
14.00 -
15.00  
Session 5: Feedback from group work 
on consenting and administering the 
tool. 
Plenary 




Session 6: Practice of data entry into 
electronic questionnaire 
Participants practice how to 
obtain consent and conduct a 
practice interview using the 
questionnaire in pairs with a 
facilitator observing. 
16:45 Summary of day one   
 






Time Activity Mode 
8.15 -
9.00 
Registration   
9.00 -
13.00 
Session 1: Standards of examination and 
completion of questionnaires 
Details of examination  
Simultaneous data entry into hand held 
devices 
Demonstration of obtaining 
blood samples 
Each data collector to 
demonstrate competency 
in examination  
13.00 -
14.00 
Lunch   
14.00 -
15.00 
Session 2. Introduction of the test kits 
and details of how to perform 
investigations 
- Details of each test kit 
- Practice conducting urine and blood 
investigations 
- Simultaneous data entry into hand 
held devices 
Interactive lecture 
Actual demonstration and 




Session3: Data management and 
logistics 
- Logistics of the use of hand held 
devices 
Monitoring and evaluation 
- Password protection 
-Storage of information 









Time Activity Mode 
8.15 -
9.00 
Registration and briefing for pilot study  
9.00 -
13.00 
Conduct pilot study under supervision - Field work at 
selected facility 





- Face to face interviews 
- Conducting basic examinations 





- Aim to conduct full 
interview, 
examination for 
one patient for 
each data collector  
13.00 -
14.00 
Lunch   
14.00 -
15.30  
Feedback from the pilot  - Plenary  










Time Activity Mode 
8.15 -
9.00 




- How to give feedback 
- Practice giving feedback for:  
➢ Face to face interviews 
➢ Conducting basic examinations 
➢ Simultaneous data entry into 
hand held device 
• Details of changes to 
questionnaires 
• In depth discussion of each item 
on questionnaire  
- Lecture theatre  




Research assistants -ongoing piloting  1 case each 
 
  






Appendix 8: Consent form  
Participant Identification Number for this Study:  
1. I confirm I have read and understood the information sheet dated 
….../….../...... for the above study. 
Yes [  ]  No [  ] 
2. I have had the opportunity to consider the information, ask questions and 
have had these answered satisfactorily.  
Yes [  ]  No [  ] 
3. I understand that participation in this study is voluntary and I am free to 
withdraw consent at any time, without giving a reason, without any 
penalties.  
Yes [  ]  No [  ] 
4. I understand that data collected during the study, may be looked at by 
individuals from LSTM and from regulatory authorities. I give permission for 
these individuals to have access to my records.  
Yes [  ]  No [  ] 
5. I hereby declare that I have not been subjected to any form of coercion in 
giving this consent. 
Yes [  ]  No [  ] 
6.  I voluntarily agree to take part in this study.  
Yes [  ]  No [  ] 
Signing this declaration does not affect your right to decline to take part in any future 
study. 
 
Name of participant   Date   Signature or thumb print 
 
 
Name of person obtaining   Date   Signature  





Appendix 9: Information sheet   
You have been contacted to participate in this study entitled, Assessing Maternal 
Morbidity.  
We are very interested to hear about your health and experiences during your 
current pregnancy and period after childbirth.  
Purpose The purpose of this study is to learn about conditions that affect women 
while pregnant, during labour and delivery or within three months of childbirth which 
may not be life-threating but could be a source of worry and discomfort to them.  
Procedure During the study, you will be asked questions about some of the problems 
related to your pregnancy or childbirth or postnatal period. Afterwards a trained 
health care provider will examine you for any pregnancy or childbirth related 
problems taking care to avoid discomfort to you as much as possible.  
As part of the physical examination, your height, weight and measurement of your 
pulse, blood pressure, and temperature will be taken. Your breasts and abdomen will 
be examined to find out any swelling, pain or infection. Depending on your 
symptoms, you may be offered an internal vaginal examination, only if this will help 
determine any ill-health.  
You will be asked to provide a urine sample which will be checked for infection and 
the presence of protein and sugar that may suggest you may have a problem related 
to high blood pressure or diabetes. You will be asked if you are willing to have a simple 
blood test (finger prick test). This will be used to test your haemoglobin level. In 
addition, we would like to be able to check your blood for infections which could 
affect you and your baby. These include malaria, syphilis and HIV. We will go through 
the details of the implications of each of these tests prior to taking the blood.  
Risks The interview will last 45-60 minutes. The physical examination procedure is 
very short and simple. Blood collection will be by a trained person taking all necessary 
precautions to avoid harm to you. All information obtained from you will be kept 






private and will be strictly used for this study only. Overall, we expect this 
consultation to take around 90 minutes. 
Benefits If during this assessment, it becomes clear that you have a health problem, 
we will provide you information about where and how to seek care for this.  
Privacy We will keep all your data private. We will use an identity number for you, so 
your name and address will never be mentioned anywhere in any form. No one will 
have access to the data other than the study staff. Data obtained from you will be 
used only for the study and your name will not be reported in any publication in the 
future.  
Voluntary participation Your participation in this interview and physical examination 
is completely voluntary. You have the right to refuse to participate at any time during 
the interview. You can also refuse to respond to specific questions or answer 
questions but not take part in the clinical examination if you choose. Finally, although 
the investigation of urine and blood will help us understand whether your health is 
in order or not -you can still participate in the first part of the study but decline to 
have any of these tests carried out.  
Right of the participant Please feel free to ask any questions you have about the 
interview, clinical examination and investigations planned at any stage. If you have 
any additional questions or questions that cannot be adequately addressed now, you 
can also contact the lead investigator of this study at this health care facility.  
Complaints If you have a concern about any aspect of this study, you should ask to 
speak to the local research leader who will do their best to answer your questions. If 
you remain unhappy and wish to complain formally, you can do this through the head 
of the department of this healthcare facility who have given us permission to conduct 
this study. You can also contact the local research committee, details of which can be 
obtained from the local research team.  
 




If you agree, we would like to interview you, and conduct the physical examination 
and collect blood and urine sample from you.  
 
Do you agree to participate? 
  
[  ] Tick box if agreed to participate in the study-interview.  
[  ] Tick box if agreed to participate in the study-clinical examination. 
[  ] Tick box if agreed to participate in the study-urine and blood tests.  
[  ] Tick if not agreed to participate in the study    
 
If participant not wishing to participate, thank her for her time and end here. 
Please document on the daily record form why the woman has refused to participate.  
If the participant wishes to participate in any part of the study, ask her to sign below 
and thank her for participating. 
 
_______________________________________    _________________ 
Signature or thumb print of women    Date     
